UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM N-CSR

 

 

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file Number: 811-07470

 

 

CARILLON SERIES TRUST

(Exact name of Registrant as Specified in Charter)

 

 

880 Carillon Parkway

St. Petersburg, FL 33716

(Address of Principal Executive Office) (Zip Code)

 

 

Registrant’s Telephone Number, including Area Code: (727) 567-1000

SUSAN L. WALZER, PRINCIPAL EXECUTIVE OFFICER

880 Carillon Parkway

St. Petersburg, FL 33716

(Name and Address of Agent for Service)

 

 

Copy to:

KATHY KRESCH INGBER, ESQ.

K&L Gates, LLP

1601 K Street, NW

Washington, D.C. 20006

 

 

Date of fiscal year end: October 31

Date of reporting period: April 30, 2022

 

 

 

 


Item 1. Reports to Shareholders

(a) The registrant’s Semiannual Report for the six-month period ended April 30, 2022, which was transmitted to shareholders pursuant to Rule 30e-1 under the Investment Company Act of 1940, as amended (the “Investment Company Act”), is as follows:

 


LOGO

CARILLON FAMILY OF FUNDS
Carillon Mutual Funds
Semiannual Report
for the six-month period ended April 30, 2022 (unaudited)
Equity Funds
Carillon ClariVest Capital Appreciation Fund Carillon ClariVest International Stock Fund Carillon Eagle Growth & Income Fund Carillon Eagle Mid Cap Growth Fund Carillon Eagle Small Cap Growth Fund Carillon ClariVest International Fund Carillon Scout Mid Cap Fund Carillon Scout Small Cap Fund
Fixed Income Funds
Carillon Reams Core Bond Fund Carillon Reams Core Plus Bond Fund Carillon Reams Unconstrained Bond Fund
880 Carillon Parkway | St. Petersburg, FL 33716 | 800.421.4184 | carillontower.com
Not FDIC insured May Lose Value No Bank Guarntee
Carillon Fund Distributors, Inc. , Member FINRA


Table of Contents

 

President’s Letter1
Investment Portfolios
Carillon ClariVest Capital Appreciation Fund2
Carillon ClariVest International Stock Fund3
Carillon Eagle Growth & Income Fund5
Carillon Eagle Mid Cap Growth Fund5
Carillon Eagle Small Cap Growth Fund7
Carillon ClariVest International Fund8
Carillon Scout Mid Cap Fund 10
Carillon Scout Small Cap Fund12
Carillon Reams Core Bond Fund14
Carillon Reams Core Plus Bond Fund17
Carillon Reams Unconstrained Bond Fund21
Statements of Assets and Liabilities25
Statements of Operations28
Statements of Changes in Net Assets 31
Financial Highlights34
Notes to Financial Statements44
Understanding Your Ongoing Costs59
Amendments to Investment Advisory and Subadvisory Agreements61
Principal Risks65

 

LOGO

 

Visit carillontower.com/eDelivery to receive shareholder communications including prospectuses and fund reports with a service that helps protect the environment:

Environmentally friendly. Go green with eDelivery by reducing the number of trees used to produce paper.

Efficient. Stop waiting on regular mail. Your documents will be sent via email as soon as they are available.

Easy. Download and save files using your home computer with a few clicks of a mouse.


President’s Letter

 

Dear Shareholders:

I hope this letter finds you and your loved ones healthy. The semiannual report of the Carillon Family of Funds for the six-month period ended April 30, 2022, follows.

News headlines—including war in Ukraine; ongoing worldwide supply-chain issues; central banks trying to navigate inflation challenges; and new COVID-19 strains even with vaccination programs - appear to have weighed on global equity and fixed-income markets. Persistently elevated volatility coupled with inflationary and growth worries has weighed on investor sentiment, which hit the lowest levels since 2008. Despite these challenges, your fund family has continued to work efficiently and effectively on your behalf amid shifting market dynamics.

Beneath the surface, there has been increased dispersion between geographies, market capitalizations, and within individual sectors and industries. U.S. equities once again outperformed Europe and Asia while smaller market capitalization companies have continued to lag larger companies. Value stocks have also meaningfully outperformed growth stocks amid a backdrop of rising rates and an increased focus on valuation. However, all of these cross currents have created long-term opportunities for our investment management teams.

The pace of change continues to be rapid, reinforcing the need for investors to focus on long-term goals and plans. We see opportunity in the current market environment for our research-driven investment managers and their actively managed

strategies. We believe that Carillon’s diverse array of funds, spanning small-cap, mid-cap, large-cap, and international equities, as well as fixed income, can help investors navigate current conditions and build toward long-term plans.

As with all investments, investing in any mutual fund carries certain risks. The principal risk factors for each fund are described at the end of this report. Carefully consider the investment objectives, risks, charges and expenses of any fund before you invest. Contact us at 800.421.4184 or carillontower.com or call your financial professional for a prospectus, or summary prospectus, which contains this and other important information about the Carillon Family of Funds. Read the prospectus, or summary prospectus, carefully before you invest or send money.

We are grateful for your continued support of the Carillon Family of Funds and hope we can continue to be a partner in helping you achieve your financial goals.

Sincerely,

 

LOGO

Susan Walzer

President

June 22, 2022

 

 

This commentary reflects the President’s views as of this report’s period end and are subject to change at any time. Diversification does not guarantee investment returns and does not eliminate risk of loss. All investments entail risks, including the possible loss of principal. For more up-to-date information, you can visit our website at carillontower.com.

The Global Industry Classification Standard (GICS®) was developed by and/or is the exclusive property of Morgan Stanley Capital International, Inc. (“MSCI”) and Standard & Poor’s Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by U.S. Bancorp Fund Services, LLC.

 

               1  


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON CLARIVEST CAPITAL APPRECIATION FUND

 

COMMON STOCKS—98.9%         Shares     Value  
Air freight & logistics—0.7%        

GXO Logistics, Inc.*

      20,634       $1,221,326  

United Parcel Service, Inc., Class B

      15,100       2,717,698  
Automobiles—3.4%        

Tesla, Inc.*

      22,600       19,679,176  
Beverages—0.5%        

Keurig Dr Pepper, Inc.

      75,100       2,808,740  
Biotechnology—2.0%        

AbbVie, Inc.

      81,000       11,897,280  
Building products—0.9%        

Carrier Global Corp.

      139,331       5,332,197  
Capital markets—1.3%        

Blackstone, Inc.

      35,000       3,554,950  

The Charles Schwab Corp.

      63,500       4,211,955  
Chemicals—1.8%        

CF Industries Holdings, Inc.

      44,900       4,347,667  

Olin Corp.

      111,700       6,411,580  
Electrical equipment—0.5%        

Generac Holdings, Inc.*

      13,700       3,005,506  
Electronic equipment, instruments & components—0.6%        

Keysight Technologies, Inc.*

      26,900       3,773,263  
Entertainment—0.4%        

Netflix, Inc.*

      12,400       2,360,464  
Equity real estate investment trusts (REITs)—0.5%        

Public Storage

      7,900       2,934,850  
Food & staples retailing—3.6%        

Costco Wholesale Corp.

      14,400       7,656,768  

The Kroger Co.

      109,100       5,887,036  

Wal-Mart, Inc.

      49,000       7,496,510  
Health care providers & services—4.5%        

CVS Health Corp.

      58,200       5,594,766  

Laboratory Corp. of America Holdings*

      11,700       2,811,276  

McKesson Corp.

      22,000       6,811,420  

UnitedHealth Group, Inc.

      22,300       11,340,665  
Hotels, restaurants & leisure—0.5%        

Expedia Group, Inc.*

      17,500       3,058,125  
Household durables—1.3%        

Lennar Corp., Class A

      51,800       3,962,182  

PulteGroup, Inc.

      83,300       3,478,608  
Insurance—0.5%        

MetLife, Inc.

      48,300       3,172,344  
Interactive media & services—6.8%        

Alphabet, Inc., Class A*

      6,514       14,866,186  

Alphabet, Inc., Class C*

      5,012       11,524,242  

Meta Platforms, Inc., Class A*

      67,500       13,531,725  
Internet & direct marketing retail—4.3%        

Amazon.com, Inc.*

      10,150       25,229,144  
IT services—6.9%        

Accenture PLC, Class A

      19,600       5,887,056  

Akamai Technologies, Inc.*

      35,100       3,941,028  

Cloudflare, Inc., Class A*

      37,900       3,264,706  

Global Payments, Inc.

      21,300       2,917,674  

MasterCard, Inc., Class A

      27,030       9,822,161  

Paychex, Inc.

      28,600       3,624,478  

Snowflake, Inc., Class A*

      10,500       1,800,120  

 

 

COMMON STOCKS—98.9%         Shares     Value  
IT services (cont'd)        

Visa, Inc., Class A

      43,000       $ 9,164,590  
Life sciences tools & services—2.3%        

Danaher Corp.

      6,400       1,607,232  

Thermo Fisher Scientific, Inc.

      21,000       11,611,320  
Machinery—1.1%        

Cummins, Inc.

      21,800       4,124,342  

The Middleby Corp.*

      13,800       2,123,682  
Media—0.5%        

Omnicom Group, Inc.

      36,352       2,767,478  
Metals & mining—0.4%        

United States Steel Corp.

      75,300       2,295,897  
Multiline retail—1.6%        

Target Corp.

      40,200       9,191,730  
Oil, gas & consumable fuels—1.1%        

APA Corp.

      44,500       1,821,385  

Marathon Oil Corp.

      195,400       4,869,368  
Pharmaceuticals—2.4%        

Bristol-Myers Squibb Co.

      106,300       8,001,201  

Pfizer, Inc.

      120,500       5,912,935  
Professional services—0.4%        

ManpowerGroup, Inc.

      22,500       2,029,500  
Road & rail—0.9%        

Old Dominion Freight Line, Inc.

      11,700       3,277,404  

XPO Logistics, Inc.*

      34,800       1,871,892  
Semiconductors & semiconductor equipment—10.1%        

Advanced Micro Devices, Inc.*

      57,800       4,943,056  

Broadcom, Inc.

      7,200       3,991,608  

KLA Corp.

      21,800       6,959,868  

Lam Research Corp.

      10,300       4,797,328  

NVIDIA Corp.

      108,300       20,086,401  

ON Semiconductor Corp.*

      52,200       2,720,142  

Qorvo, Inc.*

      36,300       4,130,214  

QUALCOMM, Inc.

      61,400       8,576,966  

Texas Instruments, Inc.

      18,100       3,081,525  
Software—19.0%        

Adobe, Inc.*

      24,600       9,740,370  

Cadence Design Systems, Inc.*

      49,400       7,451,990  

Crowdstrike Holdings, Inc., Class A*

      12,800       2,544,128  

Dropbox, Inc., Class A*

      125,300       2,725,275  

Fortinet, Inc.*

      18,000       5,202,180  

Microsoft Corp.

      214,400       59,500,288  

salesforce.com, Inc.*

      38,100       6,703,314  

SS&C Technologies Holdings, Inc.

      77,400       5,004,684  

Synopsys, Inc.*

      42,300       12,131,217  
Specialty retail—6.0%        

Advance Auto Parts, Inc.

      14,800       2,954,524  

AutoNation, Inc.*

      22,000       2,550,020  

AutoZone, Inc.*

      3,000       5,866,410  

Dick’s Sporting Goods, Inc.(a)

      80,000       7,713,600  

Lowe’s Cos., Inc.

      23,200       4,587,336  

The Home Depot, Inc.

      37,500       11,265,000  

 

2         The accompanying notes are an integral part of the financial statements.


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON CLARIVEST CAPITAL APPRECIATION FUND (cont’d)

 

COMMON STOCKS—98.9%         Shares     Value  
Technology hardware, storage & peripherals—11.0%        

Apple, Inc.

      390,964       $ 61,635,475  

Western Digital Corp.*

      47,100       2,499,597  
Trading companies & distributors—1.1%        

United Rentals, Inc.*

      20,500       6,488,660  
Total common stocks (cost $313,520,576)

 

    578,456,004  
MONEY MARKET FUNDS—0.7%        

First American Government Obligations Fund—
Class X, 0.22%#

      4,084,628       4,084,628  
Total money market funds (cost $4,084,628)         4,084,628  
Total investment portfolio (cost $317,605,204)—99.6%

 

    582,540,632  

Other assets in excess of liabilities—0.4%

        2,588,434  
Total net assets—100.0%         $585,129,066  

* Non-income producing security

(a) All or a portion of this security was on loan as of the date of this report. The total fair market value of loaned securities was $3,805,215 or 0.7% of net assets as of the date of this report.

# Annualized seven-day yield as of the date of this report. Investment made with cash collateral received for securities on loan.

 

Sector allocation      
Sector   Percent of net assets  
Information technology     47.6%  
Consumer discretionary     17.0%  
Health care     11.2%  
Communication services     7.7%  
Industrials     5.5%  
Consumer staples     4.1%  
Materials     2.2%  
Financials     1.9%  
Energy     1.2%  
Money market funds     0.7%  
Real estate     0.5%  
 
CARILLON CLARIVEST INTERNATIONAL STOCK FUND
COMMON STOCKS—95.9%         Shares     Value  
Australia—5.0%        

BlueScope Steel Ltd.

      8,582       $121,998  

Commonwealth Bank of Australia

      4,800       348,880  

National Australia Bank Ltd.

      15,743       359,392  

Perseus Mining Ltd.

      106,024       147,535  

Sonic Healthcare Ltd.

      5,917       152,814  

South32 Ltd.

      125,499       417,953  
Austria—0.3%        

voestalpine AG

      3,839       99,902  

 

 

COMMON STOCKS—95.9%         Shares     Value  
Belgium—0.6%        

Anheuser-Busch InBev S.A./N.V.

      2,129       $ 122,502  

UCB S.A.

      661       75,138  
Canada—1.1%        

Loblaw Cos Ltd.

      1,800       164,650  

Nutrien Ltd.

      1,800       176,883  
Denmark—4.1%        

AP Moeller-Maersk A/S, Class B

      175       506,490  

Danske Bank A/S

      5,251       80,544  

Novo Nordisk A/S, Class B

      5,390       615,680  

Pandora A/S

      649       56,986  
Finland—2.3%        

Nokia Oyj*

      41,726       211,554  

Nordea Bank Abp

      51,092       509,392  
France—9.3%        

Capgemini S.A.

      1,398       284,604  

Cie de Saint-Gobain

      5,952       347,230  

Eiffage S.A.

      2,489       245,786  

LVMH Moet Hennessy Louis Vuitton SE

      855       553,302  

Pernod Ricard S.A.

      1,564       322,786  

Publicis Groupe S.A.

      1,549       92,997  

Rexel S.A.*

      4,715       96,586  

Sanofi

      4,027       425,635  

Sartorius Stedim Biotech

      292       95,551  

TotalEnergies SE

      6,219       305,372  

Veolia Environnement S.A.

      4,435       129,398  
Germany—7.0%        

Bayer AG

      2,778       182,990  

Bayerische Motoren Werke AG

      2,546       207,921  

Brenntag SE

      1,032       79,633  

Deutsche Post AG

      8,666       370,234  

Deutsche Telekom AG

      18,996       349,929  

HeidelbergCement AG

      1,342       77,309  

Infineon Technologies AG

      7,769       220,510  

Mercedes-Benz Group AG

      3,425       239,070  

Merck KGaA

      2,451       454,729  
Hong Kong—2.0%        

ASM Pacific Technology Ltd.

      10,400       104,809  

CK Hutchison Holdings Ltd.

      43,500       305,280  

Pacific Basin Shipping Ltd.

      479,000       219,770  
Ireland—0.3%        

James Hardie Industries PLC, CDI

      2,974       85,735  
Israel—0.6%        

Teva Pharmaceutical Industries Ltd., Sponsored ADR*

      21,000       182,910  
Italy—1.4%        

Enel SpA

      16,501       107,304  

Eni SpA

      12,489       174,581  

Leonardo SpA*

      13,741       141,414  
Japan—24.9%        

Canon, Inc.

      21,800       501,600  

Cosmo Energy Holdings Co. Ltd.

      2,800       69,564  

Electric Power Development Co. Ltd.

      7,200       98,660  

FUJIFILM Holdings Corp.

      8,800       483,747  

Fujitsu Ltd.

      2,000       302,298  

Honda Motor Co. Ltd.

      7,700       202,537  

Ibiden Co. Ltd.

      2,700       100,904  

 

The accompanying notes are an integral part of the financial statements.           3  


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON CLARIVEST INTERNATIONAL STOCK FUND (cont’d)

 

COMMON STOCKS—95.9%         Shares     Value  
Japan (cont'd)        

Inpex Corp.

      7,100       $ 84,477  

ITOCHU Corp.

      16,200       488,932  

Japan Tobacco, Inc.

      12,400       210,946  

Marubeni Corp.

      31,200       340,568  

Mitsubishi Corp.

      9,100       305,537  

Mitsubishi UFJ Financial Group, Inc.

      51,600       299,970  

Mitsui & Co. Ltd.

      5,700       138,030  

Mizuho Financial Group, Inc.

      7,980       96,899  

Murata Manufacturing Co. Ltd.

      3,600       214,587  

Nippon Telegraph & Telephone Corp.

      24,000       707,265  

Nippon Yusen KK

      5,500       396,792  

Nomura Holdings, Inc.

      31,200       120,134  

Olympus Corp.

      6,400       112,647  

Ono Pharmaceutical Co. Ltd.

      5,300       136,160  

Sekisui House Ltd.

      12,700       220,573  

Seven & i Holdings Co. Ltd.

      7,600       336,049  

SoftBank Group Corp.

      2,000       82,261  

Sony Group Corp.

      3,200       276,164  

Sumitomo Corp.

      23,700       375,020  

Tokyo Electron Ltd.

      800       337,557  

Toyota Motor Corp.

      41,200       705,909  
Netherlands—6.1%        

Aegon N.V.

      24,793       128,544  

Akzo Nobel N.V.

      1,087       94,294  

ASML Holding N.V.

      842       477,868  

ASR Nederland N.V.

      1,700       77,263  

Koninklijke Ahold Delhaize N.V.

      11,446       337,612  

NN Group N.V.

      5,052       247,456  

Signify N.V.

      3,054       129,208  

Stellantis N.V.

      8,526       114,467  

STMicroelectronics N.V.

      7,655       282,831  
Norway—0.9%        

Equinor ASA

      6,284       212,396  

Norsk Hydro ASA

      9,221       77,434  
Singapore—1.3%        

DBS Group Holdings Ltd.

      8,300       201,364  

Yangzijiang Financial Holding Pte Ltd.*

      204,700       80,669  

Yangzijiang Shipbuilding Holdings Ltd.

      204,700       133,551  
Spain—3.5%        

Banco Bilbao Vizcaya Argentaria S.A.

      17,062       89,529  

Banco Santander S.A.

      106,796       312,096  

Iberdrola S.A.

      23,938       275,067  

Repsol S.A.

      18,094       269,925  

Telefonica S.A.

      27,102       131,842  
Sweden—0.8%        

SSAB AB, Class B

      40,595       238,724  
Switzerland—7.5%        

Alcon, Inc.

      5,708       407,556  

Cie Financiere Richemont S.A.

      470       54,610  

Julius Baer Group Ltd.

      2,902       138,680  

Nestle S.A.

      1,768       228,238  

Novartis AG

      2,527       223,309  

Roche Holding AG

      1,534       568,829  

Sonova Holding AG

      805       290,304  

UBS Group AG

      25,104       426,182  

 

 

COMMON STOCKS—95.9%         Shares     Value  
United Kingdom—16.9%        

3i Group PLC

      21,134       $345,863  

Anglo American PLC

      2,716       120,294  

Ashtead Group PLC

      2,067       106,879  

AstraZeneca PLC

      3,462       461,974  

BAE Systems PLC

      12,254       113,186  

Barclays PLC

      104,441       191,978  

Bellway PLC

      2,069       62,840  

BP PLC

      32,984       159,240  

British American Tobacco PLC

      7,894       330,856  

Coca-Cola Europacific Partners PLC

      5,536       276,523  

Diageo PLC

      12,408       619,021  

Ferguson PLC

      1,616       202,726  

GlaxoSmithKline PLC

      19,167       432,074  

Imperial Brands PLC

      15,658       325,930  

Kingfisher PLC

      32,906       103,771  

Lloyds Banking Group PLC

      212,814       120,871  

Redrow PLC

      10,045       65,848  

Rio Tinto PLC

      3,573       252,455  

Shell PLC

      9,806       263,251  

SSE PLC

      15,457       359,002  

Standard Chartered PLC

      18,760       128,249  

Vodafone Group PLC

      145,586       220,411  
Total common stocks (cost $30,614,975)

 

    29,830,545  
PREFERRED STOCKS—0.8%        
Germany—0.8%                  

Volkswagen AG

      1,636       253,362  
Total preferred stocks (cost $305,289)

 

    253,362  
EXCHANGE TRADED FUNDS—1.0%        
United States—1.0%                  

iShares MSCI EAFE ETF

      4,400       302,016  
Total exchange traded funds (cost $330,535)         302,016  
Total investment portfolio (cost $31,250,799)—97.7%

 

    30,385,923  

Other assets in excess of liabilities—2.3%

        727,929  
Total net assets—100.0%         $31,113,852  

* Non-income producing security

ADR—American Depositary Receipt

ETF—Exchange Traded Fund

CDI—CHESS Depositary Interests

 

Sector allocation      
Sector   Percent of net assets  
Industrials     16.2%  
Health care     15.5%  
Financials     13.8%  
Information technology     11.3%  
Consumer staples     10.5%  
Consumer discretionary     10.0%  
Materials     6.2%  
Communication services     5.1%  
Energy     5.0%  
Utilities     3.1%  
Exchange traded funds     1.0%  

 

4         The accompanying notes are an integral part of the financial statements.


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON EAGLE GROWTH & INCOME FUND

 

COMMON STOCKS—97.3%         Shares     Value  
Aerospace & defense—3.3%        

Raytheon Technologies Corp.

      325,245       $30,869,003  
Air freight & logistics—1.4%        

United Parcel Service, Inc.—Class B

      71,929       12,945,781  
Banks—5.9%        

JPMorgan Chase & Co.

      139,082       16,600,828  

The PNC Financial Services Group, Inc.

      131,188       21,790,327  

Truist Financial Corp.

      349,658       16,905,964  
Beverages—6.4%        

PepsiCo, Inc.

      150,146       25,781,570  

The Coca-Cola Co.

      531,660       34,350,552  
Biotechnology—2.5%        

AbbVie, Inc.

      159,231       23,387,849  
Capital markets—4.2%        

BlackRock, Inc.

      32,109       20,057,850  

CME Group, Inc.

      85,880       18,836,919  
Chemicals—2.4%        

Eastman Chemical Co.

      222,914       22,886,580  
Communications equipment—3.1%        

Cisco Systems, Inc.

      598,415       29,310,367  
Electric utilities—3.1%        

NextEra Energy, Inc.

      414,659       29,449,082  
Electrical equipment—3.4%        

Eaton Corp. PLC

      138,726       20,118,045  

Rockwell Automation, Inc.

      46,526       11,755,724  
Electronic equipment, instruments & components—1.7%        

TE Connectivity Ltd.

      128,997       16,096,246  
Equity real estate investment trusts (REITs)—5.3%        

Crown Castle International Corp.

      112,143       20,770,005  

Prologis, Inc.

      183,237       29,371,059  
Food products—2.1%        

Mondelez International, Inc.—Class A

      302,366       19,496,560  
Health care equipment & supplies—5.6%        

Abbott Laboratories

      83,985       9,532,298  

Baxter International, Inc.

      280,504       19,932,614  

Medtronic PLC

      220,701       23,032,356  
Health care providers & services—2.3%        

UnitedHealth Group, Inc.

      41,720       21,216,706  
Hotels, restaurants & leisure—2.7%        

McDonald’s Corp.

      102,891       25,636,322  
Household products—2.3%        

The Procter & Gamble Co.

      133,261       21,395,054  
Industrial conglomerates—1.5%        

Honeywell International, Inc.

      71,845       13,902,726  
Insurance—1.9%        

The Allstate Corp.

      143,454       18,152,669  
IT services—3.2%        

Automatic Data Processing, Inc.

      137,272       29,950,005  
Media—1.8%        

Comcast Corp., Class A

      414,761       16,490,897  

 

 

COMMON STOCKS—97.3%         Shares     Value  
Multiline retail—2.7%        

Target Corp.

      110,905       $ 25,358,428  
Multi-utilities—2.1%        

Dominion Energy, Inc.

      242,303       19,781,617  
Oil, gas & consumable fuels—4.1%        

Chevron Corp.

      246,961       38,691,380  
Pharmaceuticals—6.1%        

AstraZeneca PLC, Sponsored ADR

      413,228       27,438,339  

Merck & Co., Inc.

      330,370       29,300,515  
Road & rail—1.7%        

Union Pacific Corp.

      69,650       16,318,299  
Semiconductors & semiconductor equipment—7.5%        

Broadcom, Inc.

      69,457       38,506,266  

Texas Instruments, Inc.

      187,613       31,941,113  
Software—4.3%        

Microsoft Corp.

      143,908       39,937,348  
Specialty retail—2.7%        

The Home Depot, Inc.

      82,879       24,896,852  
Total common stocks (cost $617,775,598)         912,192,115  
Total investment portfolio (cost $617,775,598)—97.3%

 

    912,192,115  

Other assets in excess of liabilities—2.7%

        25,679,422  
Total net assets—100.0%         $937,871,537  

ADR—American Depositary Receipt

 

Sector allocation      
Sector   Percent of net assets  
Information technology     19.8%  
Health care     16.4%  
Financials     12.0%  
Industrials     11.3%  
Consumer staples     10.8%  
Consumer discretionary     8.1%  
Real estate     5.3%  
Utilities     5.3%  
Energy     4.1%  
Materials     2.4%  
Communication services     1.8%  

 

 
CARILLON EAGLE MID CAP GROWTH FUND
COMMON STOCKS—98.6%         Shares     Value  
Aerospace & defense—1.0%        

L3Harris Technologies, Inc.

      287,544       $66,784,969  
Auto components—0.8%        

Aptiv PLC*

      475,627       50,606,713  

 

The accompanying notes are an integral part of the financial statements.           5  


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON EAGLE MID CAP GROWTH FUND (cont’d)

 

COMMON STOCKS—98.6%         Shares     Value  
Beverages—1.9%        

Celsius Holdings, Inc.*

      577,749       $ 30,042,948  

Constellation Brands, Inc., Class A

      156,992       38,634,161  

Monster Beverage Corp.*

      605,311       51,863,047  
Biotechnology—3.2%        

Alnylam Pharmaceuticals, Inc.*

      201,572       26,895,752  

Exact Sciences Corp.*

      268,380       14,774,319  

Horizon Therapeutics PLC*

      820,758       80,893,908  

Mirati Therapeutics, Inc.*

      205,283       12,684,436  

Moderna, Inc.*

      116,290       15,630,539  

Seagen, Inc.*

      398,459       52,202,114  
Building products—1.2%        

Fortune Brands Home & Security, Inc.

      1,108,717       78,996,086  
Capital markets—6.6%        

LPL Financial Holdings, Inc.

      1,096,290       205,960,002  

MarketAxess Holdings, Inc.

      199,407       52,565,679  

Moody’s Corp.

      220,949       69,925,940  

MSCI, Inc.

      224,575       94,602,219  
Chemicals—3.0%        

Albemarle Corp.

      505,903       97,553,276  

Corteva, Inc.

      1,668,187       96,237,708  
Commercial services & supplies—5.2%        

IAA, Inc.*

      1,057,789       38,767,967  

Ritchie Bros Auctioneers, Inc.

      1,641,456       90,427,811  

Waste Connections, Inc.

      1,471,284       202,993,053  
Construction materials—1.6%        

Martin Marietta Materials, Inc.

      294,663       104,375,528  
Containers & packaging—0.9%        

Ball Corp.

      700,106       56,820,603  
Distributors—1.3%        

Pool Corp.

      208,225       84,376,934  
Electrical equipment—1.0%        

Generac Holdings, Inc.*

      296,940       65,142,697  
Electronic equipment, instruments & components—2.8%        

Cognex Corp.

      1,482,358       100,251,871  

Keysight Technologies, Inc.*

      559,725       78,512,626  
Energy equipment & services—2.1%        

Baker Hughes Co.

      4,401,458       136,533,227  
Entertainment—0.8%        

Take-Two Interactive Software, Inc.*

      444,655       53,140,719  
Equity real estate investment trusts (REITs)—2.3%        

SBA Communications Corp.

      413,625       143,573,374  
Health care equipment & supplies—3.2%        

DexCom, Inc.*

      49,730       20,318,684  

IDEXX Laboratories, Inc.*

      152,763       65,761,416  

Insulet Corp.*

      183,441       43,840,565  

ResMed, Inc.

      359,922       71,973,602  
Health care providers & services—3.1%        

Amedisys, Inc.*

      176,537       22,534,948  

McKesson Corp.

      263,432       81,561,181  

Molina Healthcare, Inc.*

      299,059       93,740,044  
Health care technology—0.5%        

Veeva Systems, Inc., Class A*

      162,239       29,519,386  
Hotels, restaurants & leisure—6.6%        

Caesars Entertainment, Inc.*

      1,116,776       74,019,913  

 

 

COMMON STOCKS—98.6%         Shares     Value  
Hotels, restaurants & leisure (cont'd)        

Chipotle Mexican Grill, Inc.*

      70,317       $ 102,354,129  

Expedia Group, Inc.*

      341,327       59,646,893  

Hyatt Hotels Corp., Class A*

      664,731       63,122,856  

MGM Resorts International

      1,193,174       48,967,861  

Planet Fitness, Inc., Class A*

      510,867       40,884,686  

Vail Resorts, Inc.

      118,858       30,208,949  
Interactive media & services—0.3%        

Bumble, Inc., Class A*

      826,159       19,819,554  
IT services—2.8%        

FleetCor Technologies, Inc.*

      473,581       118,167,931  

Global Payments, Inc.

      449,830       61,617,714  
Life sciences tools & services—5.3%        

Agilent Technologies, Inc.

      599,082       71,452,510  

Avantor, Inc.*

      2,837,774       90,468,235  

Bio-Techne Corp.

      93,967       35,678,330  

Charles River Laboratories International, Inc.*

      118,384       28,590,920  

Repligen Corp.*

      215,045       33,813,676  

West Pharmaceutical Services, Inc.

      243,915       76,847,860  
Machinery—1.3%        

Westinghouse Air Brake Technologies Corp.

      905,909       81,450,278  
Pharmaceuticals—1.1%        

Zoetis, Inc.

      382,676       67,829,321  
Professional services—2.9%        

Booz Allen Hamilton Holding Corp.

      665,315       54,309,664  

Clarivate PLC*

      2,059,050       32,285,904  

TransUnion

      1,135,885       99,412,655  
Road & rail—1.6%        

Old Dominion Freight Line, Inc.

      365,439       102,366,773  
Semiconductors & semiconductor equipment—6.0%        

Advanced Micro Devices, Inc.*

      572,475       48,958,062  

Enphase Energy, Inc.*

      379,301       61,219,182  

Entegris, Inc.

      563,703       62,790,877  

Marvell Technology, Inc.

      1,712,605       99,468,098  

Microchip Technology, Inc.

      420,058       27,387,782  

Monolithic Power Systems, Inc.

      205,934       80,775,552  
Software—19.3%        

Bill.com Holdings, Inc.*

      162,270       27,701,112  

Crowdstrike Holdings, Inc., Class A*

      944,784       187,785,268  

DocuSign, Inc.*

      589,852       47,778,012  

Elastic N.V.*

      375,071       28,557,906  

Fair Isaac Corp.*

      92,712       34,628,859  

Five9, Inc.*

      530,893       58,451,319  

Palo Alto Networks, Inc.*

      119,178       66,892,228  

Paycom Software, Inc.*

      202,832       57,091,123  

PTC, Inc.*

      456,974       52,191,001  

Qualtrics International, Inc., Class A*

      1,592,597       29,526,748  

RingCentral, Inc., Class A*

      539,261       45,756,296  

ServiceNow, Inc.*

      100,622       48,107,378  

Splunk, Inc.*

      670,505       81,815,020  

Synopsys, Inc.*

      688,709       197,514,854  

Tyler Technologies, Inc.*

      383,753       151,471,147  

Workday, Inc., Class A*

      228,683       47,268,776  

Zendesk, Inc.*

      585,812       71,492,496  
Specialty retail—4.2%        

AutoZone, Inc.*

      71,041       138,918,544  

Floor & Decor Holdings, Inc., Class A*

      440,549       35,120,567  

Ulta Beauty, Inc.*

      238,575       94,666,560  

 

6         The accompanying notes are an integral part of the financial statements.


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON EAGLE MID CAP GROWTH FUND (cont’d)

 

COMMON STOCKS—98.6%         Shares     Value  
Textiles, apparel & luxury goods—1.3%        

Lululemon Athletica, Inc.*

      224,734       $ 79,697,418  
Trading companies & distributors—3.4%        

United Rentals, Inc.*

      302,220       95,658,674  

W.W. Grainger, Inc.

      235,957       117,985,579  
Total common stocks (cost $4,398,021,142)         6,291,013,102  
Total investment portfolio (cost $4,398,021,142)—98.6%

 

    6,291,013,102  

Other assets in excess of liabilities—1.4%

        86,892,587  
Total net assets—100.0%         $6,377,905,689  

* Non-income producing security    

 

Sector allocation      
Sector   Percent of net assets  
Information technology     30.9%  
Industrials     17.7%  
Health care     16.3%  
Consumer discretionary     14.2%  
Financials     6.6%  
Materials     5.6%  
Real estate     2.2%  
Energy     2.1%  
Consumer staples     1.9%  
Communication services     1.1%  

 

 
CARILLON EAGLE SMALL CAP GROWTH FUND
COMMON STOCKS—98.4%         Shares     Value  
Aerospace & defense—2.7%        

AeroVironment, Inc.*

      45,700       $3,670,624  

Woodward, Inc.

      292,957       32,365,889  
Banks—0.9%        

First Financial Bankshares, Inc.

      300,750       12,023,985  
Beverages—1.1%        

Celsius Holdings, Inc.*

      276,204       14,362,608  
Biotechnology—10.0%        

Aldeyra Therapeutics, Inc.*

      830,888       2,550,826  

Alkermes PLC*

      185,618       5,355,079  

Arrowhead Pharmaceuticals, Inc.*

      298,814       12,284,244  

Biohaven Pharmaceutical Holding Co., Ltd.*

      161,375       14,389,809  

Blueprint Medicines Corp.*

      82,185       4,795,495  

CareDx, Inc.*

      138,438       4,214,053  

Cytokinetics, Inc.*

      184,446       7,353,862  

Denali Therapeutics, Inc.*

      146,587       3,488,771  

Fate Therapeutics, Inc.*

      116,600       3,330,096  

Halozyme Therapeutics, Inc.*

      691,558       27,593,164  

Horizon Therapeutics PLC*

      110,249       10,866,141  

Insmed, Inc.*

      319,832       7,026,709  

Intellia Therapeutics, Inc.*

      89,480       4,387,204  

 

 

COMMON STOCKS—98.4%         Shares     Value  
Biotechnology (cont'd)        

Karuna Therapeutics, Inc.*

      61,832       $ 6,891,795  

Kura Oncology, Inc.*

      432,017       6,199,444  

TG Therapeutics, Inc.*

      491,296       3,409,594  

Turning Point Therapeutics, Inc.*

      166,131       4,890,897  

Verastem, Inc.*

      3,446,517       4,894,054  
Building products—1.3%        

Trex Co., Inc.*

      133,878       7,790,361  

Zurn Water Solutions Corp.

      307,015       9,585,008  
Capital markets—3.5%        

LPL Financial Holdings, Inc.

      106,616       20,029,948  

PJT Partners, Inc., Class A

      396,623       26,173,152  
Chemicals—3.2%        

Quaker Houghton

      262,963       42,786,710  
Commercial services & supplies—5.6%        

Casella Waste Systems, Inc., Class A*

      125,000       10,280,000  

IAA, Inc.*

      398,391       14,601,030  

MSA Safety, Inc.

      147,800       17,837,982  

Ritchie Bros Auctioneers, Inc.

      573,368       31,586,843  
Communications equipment—0.9%        

Lumentum Holdings, Inc.*

      147,742       11,998,128  
Construction materials—2.1%        

Summit Materials, Inc., Class A*

      1,035,334       28,782,285  
Consumer finance—0.8%        

FirstCash Holdings, Inc.

      133,840       10,677,755  
Electrical equipment—1.0%        

Thermon Group Holdings, Inc.*

      878,545       13,178,175  
Electronic equipment, instruments & components—2.8%        

Cognex Corp.

      200,787       13,579,225  

II-VI, Inc.*

      393,888       24,109,884  
Equity real estate investment trusts (REITs)—1.5%        

EastGroup Properties, Inc.

      107,421       20,141,438  
Food & staples retailing—0.9%        

Casey’s General Stores, Inc.

      59,950       12,067,935  
Food products—2.7%        

The Simply Good Foods Co.*

      871,603       36,302,265  
Health care equipment & supplies—6.0%        

AtriCure, Inc.*

      236,478       12,280,303  

CONMED Corp.

      149,123       19,827,394  

Enovis Corp.*

      79,841       5,179,286  

Inari Medical, Inc.*

      58,013       4,681,649  

Merit Medical Systems, Inc.*

      374,751       23,238,309  

NuVasive, Inc.*

      75,841       3,901,261  

Shockwave Medical, Inc.*

      45,465       6,871,125  

STAAR Surgical Co.*

      82,009       4,681,894  
Health care providers & services—4.0%        

AMN Healthcare Services, Inc.*

      66,382       6,488,841  

Owens & Minor, Inc.

      277,047       9,832,398  

Progyny, Inc.*

      188,570       7,250,517  

Tenet Healthcare Corp.*

      134,644       9,763,036  

The Ensign Group, Inc.

      257,210       20,661,679  
Health care technology—1.7%        

Evolent Health, Inc., Class A*

      392,745       10,808,342  

 

The accompanying notes are an integral part of the financial statements.           7  


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON EAGLE SMALL CAP GROWTH FUND (cont’d)

 

COMMON STOCKS—98.4%         Shares     Value  
Health care technology (cont'd)        

Inspire Medical Systems, Inc.*

      30,319       $ 6,238,437  

Omnicell, Inc.*

      48,868       5,334,920  
Hotels, restaurants & leisure—7.4%        

Everi Holdings, Inc.*

      2,074,863       36,019,622  

Planet Fitness, Inc., Class A*

      146,260       11,705,188  

Red Rock Resorts, Inc., Class A

      385,301       16,937,832  

SeaWorld Entertainment, Inc.*

      171,405       11,559,553  

Wingstop, Inc.

      148,593       13,634,894  

Xponential Fitness, Inc., Class A*

      422,691       8,758,157  
Household durables—1.4%        

Universal Electronics, Inc.*(a)

      649,812       19,169,454  
Insurance—1.4%        

Kinsale Capital Group, Inc.

      83,818       18,581,612  
Interactive media & services—0.8%        

Bumble, Inc., Class A*

      464,677       11,147,601  
IT services—1.9%        

EVO Payments, Inc., Class A*

      770,612       17,361,888  

TaskUS, Inc., Class A*

      280,482       8,103,125  
Life sciences tools & services—0.5%        

Medpace Holdings, Inc.*

      46,136       6,162,386  
Machinery—4.5%        

Chart Industries, Inc.*

      216,361       36,526,064  

Esab Corp.*

      165,091       7,759,277  

John Bean Technologies Corp.

      136,974       16,147,865  
Media—0.5%        

TechTarget, Inc.*

      93,464       6,291,062  
Oil, gas & consumable fuels—3.5%        

Viper Energy Partners LP

      1,616,276       46,435,609  
Personal products—0.7%        

The Beauty Health Co.*

      709,612       9,295,917  
Pharmaceuticals—0.6%        

Arvinas, Inc.*

      141,245       7,764,238  
Road & rail—3.1%        

Landstar System, Inc.

      270,711       41,933,134  
Semiconductors & semiconductor equipment—7.0%        

Entegris, Inc.

      174,292       19,414,386  

Lattice Semiconductor Corp.*

      397,775       19,109,111  

MaxLinear, Inc.*

      180,196       8,625,982  

Silicon Laboratories, Inc.*

      251,882       33,981,401  

Synaptics, Inc.*

      85,185       12,644,861  
Software—7.5%        

Asana, Inc., Class A*

      321,165       8,607,222  

Digital Turbine, Inc.*

      193,950       6,138,517  

Pegasystems, Inc.

      224,639       17,205,101  

PROS Holdings, Inc.*

      419,603       11,719,512  

Q2 Holdings, Inc.*

      263,190       13,614,819  

Rapid7, Inc.*

      143,755       13,731,478  

Smartsheet, Inc., Class A*

      243,023       11,745,302  

Sprout Social, Inc., Class A*

      283,494       17,372,512  
Specialty retail—4.3%        

American Eagle Outfitters, Inc.

      681,785       10,301,772  

Boot Barn Holdings, Inc.*

      167,722       15,105,043  

 

 

COMMON STOCKS—98.4%         Shares     Value  
Specialty retail (cont'd)        

Floor & Decor Holdings, Inc., Class A*

      106,521       $ 8,491,854  

MarineMax, Inc.*

      567,465       23,220,668  
Trading companies & distributors—0.6%        

Herc Holdings, Inc.

      58,007       7,414,455  
Total common stocks (cost $1,068,106,205)         1,314,630,332  
Total investment portfolio (cost $1,068,106,205)—98.4%

 

    1,314,630,332  

Other assets in excess of liabilities—1.6%

        22,006,983  
Total net assets—100.0%         $1,336,637,315  

* Non-income producing security

(a) Affiliated issuer. See Note 4 in the Notes to Financial Statements.

 

Sector allocation      
Sector   Percent of net assets  
Health care     22.8%  
Information technology     20.1%  
Industrials     18.8%  
Consumer discretionary     13.1%  
Financials     6.5%  
Consumer staples     5.4%  
Materials     5.4%  
Energy     3.5%  
Real estate     1.5%  
Communication services     1.3%  

 

 
CARILLION CLARIVEST INTERNATIONAL FUND
COMMON STOCKS—97.8%   Shares           Value  
Australia—5.1%              

BlueScope Steel Ltd.

    113,936         $1,619,666  

Commonwealth Bank of Australia

    62,431         4,537,698  

National Australia Bank Ltd.

    204,788         4,675,036  

Perseus Mining Ltd.

    1,402,491         1,951,602  

Sonic Healthcare Ltd.

    78,326         2,022,863  

South32 Ltd.

    1,628,665         5,423,997  
Austria—0.3%              

voestalpine AG

    51,547         1,341,404  
Belgium—0.7%              

Anheuser-Busch InBev S.A./N.V.

    28,335         1,630,386  

UCB S.A.

    8,818         1,002,368  
Canada—1.2%              

Loblaw Cos Ltd.

    24,300         2,222,779  

Nutrien Ltd.

    24,400         2,397,739  
Denmark—4.1%              

AP Moeller-Maersk A/S, Class B

    2,250         6,512,011  

Danske Bank A/S

    70,782         1,085,715  

 

8         The accompanying notes are an integral part of the financial statements.


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLION CLARIVEST INTERNATIONAL FUND (cont’d)

 

COMMON STOCKS—97.8%   Shares           Value  
Denmark (cont'd)              

Novo Nordisk A/S, Class B

    69,818         $ 7,975,051  

Pandora A/S

    8,690         763,038  
Finland—2.3%              

Nokia Oyj*

    547,686         2,776,813  

Nordea Bank Abp

    662,486         6,605,041  
France—9.5%              

Capgemini SE

    18,244         3,714,105  

Cie de Saint-Gobain

    77,562         4,524,838  

Eiffage S.A.

    32,581         3,217,340  

LVMH Moet Hennessy Louis Vuitton SE

    11,068         7,162,510  

Pernod Ricard S.A.

    20,404         4,211,074  

Publicis Groupe S.A.

    20,905         1,255,070  

Rexel S.A.*

    63,521         1,301,209  

Sanofi

    52,312         5,529,126  

Sartorius Stedim Biotech

    3,921         1,283,068  

TotalEnergies SE

    81,114         3,982,948  

Veolia Environnement S.A.

    59,020         1,722,005  
Germany—7.2%              

Bayer AG

    36,502         2,404,431  

Bayerische Motoren Werke AG

    33,402         2,727,807  

Brenntag SE

    13,885         1,071,417  

Deutsche Post AG

    112,719         4,815,648  

Deutsche Telekom AG

    247,390         4,557,221  

HeidelbergCement AG

    18,088         1,042,005  

Infineon Technologies AG

    101,849         2,890,809  

Mercedes-Benz Group AG

    44,881         3,132,755  

Merck KGaA

    31,803         5,900,342  
Hong Kong—2.1%              

ASM Pacific Technology Ltd.

    140,100         1,411,898  

CK Hutchison Holdings Ltd.

    566,000         3,972,147  

Pacific Basin Shipping Ltd.

    6,256,000         2,870,319  
Ireland—0.3%              

James Hardie Industries PLC, CDI

    40,097         1,155,925  
Israel—0.6%              

Teva Pharmaceutical Industries Ltd., Sponsored ADR*

    276,000         2,403,960  
Italy—1.4%              

Enel SpA

    220,980         1,437,013  

Eni SpA

    164,422         2,298,426  

Leonardo SpA*

    182,131         1,874,384  
Japan—25.3%              

Canon, Inc.

    281,700         6,481,682  

Cosmo Energy Holdings Co. Ltd.

    36,800         914,273  

Electric Power Development Co. Ltd.

    96,600         1,323,692  

FUJIFILM Holdings Corp.

    113,200         6,222,746  

Fujitsu Ltd.

    26,900         4,065,912  

Honda Motor Co. Ltd.

    100,500         2,643,507  

Ibiden Co. Ltd.

    35,400         1,322,964  

Inpex Corp.

    96,100         1,143,414  

ITOCHU Corp.

    209,500         6,322,915  

Japan Tobacco, Inc.

    162,800         2,769,521  

Marubeni Corp.

    406,200         4,433,926  

Mitsubishi Corp.

    117,500         3,945,124  

Mitsubishi UFJ Financial Group, Inc.

    672,300         3,908,333  

Mitsui & Co. Ltd.

    74,500         1,804,078  

Mizuho Financial Group, Inc.

    107,300         1,302,913  

 

 

COMMON STOCKS—97.8%   Shares           Value  
Japan (cont'd)              

Murata Manufacturing Co. Ltd.

    46,700         $ 2,783,670  

Nippon Telegraph & Telephone Corp.

    310,000         9,135,502  

Nippon Yusen KK

    72,400         5,223,225  

Nomura Holdings, Inc.

    416,100         1,602,175  

Olympus Corp.

    86,300         1,518,977  

Ono Pharmaceutical Co. Ltd.

    70,800         1,818,891  

Sekisui House Ltd.

    167,000         2,900,446  

Seven & i Holdings Co. Ltd.

    99,100         4,381,897  

SoftBank Group Corp.

    26,900         1,106,404  

Sony Group Corp.

    42,500         3,667,796  

Sumitomo Corp.

    308,500         4,881,594  

Tokyo Electron Ltd.

    9,872         4,165,458  

Toyota Motor Corp.

    533,600         9,142,548  
Netherlands—6.2%              

Aegon N.V.

    329,141         1,706,496  

Akzo Nobel N.V.

    14,649         1,270,752  

ASML Holding N.V.

    10,884         6,177,104  

ASR Nederland N.V.

    22,787         1,035,641  

Koninklijke Ahold Delhaize N.V.

    149,065         4,396,828  

NN Group N.V.

    66,097         3,237,544  

Signify N.V.

    40,691         1,721,542  

Stellantis N.V.

    113,710         1,526,635  

STMicroelectronics N.V.

    100,000         3,694,724  
Norway—1.0%              

Equinor ASA

    82,317         2,782,280  

Norsk Hydro ASA

    124,315         1,043,939  
Singapore—1.4%              

DBS Group Holdings Ltd.

    109,000         2,644,409  

Yangzijiang Financial Holding Pte Ltd.*

    2,682,100         1,056,976  

Yangzijiang Shipbuilding Holdings Ltd.

    2,682,100         1,749,865  
Spain—3.5%              

Banco Bilbao Vizcaya Argentaria S.A.

    230,094         1,207,364  

Banco Santander S.A.

    1,390,222         4,062,726  

Iberdrola S.A.

    312,964         3,596,215  

Repsol S.A.

    236,626         3,529,969  

Telefonica S.A.

    359,500         1,748,843  
Sweden—0.8%              

SSAB AB

    531,480         3,125,435  
Switzerland—7.6%              

Alcon, Inc.

    74,108         5,291,376  

Cie Financiere Richemont S.A.

    6,426         746,642  

Julius Baer Group Ltd.

    38,455         1,837,681  

Nestle S.A.

    23,179         2,992,272  

Novartis AG

    33,140         2,928,559  

Roche Holding AG

    19,872         7,368,817  

Sonova Holding AG

    10,502         3,787,296  

UBS Group AG

    326,070         5,535,573  
United Kingdom—17.2%              

3i Group PLC

    275,060         4,501,425  

Anglo American PLC

    35,978         1,593,502  

Ashtead Group PLC

    27,529         1,423,449  

AstraZeneca PLC

    44,909         5,992,714  

BAE Systems PLC

    163,482         1,510,028  

Barclays PLC

    1,373,731         2,525,115  

Bellway PLC

    27,783         843,833  

 

The accompanying notes are an integral part of the financial statements.           9  


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON CLARIVEST INTERNATIONAL FUND (cont’d)

 

COMMON STOCKS—97.8%   Shares           Value  
United Kingdom (cont'd)              

BP PLC

    435,335         $ 2,101,709  

British American Tobacco PLC

    102,840         4,310,266  

Coca-Cola Europacific Partners PLC

    71,300         3,561,435  

Diageo PLC

    160,675         8,015,892  

Ferguson PLC

    21,216         2,661,531  

GlaxoSmithKline PLC

    248,974         5,612,517  

Imperial Brands PLC

    203,995         4,246,265  

Kingfisher PLC

    440,501         1,389,152  

Lloyds Banking Group PLC

    2,836,798         1,611,199  

Redrow PLC

    134,855         884,015  

Rio Tinto PLC

    46,678         3,298,089  

Shell PLC

    128,112         3,439,282  

SSE PLC

    201,264         4,674,524  

Standard Chartered PLC

    250,122         1,709,915  

Vodafone Group PLC

    1,906,556         2,886,450  
Total common stocks (cost $392,022,299)

 

      389,942,400  
PREFERRED STOCKS—0.8%              
Germany—0.8%              

Volkswagen AG

    21,391         3,312,756  
Total preferred stocks (cost $2,490,127)

 

      3,312,756  
Total investment portfolio (cost $394,512,426)—98.6%

 

      393,255,156  

Other assets in excess of liabilities—1.4%

 

      5,619,487  
Total net assets—100.0%

 

      $398,874,643  

CDI—CHESS Depositary Interests

ADR—American Depositary Receipt

* Non-income producing security

 

Sector allocation      
Sector   Percent of net assets  
Industrials     16.5%  
Health care     15.8%  
Financials     14.1%  
Information technology     11.5%  
Consumer staples     10.7%  
Consumer discretionary     10.2%  
Materials     6.3%  
Communication services     5.2%  
Energy     5.1%  
Utilities     3.2%  

 

 
CARILLON SCOUT MID CAP FUND
COMMON STOCKS—94.2%   Shares           Value  
Aerospace & defense—2.6%              

BWX Technologies, Inc.

    320,009         $16,614,867  

Hexcel Corp.

    165,413         8,991,851  

 

 

COMMON STOCKS—94.2%   Shares           Value  
Aerospace & defense (cont'd)              

Huntington Ingalls Industries, Inc.

    161,649         $ 34,389,208  

L3Harris Technologies, Inc.

    104,457         24,261,183  

Textron, Inc.

    421,653         29,199,470  
Airlines—2.4%                  

Delta Air Lines, Inc.*

    723,365         31,126,396  

Southwest Airlines Co.*

    1,593,978         74,470,652  
Automobiles—0.4%              

Thor Industries, Inc.

    225,134         17,234,008  
Banks—3.0%              

Citizens Financial Group, Inc.

    548,032         21,592,461  

Comerica, Inc.

    392,202         32,121,344  

Signature Bank

    145,957         35,358,083  

Synovus Financial Corp.

    969,938         40,291,224  
Beverages—0.4%              

Monster Beverage Corp.*

    173,459         14,861,967  
Biotechnology—3.7%              

BioMarin Pharmaceutical, Inc.*

    540,130         43,939,576  

Exelixis, Inc.*

    1,210,533         27,043,307  

Horizon Therapeutics PLC*

    94,026         9,267,203  

Neurocrine Biosciences, Inc.*

    204,414         18,403,392  

Vertex Pharmaceuticals, Inc.*

    227,356         62,118,206  
Building products—0.9%              

Carrier Global Corp.

    335,168         12,826,879  

Owens Corning

    286,862         26,084,362  
Capital markets—1.0%              

Cboe Global Markets, Inc.

    330,044         37,288,371  

Evercore, Inc., Class A

    36,820         3,893,715  
Chemicals—4.8%              

CF Industries Holdings, Inc.

    614,779         59,529,051  

Huntsman Corp.

    911,893         30,885,816  

The Mosaic Co.

    1,567,360         97,834,611  

Westlake Chemical Corp.

    176,951         22,393,149  
Commercial services & supplies—0.1%              

Copart, Inc.*

    18,249         2,073,999  

IAA, Inc.*

    109,176         4,001,300  
Communications equipment—0.5%              

Arista Networks, Inc.*

    92,751         10,719,233  

Lumentum Holdings, Inc.*

    135,151         10,975,613  
Construction & engineering—1.1%              

Quanta Services, Inc.

    423,154         49,077,401  
Construction materials—1.9%              

Eagle Materials, Inc.

    244,867         30,196,998  

Martin Marietta Materials, Inc.

    80,153         28,391,796  

Vulcan Materials Co.

    145,657         25,095,245  
Consumer finance—0.6%              

Discover Financial Services

    249,310         28,037,403  
Distributors—0.5%              

LKQ Corp.

    410,239         20,360,161  
Diversified consumer services—0.5%              

Service Corp International

    333,196         21,860,989  
Diversified financial services—0.5%              

Voya Financial, Inc.

    339,862         21,458,887  

 

10         The accompanying notes are an integral part of the financial statements.


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON SCOUT MID CAP FUND (cont’d)

 

COMMON STOCKS—94.2%   Shares           Value  
Electric utilities—2.0%              

Evergy, Inc.

    1,260,265         $ 85,508,980  
Electrical equipment—0.7%              

Eaton Corp. PLC

    13,430         1,947,619  

Generac Holdings, Inc.*

    123,100         27,005,678  
Electronic equipment, instruments & components—0.4%              

Keysight Technologies, Inc.*

    19,870         2,787,165  

Zebra Technologies Corp., Class A*

    35,110         12,978,762  
Energy equipment & services—0.8%              

Baker Hughes Co.

    145,102         4,501,064  

ChampionX Corp.

    210,389         4,439,208  

Valaris Ltd.*

    487,309         24,730,932  
Entertainment—2.3%              

Live Nation Entertainment, Inc.*

    703,145         73,745,848  

Spotify Technology S.A.*

    178,332         18,127,448  

Zynga, Inc., Class A*

    1,171,487         9,688,197  
Equity real estate investment trusts (REITs)—7.0%              

Agree Realty Corp.

    322,436         21,899,853  

EastGroup Properties, Inc.

    179,391         33,635,812  

Healthcare Realty Trust, Inc.

    2,415,358         65,407,895  

Host Hotels & Resorts, Inc.

    2,466,016         50,183,426  

Mid-America Apartment Communities, Inc.

    299,433         58,892,482  

STAG Industrial, Inc.

    1,978,525         73,838,553  
Food & staples retailing—2.1%              

Albertsons Cos, Inc., Class A

    887,000         27,745,360  

Casey’s General Stores, Inc.

    235,966         47,499,956  

The Kroger Co.

    318,967         17,211,459  
Food products—5.9%              

Darling Ingredients, Inc.*

    1,003,856         73,672,992  

Hormel Foods Corp.

    837,554         43,879,454  

Lamb Weston Holdings, Inc.

    247,774         16,377,861  

The Hain Celestial Group, Inc.*

    1,575,110         52,829,190  

The Hershey Co.

    177,695         40,118,200  

Tyson Foods, Inc., Class A

    324,513         30,231,631  
Health care equipment & supplies—2.6%              

ABIOMED, Inc.*

    155,974         44,699,029  

Align Technology, Inc.*

    19,230         5,574,969  

DexCom, Inc.*

    7,425         3,033,707  

Insulet Corp.*

    36,122         8,632,797  

Masimo Corp.*

    129,989         14,684,857  

NuVasive, Inc.*

    440,069         22,637,149  

Teleflex, Inc.

    49,919         14,257,865  
Health care providers & services—2.4%              

AmerisourceBergen Corp.

    194,575         29,437,252  

AMN Healthcare Services, Inc.*

    43,519         4,253,982  

Henry Schein, Inc.*

    340,213         27,591,274  

Molina Healthcare, Inc.*

    140,013         43,887,075  
Health care technology—0.4%              

Omnicell, Inc.*

    173,136         18,901,257  
Hotels, restaurants & leisure—2.7%              

Chipotle Mexican Grill, Inc.*

    3,316         4,826,803  

Darden Restaurants, Inc.

    228,216         30,062,894  

Royal Caribbean Cruises Ltd.*

    610,406         47,446,858  

Texas Roadhouse, Inc.

    411,615         33,888,263  

Vail Resorts, Inc.

    8,568         2,177,643  

 

 

COMMON STOCKS—94.2%   Shares           Value  
Household durables—0.5%              

Garmin Ltd.

    192,178         $ 21,089,614  
Household products—0.2%              

The Clorox Co.

    64,952         9,318,663  
Insurance—4.3%              

Arch Capital Group Ltd.*

    617,123         28,184,007  

Axis Capital Holdings Ltd.

    884,267         50,695,027  

Brown & Brown, Inc.

    1,013,622         62,824,292  

Everest Re Group Ltd.

    33,358         9,163,776  

White Mountains Insurance Group Ltd.

    33,937         35,566,655  
Interactive media & services—0.6%              

IAC/InterActiveCorp*

    78,737         6,525,723  

Twitter, Inc.*

    379,161         18,586,472  
IT services—3.1%              

DXC Technology Co.*

    2,113,420         60,655,154  

Gartner, Inc.*

    87,898         25,538,764  

Jack Henry & Associates, Inc.

    206,627         39,172,347  

Twilio, Inc., Class A*

    82,060         9,175,949  
Leisure products—0.5%              

Polaris, Inc.

    171,277         16,261,039  

YETI Holdings, Inc.*

    113,537         5,548,553  
Machinery—2.9%              

AGCO Corp.

    535,423         68,212,890  

Chart Industries, Inc.*

    145,153         24,504,730  

Parker-Hannifin Corp.

    57,459         15,561,046  

The Timken Co.

    307,428         17,720,150  
Media—0.6%              

Fox Corp., Class A

    753,368         27,000,709  
Metals & mining—2.0%              

Agnico Eagle Mines Ltd.

    460,032         26,787,663  

Alcoa Corp.

    160,047         10,851,187  

Freeport-McMoRan, Inc.

    847,353         34,360,164  

Nucor Corp.

    85,354         13,211,092  
Multiline retail—0.9%              

Dollar General Corp.

    108,663         25,810,722  

Ollie’s Bargain Outlet Holdings, Inc.*

    262,158         12,596,692  
Multi-utilities—5.0%              

CenterPoint Energy, Inc.

    2,081,744         63,722,184  

CMS Energy Corp.

    1,047,116         71,926,398  

WEC Energy Group, Inc.

    811,268         81,167,363  
Oil, gas & consumable fuels—7.2%              

Chesapeake Energy Corp.

    1,448,317         118,790,960  

Hess Corp.

    168,867         17,405,122  

Marathon Petroleum Corp.

    451,202         39,371,887  

Ovintiv, Inc.

    2,565,856         131,346,169  

Pioneer Natural Resources Co.

    19,643         4,566,408  
Professional services—0.4%              

Booz Allen Hamilton Holding Corp.

    155,922         12,727,913  

CoStar Group, Inc.*

    38,038         2,419,977  
Road & rail—0.7%              

AMERCO

    30,585         16,377,656  

Knight-Swift Transportation Holdings, Inc.

    251,088         12,024,604  

 

The accompanying notes are an integral part of the financial statements.           11  


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON SCOUT MID CAP FUND (cont’d)

 

COMMON STOCKS—94.2%   Shares           Value  
Semiconductors & semiconductor equipment—1.4%              

KLA Corp.

    73,244         $ 23,383,879  

NXP Semiconductors N.V.

    21,545         3,682,040  

ON Semiconductor Corp.*

    79,723         4,154,366  

Skyworks Solutions, Inc.

    156,697         17,753,770  

Teradyne, Inc.

    104,249         10,994,100  

Universal Display Corp.

    19,670         2,512,449  
Software—3.8%              

Black Knight, Inc.*

    122,393         8,052,236  

DocuSign, Inc.*

    258,275         20,920,275  

Splunk, Inc.*

    567,969         69,303,577  

Teradata Corp.*

    1,631,885         67,478,445  
Specialty retail—3.7%              

American Eagle Outfitters, Inc. (a)

    675,005         10,199,325  

Best Buy Co., Inc.

    215,620         19,390,707  

Burlington Stores, Inc.*

    272,755         55,522,008  

Floor & Decor Holdings, Inc., Class A*

    53,422         4,258,802  

Tractor Supply Co.

    149,779         30,172,980  

Ulta Beauty, Inc.*

    108,558         43,075,814  
Technology hardware, storage & peripherals—0.6%              

Pure Storage, Inc., Class A*

    950,016         27,835,469  
Textiles, apparel & luxury goods—0.6%              

Lululemon Athletica, Inc.*

    78,093         27,694,121  
Trading companies & distributors—1.0%              

United Rentals, Inc.*

    99,226         31,407,013  

W.W. Grainger, Inc.

    26,564         13,282,797  
Total common stocks (cost $3,658,330,280)

 

      4,096,991,970  
MONEY MARKET FUNDS—0.0%              

First American Government Obligations Fund—
Class X, 0.22%#

    1,597,104         1,597,104  
Total money market funds (cost $1,597,104)

 

      1,597,104  
Total investment portfolio (cost $3,659,927,384)—94.2%

 

      4,098,589,074  

Other assets in excess of liabilities—5.8%

 

      251,060,319  
Total net assets—100.0%

 

      $4,349,649,393  

* Non-income producing security

(a) All or a portion of this security was on loan as of the date of this report. The total fair market value of loaned securities was $1,508,265 or 0.0% of net assets as of the date of this report.

# Annualized seven-day yield as of the date of this report. Investment made with cash collateral received for securities on loan.

 

 

Sector allocation      
Sector   Percent of net assets  
Industrials     12.8%  
Consumer discretionary     10.3%  
Information technology     9.9%  
Financials     9.3%  
Health care     9.2%  
Materials     8.7%  
Consumer staples     8.6%  
Energy     7.9%  
Real estate     7.0%  
Utilities     7.0%  
Communication services     3.5%  
Money market funds     0.0%  

 

       
CARILLON SCOUT SMALL CAP FUND      
COMMON STOCKS—99.5%         Shares     Value  
Aerospace & defense—1.0%                  

Kratos Defense & Security Solutions, Inc.*

      208,611       $3,164,629  
Air freight & logistics—1.6%                  

Forward Air Corp.

      50,688       4,915,215  
Auto components—2.1%                  

Patrick Industries, Inc.

      60,023       3,736,432  

Stoneridge, Inc.*

      139,780       2,755,064  
Automobiles—1.1%                  

Thor Industries, Inc.

      42,539       3,256,360  
Banks—0.8%                  

Hilltop Holdings, Inc.

      95,286       2,428,840  
Biotechnology—6.9%                  

Coherus Biosciences, Inc.*

      300,080       2,712,723  

Eagle Pharmaceuticals, Inc.*

      85,549       3,775,277  

Halozyme Therapeutics, Inc.*

      146,892       5,860,991  

Insmed, Inc.*

      163,786       3,598,379  

Vericel Corp.*

      174,770       4,980,945  
Capital markets—2.3%                  

Cohen & Steers, Inc.

      73,748       5,729,482  

Open Lending Corp., Class A*

      99,217       1,353,320  
Chemicals—1.7%                  

Balchem Corp.

      40,659       5,009,189  
Commercial services & supplies—0.6%                  

Healthcare Services Group, Inc.

      100,702       1,720,997  
Construction & engineering—1.5%                  

Dycom Industries, Inc.*

      54,755       4,649,247  
Consumer finance—1.0%                  

Green Dot Corp., Class A*

      70,283       1,861,094  

LendingTree, Inc.*

      14,292       1,135,070  

 

12         The accompanying notes are an integral part of the financial statements.


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON SCOUT SMALL CAP FUND (cont’d)

 

COMMON STOCKS—99.5%         Shares     Value  
Diversified consumer services—1.3%                  

OneSpaWorld Holdings Ltd.*

      385,901       $ 3,874,446  
Electrical equipment—0.5%                  

TPI Composites, Inc.*

      141,184       1,615,145  
Electronic equipment, instruments & components—7.7%                  

Advanced Energy Industries, Inc.

      47,252       3,615,723  

ePlus, Inc.*

      87,681       4,952,223  

Fabrinet*

      49,548       4,865,118  

II-VI, Inc.*

      96,214       5,889,259  

Plexus Corp.*

      50,600       4,105,684  
Energy equipment & services—0.9%                  

Core Laboratories N.V.

      101,560       2,640,560  
Equity real estate investment trusts (REITs)—2.3%                  

CareTrust REIT, Inc.

      209,625       3,398,021  

UMH Properties, Inc.

      148,720       3,497,895  
Food & staples retailing—1.8%                  

Performance Food Group Co.*

      108,381       5,337,764  
Health care equipment & supplies—5.7%                  

ICU Medical, Inc.*

      23,340       4,994,526  

Integer Holdings Corp.*

      56,288       4,231,169  

LeMaitre Vascular, Inc.

      98,370       4,250,568  

Tactile Systems Technology, Inc.*

      93,784       1,583,074  

Varex Imaging Corp.*

      105,473       2,093,639  
Health care providers & services—9.6%                  

AdaptHealth Corp.*

      201,460       2,550,484  

AMN Healthcare Services, Inc.*

      68,949       6,739,765  

HealthEquity, Inc.*

      92,036       5,735,683  

LHC Group, Inc.*

      35,013       5,806,906  

ModivCare, Inc.*

      34,547       3,591,852  

U.S. Physical Therapy, Inc.

      45,546       4,726,308  
Health care technology—1.9%                  

Omnicell, Inc.*

      52,688       5,751,949  
Hotels, restaurants & leisure—2.7%                  

Cracker Barrel Old Country Store, Inc.

      25,912       2,875,973  

Lindblad Expeditions Holdings, Inc.*

      137,883       2,110,989  

The Cheesecake Factory, Inc.*

      90,521       3,341,130  
Household durables—3.2%                  

Installed Building Products, Inc.

      56,774       4,568,604  

LGI Homes, Inc.*

      46,261       4,335,118  

Purple Innovation, Inc.*

      159,412       656,778  
Interactive media & services—1.6%                  

Ziff Davis, Inc.*

      55,664       4,918,471  
IT services—2.8%                  

I3 Verticals, Inc., Class A*

      184,278       5,058,431  

TTEC Holdings, Inc.

      47,266       3,488,704  
Life sciences tools & services—2.2%                  

Medpace Holdings, Inc.*

      40,540       5,414,928  

NeoGenomics, Inc.*

      137,323       1,297,702  
Machinery—4.8%                  

Albany International Corp., Class A

      52,733       4,124,775  

Chart Industries, Inc.*

      53,296       8,997,431  

Proto Labs, Inc.*

      33,832       1,441,581  
Media—0.7%                  

Magnite, Inc.*

      217,595       2,099,792  

 

 

COMMON STOCKS—99.5%         Shares     Value  
Personal products—0.3%                  

Thorne HealthTech, Inc.*

      133,244       $ 892,735  
Pharmaceuticals—3.3%                  

Pacira BioSciences, Inc.*

      65,914       4,915,207  

Supernus Pharmaceuticals, Inc.*

      177,579       4,954,454  
Professional services—2.2%                  

Insperity, Inc.

      62,066       6,582,099  
Semiconductors & semiconductor equipment—7.5%                  

Ambarella, Inc.*

      53,332       4,377,491  

Credo Technology Group Holding Ltd.*

      274,121       3,026,296  

Impinj, Inc.*

      72,798       3,586,029  

Power Integrations, Inc.

      60,150       4,812,000  

Semtech Corp.*

      79,527       4,739,809  

Ultra Clean Holdings, Inc.*

      72,495       2,259,669  
Software—9.6%                  

Box, Inc., Class A*

      213,916       6,550,108  

Envestnet, Inc.*

      56,378       4,489,944  

Qualys, Inc.*

      43,272       5,897,108  

The Descartes Systems Group, Inc.*

      74,250       4,614,638  

Upland Software, Inc.*

      174,011       2,596,244  

Verint Systems, Inc.*

      90,290       4,926,222  
Specialty retail—1.0%                  

Monro, Inc.

      65,478       2,994,309  
Textiles, apparel & luxury goods—1.2%                  

G-III Apparel Group Ltd.*

      137,831       3,649,765  
Thrifts & mortgage finance—1.1%                  

Axos Financial, Inc.*

      88,911       3,367,949  
Trading companies & distributors—3.0%                  

Applied Industrial Technologies, Inc.

      51,513       5,392,896  

Global Industrial Co.

      119,130       3,676,352  
Total common stocks (cost $217,583,116)

 

    301,522,746  
Total investment portfolio (cost $217,583,116)—99.5%

 

    301,522,746  

Other assets in excess of liabilities—0.5%

 

    1,499,504  
Total net assets—100.0%

 

    $303,022,250  

* Non-income producing security

 

Sector allocation  
Sector   Percent of net assets  
Health care     29.6%  
Information technology     27.6%  
Industrials     15.3%  
Consumer discretionary     12.6%  
Financials     5.2%  
Communication services     2.3%  
Real estate     2.3%  
Consumer staples     2.1%  
Materials     1.6%  
Energy     0.9%  

 

The accompanying notes are an integral part of the financial statements.           13  


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON REAMS CORE BOND FUND

 

CORPORATE BONDS—37.0%         Principal
Amount
    Value  
Aerospace & defense—1.9%                  
Raytheon Technologies Corp.,                  

2.38%, 03/15/32

      $1,230,000       $1,057,193  

4.13%, 11/16/28

      3,680,000       3,682,544  
The Boeing Co.,                  

2.80%, 03/01/27

      315,000       290,437  

5.04%, 05/01/27

      2,830,000       2,861,219  
Agriculture—0.8%                  

BAT Capital Corp., 4.91%, 04/02/30

      3,260,000       3,142,821  
Airlines—2.9%                  

Air Canada, Pass Through Trust, Series 2020-2, Class A, 144A, 5.25%, 10/01/30

      908,819       926,642  

Alaska Airlines, Pass Through Trust, Series 2020-1, Class A, 144A, 4.80%, 02/15/29

      5,109,198       5,097,751  

British Airways, Pass Through Trust, Series 2020-1, Class A, 144A, 4.25%, 05/15/34

      1,135,533       1,099,220  

Delta Air Lines, Pass Through Trust, Series 2020-1, Class AA, 2.00%, 12/10/29

      1,570,283       1,406,156  
JetBlue, Pass Through Trust,                  

Series 2019-1, Class AA, 2.75%, 11/15/33

      1,408,561       1,266,430  

Series 2020-1, Class A, 4.00%, 05/15/34

      1,294,370       1,236,994  
United Airlines, Pass Through Trust,                  

Series 2015-1, Class AA, 3.45%, 06/01/29

      260,591       252,517  

Series 2016-2, Class AA, 2.88%, 04/07/30

      156,235       144,828  

Series 2018-1, Class AA, 3.50%, 09/01/31

      383,592       355,307  
Auto manufacturers—1.4%                  
General Motors Financial Co., Inc.,                  

1.25%, 01/08/26

      2,815,000       2,518,678  

2.75%, 06/20/25

      895,000       857,622  

Volkswagen Group of America Finance LLC, 144A, 3.75%, 05/13/30

      2,450,000       2,327,418  
Banks—5.6%                  
Bank of America Corp.,                  

(Fixed until 10/20/31, then SOFR + 1.21%), 2.57%, 10/20/32

      2,750,000       2,323,185  

3.50%, 04/19/26

      1,465,000       1,437,841  
Citigroup, Inc.,                  

(Fixed until 01/25/32, then SOFR + 1.35%), 3.06%, 01/25/33

      2,000,000       1,746,348  

(Fixed until 03/31/30, then SOFR + 3.91%), 4.41%, 03/31/31

      1,525,000       1,489,513  

Fifth Third Bancorp, 2.55%, 05/05/27

      1,745,000       1,632,938  

HSBC Holdings PLC, 4.95%, 03/31/30

      1,820,000       1,836,227  
JPMorgan Chase & Co.,                  

(Fixed until 01/25/32, then SOFR + 1.26%), 2.96%, 01/25/33

      2,000,000       1,759,544  

(Fixed until 03/24/30, then SOFR + 3.79%), 4.49%, 03/24/31

      2,270,000       2,262,435  

Mitsubishi UFJ Financial Group, Inc. (Fixed until 07/20/26, then 1 Year CMT Rate + 0.75%), 1.54%, 07/20/27

      1,900,000       1,698,275  

Sumitomo Mitsui Trust Bank Ltd., 144A, 0.80%, 09/16/24

      2,325,000       2,175,716  
Wells Fargo & Co.,                  

(Fixed until 03/02/32, then SOFR + 1.50%), 3.35%, 03/02/33

      2,005,000       1,821,748  

(Fixed until 04/04/30, then SOFR + 4.03%), 4.48%, 04/04/31

      2,305,000       2,295,636  
Beverages—0.8%                  

Anheuser-Busch InBev Worldwide, Inc., 3.50%, 06/01/30

      3,490,000       3,309,835  

 

 

CORPORATE BONDS—37.0%         Principal
Amount
    Value  
Capital markets—2.4%                  
Morgan Stanley,                  

(Fixed until 01/21/32, then SOFR + 1.29%), 2.94%, 01/21/33

      $ 2,000,000       $ 1,743,439  

(Fixed until 04/01/30, then SOFR + 3.12%), 3.62%, 04/01/31

      2,605,000       2,437,513  
The Goldman Sachs Group, Inc.,                  

(Fixed until 02/24/32, then SOFR + 1.41%), 3.10%, 02/24/33

      2,000,000       1,747,816  

3.50%, 04/01/25

      1,215,000       1,196,648  
UBS Group AG,                  

(Fixed until 01/30/26, then 1 Year CMT Rate + 1.08%), 144A, 1.36%, 01/30/27

      1,615,000       1,449,023  

(Fixed until 08/10/26, then 1 Year CMT Rate + 0.85%), 144A, 1.49%, 08/10/27

      1,215,000       1,077,899  
Containers & packaging—0.8%                  

Sonoco Products Co., 3.13%, 05/01/30

      3,750,000       3,410,301  
Diversified financial services—0.7%                  

American Express Co., 3.38%, 05/03/24

      2,950,000       2,947,645  
Diversified telecommunication services—1.7%                  
AT&T, Inc.,                  

2.55%, 12/01/33

      1,515,000       1,257,146  

2.75%, 06/01/31

      1,205,000       1,062,613  

4.30%, 02/15/30

      1,450,000       1,454,775  
Verizon Communications, Inc.,                  

2.10%, 03/22/28

      455,000       407,470  

2.55%, 03/21/31

      2,465,000       2,145,813  

4.02%, 12/03/29

      405,000       396,220  
Electric—4.4%                  

Appalachian Power Co., 2.70%, 04/01/31

      2,190,000       1,916,488  

Consolidated Edison Co. of New York, Inc., 3.35%, 04/01/30

      485,000       458,831  

DTE Electric Co., 1.90%, 04/01/28

      3,170,000       2,848,646  
Duke Energy Florida LLC,                  

1.75%, 06/15/30

      2,055,000       1,733,589  

5.65%, 04/01/40

      2,085,000       2,301,230  

Duke Energy Progress LLC, 3.70%, 09/01/28

      1,125,000       1,110,814  

Entergy Arkansas LLC, 3.35%, 06/15/52

      2,110,000       1,743,187  

Entergy Louisiana LLC, 2.35%, 06/15/32

      1,515,000       1,290,992  

Florida Power & Light Co., 2.88%, 12/04/51

      2,660,000       2,082,272  

Oncor Electric Delivery Co. LLC, 2.95%, 04/01/25

      485,000       477,036  

The Cleveland Electric Illuminating Co., 5.50%, 08/15/24

      870,000       906,686  

Wisconsin Public Service Corp., 2.85%, 12/01/51

      1,190,000       902,766  
Electric utilities—2.8%                  

American Electric Power Co., Inc., 0.75%, 11/01/23

      2,530,000       2,431,433  

Duke Energy Corp., 0.90%, 09/15/25

      2,000,000       1,831,131  

IPALCO Enterprises, Inc., 4.25%, 05/01/30

      2,035,000       1,940,469  

Southern California Edison Co., 1.20%, 02/01/26

      2,845,000       2,555,473  

Virginia Electric and Power Co., 2.30%, 11/15/31

      1,185,000       1,011,376  

Wisconsin Power and Light Co., 1.95%, 09/16/31

      1,700,000       1,423,652  
Electrical equipment—0.3%                  

Emerson Electric Co., 2.20%, 12/21/31

      1,220,000       1,057,796  
Equity real estate investment trusts (REITs)—1.2%                  

Agree LP, 2.00%, 06/15/28

      3,460,000       3,028,404  

Alexandria Real Estate Equities, Inc., 4.90%, 12/15/30

      140,000       145,700  

Ventas Realty LP, 4.75%, 11/15/30

      1,545,000       1,561,772  

 

14         The accompanying notes are an integral part of the financial statements.


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON REAMS CORE BOND FUND (cont’d)

 

CORPORATE BONDS—37.0%         Principal
Amount
    Value  
Food & staples retailing—0.3%                  

Sysco Corp., 2.45%, 12/14/31

      $ 1,380,000       $ 1,186,079  
Health care providers & services—0.5%                  

Cigna Corp., 2.38%, 03/15/31

      1,205,000       1,031,355  

CVS Health Corp., 2.13%, 09/15/31

      1,235,000       1,026,338  
Insurance—0.5%                  

Equitable Financial Life Global Funding, 144A, 1.40%, 07/07/25

      1,150,000       1,071,614  

Jackson National Life Global Funding, 144A, 1.75%, 01/12/25

      1,190,000       1,128,615  
Miscellaneous manufacturing —0.5%                  

GE Capital International Funding Co., 4.42%, 11/15/35

      1,886,000       1,843,319  
Multi-utilities—1.9%                  

CenterPoint Energy, Inc., 2.50%, 09/01/24

      2,685,000       2,611,073  

Dominion Energy, Inc., 3.38%, 04/01/30

      1,550,000       1,435,226  

Public Service Enterprise Group, Inc., 2.45%, 11/15/31

      2,095,000       1,766,688  

WEC Energy Group, Inc., 1.80%, 10/15/30

      2,215,000       1,821,465  
Oil & gas—0.3%                  

BP Capital Markets America, Inc., 2.72%, 01/12/32

      1,205,000       1,061,354  
Oil, gas & consumable fuels—0.9%                  

Chevron Corp., 1.55%, 05/11/25

      1,420,000       1,346,272  

TransCanada PipeLines Ltd., 4.10%, 04/15/30

      2,280,000       2,228,580  
Pharmaceuticals—0.3%                  

Bristol-Myers Squibb Co., 2.95%, 03/15/32

      405,000       372,131  

Merck & Co, Inc., 2.15%, 12/10/31

      1,205,000       1,049,099  
Road & rail—0.9%                  

Norfolk Southern Corp., 3.00%, 03/15/32

      1,540,000       1,397,483  

Union Pacific Corp., 2.80%, 02/14/32

      2,680,000       2,411,267  
Semiconductors—0.5%                  

TSMC Arizona Corp., 4.25%, 04/22/32

      2,255,000       2,242,292  
Specialty retail—0.3%                  

Lowe’s Cos, Inc., 2.63%, 04/01/31

      1,205,000       1,056,206  
Telecommunications—0.7%                  
T-Mobile USA, Inc.,                  

144A, 2.70%, 03/15/32

      1,275,000       1,081,743  

3.50%, 04/15/25

      1,870,000       1,843,480  
Tobacco—0.7%                  

Altria Group, Inc., 2.45%, 02/04/32

      1,650,000       1,320,383  

Reynolds American, Inc., 4.45%, 06/12/25

      1,560,000       1,571,270  
Transportation—1.0%                  

Burlington Northern Santa Fe LLC, 2.88%, 06/15/52

      1,560,000       1,197,737  

Canadian Pacific Railway Co., 1.75%, 12/02/26

      2,265,000       2,078,460  

CSX Transportation, Inc., 6.25%, 01/15/23

      172,676       176,358  
Union Pacific Railroad Co., Pass Through Trust,                  

Series 2004, 5.40%, 07/02/25

      14,353       14,339  

Series 2005, 5.08%, 01/02/29

      195,162       203,217  

Series 2006, 5.87%, 07/02/30

      214,215       231,657  
Total corporate bonds (cost $165,140,354)

 

    149,612,182  
MORTGAGE AND ASSET-BACKED SECURITIES—39.6%        
Asset-backed securities—6.6%                  

Avis Budget Rental Car Funding AESOP LLC,
Series 2022-1A, Class A, 144A, 3.83%, 08/20/28

      4,135,000       4,091,174  

 

 

MORTGAGE AND ASSET-BACKED
SECURITIES—39.6%
        Principal
Amount
    Value  
Asset-backed securities (cont'd)                  

BMW Vehicle Lease Trust, Series 2022-1, Class A2, 0.67%, 05/28/24

      $ 1,650,000       $ 1,635,645  

Capital One Prime Auto Receivables Trust, Series 2022-1, Class A3, 3.17%, 04/15/27

      4,020,000       4,011,206  

GM Financial Consumer Automobile Receivables Trust, Series 2020-3, Class A3, 0.45%, 04/16/25

      5,261,640       5,195,494  

Hertz Vehicle Financing LLC, Series 2021-1A, Class A, 144A, 1.21%, 12/25/25

      6,265,000       5,885,078  

Hertz Vehicle Financing III LLC, Series 2022-1A, Class A, 144A, 1.99%, 06/25/26

      2,100,000       1,984,724  

World Omni Auto Receivables Trust, Series 2020-C, Class A3, 0.48%, 11/17/25

      3,895,000       3,826,635  
Commercial mortgage-backed securities—6.8%                  

BANK, Series 2020-BNK30, Class A2, 1.36%, 12/17/53

      1,170,000       1,069,804  
Benchmark Mortgage Trust,                  

Series 2020-B21, Class A2, 1.74%, 12/17/53

      780,000       729,132  

Series 2020-B22, Class A2, 1.16%, 01/15/54

      2,741,000       2,471,529  

Series 2021-B23, Class A2, 1.62%, 02/15/54

      2,160,000       2,001,170  

Series 2021-B24, Class A2, 1.95%, 03/17/54

      1,935,000       1,792,194  

Series 2022-B33, Class A2, 3.32%, 03/17/55

      3,025,000       2,947,451  

CFCRE Commercial Mortgage Trust, Series 2016-C3, Class A3, 3.87%, 01/10/48

      1,855,000       1,841,631  
Citigroup Commercial Mortgage Trust,                  

Series 2014-GC21, Class AAB, 3.48%, 05/10/47

      382,331       383,263  

Series 2015-GC29, Class A3, 2.94%, 04/10/48

      1,409,169       1,376,645  
COMM Mortgage Trust,                  

Series 2013-CCRE9, Class ASB, 3.83%, 07/12/45

      140,823       141,749  

Series 2013-CCRE11, Class ASB, 3.66%, 08/12/50

      237,943       239,417  

Series 2015-LC19, Class A4, 3.18%, 02/10/48

      1,200,000       1,181,612  

DBJPM Mortgage Trust, Series 2020-C9, Class A2, 1.90%, 08/15/53

      4,385,000       4,113,014  
GS Mortgage Securities Trust,                  

Series 2013-GCJ14, Class AAB, 3.82%, 08/10/46

      76,810       77,319  

Series 2014-GCJ22, Class A5, 3.86%, 06/10/47

      355,000       354,732  

JP Morgan Chase Commercial Mortgage Securities Trust, Series 2014-C20, Class ASB, 3.46%, 07/17/47

      575,021       576,344  

JPMDB Commercial Mortgage Securities Trust,
Series 2017-C7, Class A3, 3.05%, 10/17/50

      1,385,000       1,355,054  

LSTAR Commercial Mortgage Trust, Series 2016-4, Class A3, 144A, 2.81%, 03/12/49

      460,000       440,216  
Wells Fargo Commercial Mortgage Trust,                  

Series 2016-C36, Class A3, 2.81%, 11/18/59

      1,100,000       1,039,730  

Series 2020-C56, Class A2, 2.50%, 06/17/53

      3,409,000       3,269,791  

WFRBS Commercial Mortgage Trust, Series 2014-C21, Class A4, 3.41%, 08/16/47

      373,045       368,064  
Federal agency mortgage-backed obligations—26.2%                  
Fannie Mae Pool,                  

Series 5796, Class AN, 3.03%, 06/01/27

      350,426       348,163  

Series 387770, 3.63%, 07/01/28

      455,000       459,316  

TBA, 2.00%, 07/15/52

      19,110,000       16,791,278  

TBA, 2.50%, 07/15/52

      23,170,000       21,052,901  

TBA, 3.00%, 07/15/52

      6,925,000       6,501,530  

TBA, 3.50%, 07/15/52

      36,275,000       35,010,921  

TBA, 4.00%, 07/15/52

      22,440,000       22,182,291  
Fannie Mae-Aces,                  

Series 2016-M3, Class ASQ2, 2.26%, 02/25/23

      48,965       48,822  

Series 2021-M23, Class AB, 0.50%, 11/25/31

      2,600,014       2,284,461  

 

The accompanying notes are an integral part of the financial statements.           15  


Investment Portfolios

 

 

CARILLON REAMS CORE BOND FUND (cont’d)

 

MORTGAGE AND ASSET-BACKED
SECURITIES—39.6%
        Principal
Amount
    Value  
Federal agency mortgage-backed obligations (cont'd)                  
Ginnie Mae I Pool,                  

Series 0091, Class AD, 2.73%, 06/15/32

      $ 1,057,458       $ 1,052,062  

Series 2583, Class AB, 2.14%, 08/15/23

      170,860       170,590  
Total mortgage and asset-backed securities (cost $163,807,179)         160,302,152  
FOREIGN GOVERNMENT BONDS—0.1%                  

Israel Government International Bond, 2.75%, 07/03/30

      380,000       359,100  
Total foreign government bonds (cost $380,000)         359,100  
U.S. TREASURIES—44.5%        
U.S. Treasury Bonds,                  

1.75%, 08/15/41

      17,615,000       13,954,383  

2.00%, 08/15/51

      23,155,000       18,708,516  
U.S. Treasury Notes,                  

0.13%, 11/30/22

      15,435,000       15,302,958  

0.13%, 01/31/23

      22,525,000       22,234,639  

0.75%, 03/31/26

      12,690,000       11,660,425  

0.88%, 09/30/26

      7,025,000       6,421,838  

1.38%, 10/31/28

      12,910,000       11,695,653  

1.50%, 02/29/24

      17,405,000       17,042,623  
U.S. TREASURIES—44.5%         Principal
Amount
    Value  
U.S. Treasury Notes, (cont'd)                  

1.63%, 04/30/23

      $ 41,820,000       $ 41,597,831  

1.75%, 01/31/29

      22,895,000       21,208,282  
Total U.S. Treasuries (cost $187,305,620)         179,827,148  
Total investment portfolio (cost $516,633,153)—121.2%

 

    490,100,582  

Liabilities in excess of other assets—(21.2)%

        (85,823,869
Total net assets—100.0%         $404,276,713  

144A—Securities are purchased under Rule 144A of the Securities Act of 1933 or are private placements and, unless registered under the Securities Act of 1933 or exempted from registration, generally may only be sold to qualified institutional buyers.

TBA—To-be-announced security. Securities are being used in dollar roll transactions.

 

Asset allocation      
Security type   Percent of net assets  
U.S. Treasuries     44.5%  
Mortgage and asset-backed securities     39.6%  
Corporate bonds     37.0%  
Foreign government bonds     0.1%  
 
SWAP CONTRACTS—CREDIT DEFAULT SWAPS                                                    
Central Clearing Party   Reference Entity   Rating of
Reference Entity
(Moody’s/S&P)
    Buy/Sell(a)
Protection
    Pay/Receive
Fixed Rate
    Fixed Rate   Expiration
Date
    Notional
Value(b)
    Value(c)     Premiums
Paid
(Received)
    Unrealized
Appreciation
(Depreciation)
 
Intercontinental Exchange   CDX North American Investment Grade Index Series 38     Baa2/BBB       Sell       Receive     1%/Quarterly     06/20/27       $9,830,000       $83,295       $156,781       $(73,486)  
Total swap contracts                 $9,830,000       $83,295       $156,781       $(73,486)  

There is $15,577 of variation margin due from the fund to the broker as of the date of this report.

(a) If the fund is a seller of protection and a credit event occurs, as defined under the terms of that particular swap agreement, the fund will either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation of underlying securities comprising the referenced index.

(b)The maximum potential amount the fund could be required to pay as a seller of credit protection or receive as a buyer of credit protection if a credit event occurs as defined under the terms of that particular swap agreement.

(c)The prices and resulting values for credit default swap agreements on credit indices serve as an indicator of the current status of the payment/performance risk and represent the likelihood of an expected liability (or profit) for the credit derivative should the notional amount of the swap agreement be closed/sold as of the period end. Increasing market values, in absolute terms when compared to the notional amount of the swap, represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement.

 

16         The accompanying notes are an integral part of the financial statements.


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON REAMS CORE PLUS BOND FUND

 

CORPORATE BONDS—34.7%         Principal
Amount
    Value  
Domestic—31.3%                  
Aerospace & defense—1.8%        
Raytheon Technologies Corp.,                  

2.38%, 03/15/32

      $4,070,000       $3,498,191  

4.13%, 11/16/28

      10,235,000       10,242,077  
The Boeing Co.,                  

2.80%, 03/01/27

      935,000       862,092  

3.60%, 05/01/34

      3,320,000       2,791,745  

5.04%, 05/01/27

      2,142,000       2,165,629  
Agriculture—0.8%        
BAT Capital Corp.,                  

3.56%, 08/15/27

      2,080,000       1,938,821  

4.91%, 04/02/30

      6,465,000       6,232,619  
Airlines—2.5%        

Alaska Airlines, Pass Through Trust, Series 2020-1, Class A, 144A, 4.80%, 02/15/29

      8,885,063       8,865,157  

British Airways, Pass Through Trust, Series 2020-1, Class A, 144A, 4.25%, 05/15/34

      2,392,529       2,316,019  

Delta Air Lines, Pass Through Trust, Series 2020-1, Class AA, 2.00%, 12/10/29

      8,693,452       7,784,803  
JetBlue, Pass Through Trust,                  

Series 2019-1, Class AA, 2.75%, 11/15/33

      5,094,601       4,580,531  

Series 2020-1, Class A, 4.00%, 05/15/34

      1,920,527       1,835,395  
United Airlines, Pass Through Trust,                  

Series 2015-1, Class AA, 3.45%, 06/01/29

      535,863       519,261  

Series 2016-2, Class AA, 2.88%, 04/07/30

      323,902       300,252  

Series 2018-1, Class AA, 3.50%, 09/01/31

      783,862       726,062  
Auto manufacturers—3.9%        
Ford Motor Credit Co. LLC,                  

3.37%, 11/17/23

      21,295,000       20,922,338  

3.38%, 11/13/25

      3,530,000       3,389,435  

5.58%, 03/18/24

      985,000       996,071  
General Motors Financial Co., Inc.,                  

1.25%, 01/08/26

      9,130,000       8,168,926  

2.75%, 06/20/25

      5,145,000       4,930,128  

Volkswagen Group of America Finance LLC, 144A, 3.75%, 05/13/30

      3,760,000       3,571,874  
Automobiles—0.2%        

Ford Motor Co., 3.25%, 02/12/32

      3,240,000       2,633,148  
Banks—4.7%        
Bank of America Corp.,                  

(Fixed until 10/20/31, then SOFR + 1.21%), 2.57%, 10/20/32

      7,823,000       6,608,827  

3.50%, 04/19/26

      100,000       98,146  

(Fixed until 04/23/26, then 3 Month LIBOR USD + 1.06%), 3.56%, 04/23/27

      7,000,000       6,791,597  
Citigroup, Inc.,                  

(Fixed until 01/29/30, then SOFR + 1.15%), 2.67%, 01/29/31

      2,910,000       2,528,735  

(Fixed until 01/25/32, then SOFR + 1.35%), 3.06%, 01/25/33

      6,440,000       5,623,238  

(Fixed until 03/31/30, then SOFR + 3.91%), 4.41%, 03/31/31

      3,890,000       3,799,480  

Fifth Third Bancorp, 2.55%, 05/05/27

      4,220,000       3,948,996  
JPMorgan Chase & Co.,                  

(Fixed until 01/25/32, then SOFR + 1.26%), 2.96%, 01/25/33

      6,435,000       5,661,334  

 

 

CORPORATE BONDS—34.7%         Principal
Amount
    Value  
Banks (cont'd)        
JPMorgan Chase & Co., (cont'd)                  

(Fixed until 03/24/30, then SOFR + 3.79%), 4.49%, 03/24/31

      $ 5,375,000       $ 5,357,087  
Wells Fargo & Co.,                  

(Fixed until 03/02/32, then SOFR + 1.50%), 3.35%, 03/02/33

      5,715,000       5,192,662  

(Fixed until 04/04/30, then SOFR + 4.03%), 4.48%, 04/04/31

      5,440,000       5,417,901  
Beverages—0.4%        

Anheuser-Busch InBev Worldwide, Inc., 3.50%, 06/01/30

      4,100,000       3,888,345  
Capital markets—1.9%        
Morgan Stanley,                  

(Fixed until 01/21/32, then SOFR + 1.29%), 2.94%, 01/21/33

      6,435,000       5,609,517  

(Fixed until 04/01/30, then SOFR + 3.12%), 3.62%, 04/01/31

      5,740,000       5,370,950  
The Goldman Sachs Group, Inc.,                  

(Fixed until 02/24/32, then SOFR + 1.41%), 3.10%, 02/24/33

      6,435,000       5,623,597  

3.50%, 04/01/25

      4,525,000       4,456,652  
Containers & packaging—0.3%        

Sonoco Products Co., 3.13%, 05/01/30

      4,070,000       3,701,313  
Diversified financial services—0.8%        

American Express Co., 3.38%, 05/03/24

      8,105,000       8,098,531  
Diversified telecommunication services—1.2%        
AT&T, Inc.,                  

2.55%, 12/01/33

      3,637,000       3,017,980  

2.75%, 06/01/31

      3,985,000       3,514,121  
Verizon Communications, Inc.,                  

2.10%, 03/22/28

      935,000       837,329  

2.55%, 03/21/31

      6,585,000       5,732,323  
Electric—3.7%        

Appalachian Power Co., 2.70%, 04/01/31

      6,695,000       5,858,852  

Consolidated Edison Co. of New York, Inc., 3.35%, 04/01/30

      465,000       439,910  

Constellation Energy Generation LLC, 3.25%, 06/01/25

      4,385,000       4,296,573  

Duke Energy Florida LLC, 5.65%, 04/01/40

      6,191,000       6,833,053  

Duke Energy Progress LLC, 3.70%, 09/01/28

      2,315,000       2,285,810  

Entergy Arkansas LLC, 3.35%, 06/15/52

      4,350,000       3,593,774  

Entergy Louisiana LLC, 2.35%, 06/15/32

      5,035,000       4,290,524  

Florida Power & Light Co., 2.88%, 12/04/51

      8,680,000       6,794,782  

Oncor Electric Delivery Co. LLC, 2.95%, 04/01/25

      1,130,000       1,111,445  

The Cleveland Electric Illuminating Co., 5.50%, 08/15/24

      1,855,000       1,933,221  

Wisconsin Public Service Corp., 2.85%, 12/01/51

      3,455,000       2,621,056  
Electric utilities—2.3%        

Duke Energy Corp., 0.90%, 09/15/25

      5,360,000       4,907,429  

IPALCO Enterprises, Inc., 4.25%, 05/01/30

      8,845,000       8,434,128  

Southern California Edison Co., 1.20%, 02/01/26

      5,920,000       5,317,540  

Virginia Electric and Power Co., 2.30%, 11/15/31

      3,450,000       2,944,512  

Wisconsin Power and Light Co., 1.95%, 09/16/31

      3,995,000       3,345,582  
Electrical equipment—0.3%        

Emerson Electric Co., 2.20%, 12/21/31

      4,040,000       3,502,866  
Equity real estate investment trusts (REITs)—0.6%        

Alexandria Real Estate Equities, Inc., 4.90%, 12/15/30

      670,000       697,278  

Ventas Realty LP, 4.75%, 11/15/30

      5,925,000       5,989,321  

 

The accompanying notes are an integral part of the financial statements.           17  


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON REAMS CORE PLUS BOND FUND (cont’d)

 

CORPORATE BONDS—34.7%         Principal
Amount
    Value  
Food & staples retailing—0.4%        

Sysco Corp., 2.45%, 12/14/31

      $ 4,490,000       $ 3,859,054  
Health care providers & services—0.6%        

Cigna Corp., 2.38%, 03/15/31

      3,985,000       3,410,744  

CVS Health Corp., 2.13%, 09/15/31

      4,085,000       3,394,811  
Healthcare services—0.5%        

HCA, Inc., 5.00%, 03/15/24

      5,170,000       5,290,218  
Insurance—0.6%        

Equitable Financial Life Global Funding, 144A, 1.40%, 07/07/25

      4,185,000       3,899,742  

Jackson National Life Global Funding, 144A, 1.75%, 01/12/25

      3,260,000       3,091,836  
Media—0.3%        

Charter Communications Operating LLC, 4.91%, 07/23/25

      3,030,000       3,085,934  
Multi-utilities—0.2%        

Dominion Energy, Inc., 3.38%, 04/01/30

      2,135,000       1,976,908  
Oil & gas—0.3%        

BP Capital Markets America, Inc., 2.72%, 01/12/32

      3,985,000       3,509,955  
Oil, gas & consumable fuels—0.1%        

Chevron Corp., 1.55%, 05/11/25

      1,310,000       1,241,983  
Pharmaceuticals—0.4%        

Bristol-Myers Squibb Co., 2.95%, 03/15/32

      1,380,000       1,268,001  

Merck & Co, Inc., 2.15%, 12/10/31

      3,985,000       3,469,429  
Road & rail—0.6%        

Norfolk Southern Corp., 3.00%, 03/15/32

      5,185,000       4,705,161  

Union Pacific Corp., 2.80%, 02/14/32

      1,380,000       1,241,623  
Specialty retail—0.3%        

Lowe’s Cos, Inc., 2.63%, 04/01/31

      3,985,000       3,492,929  
Telecommunications—0.8%        
T-Mobile USA, Inc.,                  

144A, 2.70%, 03/15/32

      4,220,000       3,580,357  

3.50%, 04/15/25

      4,895,000       4,825,580  
Tobacco—0.8%        

Altria Group, Inc., 2.45%, 02/04/32

      5,435,000       4,349,264  

Reynolds American, Inc., 4.45%, 06/12/25

      4,485,000       4,517,400  
Transportation—0.0%        

Burlington Northern and Santa Fe Railway Co., Pass Through Trust, Series 2005-4, 4.97%, 04/01/23

      39,118       39,413  
Total domestic corporate bonds (cost $371,304,003)

 

    339,597,233  
Foreign—3.4%        
Airlines—0.2%        

Air Canada, Pass Through Trust, Series 2020-2, Class A, 144A, 5.25%, 10/01/30

      2,032,670       2,072,534  
Banks—1.5%        

HSBC Holdings PLC, 4.95%, 03/31/30

      5,075,000       5,120,249  

Mitsubishi UFJ Financial Group, Inc. (Fixed until 07/20/26, then 1 Year CMT Rate + 0.75%), 1.54%, 07/20/27

      6,380,000       5,702,628  

Sumitomo Mitsui Trust Bank Ltd., 144A, 0.80%, 09/16/24

      5,450,000       5,100,066  
Capital markets—0.7%        
UBS Group AG,                  

(Fixed until 01/30/26, then 1 Year CMT Rate + 1.08%), 144A, 1.36%, 01/30/27

      4,805,000       4,311,179  

 

 

CORPORATE BONDS—34.7%         Principal
Amount
    Value  
Capital markets (cont'd)        
UBS Group AG, (cont'd)                  

(Fixed until 08/10/26, then 1 Year CMT Rate + 0.85%), 144A, 1.49%, 08/10/27

      $ 2,750,000       $ 2,439,689  

(Fixed until 08/13/29, then 3 Month LIBOR USD + 1.47%), 144A, 3.13%, 08/13/30

      1,190,000       1,081,766  
Miscellaneous manufacturing—0.5%        

GE Capital International Funding Co., 4.42%, 11/15/35

      5,570,000       5,443,947  
Oil, gas & consumable fuels—0.5%        

TransCanada PipeLines Ltd., 4.10%, 04/15/30

      5,595,000       5,468,818  
Total foreign corporate bonds (cost $39,749,443)

 

    36,740,876  
Total corporate bonds (cost $411,053,446)

 

    376,338,109  
MORTGAGE AND ASSET-BACKED SECURITIES—37.2%        
Asset-backed securities—5.7%        

Avis Budget Rental Car Funding AESOP LLC, Series 2022-1A, Class A, 144A, 3.83%, 08/20/28

      12,150,000       12,021,225  

BMW Vehicle Lease Trust, Series 2022-1, Class A2, 0.67%, 05/28/24

      4,485,000       4,445,980  

Capital One Prime Auto Receivables Trust, Series 2022-1, Class A3, 3.17%, 04/15/27

      5,505,000       5,492,958  

GM Financial Consumer Automobile Receivables Trust, Series 2020-3, Class A3, 0.45%, 04/16/25

      11,920,175       11,770,322  

Hertz Vehicle Financing LLC, Series 2021-1A, Class A, 144A, 1.21%, 12/25/25

      13,900,000       13,057,078  

Hertz Vehicle Financing III LLC, Series 2022-1A, Class A, 144A, 1.99%, 06/25/26

      5,785,000       5,467,442  

RFMSII Trust, Series 2006-HSA1, Class A4, SB, 5.99%, 02/25/36

      200,003       198,228  

World Omni Auto Receivables Trust, Series 2020-C, Class A3, 0.48%, 11/17/25

      9,415,000       9,249,748  
Commercial mortgage-backed securities—4.6%        

BANK, Series 2020-BNK30, Class A2, 1.36%, 12/17/53

      2,016,000       1,843,355  
Benchmark Mortgage Trust,                  

Series 2020-B21, Class A2, 1.74%, 12/17/53

      1,565,000       1,462,937  

Series 2021-B23, Class A2, 1.62%, 02/15/54

      4,555,000       4,220,059  

Series 2021-B24, Class A2, 1.95%, 03/17/54

      4,028,000       3,730,727  

Series 2022-B33, Class A2, 3.32%, 03/17/55

      8,420,000       8,204,144  

CFCRE Commercial Mortgage Trust, Series 2016-C3, Class A3, 3.87%, 01/10/48

      5,525,000       5,485,181  

Citigroup Commercial Mortgage Trust, Series 2015-GC29, Class A3, 2.94%, 04/10/48

      3,263,635       3,188,310  
COMM Mortgage Trust,                  

Series 2013-CCRE9, Class ASB, 3.83%, 07/12/45

      894,115       899,994  

Series 2015-LC19, Class A4, 3.18%, 02/10/48

      1,855,000       1,826,575  

DBJPM Mortgage Trust, Series 2020-C9, Class A2, 1.90%, 08/15/53

      9,445,000       8,859,161  

GS Mortgage Securities Trust, Series 2013-GCJ14, Class AAB, 3.82%, 08/10/46

      483,576       486,782  

JP Morgan Chase Commercial Mortgage Securities Trust, Series 2014-C20, Class ASB, 3.46%, 07/17/47

      1,283,204       1,286,158  

JPMDB Commercial Mortgage Securities Trust, Series 2017-C7, Class A3, 3.05%, 10/17/50

      3,415,000       3,341,162  

Wells Fargo Commercial Mortgage Trust, Series 2020-C56, Class A2, 2.50%, 06/17/53

      4,895,000       4,695,109  

 

18         The accompanying notes are an integral part of the financial statements.


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON REAMS CORE PLUS BOND FUND (cont’d)

 

MORTGAGE AND ASSET-BACKED
SECURITIES—37.2%
        Principal
Amount
    Value  
Federal agency mortgage-backed obligations—26.9%        
Fannie Mae Pool,                  

Series 5796, Class AN, 3.03%, 06/01/27

      $ 2,018,652       $ 2,005,615  

Series 387770, 3.63%, 07/01/28

      2,495,000       2,518,669  

TBA, 2.00%, 07/15/52

      52,245,000       45,905,824  

TBA, 2.50%, 07/15/52

      63,065,000       57,302,600  

TBA, 3.00%, 07/15/52

      19,630,000       18,429,609  

TBA, 3.50%, 07/15/52

      98,595,000       95,159,250  

TBA, 4.00%, 07/15/52

      61,470,000       60,764,055  
Fannie Mae-Aces,                  

Series 2016-M3, Class ASQ2, 2.26%, 02/25/23

      187,925       187,376  

Series 2016-M7, Class AV2, 2.16%, 10/25/23

      3,655,568       3,629,544  
Ginnie Mae I Pool,                  

Series 0091, Class AD, 2.73%, 06/15/32

      5,811,501       5,781,842  

Series 2583, Class AB, 2.14%, 08/15/23

      442,307       441,608  
Total mortgage and asset-backed securities (cost $410,320,015)

 

    403,358,627  
FOREIGN GOVERNMENT BONDS—7.1%                  

Brazil Notas do Tesouro Nacional, Series F, 10.00%, 01/01/23

      11,965,000       24,521,637  

Israel Government International Bond, 2.75%, 07/03/30

      1,995,000       1,885,275  

Malaysia Government Bond, 3.42%, 08/15/22

      14,310,000       3,302,271  

Mexico Government International Bond, 3.50%, 02/12/34

      8,195,000       6,925,103  

Petroleos Mexicanos, 7.69%, 01/23/50

      2,915,000       2,277,693  

Secretaria Tesouro Nacional, 10.00%, 01/01/31

      204,950       38,136,170  
Total foreign government bonds (cost $75,252,386)

 

    77,048,149  
U.S. TREASURIES—42.0%                  
U.S. Treasury Bonds,                  

1.75%, 08/15/41

      49,940,000       39,561,844  

2.00%, 08/15/51

      57,040,000       46,086,537  
U.S. TREASURIES—42.0%         Principal
Amount
    Value  
U.S. Treasury Notes,                  

0.13%, 11/30/22

      $ 38,050,000       $ 37,724,494  

0.13%, 01/31/23

      64,610,000       63,777,137  

0.88%, 09/30/26

      18,605,000       17,007,586  

1.38%, 10/31/28

      44,240,000       40,078,675  

1.63%, 04/30/23

      100,715,000       100,179,952  

1.75%, 01/31/29

      119,970,000       111,131,585  
Total U.S. Treasuries (cost $477,941,721)

 

    455,547,810  
Total investment portfolio (cost $1,374,567,568)—121.0%

 

    1,312,292,695  

Liabilities in excess of other assets—(21.0)%

 

    (227,701,030
Total net assets—100.0%

 

    $1,084,591,665  

144A—Securities are purchased under Rule 144A of the Securities Act of 1933 or are private placements and, unless registered under the Securities Act of 1933 or exempted from registration, generally may only be sold to qualified institutional buyers.

TBA—To-be-announced security. Securities are being used in dollar roll transactions.    

SB—Step bond. Coupon rate will either increase (step-up bond) or decrease (step-downbond) at regular intervals until maturity. Interest rate shown is the rate in effect as of the date of this report.

 

Asset allocation      
Security type   Percent of net assets  
U.S. Treasuries     42.0%  
Mortgage and asset-backed securities     37.2%  
Corporate bonds     34.7%  
Foreign government bonds     7.1%  
 
FUTURES CONTRACTS—LONG                                     
Description    Expiration
Date
       Number of
Contracts
     Notional Value
at Trade Date
     Notional Value
at April 30, 2022
     Unrealized
Appreciation
(Depreciation)
 
5-Year U.S. Treasury Note      06/30/22          2,400        $270,231,346        $270,412,500        $181,154  
FUTURES CONTRACTS—SHORT                                     
Description    Expiration
Date
       Number of
Contracts
     Notional Value
at Trade Date
     Notional Value
at April 30, 2022
     Unrealized
Appreciation
(Depreciation)
 
Long Bond U.S. Treasury Note      06/21/22          (694      $(96,537,697      $(97,637,125      $(1,099,428
Total futures contracts                    $(918,274

There is no variation margin due to or from the fund as of the date of this report.

 

The accompanying notes are an integral part of the financial statements.           19  


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON REAMS CORE PLUS BOND FUND (cont’d)

 

SWAP CONTRACTS—CREDIT DEFAULT SWAPS        
Central Clearing Party   Reference Entity   Rating of
Reference Entity
(Moody’s/S&P)
    Buy/Sell(a)
Protection
    Pay/Receive
Fixed Rate
    Fixed Rate   Expiration
Date
    Notional
Value(b)
    Value(c)     Premiums
Paid
(Received)
    Unrealized
Appreciation
(Depreciation)
 
Intercontinental Exchange   CDX North American High Yield Index Series 38     B2/B       Sell       Receive     5%/Quarterly     06/20/27       $ 51,810,000       $ 969,193       $2,281,163       $(1,311,970)  
Intercontinental Exchange   CDX North American Investment Grade Index Series 38     Baa2/BBB       Sell       Receive     1%/Quarterly     06/20/27       209,940,000       1,778,938       3,317,084       (1,538,146)  
Total credit default swap contracts

 

            $261,750,000       $2,748,131       $5,598,247       $(2,850,116)  

(a) If the fund is a seller of protection and a credit event occurs, as defined under the terms of that particular swap agreement, the fund will either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation of underlying securities comprising the referenced index.

(b)The maximum potential amount the fund could be required to pay as a seller of credit protection or receive as a buyer of credit protection if a credit event occurs as defined under the terms of that particular swap agreement.

(c)The prices and resulting values for credit default swap agreements on credit indices serve as an indicator of the current status of the payment/performance risk and represent the likelihood of an expected liability (or profit) for the credit derivative should the notional amount of the swap agreement be closed/sold as of the period end. Increasing market values, in absolute terms when compared to the notional amount of the swap, represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement.

 

INFLATION RATE SWAPS                              
Central Clearing Party   Pay/Receive Floating Rate   Floating Rate Index    Fixed
Rate
    Payment
Frequency
   Termination
Date
   Notional
Amount
     Unrealized
Appreciation/
(Depreciation)
 
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      3.10   At Termination    03/10/32      82,155,000        $(1,200,281
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      3.08   At Termination    03/10/32      29,600,000        (469,706
LCH Ltd   Receive   U.S. CPI Urban Consumers NSA (CPURNSA)      3.14   At Termination    03/22/32      60,160,000        477,483  
LCH Ltd   Receive   U.S. CPI Urban Consumers NSA (CPURNSA)      3.12   At Termination    03/22/32      20,170,000        206,925  
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      3.13   At Termination    03/29/32      29,565,000        (242,121
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      3.14   At Termination    04/21/32      50,905,000        (168,487
Total inflation rate swap contracts                   $(1,396,187

CPI—Consumer Price Index    

There is $563,376 of variation margin related to swap contracts due from the fund to the broker as of the date of this report.     

 

FORWARD CONTRACTS                                                  
Currency to be Received        Currency to be Delivered        Settlement Date        Counterparty        Unrealized
Appreciation
(Depreciation)
 
U.S. Dollar      61,195,060        Brazilian Real        319,240,218          06/02/22          J.P. Morgan          $(2,654,089)  
South Korean Won      11,350,000,000        U.S. Dollar        9,187,308          07/22/22          J.P. Morgan          (142,979)  
Total forward contracts                       $(2,797,068)  

 

20         The accompanying notes are an integral part of the financial statements.


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON REAMS UNCONSTRAINED BOND FUND

 

CORPORATE BONDS—28.9%         Principal
Amount
    Value  
Domestic—26.8%                  
Aerospace & defense—1.3%        

Raytheon Technologies Corp., 4.13%, 11/16/28

      $8,580,000       $8,585,933  
The Boeing Co.,                  

2.80%, 03/01/27

      725,000       668,467  

3.60%, 05/01/34

      6,415,000       5,394,290  

5.04%, 05/01/27

      690,000       697,612  
Agriculture—0.9%        

BAT Capital Corp., 3.56%, 08/15/27

      10,925,000       10,183,470  
Airlines—2.4%        
British Airways, Pass Through Trust,                  

Series 2020-1, Class A, 144A, 4.25%, 05/15/34

      1,482,973       1,435,549  

Series 2021-1, Class A, 144A, 2.90%, 09/15/36

      5,046,636       4,508,542  

Delta Air Lines, Pass Through Trust, Series 2020-1, Class AA, 2.00%, 12/10/29

      13,600,018       12,178,530  

JetBlue, Pass Through Trust, Series 2020-1, Class A, 4.00%, 05/15/34

      2,644,813       2,527,576  
United Airlines, Pass Through Trust,                  

Series 2014-1, Class A, 4.00%, 10/11/27

      593,997       588,173  

Series 2015-1, Class AA, 3.45%, 06/01/29

      418,414       405,450  

Series 2016-2, Class AA, 2.88%, 04/07/30

      2,530,242       2,345,500  

Series 2018-1, Class AA, 3.50%, 09/01/31

      612,914       567,719  

Series 2019-1, Class AA, 4.15%, 02/25/33

      3,221,164       3,148,250  
Auto manufacturers—3.9%        
Ford Motor Credit Co. LLC,                  

3.37%, 11/17/23

      13,845,000       13,602,712  

3.38%, 11/13/25

      2,570,000       2,467,663  

4.27%, 01/09/27

      2,570,000       2,422,225  

5.58%, 03/18/24

      5,055,000       5,111,818  
General Motors Financial Co., Inc.,                  

2.90%, 02/26/25

      1,390,000       1,342,260  

3.80%, 04/07/25

      9,960,000       9,835,443  

4.30%, 07/13/25

      2,675,000       2,682,734  

4.35%, 01/17/27

      4,125,000       4,070,145  

5.25%, 03/01/26

      2,800,000       2,875,236  
Banks—6.7%        
Bank of America Corp.,                  

(Fixed until 02/04/32, then SOFR + 1.33%), 2.97%, 02/04/33

      12,030,000       10,467,921  

(Fixed until 04/23/26, then 3 Month LIBOR USD + 1.06%), 3.56%, 04/23/27

      5,835,000       5,661,281  
Citigroup, Inc.,                  

(Fixed until 03/17/32, then SOFR + 1.94%), 3.79%, 03/17/33

      12,035,000       11,143,027  

(Fixed until 03/31/30, then SOFR + 3.91%), 4.41%, 03/31/31

      5,770,000       5,635,732  
JPMorgan Chase & Co.,                  

(Fixed until 04/22/26, then SOFR + 0.89%), 1.58%, 04/22/27

      5,970,000       5,400,584  

(Fixed until 01/25/32, then SOFR + 1.26%), 2.96%, 01/25/33

      12,030,000       10,583,659  

(Fixed until 04/26/25, then SOFR + 1.32%), 4.08%, 04/26/26

      5,900,000       5,885,035  
Wells Fargo & Co.,                  

(Fixed until 03/02/32, then SOFR + 1.50%), 3.35%, 03/02/33

      12,030,000       10,930,485  

(Fixed until 04/25/25, then SOFR + 1.32%), 3.91%, 04/25/26

      5,045,000       5,009,533  

(Fixed until 04/04/30, then SOFR + 4.03%), 4.48%, 04/04/31

      5,390,000       5,368,104  

 

 

CORPORATE BONDS—28.9%         Principal
Amount
    Value  
Capital markets—1.2%        
Morgan Stanley,                  

(Fixed until 01/21/32, then SOFR + 1.29%), 2.94%, 01/21/33

      $ 6,015,000       $ 5,243,394  

(Fixed until 04/01/30, then SOFR + 3.12%), 3.62%, 04/01/31

      2,900,000       2,713,546  

The Goldman Sachs Group, Inc. (Fixed until 02/24/32, then SOFR + 1.41%), 3.10%, 02/24/33

      6,015,000       5,256,556  
Consumer finance—1.0%        
Ally Financial, Inc.,                  

4.63%, 03/30/25

      2,000,000       2,034,066  

5.80%, 05/01/25

      8,550,000       8,935,661  
Diversified financial services—0.7%        

American Express Co., 3.38%, 05/03/24

      8,485,000       8,478,227  
Diversified telecommunication services—0.2%        
Verizon Communications, Inc.,                  

2.10%, 03/22/28

      770,000       689,565  

2.55%, 03/21/31

      2,145,000       1,867,249  
Electric—1.3%        

Appalachian Power Co., 2.70%, 04/01/31

      6,345,000       5,552,564  

Consolidated Edison Co. of New York, Inc., 3.35%, 04/01/30

      510,000       482,482  

Constellation Energy Generation LLC, 3.25%, 06/01/25

      3,340,000       3,272,646  

Entergy Louisiana LLC, 2.35%, 06/15/32

      4,010,000       3,417,080  

The Cleveland Electric Illuminating Co., 5.50%, 08/15/24

      1,580,000       1,646,625  
Electric utilities—2.7%        

Duke Energy Corp., 0.90%, 09/15/25

      2,100,000       1,922,687  

Edison International, 4.95%, 04/15/25

      750,000       763,028  
Pacific Gas and Electric Co.,                  

(SOFR + 1.15%), 1.34%, 11/14/22

      1,720,000       1,721,435  

1.70%, 11/15/23

      9,665,000       9,386,342  

1.75%, 06/16/22

      8,895,000       8,888,967  
Southern California Edison Co.,                  

1.20%, 02/01/26

      4,890,000       4,392,360  

3.70%, 08/01/25

      4,155,000       4,144,771  
Entertainment—0.9%        

Magallanes, Inc., 144A, 3.43%, 03/15/24

      10,845,000       10,773,238  
Healthcare services—0.4%        

HCA, Inc., 5.00%, 03/15/24

      4,100,000       4,195,338  
Insurance—0.3%        

Jackson National Life Global Funding, 144A, 1.75%, 01/12/25

      3,100,000       2,940,090  
Media—0.4%        

Charter Communications Operating LLC, 4.91%, 07/23/25

      4,655,000       4,740,931  
Multi-utilities—1.0%        

CenterPoint Energy, Inc., 2.50%, 09/01/24

      2,225,000       2,163,739  

Dominion Energy, Inc., 3.38%, 04/01/30

      6,250,000       5,787,201  

Public Service Enterprise Group, Inc., 0.84%, 11/08/23

      3,605,000       3,473,634  
Telecommunications—0.4%        

T-Mobile USA, Inc., 3.50%, 04/15/25

      5,125,000       5,052,318  
Tobacco—1.1%        

Altria Group, Inc., 4.80%, 02/14/29

      7,705,000       7,631,341  

Reynolds American, Inc., 4.45%, 06/12/25

      5,371,000       5,409,801  
Total domestic corporate bonds (cost $321,596,480)

 

    306,707,540  

 

The accompanying notes are an integral part of the financial statements.           21  


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON REAMS UNCONSTRAINED BOND FUND (cont’d)

 

CORPORATE BONDS—28.9%         Principal
Amount
    Value  
Foreign—2.1%                  
Airlines—0.2%        

Air Canada, Pass Through Trust, Series 2020-2, Class A, 144A, 5.25%, 10/01/30

      $ 1,724,321       $ 1,758,138  
Banks—0.8%        

Mitsubishi UFJ Financial Group, Inc. (Fixed until 07/20/26, then 1 Year CMT Rate + 0.75%), 1.54%, 07/20/27

      5,565,000       4,974,157  

Sumitomo Mitsui Trust Bank Ltd., 144A, 0.80%, 09/16/24

      4,860,000       4,547,949  
Capital markets—0.6%        
UBS Group AG,                  

(Fixed until 01/30/26, then 1 Year CMT Rate + 1.08%), 144A, 1.36%, 01/30/27

      5,095,000       4,571,375  

(Fixed until 08/10/26, then 1 Year CMT Rate + 0.85%), 144A, 1.49%, 08/10/27

      2,450,000       2,173,541  
Miscellaneous manufacturing—0.1%                  

GE Capital International Funding Co., 4.42%, 11/15/35

      854,000       834,673  
Oil, gas & consumable fuels—0.4%        

TransCanada PipeLines Ltd., 4.10%, 04/15/30

      5,011,000       4,897,989  
Total foreign corporate bonds (cost $25,809,105)

 

    23,757,822  
Total corporate bonds (cost $347,405,585)

 

    330,465,362  
MORTGAGE AND ASSET-BACKED SECURITIES—14.3%        
Asset-backed securities—4.1%        

Avis Budget Rental Car Funding AESOP LLC, Series 2020-2A, Class A, 144A, 2.02%, 02/20/27

      19,365,000       18,111,339  

Capital One Prime Auto Receivables Trust, Series 2022-1, Class A3, 3.17%, 04/15/27

      5,760,000       5,747,400  

Hertz Vehicle Financing LLC, Series 2021-1A, Class A, 144A, 1.21%, 12/25/25

      17,285,000       16,236,805  

Hertz Vehicle Financing III LLC, Series 2022-1A, Class A, 144A, 1.99%, 06/25/26

      7,025,000       6,639,374  
Commercial mortgage-backed securities—2.4%        

BANK, Series 2021-BNK35, Class A2, 1.87%, 06/17/64

      6,280,000       5,789,085  

Benchmark Mortgage Trust, Series 2021-B28, Class A2, 1.79%, 08/17/54

      4,640,000       4,276,675  

Citigroup Commercial Mortgage Trust, Series 2015-GC29, Class A3, 2.94%, 04/10/48

      962,932       940,707  
COMM Mortgage Trust,                  

Series 2012-CCRE4, Class ASB, 2.44%, 10/17/45

      595,674       595,613  

Series 2013-CCRE10, Class ASB, 3.80%, 08/10/46

      526,539       528,946  

DBJPM Mortgage Trust, Series 2020-C9, Class A2, 1.90%, 08/15/53

      4,255,000       3,991,078  
GS Mortgage Securities Trust,                  

Series 2013-GCJ12, Class A3, 2.86%, 06/12/46

      2,120,000       2,112,101  

Series 2013-GCJ14, Class AAB, 3.82%, 08/10/46

      1,027,734       1,034,547  
J.P. Morgan Chase Commercial Mortgage Securities
Trust,
                 

Series 2012-LC9, Class ASB, 2.44%, 12/17/47

      1,716,449       1,716,261  

Series 2019-MFP, Class A (1 Month LIBOR USD + 0.96%), 144A, 1.51%, 07/15/36

      3,945,000       3,899,378  

JPMBB Commercial Mortgage Securities Trust, Series 2014-C22, Class A4, 3.80%, 09/17/47

      825,000       825,649  

 

 

MORTGAGE AND ASSET-BACKED
SECURITIES—14.3%
        Principal
Amount
    Value  
Commercial mortgage-backed securities (cont'd)        
WFRBS Commercial Mortgage Trust,                  

Series 2012-C10, Class ASB, 2.45%, 12/15/45

      $ 356,395       $ 356,352  

Series 2013-C15, Class ASB, 3.72%, 08/17/46

      892,432       897,966  
Federal agency mortgage-backed obligations—7.8%        
Fannie Mae Pool,                  

Series 5796, Class AN, 3.03%, 06/01/27

      4,042,239       4,016,133  

Series 387770, 3.63%, 07/01/28

      4,760,000       4,805,156  

TBA, 3.00%, 07/15/52

      24,795,000       23,278,765  

TBA, 3.50%, 07/15/52

      29,500,000       28,472,010  

TBA, 4.00%, 07/15/52

      29,490,000       29,151,326  
Total mortgage and asset-backed securities (cost $167,998,103)

 

    163,422,666  
FOREIGN GOVERNMENT BONDS—8.1%        

Brazil Notas do Tesouro Nacional, Series F, 10.00%, 01/01/23

      3,627,500       7,434,370  

Malaysia Government Bond, 3.42%, 08/15/22

      25,590,000       5,905,318  

Mexico Bonos, 7.75%, 05/29/31

      2,483,213       11,157,027  

Mexico Udibonos, 4.50%, 11/22/35

      1,866,800       9,619,496  

Petroleos Mexicanos, 7.69%, 01/23/50

      2,675,000       2,090,165  

Secretaria Tesouro Nacional, 10.00%, 01/01/31

      301,510       56,103,618  
Total foreign government bonds (cost $90,971,380)         92,309,994  
U.S. TREASURIES—51.1%        
U.S. Treasury Notes,                  

0.88%, 01/31/24

      89,185,000       86,481,580  

0.88%, 09/30/26

      345,685,000       316,004,700  

1.50%, 02/29/24

      13,185,000       12,910,484  

1.75%, 01/31/29

      112,300,000       104,026,648  

2.25%, 03/31/24

      4,300,000       4,263,719  

2.75%, 04/30/23

      60,025,000       60,362,640  
Total U.S. Treasuries (cost $606,257,554)

 

    584,049,771  
MEDIUM-TERM NOTES—0.1%        

Citigroup Global Markets Holdings, Inc., 144A, 06/27/22*

      420,000       589,415  
Total medium-term notes (cost $420,000)

 

    589,415  
Total investment portfolio (cost $1,213,052,622)—102.5%

 

    1,170,837,208  

Liabilities in excess of other assets—(2.5)%

 

    (28,771,121
Total net assets—100.0%

 

    $1,142,066,087  

144A—Securities are purchased under Rule 144A of the Securities Act of 1933 or are private placements and, unless registered under the Securities Act of 1933 or exempted from registration, generally may only be sold to qualified institutional buyers.

TBA—To-be-announced security. Securities are being used in dollar roll transactions.

* This security does not pay interest and does not guarantee full repayment of principal at maturity. Instead, the security offers a payment at maturity that may be greater than or less than the stated principal amount, depending on the performance of the S&P 500 Index (“SPX”) from its initial underlying value to its final underlying value.

 

22         The accompanying notes are an integral part of the financial statements.


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON REAMS UNCONSTRAINED BOND FUND (cont’d)

 

Asset allocation      
Security type   Percent of net assets  
U.S. Treasuries     51.1%  
Corporate bonds     28.9%  
Mortgage and asset-backed securities     14.3%  
Foreign government bonds     8.1%  
Medium-term notes     0.1%  
FUTURES CONTRACTS—LONG                                     
Description    Expiration
Date
       Number of
Contracts
     Notional Value
at Trade Date
     Notional Value
at April 30, 2022
     Unrealized
Appreciation
(Depreciation)
 
Canadian 10-Year Bond*      06/21/22          761        $75,670,132        $74,853,041        $(817,091
5-Year U.S. Treasury Note      06/30/22          6,005        679,945,670        676,594,609        (3,351,061
Euro BOBL Future^      06/08/22          1,741        234,596,924        233,587,977        (1,008,947
FUTURES CONTRACTS—SHORT                                     
Description    Expiration
Date
       Number of
Contracts
     Notional Value
at Trade Date
     Notional Value
at April 30, 2022
     Unrealized
Appreciation
(Depreciation)
 
Euro SCHATZ Future^      06/08/22          (880      $(102,544,365      $(102,254,010      $290,355  
Euro BUND Future^      06/08/22          (780      (127,689,304      (126,383,517      1,305,787  
U.S. Treasury Long Bond      06/21/22          (1,699      (243,833,593      (239,028,062      4,805,531  
Ultra 10-Year U.S. Treasury Note      06/21/22          (500      (65,353,425      (64,500,000      853,425  
Total futures contracts                    $2,077,999  

There is $242,454 of variation margin due to the broker from the fund as of the date of this report.

* These futures contracts are denominated in Canadian Dollars. Notional Value at Trade Date, Notional Value at April 30, 2022 and Unrealized Appreciation (Depreciation) have been translated into U.S. Dollars as of April 30, 2022.

^ These futures contracts are denominated in Euro. Notional Value at Trade Date, Notional Value at April 30, 2022 and Unrealized Appreciation (Depreciation) have been translated into U.S. Dollars as of April 30, 2022.

 

SCHEDULE OF WRITTEN OPTIONS                           
WRITTEN OPTIONS      Number of
Contracts
       Notional
Amount
       Value  
Exchange traded put options               
S&P Index E-mini Futures, Expires 06/17/22, Exercise price $3,200        162          $33,432,750          $(145,800
Total written options (premiums received $291,273)                  $(145,800

 

The accompanying notes are an integral part of the financial statements.           23  


Investment Portfolios

(UNAUDITED)    |    04.30.2022

 

CARILLON REAMS UNCONSTRAINED BOND FUND (cont’d)

 

SWAP CONTRACTS—CREDIT DEFAULT SWAPS        
Central Clearing Party   Reference Entity   Rating of
Reference Entity
(Moody’s/S&P)
    Buy/Sell(a)
Protection
    Pay/Receive
Fixed Rate
    Fixed Rate   Expiration
Date
    Notional
Value(b)
    Value(c)     Premiums
Paid
(Received)
    Unrealized
Appreciation
(Depreciation)
 
Intercontinental Exchange   CDX North American High Yield Index Series 38     B2/B       Sell       Receive     5%/Quarterly     06/20/27       $125,445,000       $2,416,005       $6,055,051       $(3,639,046
Intercontinental Exchange   CDX North American Investment Grade Index Series 38     Baa2/BBB       Sell       Receive     1%/Quarterly     06/20/27       180,660,000       1,530,833       2,848,371       (1,317,538
Total credit default swap contracts

 

            $306,105,000       $3,946,838       $8,903,422       $(4,956,584

(a) If the fund is a seller of protection and a credit event occurs, as defined under the terms of that particular swap agreement, the fund will either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation of underlying securities comprising the referenced index.

(b)The maximum potential amount the fund could be required to pay as a seller of credit protection or receive as a buyer of credit protection if a credit event occurs as defined under the terms of that particular swap agreement.

(c)The prices and resulting values for credit default swap agreements on credit indices serve as an indicator of the current status of the payment/performance risk and represent the likelihood of an expected liability (or profit) for the credit derivative should the notional amount of the swap agreement be closed/sold as of the period end. Increasing market values, in absolute terms when compared to the notional amount of the swap, represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement.

 

INFLATION RATE SWAPS  
Central Clearing Party   Pay/Receive Floating Rate   Floating Rate Index    Fixed
Rate
    Payment
Frequency
   Termination
Date
   Notional
Amount
     Unrealized
Appreciation/
(Depreciation)
 
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      2.90   At Termination    02/28/32      28,166,000        $(1,005,887
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      2.88   At Termination    02/28/32      56,332,000        (2,123,310
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      2.88   At Termination    03/02/32      28,365,000        (1,065,150
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      2.97   At Termination    03/09/32      59,985,000        (1,657,751
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      3.04   At Termination    03/11/32      28,150,000        (562,530
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      3.08   At Termination    03/11/32      28,150,000        (435,298
LCH Ltd   Receive   U.S. CPI Urban Consumers NSA (CPURNSA)      3.14   At Termination    03/22/32      60,440,000        479,705  
LCH Ltd   Receive   U.S. CPI Urban Consumers NSA (CPURNSA)      3.12   At Termination    03/22/32      43,765,000        448,987  
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      3.14   At Termination    03/28/32      53,865,000        (394,862
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      3.12   At Termination    03/29/32      12,255,000        (112,720
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      3.13   At Termination    03/29/32      10,400,000        (87,793
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      3.13   At Termination    03/29/32      12,255,000        (100,362
LCH Ltd   Pay   U.S. CPI Urban Consumers NSA (CPURNSA)      3.14   At Termination    03/29/32      12,255,000        (87,992
Total inflation rate swap contracts                   $(6,704,963

CPI—Consumer Price Index

There is $1,769,994 of variation margin related to swap contracts due from the fund to the broker as of the date of this report.

 

FORWARD CONTRACTS                                                  
Currency to be Received        Currency to be Delivered        Settlement Date        Counterparty        Unrealized
Appreciation
(Depreciation)
 
U.S. Dollar      62,854,128        Brazilian Real        326,679,571          06/02/22          J.P. Morgan          $(2,482,919)  
South Korean Won      21,850,000,000        U.S. Dollar        17,686,579          07/22/22          J.P. Morgan          (275,250)  
U.S. Dollar      20,737,026        Mexican Peso        442,441,156          06/14/22          J.P. Morgan          (745,754)  
Total forward contracts                       $(3,503,923)  

 

24         The accompanying notes are an integral part of the financial statements.


Statements of Assets and Liabilities

(UNAUDITED)    |    04.30.2022

 

     Carillon ClariVest
Capital
Appreciation
Fund
    Carillon ClariVest
International
Stock
Fund
    Carillon Eagle
Growth
& Income
Fund
    Carillon Eagle
Mid Cap
Growth
Fund
 
Assets        

Investments—unaffiliated, at value (a)(b)

    $582,540,632       $30,385,923       $912,192,115       $6,291,013,102  

Cash

    6,612,002       495,742       28,979,981       95,191,665  

Receivable for investments sold

                      15,060,476  

Receivable for fund shares sold

    670,595       21,168       1,816,276       5,779,050  

Receivable for dividends and interest, net

    386,255       164,305       723,175       175,039  

Receivable for foreign tax reclaims

          88,298              

Receivable due from adviser, net

          14,346              

Prepaid expenses

    24,463       32,765       1,501       29,475  
Total assets     590,233,947       31,202,547       943,713,048       6,407,248,807  

Liabilities

       

Payable for securities lending collateral received

    4,084,628                    

Payable for investments purchased

                4,553,457       17,239,042  

Payable for fund shares redeemed

    551,006       5,686       573,428       7,826,373  

Accrued custody fees

    3,393       10,197       5,053       31,359  

Accrued investment advisory fees, net

    228,857             355,784       2,878,109  

Accrued administrative fees

    50,500       2,628       80,726       563,293  

Accrued distribution fees

    49,240       2,222       104,540       253,754  

Accrued shareholder servicing fees

    56,133       1,861       71,849       276,531  

Accrued professional fees

    35,848       38,637       36,554       36,866  

Accrued trustees compensation

    17,581       17,581       17,581       17,581  

Accrued officers compensation

    46       46       46       46  

Other accrued expenses

    27,649       9,837       42,493       220,164  
Total liabilities     5,104,881       88,695       5,841,511       29,343,118  
Net assets     585,129,066       31,113,852       937,871,537       6,377,905,689  
Net assets consists of        

Paid-in capital

    306,653,712       32,436,789       620,905,453       4,179,342,476  
Total distributable earnings (loss)     278,475,354       (1,322,937     316,966,084       2,198,563,213  
Net assets     585,129,066       31,113,852       937,871,537       6,377,905,689  
Net assets, at market value        

Class A

    178,630,819       3,415,789       221,607,047       672,954,509  

Class C

    10,619,899       1,629,369       64,738,602       98,651,974  

Class I

    388,416,203       12,153,057       634,544,528       1,451,102,752  

Class R-3

    295,605       166,385       1,719,455       37,461,247  

Class R-5

    5,286,921       4,033       6,430,075       753,287,081  

Class R-6

    1,856,659       13,731,444       8,671,252       3,361,741,991  

Class Y

    22,960       13,775       160,578       2,706,135  
NAV, offering and redemption price per share (c)        

Class A

    $50.56       $18.88       $23.24       $72.54  

Class A maximum offering price (d)

    53.08       19.82       24.40       76.16  

Class C

    30.53       18.52       21.95       53.10  

Class I

    54.19       18.85       23.16       78.44  

Class R-3

    47.57       18.77       23.12       69.08  

Class R-5

    53.98       18.87       23.19       78.16  

Class R-6

    53.72       18.91       23.12       79.32  

Class Y

    53.87       18.79       23.09       77.15  
Shares of beneficial interest outstanding        

Class A

    3,533,349       180,877       9,536,816       9,277,507  

Class C

    347,832       87,970       2,949,105       1,857,838  

Class I

    7,167,436       644,805       27,399,285       18,499,124  

Class R-3

    6,214       8,863       74,365       542,324  

Class R-5

    97,939       214       277,324       9,638,089  

Class R-6

    34,559       726,099       375,114       42,379,599  

Class Y

    426       733       6,953       35,078  
(a) Identified cost     $317,605,204       $31,250,799       $617,775,598       $4,398,021,142  
(b) Includes securities on loan, at value     $3,805,215       $—       $—       $—  

(c) NAV amounts may not recalculate due to rounding of net assets and / or shares outstanding.

(d) The maximum offering price is computed as 100/95.25 of NAV.

 

The accompanying notes are an integral part of the financial statements.           25  


Statements of Assets and Liabilities

(UNAUDITED)    |    04.30.2022

 

     Carillon Eagle
Small Cap
Growth
Fund
   

Carillon

ClariVest

International
Fund

    Carillon
Scout
Mid Cap
Fund
    Carillon
Scout
Small Cap
Fund
 
Assets        

Investments—unaffiliated, at value (a)(b)

    $1,295,460,878       $393,255,156       $4,098,589,074       $301,522,746  

Investments—affiliated, at value (c)

    19,169,454                    

Cash

    23,610,556       2,317,187       249,368,879       665,681  

Foreign currency (cost of $—, $1, $—, and $—)

          1              

Receivable for investments sold

    16,660,348             75,715,822       1,024,617  

Receivable for fund shares sold

    835,371       117,942       4,462,446       126,627  

Receivable for dividends and interest, net

    22,631       2,285,134       1,316,575       35,216  

Receivable for foreign tax reclaims

          3,858,614       6,539        

Prepaid expenses

    28,897       29,753       4,311       1,014  
Total assets     1,355,788,135       401,863,787       4,429,463,646       303,375,901  
Liabilities        

Payable for securities lending collateral received

                1,597,104        

Payable for investments purchased

    14,484,685             70,642,024        

Payable for fund shares redeemed

    3,511,873       190,426       3,877,049       51,123  

Accrued custody fees

    7,452       14,076       22,270       4,030  

Accrued investment advisory fees, net

    657,981       199,662       2,748,316       158,753  

Accrued administrative fees

    119,267       34,336       380,875       26,458  

Accrued distribution fees

    87,118       304       32,047       5,064  

Accrued shareholder servicing fees

    117,965       33,670       292,188       26,978  

Accrued professional fees

    36,561       28,039       36,585       36,842  

Accrued trustees compensation

    17,581       17,581       17,581       17,581  

Accrued officers compensation

    46       46       46       46  

Other accrued expenses

    110,291       16,635       168,168       26,776  

IRS compliance fee and related expenses for withholding tax claims

          2,454,369              
Total liabilities     19,150,820       2,989,144       79,814,253       353,651  
Net assets     1,336,637,315       398,874,643       4,349,649,393       303,022,250  
Net assets consists of        

Paid-in capital

    828,873,641       244,636,621       3,622,177,359       213,023,281  

Total distributable earnings (loss)

    507,763,674       154,238,022       727,472,034       89,998,969  
Net assets     1,336,637,315       398,874,643       4,349,649,393       303,022,250  
Net assets, at market value        

Class A

    233,504,572       930,144       28,552,130       14,331,991  

Class C

    19,674,387       113,782       26,487,626       2,121,473  

Class I

    494,284,840       394,974,688       3,929,721,054       277,267,820  

Class R-3

    40,496,629       11,008       4,218,570       98,184  

Class R-5

    43,108,393       11,281       4,637,641       20,579  

Class R-6

    505,544,054       2,814,213       351,942,755       9,079,189  

Class Y

    24,440       19,527       4,089,617       103,014  
NAV, offering and redemption price per share (d)        

Class A

    $31.65       $15.76       $22.26       $26.41  

Class A maximum offering price (e)

    33.23       16.55       23.37       27.73  

Class C

    11.97       15.56       21.65       25.29  

Class I

    36.04       15.92       22.43       26.76  

Class R-3

    28.78       15.81       22.01       25.92  

Class R-5

    36.38       15.93       22.28       26.64  

Class R-6

    37.28       15.91       22.42       26.90  

Class Y

    34.92       15.83       22.23       26.34  
Shares of beneficial interest outstanding        

Class A

    7,378,417       59,006       1,282,759       542,664  

Class C

    1,643,365       7,311       1,223,573       83,900  

Class I

    13,714,407       24,804,144       175,237,602       10,362,518  

Class R-3

    1,407,303       696       191,662       3,788  

Class R-5

    1,184,905       708       208,130       772  

Class R-6

    13,559,602       176,900       15,700,667       337,506  

Class Y

    700       1,234       183,984       3,911  
(a) Identified cost     $1,055,054,177       $394,512,426       $3,659,927,384       $217,583,116  
(b) Includes securities on loan, at value     $—       $—       $1,508,265       $—  
(c) Identified cost     $13,052,028       $—       $—       $—  
(d) NAV amounts may not recalculate due to rounding of net assets and / or shares outstanding.

 

     

(e) The maximum offering price is computed as 100/95.25 of NAV.

 

26         The accompanying notes are an integral part of the financial statements.


Statements of Assets and Liabilities

(UNAUDITED)    |    04.30.2022

 

     Carillon
Reams
Core Bond
Fund
    Carillon
Reams Core
Plus Bond
Fund
    Carillon Reams
Unconstrained
Bond
Fund
 
Assets      

Investments—unaffiliated, at value (a)

    $490,100,582       $1,312,292,695       $1,170,837,208  

Cash

    22,697,732       41,158,122       6,431,439  

Deposit at broker—open swap contracts

    275,364       15,039,849       25,329,029  

Deposit at broker—open futures contracts

          1,387,454       5,638,930  

Segregated cash—open forward contracts and/or TBA transactions

    3,813,000       11,826,681       21,803,000  

Receivable for investments sold

    95,739,954       278,836,425       7,895,943  

Receivable for fund shares sold

    2,765,279       960,862       1,358,833  

Receivable for dividends and interest, net

    2,093,795       6,048,613       5,523,654  

Prepaid expenses

    1,447       2,213       1,632  
Total assets     617,487,153       1,667,552,914       1,244,819,668  
Liabilities      

Written Options, at value (Premiums received of $—, $—, and $291,273)

                145,800  

Unrealized depreciation—open forward contracts

          2,797,068       3,503,923  

Variation margin payable—open swap contracts

    15,577       563,376       1,769,994  

Variation margin payable—open futures contracts

                242,454  

Payable for investments purchased

    212,053,825       575,990,687       95,488,575  

Payable for fund shares redeemed

    925,377       3,122,180       1,051,647  

Accrued custody fees

    3,530       13,474       21,269  

Accrued investment advisory fees, net

    32,187       145,795       233,114  

Accrued administrative fees

    32,735       93,880       95,726  

Accrued distribution fees

    13,667       15,618       8,646  

Accrued shareholder servicing fees

    35,983       101,485       89,436  

Accrued professional fees

    39,260       39,359       39,359  

Accrued trustees compensation

    17,581       17,581       17,581  

Accrued officers compensation

    46       46       46  

Other accrued expenses

    40,672       60,700       46,011  
Total liabilities     213,210,440       582,961,249       102,753,581  
Net assets     404,276,713       1,084,591,665       1,142,066,087  
Net assets consists of      

Paid-in capital

    454,694,130       1,201,521,549       1,200,874,209  

Total distributable earnings (loss)

    (50,417,417     (116,929,884     (58,808,122
Net assets     404,276,713       1,084,591,665       1,142,066,087  
Net assets, at market value      

Class A

    3,830,256       4,482,502       4,586,074  

Class C

    8,037,716       4,578,060       1,974,057  

Class I

    364,592,217       1,021,666,755       1,011,287,095  

Class R-3

    124,182       157,421       10,896  

Class R-5

    11,192       11,299       731,095  

Class R-6

    261,682       3,415,903       96,505,667  

Class Y

    27,419,468       50,279,725       26,971,203  
NAV, offering and redemption price per share (b)      

Class A

    $11.42       $31.20       $11.93  

Class A maximum offering price (c)

    11.86       32.42       12.39  

Class C

    11.37       31.03       11.85  

Class I

    11.44       31.32       11.95  

Class R-3

    11.43       31.20       11.92  

Class R-5

    11.44       31.31       11.95  

Class R-6

    11.45       31.33       11.95  

Class Y

    11.43       31.23       12.00  
Shares of beneficial interest outstanding      

Class A

    335,418       143,658       384,350  

Class C

    707,215       147,544       166,520  

Class I

    31,883,873       32,615,807       84,615,770  

Class R-3

    10,866       5,046       914  

Class R-5

    978       361       61,169  

Class R-6

    22,847       109,039       8,072,450  

Class Y

    2,399,496       1,609,814       2,247,260  
(a) Identified cost     $516,633,153       $1,374,567,568       $1,213,052,622  

(b) NAV amounts may not recalculate due to rounding of net assets and / or shares outstanding.

(c) The maximum offering price is computed as 100/96.25 of NAV.

 

The accompanying notes are an integral part of the financial statements.           27  


Statements of Operations

(UNAUDITED)    |    11.01.21 to 04.30.2022

 

     Carillon ClariVest
Capital
Appreciation
Fund
    Carillon ClariVest
International
Stock
Fund
    Carillon Eagle
Growth
& Income
Fund
    Carillon Eagle
Mid Cap
Growth
Fund
 
Investment income        

Dividends—unaffiliated

    $2,387,238       $636,924       $11,327,055       $14,175,273  

Less: foreign taxes withheld

          (49,029     (9,951     (224,628

Interest

    904       95       2,146       8,895  

Securities lending, net (Note 7)

    6,819       12             1,795  
Total investment income     2,394,961       588,002       11,319,250       13,961,335  
Expenses        

Investment advisory fees

    1,847,628       74,857       2,152,524       18,953,997  

Administrative fees:

       

Class A

    103,175       1,838       116,011       399,842  

Class C

    6,316       882       35,976       59,085  

Class I

    194,690       5,058       327,450       842,485  

Class R-3

    217       80       841       22,657  

Class R-5

    2,822       2       3,546       448,587  

Class R-6

    704       2,827       4,416       1,941,814  

Class Y

    13       7       302       1,946  

Distribution and service fees:

       

Class A

    257,938       4,594       290,028       999,604  

Class C

    63,165       8,820       359,758       590,851  

Class R-3

    1,086       398       4,203       113,287  

Class Y

    32       18       756       4,864  

Shareholder servicing fees:

       

Class A

    82,699       1,444       115,438       577,444  

Class C

    4,159       555       29,305       46,428  

Class I

    164,041       3,401       257,441       672,830  

Class R-3

    312       116       1,195       33,986  

Class R-5

    2,751             3,546       448,587  

Class Y

                416       2,856  

Custodian fees

    7,366       27,833       13,113       96,516  

Professional fees

    49,247       51,656       49,617       49,790  

State registration fees

    58,150       47,145       54,529       91,902  

Trustees compensation

    37,445       37,445       37,445       37,445  

Officers compensation

    6,761       6,761       6,761       6,761  

Internal audit fees

    1,891       1,891       1,891       1,891  

Interest expense on line of credit

    200       95             3,091  

Other expenses

    91,450       39,277       136,575       694,315  
Total expenses before adjustments     2,984,258       317,000       4,003,083       27,142,861  

Fees and expenses waived

    (452,314     (192,071            

Recovered fees previously waived by Manager

                       
Total expenses after adjustments     2,531,944       124,929       4,003,083       27,142,861  
Net investment income (loss)     (136,983     463,073       7,316,167       (13,181,526
Realized and unrealized gain (loss)        

Net realized gain (loss) on:

       

Investments—unaffiliated

    14,703,690       (798,975     22,614,884       345,051,805  

Foreign currency transactions

          (34,973            
Net realized gain (loss)     14,703,690       (833,948     22,614,884       345,051,805  

Net change in unrealized appreciation (depreciation) on

       

investments—unaffiliated and foreign currency translations

    (117,924,548     (2,414,229     (72,133,805     (2,222,787,808
Net gain (loss) on investments     (103,220,858     (3,248,177     (49,518,921     (1,877,736,003
Net increase (decrease) in assets resulting from operations     (103,357,841     (2,785,104     (42,202,754     (1,890,917,529

 

28         The accompanying notes are an integral part of the financial statements.


Statements of Operations

(UNAUDITED)    |    11.01.21 to 04.30.2022

 

     Carillon Eagle
Small Cap
Growth
Fund
   

Carillon

ClariVest

International
Fund

    Carillon
Scout
Mid Cap
Fund
    Carillon
Scout
Small Cap
Fund
 
Investment income        

Dividends—unaffiliated

    $4,870,221       $9,954,776       $30,579,000       $1,158,197  

Less: foreign taxes withheld

    (57,845     (820,317     (54,018     (147

Interest

    2,019       419       7,193       103  

Securities lending, net (Note 7)

    8,574       18,193       9,448       5,970  

IRS compliance fee and related expenses for withholding tax claims

          (33,385            
Total investment income     4,822,969       9,119,686       30,541,623       1,164,123  
Expenses        

Investment advisory fees

    4,843,575       1,575,185       16,637,822       1,042,778  

Administrative fees:

       

Class A

    148,067       490       14,530       8,224  

Class C

    12,804       62       14,249       1,374  

Class I

    322,669       222,839       2,110,049       158,854  

Class R-3

    25,117       6       2,314       69  

Class R-5

    32,575       6       2,247       12  

Class R-6

    353,086       1,613       161,105       5,203  

Class Y

    12       10       1,497       61  

Distribution and service fees:

       

Class A

    370,169       1,225       36,324       20,559  

Class C

    128,045       618       142,492       13,738  

Class R-3

    125,584       30       11,567       344  

Class Y

    30       25       3,741       154  

Shareholder servicing fees:

       

Class A

    208,416       671       15,074       7,298  

Class C

    11,512       41       14,715       1,225  

Class I

    307,963       214,881       2,110,049       158,853  

Class R-3

    37,675             3,371       96  

Class R-5

    32,575             2,247        

Class Y

    1             1,367       37  

Custodian fees

    26,472       36,716       66,115       8,536  

Professional fees

    49,627       74,311       49,664       49,752  

State registration fees

    71,400       47,532       129,192       49,992  

Trustees compensation

    37,445       37,445       37,445       37,445  

Officers compensation

    6,761       6,761       6,761       6,761  

Internal audit fees

    1,891       1,891       1,891       1,891  

Interest expense on line of credit

    18,240       520       2,647        

Other expenses

    262,628       119,085       449,754       70,803  
Total expenses before adjustments     7,434,339       2,341,963       22,028,229       1,644,059  

Fees and expenses waived

          (203,653            

Recovered fees previously waived by Manager

    4       10             37  
Total expenses after adjustments     7,434,343       2,138,320       22,028,229       1,644,096  
Net investment income (loss)     (2,611,374     6,981,366       8,513,394       (479,973
Realized and unrealized gain (loss)        

Net realized gain (loss) on:

       

Investments—unaffiliated

    279,070,700       160,130,025       361,346,131       11,183,065  

Investments—affiliated

    (1,794,317                  

Foreign currency transactions

          (250,257     43        
Net realized gain (loss)     277,276,383       159,879,768       361,346,174       11,183,065  

Net change in unrealized appreciation (depreciation) on:

       

Investments—unaffiliated and foreign currency translations

    (823,444,580     (212,224,113     (851,376,525     (89,580,455

Investments—affiliated

    (11,769,884                  
Net change in unrealized appreciation (depreciation)     (835,214,464     (212,224,113     (851,376,525     (89,580,455
Net gain (loss) on investments     (557,938,081     (52,344,345     (490,030,351     (78,397,390
Net increase (decrease) in assets resulting from operations     (560,549,455     (45,362,979     (481,516,957     (78,877,363

 

The accompanying notes are an integral part of the financial statements.           29  


Statements of Operations

(UNAUDITED)    |    11.01.21 to 04.30.2022

 

     Carillon Reams
Core Bond
Fund
    Carillon Reams
Core Plus Bond
Fund
    Carillon Reams
Unconstrained Bond
Fund
 
Investment income      

Interest

    $3,776,893       $11,390,397       $10,435,404  

Securities lending, net (Note 7)

    44       531       74  
Total investment income     3,776,937       11,390,928       10,435,478  
Expenses      

Investment advisory fees

    887,396       2,472,796       3,609,349  

Administrative fees:

     

Class A

    2,148       3,044       2,452  

Class C

    5,303       2,785       1,011  

Class I

    196,791       578,887       542,159  

Class R-3

    64       77       6  

Class R-5

    6       6       108  

Class R-6

    505       1,827       40,729  

Class Y

    17,032       31,573       15,093  

Distribution and service fees:

     

Class A

    5,371       7,609       6,130  

Class C

    53,027       27,853       10,113  

Class R-3

    319       385       28  

Class Y

    42,580       78,931       37,733  

Shareholder servicing fees:

     

Class A

    1,783       2,620       1,933  

Class C

    3,853       3,174       1,007  

Class I

    188,512       505,859       519,307  

Class R-3

    73       87        

Class R-5

                100  

Class Y

    25,350       45,014       21,940  

Custodian fees

    8,061       39,324       50,942  

Professional fees

    52,311       52,362       52,362  

State registration fees

    70,751       84,204       63,078  

Trustees compensation

    37,445       37,445       37,445  

Officers compensation

    6,761       6,761       6,761  

Internal audit fees

    1,891       1,891       1,891  

Other expenses

    88,112       168,146       127,160  
Total expenses before adjustments     1,695,445       4,152,660       5,148,837  

Fees and expenses waived

    (669,925     (1,508,862     (2,118,489

Recovered fees previously waived by Manager

                 
Total expenses after adjustments     1,025,520       2,643,798       3,030,348  
Net investment income (loss)     2,751,417       8,747,130       7,405,130  
Realized and unrealized gain (loss)      

Net realized gain (loss) on:

     

Investments—unaffiliated

    (13,805,481     (42,785,949     (16,141,159

Written options

                1,099,712  

Foreign currency transactions

          (248,715     4,015,946  

Swap contracts—credit default

    (41,722     46,516       2,093,947  

Swap contracts—inflation rate

      1,796,868       1,804,987  

Futures contracts

          2,599,510       6,996,846  

Forward contracts

          (390,557     (4,796,887
Net realized gain (loss)     (13,847,203     (38,982,327     (4,926,608

Net change in unrealized appreciation (depreciation) on:

     

Investments—unaffiliated and foreign currency translations

    (29,023,245     (70,302,990     (50,443,142

Written options

                145,473  

Swap contracts—credit default

    (77,845     (3,047,349     (5,071,765

Swap contracts—inflation rate

      (1,396,187     (6,704,963

Futures contracts

          559,486       2,592,369  

Forward contracts

          (6,318,832     (8,030,787
Net change in unrealized appreciation (depreciation)     (29,101,090     (80,505,872     (67,512,815
Net gain (loss) on investments     (42,948,293     (119,488,199     (72,439,423
Net increase (decrease) in assets resulting from operations     (40,196,876     (110,741,069     (65,034,293

 

30         The accompanying notes are an integral part of the financial statements.


Statements of Changes in Net Assets

 

    Carillon ClariVest
Capital Appreciation Fund
    Carillon ClariVest
International Stock Fund
    Carillon Eagle
Growth & Income Fund
    Carillon Eagle
Mid Cap Growth Fund
 
     11/1/21 to
04/30/22(†)
    11/1/20 to
10/31/21
    11/1/21 to
04/30/22 (†)
    11/1/20 to
10/31/21
    11/1/21 to
04/30/22 (†)
    11/1/20 to
10/31/21
    11/1/21 to
04/30/22 (†)
    11/1/20 to
10/31/21
 

Net assets, beginning of period

    $644,094,079       $465,275,149       $11,753,312       $8,341,303       $992,237,995       $741,554,876       $8,759,476,768       $6,618,025,126  
Increase (decrease) in net assets from operations                

Net investment income (loss)

    (136,983     117,984       463,073       161,202       7,316,167       14,101,451       (13,181,526     (30,699,283

Net realized gain (loss)

    14,703,690       42,101,898       (833,948     1,247,289       22,614,884       76,617,294       345,051,805       788,254,782  

Net change in unrealized appreciation (depreciation)

    (117,924,548     155,328,378       (2,414,229     1,603,556       (72,133,805     188,176,123       (2,222,787,808     1,707,606,419  
Net increase (decrease) in net assets resulting from operations     (103,357,841     197,548,260       (2,785,104     3,012,047       (42,202,754     278,894,868       (1,890,917,529     2,465,161,918  

Distributions to shareholders from earnings

    (42,228,090     (68,705,690     (235,421     (75,569     (83,997,689     (41,379,128     (759,309,582     (166,160,322
Fund share transactions                

Proceeds from shares sold-Class A

    2,657,371       7,225,814       331,951       799,435       18,912,507       44,038,316       43,782,932       159,446,649  

Issued as reinvestment of distributions-Class A

    14,336,613       24,692,681       56,138       22,333       16,782,707       7,437,132       81,392,202       18,726,911  

Cost of shares redeemed-Class A

    (12,910,474     (25,277,169     (284,457     (514,433     (18,424,373     (36,349,151     (103,611,587     (281,953,398

Proceeds from shares sold-Class C

    330,787       896,180       280,693       257,965       3,875,055       8,475,970       2,971,423       8,482,961  

Issued as reinvestment of distributions-Class C

    1,443,347       2,718,143       17,493       1,250       5,214,215       2,978,724       16,318,983       4,229,943  

Cost of shares redeemed-Class C

    (1,832,590     (4,176,638     (209,113     (501,512     (13,779,456     (33,449,722     (13,893,508     (44,382,555

Proceeds from shares sold-Class I

    104,909,812       79,241,131       10,007,836       2,017,047       78,824,295       122,277,593       145,370,969       303,120,924  

Issued as reinvestment of distributions-Class I

    25,281,641       38,966,589       158,861       42,418       45,622,567       21,909,283       156,922,110       35,287,069  

Cost of shares redeemed-Class I

    (49,032,870     (73,737,533     (2,886,701     (561,134     (66,745,700     (127,707,382     (242,924,288     (424,096,244

Proceeds from shares sold-Class R-3

    15,458       54,135       36,248       62,923       257,145       359,985       5,707,655       13,804,066  

Issued as reinvestment of distributions-Class R-3

    37,541       55,541       744       6,690       137,755       54,617       5,203,261       1,200,286  

Cost of shares redeemed-Class R-3

    (176,220     (29,092     (6,692     (1,051,457     (77,298     (201,437     (9,475,228     (20,885,838

Proceeds from shares sold-Class R-5

    3,933,528       6,691,034                   1,550,423       1,922,476       52,574,281       273,863,617  

Issued as reinvestment of distributions-Class R-5

    379,817       673,814       77       41       538,270       340,420       90,128,089       19,714,798  

Cost of shares redeemed-Class R-5

    (3,354,459     (8,435,060                 (2,330,738     (3,569,456     (133,400,516     (319,883,074

Proceeds from shares sold-Class R-6

    909,493       761,333       15,302,441       14,930       2,258,063       5,058,007       309,091,181       924,109,834  

Issued as reinvestment of distributions-Class R-6

    94,234       148,117       1,188       1,825       732,366       200,102       378,818,417       80,238,573  

Cost of shares redeemed-Class R-6

    (403,835     (498,010     (426,265     (125,080     (1,264,945     (856,755     (515,799,752     (908,509,797

Proceeds from shares sold-Class Y

          3,000       407       2,192       664,613       264,800       573,836       891,474  

Issued as reinvestment of distributions-Class Y

    1,724       2,350       220       104       39,701       11,764       418,862       85,197  

Cost of shares redeemed-Class Y

                (4     (6     (953,187     (27,907     (1,513,290     (1,041,350
Net increase (decrease) from fund share transactions     86,620,918       49,976,360       22,381,065       475,531       71,833,985       13,167,379       268,656,032       (157,549,954
Increase (decrease) in net assets     (58,965,013     178,818,930       19,360,540       3,412,009       (54,366,458     250,683,119       (2,381,571,079     2,141,451,642  

Net assets, end of period

    585,129,066       644,094,079       31,113,852       11,753,312       937,871,537       992,237,995       6,377,905,689       8,759,476,768  
Shares issued and redeemed                

Shares sold-Class A

    45,498       131,441       16,348       39,353       756,731       1,868,908       521,236       1,740,398  

Issued as reinvestment of distributions-Class A

    242,747       487,709       2,687       1,241       683,693       331,240       946,531       207,110  

Shares redeemed-Class A

    (217,284     (457,323     (14,290     (26,409     (739,819     (1,517,347     (1,230,870     (3,034,864

Shares sold-Class C

    8,596       25,181       14,090       13,027       165,465       377,216       47,282       119,600  

Issued as reinvestment of distributions-Class C

    40,351       84,257       852       71       224,620       141,804       258,622       61,047  

Shares redeemed-Class C

    (49,369     (121,369     (10,507     (26,556     (574,583     (1,492,703     (224,443     (633,930

Shares sold-Class I

    1,727,869       1,313,257       496,889       95,518       3,206,325       5,226,783       1,625,528       3,069,596  

Issued as reinvestment of distributions-Class I

    399,773       724,017       7,627       2,366       1,865,321       976,671       1,689,515       365,139  

Shares redeemed-Class I

    (799,981     (1,247,081     (150,475     (29,573     (2,693,815     (5,353,901     (2,672,508     (4,267,021

Shares sold-Class R-3

    282       1,033       1,836       3,363       10,371       15,188       66,478       155,656  

Issued as reinvestment of distributions-Class R-3

    675       1,157       36       376       5,637       2,453       63,485       13,822  

Shares redeemed-Class R-3

    (3,378     (515     (334     (54,887     (3,235     (8,492     (117,411     (233,607

Shares sold-Class R-5

    62,728       113,251                   61,952       84,457       578,180       2,757,998  

Issued as reinvestment of distributions-Class R-5

    6,029       12,566       4       2       21,981       15,231       973,831       204,638  

Shares redeemed-Class R-5

    (52,856     (141,446                 (92,844     (156,265     (1,490,527     (3,185,565

Shares sold-Class R-6

    15,645       13,097       744,705       795       89,223       218,329       3,338,560       9,224,959  

Issued as reinvestment of distributions-Class R-6

    1,503       2,776       57       102       30,004       8,757       4,034,275       822,875  

Shares redeemed-Class R-6

    (6,310     (8,201     (21,700     (6,290     (51,430     (35,042     (5,454,785     (9,039,986

Shares sold-Class Y

          53       20       129       27,266       11,614       6,688       8,912  

Issued as reinvestment of distributions-Class Y

    27       44       11       6       1,626       520       4,580       891  

Shares redeemed-Class Y

                            (39,043     (1,121     (19,124     (10,698
Shares issued and redeemed     1,422,545       933,904       1,087,856       12,634       2,955,446       714,300       2,945,123       (1,653,030

(†) The data for fiscal periods ending after October 31, 2021 is unaudited.

 

The accompanying notes are an integral part of the financial statements.           31  


Statements of Changes in Net Assets

 

    Carillon Eagle
Small Cap Growth Fund
    Carillon ClariVest

International Fund
    Carillon Scout
Mid Cap Fund
    Carillon Scout
Small Cap Fund
 
     11/1/21 to
04/30/22 (†)
    11/1/20 to
10/31/21
    11/1/21 to
04/30/22 (†)
    11/1/20 to
10/31/21
    11/1/21 to
04/30/22 (†)
    11/1/20 to
10/31/21
    11/1/21 to
04/30/22 (†)
    11/1/20 to
10/31/21
 

Net assets, beginning of period

    $2,346,648,459       $2,876,211,347       $490,891,895       $454,817,921       $4,915,165,823       $2,805,727,211       $395,870,511       $294,939,896  
Increase (decrease) in net assets from operations                

Net investment income (loss)

    (2,611,374     (13,289,093     6,981,366       11,340,427       8,513,394       548,459       (479,973     (2,293,895

Net realized gain (loss) on investments

    277,276,383       879,098,945       159,879,768       48,967,535       361,346,174       536,578,876       11,183,065       59,157,671  

Net change in unrealized appreciation (depreciation)

    (835,214,464     57,793,717       (212,224,113     113,884,491       (851,376,525     730,465,259       (89,580,455     74,648,537  
Net increase (decrease) in net assets resulting from operations     (560,549,455     923,603,569       (45,362,979     174,192,453       (481,516,957     1,267,592,594       (78,877,363     131,512,313  

Distributions to shareholders from earnings

    (595,177,276     (511,775,483     (56,326,474     (45,202,786     (496,708,988     (79,310,015     (57,666,725     (27,973,047
Fund share transactions                

Proceeds from shares sold-Class A

    25,063,862       72,748,634       55,958       87,464       5,747,904       12,526,852       958,161       3,779,223  

Issued as reinvestment of distributions-Class A

    88,353,278       60,001,335       117,945       77,987       2,540,521       458,034       2,685,204       1,100,799  

Cost of shares redeemed-Class A

    (76,218,452     (132,257,396     (29,521     (127,570     (6,824,012     (7,200,825     (1,221,224     (2,537,871

Proceeds from shares sold-Class C

    1,137,315       2,944,863       4,184       60,179       3,097,921       7,884,267       87,921       156,981  

Issued as reinvestment of distributions-Class C

    14,385,326       13,686,709       14,207       8,947       2,668,763       438,271       491,408       493,427  

Cost of shares redeemed-Class C

    (6,987,401     (30,957,718     (9,965     (51,201     (3,777,247     (4,057,894     (769,046     (4,078,779

Proceeds from shares sold-Class I

    245,783,754       142,641,031       4,894,576       12,480,786       438,703,994       1,632,392,757       16,087,062       64,910,572  

Issued as reinvestment of distributions-Class I

    171,230,338       117,692,817       55,312,173       44,337,947       426,534,005       67,739,332       51,319,499       24,763,589  

Cost of shares redeemed-Class I

    (263,465,380     (408,322,911     (50,666,305     (149,199,597     (592,433,693     (817,661,397     (27,329,538     (90,225,972

Proceeds from shares sold-Class R-3

    6,944,221       10,908,987                   528,460       1,581,129       1,712       16,641  

Issued as reinvestment of distributions-Class R-3

    17,101,074       11,737,240       1,397       905       505,625       77,809       25,405       14,180  

Cost of shares redeemed-Class R-3

    (10,822,591     (27,729,272                 (756,918     (1,015,320     (65,278     (38,186

Proceeds from shares sold-Class R-5

    6,049,126       38,396,193                   1,145,090       1,647,038              

Issued as reinvestment of distributions-Class R-5

    20,605,197       36,465,064       1,481       926       430,678       63,485       3,817       2,044  

Cost of shares redeemed-Class R-5

    (48,147,250     (203,256,824                 (397,198     (716,898           (71,139

Proceeds from shares sold-Class R-6

    46,228,212       268,107,874       206,537       537,337       147,087,557       87,233,527       659,440       2,605,402  

Issued as reinvestment of distributions-Class R-6

    209,808,706       241,425,823       409,035       344,188       22,627,395       3,828,565       1,702,996       877,259  

Cost of shares redeemed-Class R-6

    (301,347,611     (1,155,618,028     (647,954     (1,476,038     (35,807,461     (55,519,435     (942,120     (4,325,364

Proceeds from shares sold-Class Y

    7,494             5,928       1,010       2,367,466       1,328,136       150       600  

Issued as reinvestment of distributions-Class Y

    6,377       4,790       2,540       1,087       381,187       251,046       22,752       14,776  

Cost of shares redeemed-Class Y

    (8     (10,185     (15     (50     (1,660,522     (10,122,446     (22,494     (66,833
Net increase (decrease) from fund share transactions     145,715,587       (941,390,974     9,672,201       (92,915,693     412,709,515       921,156,033       43,695,827       (2,608,651
Increase (decrease) in net assets     (1,010,011,144     (529,562,888     (92,017,252     36,073,974       (565,516,430     2,109,438,612       (92,848,261     100,930,615  

Net assets, end of period

    1,336,637,315       2,346,648,459       398,874,643       490,891,895       4,349,649,393       4,915,165,823       303,022,250       395,870,511  
Shares issued and redeemed                

Shares sold-Class A

    635,185       1,223,856       3,236       4,619       236,345       487,729       30,698       98,335  

Issued as reinvestment of distributions-Class A

    2,271,877       1,053,579       6,664       4,396       110,361       19,709       86,119       31,424  

Shares redeemed-Class A

    (1,791,068     (2,238,239     (1,698     (6,747     (261,191     (281,098     (39,922     (66,508

Shares sold-Class C

    76,417       88,279       239       3,198       132,688       314,896       2,893       4,160  

Issued as reinvestment of distributions-Class C

    975,277       424,000       810       509       118,876       19,147       16,419       14,462  

Shares redeemed-Class C

    (397,480     (915,712     (548     (2,765     (161,373     (164,236     (25,512     (109,707

Shares sold-Class I

    4,356,771       2,196,036       274,695       650,928       18,162,926       63,551,360       522,838       1,688,362  

Issued as reinvestment of distributions-Class I

    3,870,487       1,889,434       3,096,986       2,479,751       18,400,949       2,904,774       1,626,093       701,319  

Shares redeemed-Class I

    (6,058,812     (6,309,719     (2,810,843     (7,904,153     (24,780,847     (31,908,746     (861,742     (2,336,734

Shares sold-Class R-3

    164,380       194,065                   22,815       63,310       54       441  

Issued as reinvestment of distributions-Class R-3

    483,217       219,470       79       50       22,186       3,370       829       409  

Shares redeemed-Class R-3

    (290,270     (500,447                 (33,045     (39,856     (2,028     (1,027

Shares sold-Class R-5

    141,803       585,350                   49,660       62,667              

Issued as reinvestment of distributions-Class R-5

    461,379       581,302       83       51       18,701       2,738       121       58  

Shares redeemed-Class R-5

    (980,481     (3,092,063                 (16,842     (28,314           (1,892

Shares sold-Class R-6

    961,931       4,010,002       11,504       28,492       6,231,353       3,440,108       21,408       67,370  

Issued as reinvestment of distributions-Class R-6

    4,585,983       3,785,290       22,928       19,271       977,003       164,387       53,688       24,753  

Shares redeemed-Class R-6

    (6,271,354     (17,501,937     (36,126     (76,825     (1,488,324     (2,183,062     (30,571     (110,999

Shares sold-Class Y

    179             309       53       97,768       54,821       4       16  

Issued as reinvestment of distributions-Class Y

    149       78       143       61       16,581       10,812       732       423  

Shares redeemed-Class Y

          (159     (1     (3     (70,229     (392,753     (709     (1,759
Shares issued and redeemed     3,195,570       (14,307,535     568,460       (4,799,114     17,786,361       36,101,763       1,401,412       2,906  

(†) The data for fiscal periods ending after October 31, 2021 is unaudited.

 

32         The accompanying notes are an integral part of the financial statements.


Statements of Changes in Net Assets

 

    Carillon Reams
Core Bond Fund
    Carillon Reams
Core Plus Bond Fund
    Carillon Reams
Unconstrained Bond Fund
 
     11/1/21 to
04/30/22 (†)
    11/1/20 to
10/31/21
    11/1/21 to
04/30/22 (†)
    11/1/20 to
10/31/21
    11/1/21 to
04/30/22 (†)
    11/1/20 to
10/31/21
 

Net assets, beginning of period

    $506,325,026       $624,171,581       $1,236,644,772       $1,241,254,330       $1,215,980,154       $948,168,113  
Increase (decrease) in net assets from operations            

Net investment income (loss)

    2,751,417       4,942,608       8,747,130       13,327,512       7,405,130       9,944,852  

Net realized gain (loss) on investments

    (13,847,203     (8,310,811     (38,982,327     (8,109,675     (4,926,608     20,499,395  

Net change in unrealized appreciation (depreciation)

    (29,101,090     (3,675,775     (80,505,872     (18,278,265     (67,512,815     (13,462,867
Net increase (decrease) in net assets resulting from operations     (40,196,876     (7,043,978     (110,741,069     (13,060,428     (65,034,293     16,981,380  

Distributions to shareholders from earnings

    (3,360,263     (17,815,158     (7,449,820     (68,592,494     (17,605,258     (21,332,749
Fund share transactions            

Proceeds from shares sold-Class A

    1,176,270       2,645,927       1,088,021       5,927,861       86,682       4,468,435  

Issued as reinvestment of distributions-Class A

    24,535       105,118       17,937       168,196       67,703       24,362  

Cost of shares redeemed-Class A

    (1,193,755     (2,342,514     (2,906,528     (4,339,112     (322,068     (262,971

Proceeds from shares sold-Class C

    342,524       5,194,144       137,272       2,742,903       167,050       1,471,386  

Issued as reinvestment of distributions-Class C

    25,431       235,434       15,975       162,439       22,902       27,393  

Cost of shares redeemed-Class C

    (4,051,796     (2,812,383     (1,431,693     (1,382,929     (340,704     (816,051

Proceeds from shares sold-Class I

    98,875,165       340,253,360       258,444,159       625,742,436       234,622,473       581,892,623  

Issued as reinvestment of distributions-Class I

    3,014,171       15,690,576       5,563,597       51,334,825       13,993,828       16,978,216  

Cost of shares redeemed-Class I

    (145,047,082     (439,291,961     (273,364,172     (592,968,214     (273,115,753     (363,315,028

Proceeds from shares sold-Class R-3

    12,885       93,364       51,054       82,407              

Issued as reinvestment of distributions-Class R-3

    567       1,143       704       4,494       143       202  

Cost of shares redeemed-Class R-3

    (109     (4,503     (30,432     (11,713            

Proceeds from shares sold-Class R-5

                            591,615       153,378  

Issued as reinvestment of distributions-Class R-5

    87       340       69       635       2,352       1,285  

Cost of shares redeemed-Class R-5

                            (4,278      

Proceeds from shares sold-Class R-6

    88,667       748,278       149,467       4,504,039       39,470,895       25,212,844  

Issued as reinvestment of distributions-Class R-6

    8,045       20,639       21,859       69,620       1,052,582       1,081,790  

Cost of shares redeemed-Class R-6

    (828,388     (194,303     (169,596     (730,556     (5,893,208     (718,428

Proceeds from shares sold-Class Y

    2,737,080       24,882,402       4,032,824       85,343,216       8,809,458       100,565,169  

Issued as reinvestment of distributions-Class Y

    201,636       1,405,708       357,377       5,317,461       388,707       591,350  

Cost of shares redeemed-Class Y

    (13,877,107     (39,618,188     (25,840,112     (104,924,644     (10,874,895     (95,192,545
Net increase (decrease) from fund share transactions     (58,491,174     (92,987,419     (33,862,218     77,043,364       8,725,484       272,163,410  
Increase (decrease) in net assets     (102,048,313     (117,846,555     (152,053,107     (4,609,558     (73,914,067     267,812,041  

Net assets, end of period

    404,276,713       506,325,026       1,084,591,665       1,236,644,772       1,142,066,087       1,215,980,154  
Shares issued and redeemed            

Shares sold-Class A

    95,474       204,729       32,146       167,021       6,916       345,574  

Issued as reinvestment of distributions-Class A

    1,970       8,098       519       4,721       5,340       1,887  

Shares redeemed-Class A

    (98,659     (182,110     (87,615     (124,265     (25,999     (20,295

Shares sold-Class C

    27,850       402,786       4,109       77,456       13,889       113,580  

Issued as reinvestment of distributions-Class C

    2,034       18,114       464       4,554       1,816       2,124  

Shares redeemed-Class C

    (332,511     (221,318     (42,920     (39,860     (27,200     (63,242

Shares sold-Class I

    8,188,008       26,342,104       7,587,655       17,649,041       18,690,143       44,891,635  

Issued as reinvestment of distributions-Class I

    241,693       1,209,383       160,743       1,439,650       1,103,372       1,313,341  

Shares redeemed-Class I

    (11,779,606     (34,263,292     (8,200,209     (16,902,368     (21,869,205     (28,017,097

Shares sold-Class R-3

    1,030       7,281       1,518       2,342              

Issued as reinvestment of distributions-Class R-3

    45       88       20       126       11       16  

Shares redeemed-Class R-3

    (9     (355     (892     (337            

Shares sold-Class R-5

                            48,527       11,812  

Issued as reinvestment of distributions-Class R-5

    7       26       2       18       185       99  

Shares redeemed-Class R-5

                            (355      

Shares sold-Class R-6

    7,354       58,058       4,429       126,968       3,160,578       1,944,350  

Issued as reinvestment of distributions-Class R-6

    645       1,594       632       1,956       82,993       83,713  

Shares redeemed-Class R-6

    (71,260     (14,724     (5,036     (20,796     (479,940     (55,404

Shares sold-Class Y

    222,863       1,928,969       121,014       2,404,633       701,275       7,697,691  

Issued as reinvestment of distributions-Class Y

    16,135       108,143       10,339       149,029       30,494       45,509  

Shares redeemed-Class Y

    (1,122,096     (3,095,565     (766,613     (3,006,328     (874,571     (7,297,690
Shares issued and redeemed     (4,599,033     (7,487,991     (1,179,695     1,933,561       568,269       20,997,603  

(†) The data for fiscal periods ending after October 31, 2021 is unaudited.

 

The accompanying notes are an integral part of the financial statements.           33  


Financial Highlights

 

Fiscal period

          From investment operations     Dividends & distributions          

Ratios to average net asset (%)

                   
  Beginning
net asset
value
    Income
(loss)
    Realized &
unrealized
gain (loss)
    Total     From
investment
income
    From
realized
gains
    From
return
of
capital
    Total     Ending
net
asset
value
    With
expenses
waived/
recovered (a)
    Without
expenses
waived/
recovered (a)
    Net
income
(loss) (a)
    Portfolio
turnover
rate (%) (b)
    Total
return
(%) (b)(c)
    Ending
net
assets
(millions)
 
Beginning   Ending  
Carillon ClariVest Capital Appreciation Fund                                                                                                
Class A*                                
11/01/21     04/30/22       $64.23       $(0.06     $(9.29     $(9.35     $—       $(4.32     $—       $(4.32     $50.56       1.00       1.11       (0.22     8       (15.52     $179  
11/01/20     10/31/21       51.65       (0.08     20.42       20.34       (0.05     (7.71           (7.76     64.23       1.00       1.11       (0.14     20       43.42       222  
11/01/19     10/31/20       43.14       0.04       9.19       9.23       (0.13     (0.59           (0.72     51.65       1.00       1.15       0.08       31       21.63       170  
11/01/18     10/31/19       42.91       0.14       3.75       3.89       (0.06     (3.60           (3.66     43.14       1.00       1.14       0.34       49       11.23       170  
11/01/17     10/31/18       43.14       0.07       2.40       2.47             (2.70           (2.70     42.91       1.02       1.12       0.15       45       5.83       177  
11/01/16     10/31/17       35.05       0.02       10.24       10.26       (0.03     (2.14           (2.17     43.14       1.20       1.20       0.07       33       30.84       164  
Class C*                                
11/01/21     04/30/22       40.66       (0.17     (5.64     (5.81           (4.32           (4.32     30.53       1.75       1.85       (0.97     8       (15.84     11  
11/01/20     10/31/21       35.39       (0.32     13.30       12.98             (7.71           (7.71     40.66       1.75       1.86       (0.89     20       42.34       14  
11/01/19     10/31/20       29.87       (0.21     6.32       6.11             (0.59           (0.59     35.39       1.75       1.89       (0.66     31       20.71       13  
11/01/18     10/31/19       31.12       (0.11     2.46       2.35             (3.60           (3.60     29.87       1.75       1.90       (0.39     49       10.38       15  
11/01/17     10/31/18       32.23       (0.17     1.76       1.59             (2.70           (2.70     31.12       1.80       1.90       (0.53     45       5.02       20  
11/01/16     10/31/17       26.88       (0.20     7.69       7.49             (2.14           (2.14     32.23       1.97       1.97       (0.70     33       29.83       63  
Class I*                                
11/01/21     04/30/22       68.46       0.02       (9.95     (9.93     (0.02     (4.32           (4.34     54.19       0.70       0.87       0.08       8       (15.41     388  
11/01/20     10/31/21       54.56       0.09       21.70       21.79       (0.18     (7.71           (7.89     68.46       0.70       0.87       0.15       20       43.87       400  
11/01/19     10/31/20       45.52       0.19       9.70       9.89       (0.26     (0.59           (0.85     54.56       0.70       0.89       0.39       31       22.00       276  
11/01/18     10/31/19       45.09       0.26       3.97       4.23       (0.20     (3.60           (3.80     45.52       0.70       0.90       0.61       49       11.54       314  
11/01/17     10/31/18       45.13       0.21       2.51       2.72       (0.06     (2.70           (2.76     45.09       0.72       0.88       0.46       45       6.15       203  
11/01/16     10/31/17       36.55       0.16       10.68       10.84       (0.12     (2.14           (2.26     45.13       0.88       0.88       0.39       33       31.26       119  
Class R-3*                                
11/01/21     04/30/22       60.77       (0.13     (8.75     (8.88           (4.32           (4.32     47.57       1.25       1.42       (0.48     8       (15.64     0  
11/01/20     10/31/21       49.29       (0.21     19.40       19.19             (7.71           (7.71     60.77       1.25       1.42       (0.40     20       43.09       1  
11/01/19     10/31/20       41.18       (0.06     8.76       8.70             (0.59           (0.59     49.29       1.25       1.56       (0.14     31       21.32       0  
11/01/18     10/31/19       41.17       0.05       3.56       3.61             (3.60           (3.60     41.18       1.25       1.58       0.12       49       10.96       1  
11/01/17     10/31/18       41.60       (0.04     2.31       2.27             (2.70           (2.70     41.17       1.29       1.47       (0.11     45       5.56       1  
11/01/16     10/31/17       33.95       (0.10     9.89       9.79             (2.14           (2.14     41.60       1.51       1.56       (0.28     33       30.43       1  
Class R-5*                                
11/01/21     04/30/22       68.21       0.02       (9.91     (9.89     (0.02     (4.32           (4.34     53.98       0.70       0.88       0.08       8       (15.41     5  
11/01/20     10/31/21       54.38       0.10       21.62       21.72       (0.18     (7.71           (7.89     68.21       0.70       0.87       0.16       20       43.88       6  
11/01/19     10/31/20       45.37       0.19       9.67       9.86       (0.26     (0.59           (0.85     54.38       0.70       0.90       0.38       31       22.00       5  
11/01/18     10/31/19       44.97       0.27       3.94       4.21       (0.21     (3.60           (3.81     45.37       0.70       0.90       0.64       49       11.53       7  
11/01/17     10/31/18       44.97       0.18       2.53       2.71       (0.01     (2.70           (2.71     44.97       0.72       0.86       0.38       45       6.14       7  
11/01/16     10/31/17       36.44       0.17       10.63       10.80       (0.13     (2.14           (2.27     44.97       0.89       0.89       0.45       33       31.26       3  
Class R-6*                                
11/01/21     04/30/22       67.92       0.06       (9.87     (9.81     (0.07     (4.32           (4.39     53.72       0.60       0.78       0.18       8       (15.37     2  
11/01/20     10/31/21       54.19       0.15       21.52       21.67       (0.23     (7.71           (7.94     67.92       0.60       0.79       0.24       20       43.99       2  
11/01/19     10/31/20       45.16       0.44       9.48       9.92       (0.30     (0.59           (0.89     54.19       0.60       0.79       0.95       31       22.26       1  
11/01/18     10/31/19       44.77       0.31       3.93       4.24       (0.25     (3.60           (3.85     45.16       0.60       0.80       0.73       49       11.67       45  
11/01/17     10/31/18       44.82       0.26       2.48       2.74       (0.09     (2.70           (2.79     44.77       0.63       0.79       0.55       45       6.23       44  
11/01/16     10/31/17       36.35       0.14       10.66       10.80       (0.19     (2.14           (2.33     44.82       0.82       0.82       0.34       33       31.36       41  
Class Y*                                
11/01/21     04/30/22       68.16       (0.07     (9.90     (9.97           (4.32           (4.32     53.87       1.00       1.03       (0.22     8       (15.54     0  
11/01/20     10/31/21       54.39       (0.09     21.64       21.55       (0.07     (7.71           (7.78     68.16       1.00       1.04       (0.15     20       43.45       0  
11/01/19     10/31/20       45.42       0.03       9.68       9.71       (0.15     (0.59           (0.74     54.39       1.00       1.62       0.06       31       21.60       0  
11/01/18     10/31/19       44.90       0.14       3.99       4.13       (0.01     (3.60           (3.61     45.42       1.00       1.73       0.33       49       11.23       0  
11/20/17     10/31/18       45.64       0.08       2.00       2.08       (0.12     (2.70           (2.82     44.90       1.01       1.55       0.18       45       4.67       0  
Carillon ClariVest International Stock Fund                                                                                                
Class A*                                
11/01/21     04/30/22       21.00       0.41       (2.22     (1.81     (0.31                 (0.31     18.88       1.38       3.40       4.11       96       (8.74     3  
11/01/20     10/31/21       15.27       0.33       5.54       5.87       (0.14                 (0.14     21.00       1.45       5.16       1.66       80       38.61       4  
11/01/19     10/31/20       17.47       0.17       (1.99     (1.82     (0.38                 (0.38     15.27       1.45       4.90       1.08       54       (10.73     2  
11/01/18     10/31/19       16.92       0.28       0.49       0.77       (0.22                 (0.22     17.47       1.45       4.12       1.67       43       4.74       4  
11/01/17     10/31/18       18.71       0.28       (1.86     (1.58     (0.21                 (0.21     16.92       1.45       2.85       1.50       49       (8.56     5  
11/01/16     10/31/17       15.02       0.17       3.71       3.88       (0.19                 (0.19     18.71       1.54       3.72       1.03       80       26.15       4  

 

34         The accompanying notes are an integral part of the financial statements.


Financial Highlights

 

Fiscal period

          From investment operations     Dividends & distributions          

Ratios to average net asset (%)

                   
  Beginning
net asset
value
    Income
(loss)
    Realized &
unrealized
gain (loss)
    Total     From
investment
income
    From
realized
gains
    From
return
of
capital
    Total     Ending
net
asset
value
    With
expenses
waived/
recovered (a)
    Without
expenses
waived/
recovered (a)
    Net
income
(loss) (a)
    Portfolio
turnover
rate (%) (b)
    Total
return
(%) (b)(c)
    Ending
net
assets
(millions)
 
Beginning   Ending  
Carillon ClariVest International Stock Fund (cont'd)                                                                                                
Class C*                                
11/01/21     04/30/22       $20.56       $0.33       $(2.18     $(1.85     $(0.19     $—       $—       $(0.19     $18.52       2.14       4.14       3.36       96       (9.08     $2  
11/01/20     10/31/21       14.95       0.17       5.45       5.62       (0.01                 (0.01     20.56       2.20       5.90       0.90       80       37.63       2  
11/01/19     10/31/20       17.14       0.07       (1.99     (1.92     (0.27                 (0.27     14.95       2.20       5.74       0.43       54       (11.44     1  
11/01/18     10/31/19       16.53       0.15       0.51       0.66       (0.05                 (0.05     17.14       2.20       4.91       0.90       43       4.01       2  
11/01/17     10/31/18       18.32       0.04       (1.73     (1.69     (0.10                 (0.10     16.53       2.20       3.68       0.21       49       (9.28     3  
11/01/16     10/31/17       14.79       0.04       3.65       3.69       (0.16                 (0.16     18.32       2.29       4.50       0.27       80       25.21       5  
Class I*                                
11/01/21     04/30/22       20.99       0.45       (2.21     (1.76     (0.38                 (0.38     18.85       1.07       3.02       4.43       96       (8.57     12  
11/01/20     10/31/21       15.26       0.38       5.55       5.93       (0.20                 (0.20     20.99       1.15       4.90       1.95       80       39.05       6  
11/01/19     10/31/20       17.46       0.23       (2.01     (1.78     (0.42                 (0.42     15.26       1.15       4.63       1.44       54       (10.51     3  
11/01/18     10/31/19       16.92       0.31       0.51       0.82       (0.28                 (0.28     17.46       1.15       3.82       1.88       43       5.07       5  
11/01/17     10/31/18       18.70       0.30       (1.82     (1.52     (0.26                 (0.26     16.92       1.15       2.59       1.60       49       (8.29     9  
11/01/16     10/31/17       15.11       0.23       3.71       3.94       (0.35                 (0.35     18.70       1.15       3.28       1.40       80       26.63       8  
Class R-3*                                
11/01/21     04/30/22       20.69       0.39       (2.21     (1.82     (0.10                 (0.10     18.77       1.63       3.68       3.87       96       (8.85     0  
11/01/20     10/31/21       15.07       0.15       5.58       5.73       (0.11                 (0.11     20.69       1.70       5.47       0.85       80       38.17       0  
11/01/19     10/31/20       17.27       0.15       (2.00     (1.85     (0.35                 (0.35     15.07       1.70       5.26       0.96       54       (11.01     1  
11/01/18     10/31/19       16.74       0.24       0.49       0.73       (0.20                 (0.20     17.27       1.70       4.49       1.44       43       4.54       1  
11/01/17     10/31/18       18.53       0.19       (1.80     (1.61     (0.18                 (0.18     16.74       1.70       3.17       1.01       49       (8.80     1  
11/01/16     10/31/17       15.04       0.15       3.67       3.82       (0.33                 (0.33     18.53       1.71       3.98       0.89       80       25.91       1  
Class R-5*                                
11/01/21     04/30/22       21.00       0.44       (2.20     (1.76     (0.37                 (0.37     18.87       1.09       3.08       4.41       96       (8.55     0  
11/01/20     10/31/21       15.28       0.39       5.53       5.92       (0.20                 (0.20     21.00       1.15       4.83       1.97       80       38.95       0  
11/01/19     10/31/20       17.48       0.24       (2.02     (1.78     (0.42                 (0.42     15.28       1.15       6.63       1.49       54       (10.48     0  
11/01/18     10/31/19       16.94       0.33       0.49       0.82       (0.28                 (0.28     17.48       1.15       6.06       1.99       43       5.06       0  
11/01/17     10/31/18       18.69       0.29       (1.81     (1.52     (0.23                 (0.23     16.94       1.15       4.65       1.56       49       (8.26     0  
11/01/16     10/31/17       15.11       0.08       3.85       3.93       (0.35                 (0.35     18.69       1.15       3.69       0.49       80       26.56       0  
Class R-6*                                
11/01/21     04/30/22       21.06       0.46       (2.22     (1.76     (0.39                 (0.39     18.91       0.88       2.19       4.62       96       (8.54     14  
11/01/20     10/31/21       15.31       0.39       5.57       5.96       (0.21                 (0.21     21.06       1.05       4.82       2.03       80       39.19       0  
11/01/19     10/31/20       17.51       0.25       (2.01     (1.76     (0.44                 (0.44     15.31       1.05       4.66       1.59       54       (10.39     0  
11/01/18     10/31/19       16.97       0.34       0.49       0.83       (0.29                 (0.29     17.51       1.05       3.90       2.02       43       5.16       0  
11/01/17     10/31/18       18.75       0.29       (1.80     (1.51     (0.27                 (0.27     16.97       1.05       2.81       1.55       49       (8.21     0  
11/01/16     10/31/17       15.14       0.26       3.71       3.97       (0.36                 (0.36     18.75       1.05       3.78       1.55       80       26.82       0  
Class Y*                                
11/01/21     04/30/22       20.89       0.41       (2.20     (1.79     (0.31                 (0.31     18.79       1.38       3.32       4.11       96       (8.71     0  
11/01/20     10/31/21       15.21       0.33       5.51       5.84       (0.16                 (0.16     20.89       1.45       5.09       1.68       80       38.55       0  
11/01/19     10/31/20       17.34       0.19       (2.01     (1.82     (0.31                 (0.31     15.21       1.45       5.72       1.19       54       (10.73     0  
11/01/18     10/31/19       16.86       0.35       0.40       0.75       (0.27                 (0.27     17.34       1.45       4.35       2.10       43       4.70       0  
11/20/17     10/31/18       18.54       0.21       (1.62     (1.41     (0.27                 (0.27     16.86       1.45       3.59       1.20       49       (7.77     0  
Carillon Eagle Growth & Income Fund                                                                                                
Class A*                                
11/01/21     04/30/22       26.51       0.17       (1.22     (1.05     (0.18     (2.04           (2.22     23.24       0.95       0.95       1.36       10       (4.38     222  
11/01/20     10/31/21       20.22       0.34       7.02       7.36       (0.34     (0.73           (1.07     26.51       0.96       0.96       1.42       32       37.44       234  
11/01/19     10/31/20       21.70       0.37       (0.82     (0.45     (0.37     (0.66           (1.03     20.22       0.97       0.97       1.81       41       (2.09     165  
11/01/18     10/31/19       21.44       0.41       1.74       2.15       (0.39     (1.50           (1.89     21.70       0.97       0.97       1.98       25       11.47       171  
11/01/17     10/31/18       20.39       0.40       1.57       1.97       (0.42     (0.50           (0.92     21.44       0.98       0.98       1.91       10       9.76       147  
11/01/16     10/31/17       18.39       0.34       2.93       3.27       (0.33     (0.94           (1.27     20.39       1.03       1.03       1.74       10       18.56       147  
Class C*                                
11/01/21     04/30/22       25.17       0.08       (1.17     (1.09     (0.09     (2.04           (2.13     21.95       1.68       1.68       0.64       10       (4.77     65  
11/01/20     10/31/21       19.24       0.16       6.67       6.83       (0.17     (0.73           (0.90     25.17       1.69       1.69       0.72       32       36.47       79  
11/01/19     10/31/20       20.68       0.21       (0.77     (0.56     (0.22     (0.66           (0.88     19.24       1.73       1.73       1.08       41       (2.82     79  
11/01/18     10/31/19       20.52       0.24       1.66       1.90       (0.24     (1.50           (1.74     20.68       1.72       1.72       1.23       25       10.66       133  
11/01/17     10/31/18       19.54       0.24       1.49       1.73       (0.25     (0.50           (0.75     20.52       1.73       1.73       1.16       10       8.94       130  
11/01/16     10/31/17       17.68       0.18       2.81       2.99       (0.19     (0.94           (1.13     19.54       1.79       1.79       0.98       10       17.62       169  

 

The accompanying notes are an integral part of the financial statements.           35  


Financial Highlights

 

Fiscal period

          From investment operations     Dividends & distributions          

Ratios to average net asset (%)

                   
  Beginning
net asset
value
    Income
(loss)
    Realized &
unrealized
gain (loss)
    Total     From
investment
income
    From
realized
gains
    From
return
of
capital
    Total     Ending
net
asset
value
    With
expenses
waived/
recovered (a)
    Without
expenses
waived/
recovered (a)
    Net
income
(loss) (a)
    Portfolio
turnover
rate (%) (b)
    Total
return
(%) (b)(c)
    Ending
net
assets
(millions)
 
Beginning   Ending  
Carillon Eagle Growth & Income Fund (cont'd)                                                                                                
Class I*                                
11/01/21     04/30/22       $26.43       $0.20       $(1.22     $(1.02     $(0.21     $(2.04     $—       $(2.25     $23.16       0.68       0.68       1.64       10       (4.26     $635  
11/01/20     10/31/21       20.16       0.41       7.00       7.41       (0.41     (0.73           (1.14     26.43       0.68       0.68       1.70       32       37.83       661  
11/01/19     10/31/20       21.64       0.42       (0.81     (0.39     (0.43     (0.66           (1.09     20.16       0.70       0.70       2.07       41       (1.82     487  
11/01/18     10/31/19       21.39       0.46       1.74       2.20       (0.45     (1.50           (1.95     21.64       0.70       0.70       2.21       25       11.76       492  
11/01/17     10/31/18       20.34       0.46       1.56       2.02       (0.47     (0.50           (0.97     21.39       0.72       0.72       2.16       10       10.06       272  
11/01/16     10/31/17       18.35       0.39       2.93       3.32       (0.39     (0.94           (1.33     20.34       0.75       0.75       2.00       10       18.90       246  
Class R-3*                                
11/01/21     04/30/22       26.39       0.13       (1.22     (1.09     (0.14     (2.04           (2.18     23.12       1.24       1.24       1.05       10       (4.53     2  
11/01/20     10/31/21       20.13       0.27       6.99       7.26       (0.27     (0.73           (1.00     26.39       1.25       1.25       1.12       32       37.07       2  
11/01/19     10/31/20       21.61       0.31       (0.82     (0.51     (0.31     (0.66           (0.97     20.13       1.27       1.27       1.53       41       (2.41     1  
11/01/18     10/31/19       21.35       0.34       1.74       2.08       (0.32     (1.50           (1.82     21.61       1.30       1.30       1.66       25       11.12       2  
11/01/17     10/31/18       20.30       0.33       1.56       1.89       (0.34     (0.50           (0.84     21.35       1.31       1.31       1.59       10       9.40       2  
11/01/16     10/31/17       18.32       0.28       2.91       3.19       (0.27     (0.94           (1.21     20.30       1.34       1.34       1.44       10       18.15       2  
Class R-5*                                
11/01/21     04/30/22       26.46       0.20       (1.22     (1.02     (0.21     (2.04           (2.25     23.19       0.70       0.70       1.62       10       (4.27     6  
11/01/20     10/31/21       20.18       0.40       7.01       7.41       (0.40     (0.73           (1.13     26.46       0.71       0.71       1.69       32       37.79       8  
11/01/19     10/31/20       21.66       0.41       (0.80     (0.39     (0.43     (0.66           (1.09     20.18       0.72       0.72       2.05       41       (1.82     7  
11/01/18     10/31/19       21.41       0.47       1.73       2.20       (0.45     (1.50           (1.95     21.66       0.72       0.72       2.23       25       11.73       4  
11/01/17     10/31/18       20.36       0.45       1.56       2.01       (0.46     (0.50           (0.96     21.41       0.78       0.78       2.10       10       9.99       0  
11/01/16     10/31/17       18.38       0.38       2.93       3.31       (0.39     (0.94           (1.33     20.36       0.76       0.76       1.97       10       18.82       0  
Class R-6*                                
11/01/21     04/30/22       26.39       0.21       (1.21     (1.00     (0.23     (2.04           (2.27     23.12       0.60       0.60       1.72       10       (4.22     9  
11/01/20     10/31/21       20.13       0.42       7.00       7.42       (0.43     (0.73           (1.16     26.39       0.61       0.61       1.73       32       37.94       8  
11/01/19     10/31/20       21.59       0.54       (0.98     (0.44     (0.36     (0.66           (1.02     20.13       0.62       0.62       2.58       41       (2.03     2  
11/01/18     10/31/19       21.34       0.48       1.73       2.21       (0.46     (1.50           (1.96     21.59       0.63       0.63       2.31       25       11.87       49  
11/01/17     10/31/18       20.30       0.47       1.56       2.03       (0.49     (0.50           (0.99     21.34       0.64       0.64       2.24       10       10.12       42  
11/01/16     10/31/17       18.32       0.40       2.93       3.33       (0.41     (0.94           (1.35     20.30       0.65       0.65       2.10       10       18.98       40  
Class Y*                                
11/01/21     04/30/22       26.37       0.20       (1.27     (1.07     (0.17     (2.04           (2.21     23.09       0.99       0.99       1.65       10       (4.46     0  
11/01/20     10/31/21       20.13       0.33       6.99       7.32       (0.35     (0.73           (1.08     26.37       0.98       0.98       1.35       32       37.41       0  
11/01/19     10/31/20       21.60       0.34       (0.80     (0.46     (0.35     (0.66           (1.01     20.13       1.08       1.08       1.68       41       (2.18     0  
11/01/18     10/31/19       21.35       0.38       1.74       2.12       (0.37     (1.50           (1.87     21.60       1.10       1.07       1.82       25       11.35       0  
11/20/17     10/31/18       20.48       0.28       1.49       1.77       (0.40     (0.50           (0.90     21.35       1.25       1.43       1.35       10       8.74       0  
Carillon Eagle Mid Cap Growth Fund                                                                                                
Class A*                                
11/01/21     04/30/22       104.16       (0.28     (21.59     (21.87           (9.75           (9.75     72.54       1.03       1.03       (0.65     14       (22.46     673  
11/01/20     10/31/21       77.60       (0.63     29.23       28.60             (2.04           (2.04     104.16       1.03       1.03       (0.67     23       37.25       942  
11/01/19     10/31/20       63.14       (0.37     16.27       15.90             (1.44           (1.44     77.60       1.04       1.04       (0.54     27       25.62       786  
11/01/18     10/31/19       56.19       (0.26     8.71       8.45             (1.50           (1.50     63.14       1.05       1.05       (0.44     32       15.81       719  
11/01/17     10/31/18       56.41       (0.28     3.06       2.78             (3.00           (3.00     56.19       1.05       1.05       (0.46     44       4.75       688  
11/01/16     10/31/17       42.29       (0.26     14.38       14.12                               56.41       1.12       1.12       (0.53     44       33.39       459  
Class C*                                
11/01/21     04/30/22       79.34       (0.42     (16.07     (16.49           (9.75           (9.75     53.10       1.71       1.71       (1.34     14       (22.73     99  
11/01/20     10/31/21       59.92       (0.97     22.43       21.46             (2.04           (2.04     79.34       1.71       1.71       (1.35     23       36.30       141  
11/01/19     10/31/20       49.40       (0.65     12.61       11.96             (1.44           (1.44     59.92       1.74       1.74       (1.24     27       24.75       134  
11/01/18     10/31/19       44.61       (0.52     6.81       6.29             (1.50           (1.50     49.40       1.74       1.74       (1.12     32       15.05       136  
11/01/17     10/31/18       45.67       (0.55     2.49       1.94             (3.00           (3.00     44.61       1.74       1.74       (1.14     44       4.00       147  
11/01/16     10/31/17       34.48       (0.50     11.69       11.19                               45.67       1.84       1.84       (1.24     44       32.45       146  
Class I*                                
11/01/21     04/30/22       111.62       (0.16     (23.27     (23.43           (9.75           (9.75     78.44       0.72       0.72       (0.34     14       (22.35     1,451  
11/01/20     10/31/21       82.78       (0.37     31.25       30.88             (2.04           (2.04     111.62       0.72       0.72       (0.37     23       37.68       1,993  
11/01/19     10/31/20       67.06       (0.17     17.33       17.16             (1.44           (1.44     82.78       0.72       0.72       (0.23     27       26.01       1,547  
11/01/18     10/31/19       59.38       (0.08     9.26       9.18             (1.50           (1.50     67.06       0.74       0.74       (0.12     32       16.20       1,319  
11/01/17     10/31/18       59.29       (0.10     3.19       3.09             (3.00           (3.00     59.38       0.75       0.75       (0.16     44       5.05       1,134  
11/01/16     10/31/17       44.30       (0.11     15.10       14.99        (d)                   (d)      59.29       0.78       0.78       (0.21     44       33.84       763  

 

36         The accompanying notes are an integral part of the financial statements.


Financial Highlights

 

Fiscal period

          From investment operations     Dividends & distributions          

Ratios to average net asset (%)

                   
  Beginning
net asset
value
    Income
(loss)
    Realized &
unrealized
gain (loss)
    Total     From
investment
income
    From
realized
gains
    From
return
of
capital
    Total     Ending
net
asset
value
    With
expenses
waived/
recovered (a)
    Without
expenses
waived/
recovered (a)
    Net
income
(loss) (a)
    Portfolio
turnover
rate (%) (b)
    Total
return
(%) (b)(c)
    Ending
net
assets
(millions)
 
Beginning   Ending  
Carillon Eagle Mid Cap Growth Fund (cont'd)                                                                                                
Class R-3*                                
11/01/21     04/30/22       $99.82       $(0.37     $(20.62     $(20.99     $—       $(9.75     $—       $(9.75     $69.08       1.29       1.29       (0.91     14       (22.56     $37  
11/01/20     10/31/21       74.62       (0.83     28.07       27.24             (2.04           (2.04     99.82       1.28       1.28       (0.92     23       36.91       53  
11/01/19     10/31/20       60.92       (0.53     15.67       15.14             (1.44           (1.44     74.62       1.31       1.31       (0.81     27       25.30       44  
11/01/18     10/31/19       54.42       (0.42     8.42       8.00             (1.50           (1.50     60.92       1.34       1.34       (0.73     32       15.49       45  
11/01/17     10/31/18       54.88       (0.42     2.96       2.54             (3.00           (3.00     54.42       1.32       1.32       (0.72     44       4.43       35  
11/01/16     10/31/17       41.25       (0.39     14.02       13.63                               54.88       1.38       1.38       (0.80     44       33.04       32  
Class R-5*                                
11/01/21     04/30/22       111.26       (0.16     (23.19     (23.35           (9.75           (9.75     78.16       0.74       0.74       (0.36     14       (22.35     753  
11/01/20     10/31/21       82.53       (0.38     31.15       30.77             (2.04           (2.04     111.26       0.73       0.73       (0.38     23       37.66       1,066  
11/01/19     10/31/20       66.87       (0.17     17.27       17.10             (1.44           (1.44     82.53       0.73       0.73       (0.24     27       25.99       809  
11/01/18     10/31/19       59.22       (0.09     9.24       9.15             (1.50           (1.50     66.87       0.75       0.75       (0.14     32       16.19       758  
11/01/17     10/31/18       59.14       (0.11     3.19       3.08             (3.00           (3.00     59.22       0.75       0.75       (0.18     44       5.04       648  
11/01/16     10/31/17       44.19       (0.11     15.06       14.95        (d)                   (d)      59.14       0.79       0.79       (0.22     44       33.84       284  
Class R-6*                                
11/01/21     04/30/22       112.71       (0.12     (23.52     (23.64           (9.75           (9.75     79.32       0.64       0.64       (0.26     14       (22.31     3,362  
11/01/20     10/31/21       83.51       (0.28     31.52       31.24             (2.04           (2.04     112.71       0.63       0.63       (0.28     23       37.79       4,561  
11/01/19     10/31/20       67.58       (0.11     17.48       17.37             (1.44           (1.44     83.51       0.64       0.64       (0.15     27       26.12       3,295  
11/01/18     10/31/19       59.78       (0.03     9.33       9.30             (1.50           (1.50     67.58       0.65       0.65       (0.04     32       16.30       2,695  
11/01/17     10/31/18       59.62       (0.06     3.22       3.16             (3.00           (3.00     59.78       0.66       0.66       (0.09     44       5.14       1,636  
11/01/16     10/31/17       44.51       (0.07     15.19       15.12       (0.01                 (0.01     59.62       0.69       0.69       (0.12     44       33.97       692  
Class Y*                                
11/01/21     04/30/22       110.11       (0.29     (22.92     (23.21           (9.75           (9.75     77.15       1.03       1.03       (0.64     14       (22.46     3  
11/01/20     10/31/21       81.94       (0.67     30.88       30.21             (2.04           (2.04     110.11       1.03       1.03       (0.68     23       37.24       5  
11/01/19     10/31/20       66.60       (0.39     17.17       16.78             (1.44           (1.44     81.94       1.05       1.05       (0.55     27       25.61       4  
11/01/18     10/31/19       59.14       (0.29     9.25       8.96             (1.50           (1.50     66.60       1.01       1.01       (0.44     32       15.89       4  
11/20/17     10/31/18       60.71       (0.44     1.87       1.43             (3.00           (3.00     59.14       1.13       1.13       (0.72     44       2.18       0  
Carillon Eagle Small Cap Growth Fund                                                                                                
Class A*                                
11/01/21     04/30/22       61.37       (0.11     (13.29     (13.40           (16.32           (16.32     31.65       1.09       1.09       (0.54     20       (26.78     234  
11/01/20     10/31/21       54.04       (0.43     18.33       17.90             (10.57           (10.57     61.37       1.06       1.06       (0.73     28       34.65       384  
11/01/19     10/31/20       48.23       (0.37     9.45       9.08             (3.27           (3.27     54.04       1.08       1.08       (0.77     21       19.50       336  
11/01/18     10/31/19       59.15       (0.32     0.39       0.07             (10.99           (10.99     48.23       1.08       1.08       (0.65     26       3.64       394  
11/01/17     10/31/18       62.31       (0.40     2.07       1.67             (4.83           (4.83     59.15       1.05       1.05       (0.63     35       2.61       544  
11/01/16     10/31/17       50.48       (0.27     13.72       13.45             (1.62           (1.62     62.31       1.13       1.13       (0.47     40       27.22       640  
Class C*                                
11/01/21     04/30/22       34.57       (0.10     (6.18     (6.28           (16.32           (16.32     11.97       1.78       1.78       (1.25     20       (27.05     20  
11/01/20     10/31/21       34.32       (0.48     11.30       10.82             (10.57           (10.57     34.57       1.76       1.76       (1.41     28       33.73       34  
11/01/19     10/31/20       31.93       (0.45     6.11       5.66             (3.27           (3.27     34.32       1.77       1.77       (1.45     21       18.67       48  
11/01/18     10/31/19       43.65       (0.44     (0.29     (0.73           (10.99           (10.99     31.93       1.76       1.76       (1.32     26       2.92       68  
11/01/17     10/31/18       47.51       (0.62     1.59       0.97             (4.83           (4.83     43.65       1.75       1.75       (1.31     35       1.89       111  
11/01/16     10/31/17       39.10       (0.51     10.54       10.03             (1.62           (1.62     47.51       1.82       1.82       (1.17     40       26.37       169  
Class I*                                
11/01/21     04/30/22       67.29       (0.06     (14.87     (14.93           (16.32           (16.32     36.04       0.79       0.79       (0.24     20       (26.68     494  
11/01/20     10/31/21       58.29       (0.28     19.85       19.57             (10.57           (10.57     67.29       0.77       0.77       (0.44     28       35.04       777  
11/01/19     10/31/20       51.64       (0.24     10.16       9.92             (3.27           (3.27     58.29       0.78       0.78       (0.46     21       19.86       803  
11/01/18     10/31/19       62.28       (0.17     0.52       0.35             (10.99           (10.99     51.64       0.76       0.76       (0.33     26       3.96       1,040  
11/01/17     10/31/18       65.18       (0.22     2.15       1.93             (4.83           (4.83     62.28       0.75       0.75       (0.33     35       2.91       1,369  
11/01/16     10/31/17       52.55       (0.08     14.33       14.25             (1.62           (1.62     65.18       0.78       0.78       (0.13     40       27.68       1,691  
Class R-3*                                
11/01/21     04/30/22       57.51       (0.15     (12.26     (12.41           (16.32           (16.32     28.78       1.35       1.35       (0.80     20       (26.87     40  
11/01/20     10/31/21       51.28       (0.54     17.34       16.80             (10.57           (10.57     57.51       1.30       1.30       (0.97     28       34.32       60  
11/01/19     10/31/20       46.02       (0.46     8.99       8.53             (3.27           (3.27     51.28       1.31       1.31       (1.00     21       19.22       58  
11/01/18     10/31/19       57.14       (0.43     0.30       (0.13           (10.99           (10.99     46.02       1.34       1.34       (0.90     26       3.37       66  
11/01/17     10/31/18       60.51       (0.55     2.01       1.46             (4.83           (4.83     57.14       1.32       1.32       (0.90     35       2.32       85  
11/01/16     10/31/17       49.18       (0.40     13.35       12.95             (1.62           (1.62     60.51       1.38       1.38       (0.73     40       26.92       98  

 

The accompanying notes are an integral part of the financial statements.           37  


Financial Highlights

 

Fiscal period

          From investment operations     Dividends & distributions          

Ratios to average net asset (%)

                   
  Beginning
net asset
value
    Income
(loss)
    Realized &
unrealized
gain (loss)
    Total     From
investment
income
    From
realized
gains
    From
return
of
capital
    Total     Ending
net
asset
value
    With
expenses
waived/
recovered (a)
    Without
expenses
waived/
recovered (a)
    Net
income
(loss) (a)
    Portfolio
turnover
rate (%) (b)
    Total
return
(%) (b)(c)
    Ending
net
assets
(millions)
 
Beginning   Ending  
Carillon Eagle Small Cap Growth Fund (cont'd)                                                                                                
Class R-5*                                
11/01/21     04/30/22       $67.76       $(0.06     $(15.00     $(15.06     $—       $(16.32     $—       $(16.32     $36.38       0.79       0.79       (0.27     20       (26.69     $43  
11/01/20     10/31/21       58.64       (0.26     19.95       19.69             (10.57           (10.57     67.76       0.77       0.77       (0.39     28       35.03       106  
11/01/19     10/31/20       51.92       (0.23     10.22       9.99             (3.27           (3.27     58.64       0.76       0.76       (0.43     21       19.88       205  
11/01/18     10/31/19       62.56       (0.18     0.53       0.35             (10.99           (10.99     51.92       0.77       0.77       (0.34     26       3.94       362  
11/01/17     10/31/18       65.45       (0.22     2.16       1.94             (4.83           (4.83     62.56       0.75       0.75       (0.33     35       2.92       441  
11/01/16     10/31/17       52.75       (0.07     14.39       14.32             (1.62           (1.62     65.45       0.77       0.77       (0.11     40       27.71       469  
Class R-6*                                
11/01/21     04/30/22       68.96       (0.04     (15.32     (15.36           (16.32           (16.32     37.28       0.69       0.69       (0.16     20       (26.65     506  
11/01/20     10/31/21       59.47       (0.22     20.28       20.06             (10.57           (10.57     68.96       0.66       0.66       (0.33     28       35.18       985  
11/01/19     10/31/20       52.56       (0.18     10.36       10.18             (3.27           (3.27     59.47       0.66       0.66       (0.34     21       20.01       1,427  
11/01/18     10/31/19       63.11       (0.12     0.56       0.44             (10.99           (10.99     52.56       0.65       0.65       (0.23     26       4.07       2,186  
11/01/17     10/31/18       65.92       (0.16     2.18       2.02             (4.83           (4.83     63.11       0.65       0.65       (0.24     35       3.02       2,141  
11/01/16     10/31/17       53.06       (0.04     14.52       14.48             (1.62           (1.62     65.92       0.66       0.66       (0.06     40       27.86       2,005  
Class Y*                                
11/01/21     04/30/22       65.82       (0.09     (14.49     (14.58           (16.32           (16.32     34.92       0.98       0.95       (0.40     20       (26.75     0  
11/01/20     10/31/21       57.44       (0.59     19.54       18.95             (10.57           (10.57     65.82       1.25       0.91       (0.92     28       34.40       0  
11/01/19     10/31/20       51.16       (0.51     10.06       9.55             (3.27           (3.27     57.44       1.25       1.52       (0.97     21       19.29       0  
11/01/18     10/31/19       62.03       (0.33     0.45       0.12             (10.99           (10.99     51.16       1.17       1.37       (0.61     26       3.53       0  
11/20/17     10/31/18       65.89       (0.50     1.47       0.97             (4.83           (4.83     62.03       1.12       1.12       (0.77     35       1.40       0  
Carillon ClariVest International Fund                                                                                                
Class A*                                
11/01/21     04/30/22       19.85       0.26       (2.04     (1.78     (0.42     (1.89           (2.31     15.76       1.25       1.33       2.92       90       (10.23     1  
11/01/20     10/31/21       15.42       0.36       5.67       6.03       (0.32     (1.28           (1.60     19.85       1.31       1.34       1.91  +      15       40.37  ~      1  
11/01/19     10/31/20       18.93       0.21       (2.28     (2.07     (0.39     (1.05           (1.44     15.42       1.45       1.46       1.28       21       (12.26     1  
11/01/18     10/31/19       19.02       0.35       1.50       1.85       (0.66     (1.28           (1.94     18.93       1.44       1.51       1.97       20       11.82       1  
11/20/17     10/31/18       25.05       0.21       (2.26     (2.05     (0.22     (3.76           (3.98     19.02       1.31       1.31       1.05       13       (9.90     0  
Class C*                                
11/01/21     04/30/22       19.55       0.19       (2.01     (1.82     (0.28     (1.89           (2.17     15.56       2.00       2.01       2.14       90       (10.54     0  
11/01/20     10/31/21       15.30       0.23       5.60       5.83       (0.30     (1.28           (1.58     19.55       2.06       2.03       1.20  +      15       39.28  ~      0  
11/01/19     10/31/20       18.83       0.10       (2.29     (2.19     (0.29     (1.05           (1.34     15.30       2.20       2.25       0.58       21       (12.90     0  
11/01/18     10/31/19       18.89       0.20       1.52       1.72       (0.50     (1.28           (1.78     18.83       2.19       2.21       1.15       20       10.99       0  
11/20/17     10/31/18       25.05       0.18       (2.38     (2.20     (0.20     (3.76           (3.96     18.89       2.20       2.23       0.87       13       (10.59     0  
Class I*                                
11/01/21     04/30/22       20.05       0.28       (2.04     (1.76     (0.48     (1.89           (2.37     15.92       0.95       1.04       3.10       90       (10.07     395  
11/01/20     10/31/21       15.53       0.42       5.71       6.13       (0.33     (1.28           (1.61     20.05       1.01       1.05       2.20  +      15       40.76  ~      486  
11/01/19     10/31/20       19.06       0.27       (2.31     (2.04     (0.44     (1.05           (1.49     15.53       1.14       1.14       1.60       21       (12.03     451  
11/01/18     10/31/19       19.07       0.37       1.56       1.93       (0.66     (1.28           (1.94     19.06       1.10       1.10       2.05       20       12.24       711  
11/01/17     10/31/18       25.18       0.38       (2.51     (2.13     (0.22     (3.76           (3.98     19.07       1.06       1.06       1.73       13       (10.12     821  
07/01/17     10/31/17       23.21       0.07       1.90       1.97                               25.18       1.08       1.08       0.81       7       8.49       1,161  
07/01/16     06/30/17       23.10       0.37       3.50       3.87       (0.42     (3.34           (3.76     23.21       1.06       1.06       1.61       20       18.80       1,186  
Class R-3*                                
11/01/21     04/30/22       19.88       0.24       (2.05     (1.81     (0.37     (1.89           (2.26     15.81       1.50       1.43       2.66       90       (10.35     0  
11/01/20     10/31/21       15.47       0.32       5.69       6.01       (0.32     (1.28           (1.60     19.88       1.56       1.45       1.66  +      15       40.03  ~      0  
11/01/19     10/31/20       18.99       0.17       (2.30     (2.13     (0.34     (1.05           (1.39     15.47       1.70       2.21       1.03       21       (12.51     0  
11/01/18     10/31/19       18.97       0.26       1.56       1.82       (0.52     (1.28           (1.80     18.99       1.70       2.18       1.48       20       11.53       0  
11/20/17     10/31/18       25.05       0.23       (2.33     (2.10     (0.22     (3.76           (3.98     18.97       1.70       2.16       1.14       13       (10.16     0  
Class R-5*                                
11/01/21     04/30/22       20.05       0.29       (2.04     (1.75     (0.48     (1.89           (2.37     15.93       0.95       0.93       3.21       90       (10.01     0  
11/01/20     10/31/21       15.53       0.43       5.70       6.13       (0.33     (1.28           (1.61     20.05       1.01       0.95       2.21  +      15       40.76  ~      0  
11/01/19     10/31/20       19.05       0.26       (2.29     (2.03     (0.44     (1.05           (1.49     15.53       1.15       1.69       1.58       21       (12.01     0  
11/01/18     10/31/19       19.06       0.36       1.55       1.91       (0.64     (1.28           (1.92     19.05       1.15       1.68       2.03       20       12.10       0  
11/20/17     10/31/18       25.05       0.34       (2.34     (2.00     (0.23     (3.76           (3.99     19.06       1.15       1.66       1.69       13       (9.68     0  

 

38         The accompanying notes are an integral part of the financial statements.


Financial Highlights

 

Fiscal period

          From investment operations     Dividends & distributions          

Ratios to average net asset (%)

                   
  Beginning
net asset
value
    Income
(loss)
    Realized &
unrealized
gain (loss)
    Total     From
investment
income
    From
realized
gains
    From
return
of
capital
    Total     Ending
net
asset
value
    With
expenses
waived/
recovered (a)
    Without
expenses
waived/
recovered (a)
    Net
income
(loss) (a)
    Portfolio
turnover
rate (%) (b)
    Total
return
(%) (b)(c)
    Ending
net
assets
(millions)
 
Beginning   Ending  
Carillon ClariVest International Fund (cont'd)                                                                                                
Class R-6*                                
11/01/21     04/30/22       $ 20.05       $ 0.28       $ (2.03     $ (1.75     $ (0.50     $ (1.89     $ —       $ (2.39     $ 15.91       0.85       0.94       3.15       90       (10.02     $3  
11/01/20     10/31/21       15.52       0.46       5.69       6.15       (0.34     (1.28           (1.62     20.05       0.91       0.96       2.38  +      15       40.89  ~      4  
11/01/19     10/31/20       19.04       0.28       (2.29     (2.01     (0.46     (1.05           (1.51     15.52       1.04       1.04       1.73       21       (11.89     3  
11/01/18     10/31/19       19.08       0.39       1.54       1.93       (0.69     (1.28           (1.97     19.04       1.02       1.02       2.20       20       12.27       3  
11/20/17     10/31/18       25.05       0.32       (2.30     (1.98     (0.23     (3.76           (3.99     19.08       0.99       0.99       1.60       13       (9.59     3  
Class Y*                                
11/01/21     04/30/22       19.94       0.27       (2.04     (1.77     (0.45     (1.89           (2.34     15.83       1.25       1.20       3.05       90       (10.18     0  
11/01/20     10/31/21       15.49       0.37       5.68       6.05       (0.32     (1.28           (1.60     19.94       1.31       1.20       1.91  +      15       40.31  ~      0  
11/01/19     10/31/20       19.01       0.21       (2.29     (2.08     (0.39     (1.05           (1.44     15.49       1.45       2.19       1.28       21       (12.27     0  
11/01/18     10/31/19       19.01       0.31       1.55       1.86       (0.58     (1.28           (1.86     19.01       1.45       2.19       1.73       20       11.79       0  
11/20/17     10/31/18       25.05       0.28       (2.34     (2.06     (0.22     (3.76           (3.98     19.01       1.45       2.16       1.39       13       (9.94     0  
Carillon Scout Mid Cap Fund                                                                                                
Class A*                                
11/01/21     04/30/22       27.73       0.01       (2.67     (2.66     (0.01     (2.80           (2.81     22.26       1.21       1.21       0.12       76       (9.94     29  
11/01/20     10/31/21       19.92       (0.06     8.39       8.33             (0.52           (0.52     27.73       1.19       1.19       (0.22     109       42.31       33  
11/01/19     10/31/20       18.38       0.02       1.63       1.65       (0.10     (0.01           (0.11     19.92       1.22       1.22       0.12       109       9.01       19  
11/01/18     10/31/19       18.37       0.09       1.20       1.29       (0.09     (1.19           (1.28     18.38       1.20       1.20       0.50       170       8.31       21  
11/20/17     10/31/18       20.18       0.05       (0.30     (0.25     (0.02     (1.54           (1.56     18.37       1.19       1.19       0.28       106       (1.51     7  
Class C*                                
11/01/21     04/30/22       27.14       (0.07     (2.62     (2.69           (2.80           (2.80     21.65       1.96       1.96       (0.63     76       (10.29     26  
11/01/20     10/31/21       19.65       (0.25     8.26       8.01             (0.52           (0.52     27.14       1.96       1.96       (0.99     109       41.25       31  
11/01/19     10/31/20       18.17       (0.12     1.61       1.49             (0.01           (0.01     19.65       2.00       2.00       (0.65     109       8.23       19  
11/01/18     10/31/19       18.26       (0.05     1.18       1.13       (0.03     (1.19           (1.22     18.17       1.99       1.99       (0.28     170       7.34       20  
11/20/17     10/31/18       20.18       (0.09     (0.28     (0.37     (0.01     (1.54           (1.55     18.26       1.94       1.94       (0.47     106       (2.16     9  
Class I*                                
11/01/21     04/30/22       27.90       0.05       (2.70     (2.65     (0.02     (2.80           (2.82     22.43       0.95       0.95       0.37       76       (9.84     3,930  
11/01/20     10/31/21       20.03        (d)      8.44       8.44       (0.05     (0.52           (0.57     27.90       0.95       0.95       0.02       109       42.67       4,560  
11/01/19     10/31/20       18.46       0.07       1.64       1.71       (0.13     (0.01           (0.14     20.03       0.97       0.97       0.37       109       9.31       2,581  
11/01/18     10/31/19       18.41       0.13       1.20       1.33       (0.09     (1.19           (1.28     18.46       0.98       0.98       0.75       170       8.48       2,685  
11/01/17     10/31/18       19.77       0.08       0.12       0.20       (0.02     (1.54           (1.56     18.41       0.97       0.97       0.40       106       0.74       2,420  
07/01/17     10/31/17       18.11        (d)      1.66       1.66                               19.77       1.01       1.01       0.03       20       9.17       1,675  
07/01/16     06/30/17       15.06       0.07       3.35       3.42       (0.07     (0.30           (0.37     18.11       1.03       1.03       0.43       87       22.93       1,437  
Class R-3*                                
11/01/21     04/30/22       27.48       (0.02     (2.65     (2.67           (2.80           (2.80     22.01       1.50       1.50       (0.17     76       (10.08     4  
11/01/20     10/31/21       19.81       (0.13     8.32       8.19             (0.52           (0.52     27.48       1.50       1.50       (0.53     109       41.84       5  
11/01/19     10/31/20       18.29       (0.04     1.63       1.59       (0.06     (0.01           (0.07     19.81       1.54       1.54       (0.22     109       8.71       3  
11/01/18     10/31/19       18.32       0.03       1.19       1.22       (0.06     (1.19           (1.25     18.29       1.56       1.56       0.16       170       7.87       3  
11/20/17     10/31/18       20.18       0.01       (0.32     (0.31     (0.01     (1.54           (1.55     18.32       1.44       1.44       0.04       106       (1.83     2  
Class R-5*                                
11/01/21     04/30/22       27.74       0.04       (2.68     (2.64     (0.02     (2.80           (2.82     22.28       0.95       0.95       0.37       76       (9.86     5  
11/01/20     10/31/21       19.91       0.01       8.39       8.40       (0.05     (0.52           (0.57     27.74       0.93       0.93       0.04       109       42.73       4  
11/01/19     10/31/20       18.37       0.06       1.63       1.69       (0.14     (0.01           (0.15     19.91       0.97       0.97       0.33       109       9.30       2  
11/01/18     10/31/19       18.35       0.13       1.19       1.32       (0.11     (1.19           (1.30     18.37       1.00       1.00       0.72       170       8.47       2  
11/20/17     10/31/18       20.18       0.10       (0.36     (0.26     (0.03     (1.54           (1.57     18.35       0.99       0.99       0.53       106       (1.62     1  
Class R-6*                                
11/01/21     04/30/22       27.88       0.06       (2.70     (2.64     (0.02     (2.80           (2.82     22.42       0.85       0.85       0.47       76       (9.79     352  
11/01/20     10/31/21       20.01       0.03       8.43       8.46       (0.07     (0.52           (0.59     27.88       0.86       0.86       0.11       109       42.85       278  
11/01/19     10/31/20       18.45       0.07       1.65       1.72       (0.15     (0.01           (0.16     20.01       0.88       0.88       0.36       109       9.38       171  
11/01/18     10/31/19       18.41       0.15       1.19       1.34       (0.11     (1.19           (1.30     18.45       0.88       0.88       0.82       170       8.60       108  
11/20/17     10/31/18       20.18       0.12       (0.32     (0.20     (0.03     (1.54           (1.57     18.41       0.90       0.90       0.62       106       (1.29     34  
Class Y*                                
11/01/21     04/30/22       27.70       0.01       (2.67     (2.66     (0.01     (2.80           (2.81     22.23       1.19       1.19       0.06       76       (9.95     4  
11/01/20     10/31/21       19.90       (0.06     8.38       8.32             (0.52           (0.52     27.70       1.26       1.26       (0.24     109       42.31       4  
11/01/19     10/31/20       18.36       0.03       1.60       1.63       (0.08     (0.01           (0.09     19.90       1.28       1.28       0.17       109       8.94       9  
11/01/18     10/31/19       18.37       0.08       1.20       1.28       (0.10     (1.19           (1.29     18.36       1.26       1.26       0.45       170       8.20       24  
11/20/17     10/31/18       20.18       0.07       (0.32     (0.25     (0.02     (1.54           (1.56     18.37       1.19       1.19       0.36       106       (1.51     2  

 

The accompanying notes are an integral part of the financial statements.           39  


Financial Highlights

 

Fiscal period

          From investment operations     Dividends & distributions          

Ratios to average net asset (%)

                   
  Beginning
net asset
value
    Income
(loss)
    Realized &
unrealized
gain (loss)
    Total     From
investment
income
    From
realized
gains
    From
return
of
capital
    Total     Ending
net
asset
value
    With
expenses
waived/
recovered (a)
    Without
expenses
waived/
recovered (a)
    Net
income
(loss) (a)
    Portfolio
turnover
rate (%) (b)
    Total
return
(%) (b)(c)
    Ending
net
assets
(millions)
 
Beginning   Ending  
Carillon Scout Small Cap Fund                                                                                                
Class A*                                
11/01/21     04/30/22       $ 39.48       $ (0.08     $ (7.14     $ (7.22     $ —       $ (5.85     $ —       $ (5.85     $ 26.41       1.17       1.17       (0.50     8       (20.55     $14  
11/01/20     10/31/21       29.50       (0.30     13.12       12.82             (2.84           (2.84     39.48       1.15       1.15       (0.80     28       44.67       18  
11/01/19     10/31/20       28.20       (0.16     2.56       2.40             (1.10           (1.10     29.50       1.19       1.19       (0.58     22       8.69       12  
11/01/18     10/31/19       27.10       (0.07     1.23       1.16             (0.06           (0.06     28.20       1.16       1.16       (0.27     21       4.30       13  
11/20/17     10/31/18       29.63       (0.26     2.68       2.42             (4.95           (4.95     27.10       1.23       1.23       (0.95     22       8.00       12  
Class C*                                
11/01/21     04/30/22       38.19       (0.19     (6.86     (7.05           (5.85           (5.85     25.29       1.92       1.92       (1.23     8       (20.83     $2  
11/01/20     10/31/21       28.82       (0.56     12.77       12.21             (2.84           (2.84     38.19       1.91       1.91       (1.52     28       43.53       3  
11/01/19     10/31/20       27.78       (0.35     2.49       2.14             (1.10           (1.10     28.82       1.95       1.95       (1.32     22       7.85       5  
11/01/18     10/31/19       26.89       (0.25     1.20       0.95             (0.06           (0.06     27.78       1.92       1.92       (0.92     21       3.55       8  
11/20/17     10/31/18       29.63       (0.47     2.68       2.21             (4.95           (4.95     26.89       1.97       1.97       (1.69     22       7.21       14  
Class I*                                
11/01/21     04/30/22       39.88       (0.04     (7.22     (7.26     (0.01     (5.85           (5.86     26.76       0.93       0.93       (0.26     8       (20.43     277  
11/01/20     10/31/21       29.72       (0.21     13.22       13.01       (0.01     (2.84           (2.85     39.88       0.90       0.90       (0.55     28       45.02       362  
11/01/19     10/31/20       28.34       (0.09     2.57       2.48             (1.10           (1.10     29.72       0.95       0.95       (0.34     22       8.93       268  
11/01/18     10/31/19       27.17       (0.02     1.25       1.23             (0.06           (0.06     28.34       0.95       0.94       (0.06     21       4.55       297  
11/01/17     10/31/18       29.33       (0.14     2.93       2.79             (4.95           (4.95     27.17       0.95       0.97       (0.49     22       9.36       287  
07/01/17     10/31/17       26.81       (0.04     2.56       2.52                               29.33       1.03       1.03       (0.45     6       9.40       271  
07/01/16     06/30/17       21.45       (0.09     6.52       6.43             (1.07           (1.07     26.81       1.04       1.04       (0.39     25       30.70       242  
Class R-3*                                
11/01/21     04/30/22       38.92       (0.12     (7.03     (7.15           (5.85           (5.85     25.92       1.50       1.47       (0.79     8       (20.68     0  
11/01/20     10/31/21       29.22       (0.43     12.97       12.54             (2.84           (2.84     38.92       1.50       1.44       (1.14     28       44.10       0  
11/01/19     10/31/20       28.03       (0.23     2.52       2.29             (1.10           (1.10     29.22       1.50       1.66       (0.86     22       8.34       0  
11/01/18     10/31/19       27.02       (0.16     1.23       1.07             (0.06           (0.06     28.03       1.50       1.55       (0.56     21       3.98       0  
11/20/17     10/31/18       29.63       (0.33     2.67       2.34             (4.95           (4.95     27.02       1.50       1.67       (1.20     22       7.70       0  
Class R-5*                                
11/01/21     04/30/22       39.74       (0.05     (7.19     (7.24     (0.01     (5.85           (5.86     26.64       0.95       0.83       (0.29     8       (20.46     0  
11/01/20     10/31/21       29.72       (0.18     13.04       12.86             (2.84           (2.84     39.74       0.95       0.86       (0.50     28       44.46       0  
11/01/19     10/31/20       28.34       (0.10     2.58       2.48             (1.10           (1.10     29.72       0.95       1.05       (0.36     22       8.93       0  
11/01/18     10/31/19       27.17       (0.02     1.25       1.23             (0.06           (0.06     28.34       0.95       0.99       (0.07     21       4.55       0  
11/20/17     10/31/18       29.63       (0.17     2.66       2.49             (4.95           (4.95     27.17       0.95       1.32       (0.60     22       8.26       0  
Class R-6*                                
11/01/21     04/30/22       40.06       (0.03     (7.26     (7.29     (0.02     (5.85           (5.87     26.90       0.83       0.83       (0.16     8       (20.42     9  
11/01/20     10/31/21       29.82       (0.17     13.27       13.10       (0.02     (2.84           (2.86     40.06       0.81       0.81       (0.45     28       45.16       12  
11/01/19     10/31/20       28.41       (0.08     2.59       2.51             (1.10           (1.10     29.82       0.85       0.85       (0.30     22       9.02       9  
11/01/18     10/31/19       27.20        (d)      1.27       1.27             (0.06           (0.06     28.41       0.84       0.84       0.01       21       4.69       6  
11/20/17     10/31/18       29.63       (0.13     2.65       2.52             (4.95           (4.95     27.20       0.85       0.86       (0.47     22       8.37       5  
Class Y*                                
11/01/21     04/30/22       39.38       (0.07     (7.12     (7.19           (5.85           (5.85     26.34       1.14       1.14       (0.45     8       (20.52     0  
11/01/20     10/31/21       29.45       (0.28     13.05       12.77        (d)      (2.84           (2.84     39.38       1.11       1.11       (0.74     28       44.57       0  
11/01/19     10/31/20       28.17       (0.19     2.57       2.38             (1.10           (1.10     29.45       1.25       1.25       (0.69     22       8.62       0  
11/01/18     10/31/19       27.09       (0.10     1.24       1.14             (0.06           (0.06     28.17       1.25       1.23       (0.36     21       4.23       0  
11/20/17     10/31/18       29.63       (0.24     2.65       2.41             (4.95           (4.95     27.09       1.25       1.59       (0.87     22       7.96       0  
Carillon Reams Core Bond Fund                                                                                                
Class A*                                
11/01/21     04/30/22       12.66       0.06       (1.23     (1.17     (0.07                 (0.07     11.42       0.80       0.95       0.91       251       (9.28     4  
11/01/20     10/31/21       13.14       0.06       (0.22     (0.16     (0.07     (0.25           (0.32     12.66       0.80       0.93       0.47       227       (1.27     4  
11/01/19     10/31/20       12.02       0.12       1.40       1.52       (0.16     (0.24           (0.40     13.14       0.80       1.03       0.93       549       12.94       4  
11/01/18     10/31/19       11.03       0.22       0.99       1.21       (0.22                 (0.22     12.02       0.80       1.20       1.85       409       11.12       1  
11/20/17     10/31/18       11.42       0.20       (0.40     (0.20     (0.19                 (0.19     11.03       0.80       1.16       1.88       278       (1.78     1  
Class C*                                
11/01/21     04/30/22       12.60       0.01       (1.21     (1.20     (0.03                 (0.03     11.37       1.55       1.69       0.14       251       (9.56     8  
11/01/20     10/31/21       13.11       (0.04     (0.21     (0.25     (0.01     (0.25           (0.26     12.60       1.55       1.67       (0.27     227       (2.01     13  
11/01/19     10/31/20       12.01       (0.02     1.44       1.42       (0.08     (0.24           (0.32     13.11       1.55       1.72       (0.14     549       12.09       11  
11/01/18     10/31/19       11.02       0.13       0.99       1.12       (0.13                 (0.13     12.01       1.55       2.00       1.09       409       10.25       1  
11/20/17     10/31/18       11.42       0.12       (0.40     (0.28     (0.12                 (0.12     11.02       1.55       1.99       1.11       278       (2.43     0  

 

40         The accompanying notes are an integral part of the financial statements.


Financial Highlights

 

Fiscal period

          From investment operations     Dividends & distributions          

Ratios to average net asset (%)

                   
  Beginning
net asset
value
    Income
(loss)
    Realized &
unrealized
gain (loss)
    Total     From
investment
income
    From
realized
gains
    From
return
of
capital
    Total     Ending
net
asset
value
    With
expenses
waived/
recovered (a)
    Without
expenses
waived/
recovered (a)
    Net
income
(loss) (a)
    Portfolio
turnover
rate (%) (b)
    Total
return
(%) (b)(c)
    Ending
net
assets
(millions)
 
Beginning   Ending  
Carillon Reams Core Bond Fund (cont'd)                                                                                                
Class I*                                
11/01/21     04/30/22       $ 12.67       $ 0.08       $ (1.21     $ (1.13     $ (0.10     $ —       $ —       $ (0.10     $ 11.44       0.40       0.72       1.30       251       (9.01     $ 365  
11/01/20     10/31/21       13.16       0.11       (0.23     (0.12     (0.12     (0.25           (0.37     12.67       0.40       0.70       0.88       227       (0.95     447  
11/01/19     10/31/20       12.04       0.15       1.41       1.56       (0.20     (0.24           (0.44     13.16       0.40       0.76       1.19       549       13.35       552  
11/01/18     10/31/19       11.04       0.26       1.01       1.27       (0.27                 (0.27     12.04       0.40       0.98       2.28       409       11.64       105  
11/01/17     10/31/18       11.40       0.24       (0.38     (0.14     (0.22                 (0.22     11.04       0.40       0.87       2.12       278       (1.23     105  
07/01/17     10/31/17       11.37       0.07       0.03       0.10       (0.07                 (0.07     11.40       0.40       0.69       1.65       126       0.85       141  
07/01/16     06/30/17       11.90       0.15       (0.24     (0.09     (0.19     (0.25           (0.44     11.37       0.40       0.66       1.30       390       (0.71     166  
Class R-3*                                
11/01/21     04/30/22       12.67       0.04       (1.22     (1.18     (0.06                 (0.06     11.43       1.05       1.23       0.67       251       (9.39     0  
11/01/20     10/31/21       13.15       0.03       (0.22     (0.19     (0.04     (0.25           (0.29     12.67       1.05       1.20       0.22       227       (1.49     0  
11/01/19     10/31/20       12.03       0.08       1.40       1.48       (0.12     (0.24           (0.36     13.15       1.05       1.59       0.59       549       12.63       0  
11/01/18     10/31/19       11.04       0.19       0.99       1.18       (0.19                 (0.19     12.03       1.05       1.97       1.61       409       10.82       0  
11/20/17     10/31/18       11.42       0.16       (0.38     (0.22     (0.16                 (0.16     11.04       1.05       2.02       1.51       278       (1.96     0  
Class R-5*                                
11/01/21     04/30/22       12.68       0.07       (1.22     (1.15     (0.09                 (0.09     11.44       0.50       0.58       1.22       251       (9.13     0  
11/01/20     10/31/21       13.16       0.10       (0.22     (0.12     (0.11     (0.25           (0.36     12.68       0.50       0.59       0.77       227       (0.98     0  
11/01/19     10/31/20       12.04       0.17       1.38       1.55       (0.19     (0.24           (0.43     13.16       0.50       1.25       1.36       549       13.23       0  
11/01/18     10/31/19       11.05       0.25       1.00       1.25       (0.26                 (0.26     12.04       0.50       1.46       2.17       409       11.42       0  
11/20/17     10/31/18       11.42       0.22       (0.38     (0.16     (0.21                 (0.21     11.05       0.50       1.52       2.06       278       (1.40     0  
Class R-6*                                
11/01/21     04/30/22       12.68       0.08       (1.21     (1.13     (0.10                 (0.10     11.45       0.40       0.62       1.30       251       (9.01     0  
11/01/20     10/31/21       13.16       0.11       (0.22     (0.11     (0.12     (0.25           (0.37     12.68       0.40       0.59       0.87       227       (0.88     1  
11/01/19     10/31/20       12.04       0.12       1.44       1.56       (0.20     (0.24           (0.44     13.16       0.40       0.72       0.92       549       13.35       1  
11/01/18     10/31/19       11.05       0.26       1.00       1.26       (0.27                 (0.27     12.04       0.40       1.46       2.26       409       11.53       0  
11/20/17     10/31/18       11.42       0.23       (0.38     (0.15     (0.22                 (0.22     11.05       0.40       1.52       2.16       278       (1.32     0  
Class Y*                                
11/01/21     04/30/22       12.66       0.05       (1.21     (1.16     (0.07                 (0.07     11.43       0.80       1.02       0.89       251       (9.21     27  
11/01/20     10/31/21       13.15       0.06       (0.23     (0.17     (0.07     (0.25           (0.32     12.66       0.80       1.01       0.48       227       (1.35     42  
11/01/19     10/31/20       12.03       0.07       1.45       1.52       (0.16     (0.24           (0.40     13.15       0.80       0.98       0.55       549       12.96       57  
11/01/18     10/31/19       11.04       0.22       0.99       1.21       (0.22                 (0.22     12.03       0.80       1.26       1.89       409       11.09       1  
11/01/17     10/31/18       11.40       0.19       (0.37     (0.18     (0.18                 (0.18     11.04       0.80       1.19       1.71       278       (1.60     2  
07/01/17     10/31/17       11.37       0.05       0.03       0.08       (0.05                 (0.05     11.40       0.80       1.00       1.25       126       0.71       3  
07/01/16     06/30/17       11.90       0.10       (0.24     (0.14     (0.14     (0.25           (0.39     11.37       0.79       0.97       0.91       390       (1.09     3  
Carillon Reams Core Plus Bond Fund                                                                                                
Class A*                                
11/01/21     04/30/22       34.45       0.17       (3.24     (3.07     (0.18                 (0.18     31.20       0.80       0.90       1.03       249       (8.97     4  
11/01/20     10/31/21       36.57       0.23       (0.60     (0.37     (0.38     (1.37           (1.75     34.45       0.80       0.90       0.65       220       (1.12     7  
11/01/19     10/31/20       33.43       0.40       3.99       4.39       (0.64     (0.61           (1.25     36.57       0.80       0.90       1.09       559       13.56       6  
11/01/18     10/31/19       30.44       0.58       3.01       3.59       (0.60                 (0.60     33.43       0.80       0.98       1.79       413       11.89       0  
11/20/17     10/31/18       31.76       0.54       (1.36     (0.82     (0.50                 (0.50     30.44       0.80       0.97       1.85       292       (2.60     0  
Class C*                                
11/01/21     04/30/22       34.35       0.05       (3.23     (3.18     (0.14                 (0.14     31.03       1.55       1.68       0.28       249       (9.29     5  
11/01/20     10/31/21       36.55       (0.04     (0.60     (0.64     (0.19     (1.37           (1.56     34.35       1.55       1.67       (0.11     220       (1.87     6  
11/01/19     10/31/20       33.38       0.11       4.06       4.17       (0.39     (0.61           (1.00     36.55       1.55       1.66       0.30       559       12.84       5  
11/01/18     10/31/19       30.41       0.34       3.00       3.34       (0.37                 (0.37     33.38       1.55       1.78       1.05       413       11.06       0  
11/20/17     10/31/18       31.76       0.32       (1.36     (1.04     (0.31                 (0.31     30.41       1.55       1.85       1.09       292       (3.31     0  
Class I*                                
11/01/21     04/30/22       34.54       0.24       (3.26     (3.02     (0.20                 (0.20     31.32       0.40       0.65       1.44       249       (8.80     1,022  
11/01/20     10/31/21       36.64       0.37       (0.59     (0.22     (0.51     (1.37           (1.88     34.54       0.40       0.65       1.04       220       (0.71     1,142  
11/01/19     10/31/20       33.45       0.60       3.96       4.56       (0.76     (0.61           (1.37     36.64       0.40       0.65       1.72       559       14.11       1,132  
11/01/18     10/31/19       30.46       0.72       2.99       3.71       (0.72                 (0.72     33.45       0.40       0.66       2.23       413       12.32       635  
11/01/17     10/31/18       31.74       0.66       (1.34     (0.68     (0.60                 (0.60     30.46       0.40       0.60       2.11       292       (2.17     607  
07/01/17     10/31/17       31.64       0.16       0.11       0.27       (0.16           (0.01     (0.17     31.74       0.40       0.58       1.53       123       0.85       741  
07/01/16     06/30/17       32.98       0.42       (0.51     (0.09     (0.52     (0.73           (1.25     31.64       0.40       0.59       1.32       433       (0.18     784  

 

The accompanying notes are an integral part of the financial statements.           41  


Financial Highlights

 

Fiscal period

          From investment operations     Dividends & distributions          

Ratios to average net asset (%)

                   
  Beginning
net asset
value
    Income
(loss)
    Realized &
unrealized
gain (loss)
    Total     From
investment
income
    From
realized
gains
    From
return
of
capital
    Total     Ending
net
asset
value
    With
expenses
waived/
recovered (a)
    Without
expenses
waived/
recovered (a)
    Net
income
(loss) (a)
    Portfolio
turnover
rate (%) (b)
    Total
return
(%) (b)(c)
    Ending
net
assets
(millions)
 
Beginning   Ending  
Carillon Reams Core Plus Bond Fund (cont'd)                                                                                                
Class R-3*                                
11/01/21     04/30/22       $ 34.47       $ 0.13       $ (3.24     $ (3.11     $ (0.16     $ —       $ —       $ (0.16     $ 31.20       1.05       1.18       0.79       249       (9.07     $0  
11/01/20     10/31/21       36.62       0.14       (0.60     (0.46     (0.32     (1.37           (1.69     34.47       1.05       1.16       0.38       220       (1.37     0  
11/01/19     10/31/20       33.43       0.37       3.97       4.34       (0.54     (0.61           (1.15     36.62       1.05       1.55       1.06       559       13.40       0  
11/01/18     10/31/19       30.44       0.50       3.00       3.50       (0.51                 (0.51     33.43       1.05       1.68       1.57       413       11.60       0  
11/20/17     10/31/18       31.76       0.45       (1.34     (0.89     (0.43                 (0.43     30.44       1.05       1.77       1.51       292       (2.84     0  
Class R-5*                                
11/01/21     04/30/22       34.54       0.22       (3.26     (3.04     (0.19                 (0.19     31.31       0.50       0.53       1.34       249       (8.85     0  
11/01/20     10/31/21       36.65       0.33       (0.60     (0.27     (0.47     (1.37           (1.84     34.54       0.50       0.56       0.94       220       (0.84     0  
11/01/19     10/31/20       33.45       0.59       3.95       4.54       (0.73     (0.61           (1.34     36.65       0.50       1.08       1.68       559       14.03       0  
11/01/18     10/31/19       30.46       0.68       3.00       3.68       (0.69                 (0.69     33.45       0.50       1.18       2.12       413       12.20       0  
11/20/17     10/31/18       31.76       0.61       (1.34     (0.73     (0.57                 (0.57     30.46       0.50       1.27       2.07       292       (2.31     0  
Class R-6*                                
11/01/21     04/30/22       34.54       0.24       (3.25     (3.01     (0.20                 (0.20     31.33       0.40       0.56       1.45       249       (8.77     3  
11/01/20     10/31/21       36.65       0.37       (0.60     (0.23     (0.51     (1.37           (1.88     34.54       0.40       0.56       1.06       220       (0.74     4  
11/01/19     10/31/20       33.45       0.59       3.98       4.57       (0.76     (0.61           (1.37     36.65       0.40       0.93       1.63       559       14.14       0  
11/01/18     10/31/19       30.46       0.71       3.00       3.71       (0.72                 (0.72     33.45       0.40       1.18       2.22       413       12.32       0  
11/20/17     10/31/18       31.76       0.64       (1.34     (0.70     (0.60                 (0.60     30.46       0.40       1.27       2.17       292       (2.23     0  
Class Y*                                
11/01/21     04/30/22       34.48       0.17       (3.25     (3.08     (0.17                 (0.17     31.23       0.80       0.96       1.03       249       (8.97     50  
11/01/20     10/31/21       36.60       0.23       (0.60     (0.37     (0.38     (1.37           (1.75     34.48       0.80       0.95       0.64       220       (1.12     77  
11/01/19     10/31/20       33.43       0.43       3.98       4.41       (0.63     (0.61           (1.24     36.60       0.80       0.93       1.18       559       13.64       99  
11/01/18     10/31/19       30.44       0.59       2.99       3.58       (0.59                 (0.59     33.43       0.80       0.97       1.84       413       11.87       14  
11/01/17     10/31/18       31.73       0.53       (1.34     (0.81     (0.48                 (0.48     30.44       0.80       0.96       1.70       292       (2.56     17  
07/01/17     10/31/17       31.63       0.12       0.10       0.22       (0.11           (0.01     (0.12     31.73       0.80       0.93       1.13       123       0.71       28  
07/01/16     06/30/17       32.97       0.30       (0.51     (0.21     (0.39     (0.74           (1.13     31.63       0.78       0.91       0.94       433       (0.57     30  
Carillon Reams Unconstrained Bond Fund                                                                                                
Class A*                                
11/01/21     04/30/22       12.79       0.06       (0.75     (0.69     (0.04     (0.13           (0.17     11.93       0.80       1.09       0.94       154       (5.46     5  
11/01/20     10/31/21       12.81       0.06       0.17       0.23       (0.25                 (0.25     12.79       0.80       1.08       0.46       80       1.78       5  
11/01/19     10/31/20       12.13       0.19       0.76       0.95       (0.27                 (0.27     12.81       0.80       1.09       1.56       435       7.97       1  
11/01/18     10/31/19       11.45       0.21       0.69       0.90       (0.22                 (0.22     12.13       0.80       1.14       1.74       289       7.92       0  
11/20/17     10/31/18       11.83       0.21       (0.41     (0.20     (0.18                 (0.18     11.45       0.80       1.20       1.85       139       (1.71     0  
Class C*                                
11/01/21     04/30/22       12.72       0.01       (0.75     (0.74           (0.13           (0.13     11.85       1.55       1.86       0.19       154       (5.83     2  
11/01/20     10/31/21       12.79       (0.02     0.15       0.13       (0.20                 (0.20     12.72       1.55       1.86       (0.13     80       1.02       2  
11/01/19     10/31/20       12.10       0.10       0.77       0.87       (0.18                 (0.18     12.79       1.55       1.88       0.77       435       7.25       2  
11/01/18     10/31/19       11.42       0.11       0.71       0.82       (0.14                 (0.14     12.10       1.55       1.96       0.92       289       7.19       0  
11/20/17     10/31/18       11.83       0.11       (0.41     (0.30     (0.11                 (0.11     11.42       1.55       2.42       0.99       139       (2.55     0  
Class I*                                
11/01/21     04/30/22       12.80       0.08       (0.75     (0.67     (0.05     (0.13           (0.18     11.95       0.50       0.85       1.23       154       (5.29     1,011  
11/01/20     10/31/21       12.81       0.12       0.15       0.27       (0.28                 (0.28     12.80       0.50       0.85       0.92       80       2.08       1,110  
11/01/19     10/31/20       12.12       0.23       0.76       0.99       (0.30                 (0.30     12.81       0.50       0.85       1.86       435       8.36       878  
11/01/18     10/31/19       11.43       0.24       0.70       0.94       (0.25                 (0.25     12.12       0.50       0.85       2.07       289       8.31       907  
11/01/17     10/31/18       11.85       0.22       (0.43     (0.21     (0.21                 (0.21     11.43       0.50       0.83       1.90       139       (1.79     1,183  
07/01/17     10/31/17       11.83       0.04       0.02       0.06       (0.04                 (0.04     11.85       0.50       0.80       1.00       83       0.48       1,521  
07/01/16     06/30/17       11.70       0.10       0.15       0.25       (0.12                 (0.12     11.83       0.50       0.80       0.86       370       2.15       1,475  
Class R-3*                                
11/01/21     04/30/22       12.77       0.04       (0.74     (0.70     (0.02     (0.13           (0.15     11.92       1.05       1.22       0.71       154       (5.49     0  
11/01/20     10/31/21       12.81       0.05       0.14       0.19       (0.23                 (0.23     12.77       1.05       1.25       0.39       80       1.45       0  
11/01/19     10/31/20       12.11       0.16       0.78       0.94       (0.24                 (0.24     12.81       1.05       1.81       1.32       435       7.85       0  
11/01/18     10/31/19       11.43       0.18       0.69       0.87       (0.19                 (0.19     12.11       1.05       1.80       1.51       289       7.63       0  
11/20/17     10/31/18       11.83       0.15       (0.39     (0.24     (0.16                 (0.16     11.43       1.05       2.25       1.40       139       (2.09     0  

 

42         The accompanying notes are an integral part of the financial statements.


Financial Highlights

 

Fiscal period

          From investment operations     Dividends & distributions          

Ratios to average net asset (%)

                   
  Beginning
net asset
value
    Income
(loss)
    Realized &
unrealized
gain (loss)
    Total     From
investment
income
    From
realized
gains
    From
return
of
capital
    Total     Ending
net
asset
value
    With
expenses
waived/
recovered (a)
    Without
expenses
waived/
recovered (a)
    Net
income
(loss) (a)
    Portfolio
turnover
rate (%) (b)
    Total
return
(%) (b)(c)
    Ending
net
assets
(millions)
 
Beginning   Ending  
Carillon Reams Unconstrained Bond Fund (cont'd)                                                                                                
Class R-5*                                
11/01/21     04/30/22       $ 12.80       $ 0.09       $ (0.76     $ (0.67     $ (0.05     $ (0.13     $ —       $ (0.18     $ 11.95       0.50       0.85       1.38       154       (5.29     $ 1  
11/01/20     10/31/21       12.81       0.11       0.16       0.27       (0.28                 (0.28     12.80       0.50       0.84       0.86       80       2.09       0  
11/01/19     10/31/20       12.12       0.23       0.76       0.99       (0.30                 (0.30     12.81       0.50       1.30       1.87       435       8.36       0  
11/01/18     10/31/19       11.43       0.24       0.70       0.94       (0.25                 (0.25     12.12       0.50       1.37       2.06       289       8.31       0  
11/20/17     10/31/18       11.83       0.21       (0.40     (0.19     (0.21                 (0.21     11.43       0.50       1.45       1.95       139       (1.62     0  
Class R-6*                                
11/01/21     04/30/22       12.80       0.08       (0.75     (0.67     (0.05     (0.13           (0.18     11.95       0.40       0.76       1.34       154       (5.26     97  
11/01/20     10/31/21       12.81       0.13       0.15       0.28       (0.29                 (0.29     12.80       0.40       0.76       1.01       80       2.17       68  
11/01/19     10/31/20       12.12       0.24       0.77       1.01       (0.32                 (0.32     12.81       0.40       0.76       1.97       435       8.47       43  
11/01/18     10/31/19       11.43       0.26       0.69       0.95       (0.26                 (0.26     12.12       0.40       0.76       2.17       289       8.42       34  
11/20/17     10/31/18       11.83       0.25       (0.43     (0.18     (0.22                 (0.22     11.43       0.40       0.76       2.32       139       (1.53     29  
Class Y*                                
11/01/21     04/30/22       12.86       0.06       (0.76     (0.70     (0.03     (0.13           (0.16     12.00       0.80       1.15       0.94       154       (5.46     27  
11/01/20     10/31/21       12.88       0.08       0.15       0.23       (0.25                 (0.25     12.86       0.80       1.14       0.62       80       1.76       31  
11/01/19     10/31/20       12.18       0.19       0.78       0.97       (0.27                 (0.27     12.88       0.80       1.15       1.55       435       8.07       25  
11/01/18     10/31/19       11.49       0.21       0.69       0.90       (0.21                 (0.21     12.18       0.80       1.15       1.77       289       7.93       23  
11/01/17     10/31/18       11.90       0.18       (0.41     (0.23     (0.18                 (0.18     11.49       0.80       1.14       1.58       139       (1.97     37  
07/01/17     10/31/17       11.88       0.03       0.02       0.05       (0.03                 (0.03     11.90       0.80       1.07       0.69       83       0.38       71  
07/01/16     06/30/17       11.75       0.07       0.14       0.21       (0.08                 (0.08     11.88       0.80       1.09       0.56       370       1.78       99  

* Information for periods beginning after October 31, 2021 is unaudited. Per share amounts have been calculated using the daily average share method.     

+ Excluding non-recurring income and associated expense amounts the net income (loss) to average net assets ratio would have been 1.04%, 0.27%, 1.31%, 0.80%, 1.35%, 1.37%, and 1.06% in Class A, Class C, Class I, Class R-3 , Class R-5, Class R-6, and Class Y, respectively.    

For more information on these non-recurring income and associated expense amounts, please see the “Foreign Taxes” section of Note 2 in the Notes to the Financial Statements.

~ Excluding non-recurring income and associated expense amounts the total return would have been 39.17%, 38.14%, 39.64%, 38.83%, 39.63%, 39.69%, and 39.19%, in Class A, Class C, Class I, Class R-3, Class R-5, Class R-6, and Class Y, respectively.    

For more information on these non-recurring income and associated expense amounts, please see the “Foreign Taxes” section of Note 2 in the Notes to the Financial Statements.

(a) Annualized for periods less than one year.    

(b) Not annualized for periods less than one year.    

(c) Total returns are calculated without the imposition of either front-end or contingent deferred sales charges.    

(d) Per share amount is less than $0.005.    

 

The accompanying notes are an integral part of the financial statements.           43  


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

Note 1  |  Organization and investment objective  |  Carillon Series Trust (the “Trust” or the “Carillon Family of Funds”) is a Delaware statutory trust, and is registered under the Investment Company Act of 1940, as amended, as an open-end diversified management investment company. The Trust offers shares in the following series (each a “fund” and collectively the “Funds”), each of which is advised by Carillon Tower Advisers, Inc. (“Carillon Tower” or “Manager”):

 

   

Carillon ClariVest Capital Appreciation Fund (“Capital Appreciation Fund”) seeks long-term capital appreciation,

   

Carillon ClariVest International Stock Fund (“International Stock Fund”) seeks capital appreciation,

   

Carillon Eagle Growth & Income Fund (“Growth & Income Fund”) primarily seeks long-term capital appreciation and, secondarily, seeks current income,

   

Carillon Eagle Mid Cap Growth Fund (“Mid Cap Growth Fund”) seeks long-term capital appreciation,

   

Carillon Eagle Small Cap Growth Fund (“Small Cap Growth Fund”) seeks long-term capital appreciation,

   

Carillon ClariVest International Fund (“International Fund”) seeks long-term growth of capital and income,

   

Carillon Scout Mid Cap Fund (“Mid Cap Fund”) seeks long-term growth of capital,

   

Carillon Scout Small Cap Fund (“Small Cap Fund”) seeks long-term growth of capital,

   

Carillon Reams Core Bond Fund (“Core Bond Fund”) seeks a high level of total return consistent with the preservation of capital,

   

Carillon Reams Core Plus Bond Fund (“Core Plus Bond Fund”) seeks a high level of total return consistent with the preservation of capital, and

   

Carillon Reams Unconstrained Bond Fund (“Unconstrained Bond Fund”) seeks to maximize total return consistent with the preservation of capital.

Class offerings  |  As of April 30, 2022, each fund was authorized and offered Class A, Class C, Class I, Class R-3, Class R-5, Class R-6, and Class Y shares to qualified buyers.

 

   

For all funds except the Core Bond Fund, Core Plus Bond Fund and Unconstrained Bond Fund, Class A shares are sold at a maximum front-end sales charge of 4.75%. For the Core Bond Fund, Core Plus Bond Fund, and Unconstrained Bond Fund, Class A shares are sold at a maximum front-end sales charge of 3.75%. Class A share investments greater than $1 million, which are not sold subject to a sales charge, may be subject to a contingent deferred sales charge (“CDSC”) of up to 1.00% of the lower of net asset value (“NAV”) or purchase price if redeemed within 18 months of purchase.

   

Class C shares are sold subject to a CDSC of 1.00% of the lower of NAV or purchase price if redeemed less than one year after purchase. Class C shares automatically convert to Class A shares for all purchases that have surpassed their 8-year anniversary date.

   

Class I, Class R-3, Class R-5, Class R-6 and Class Y shares are each sold without a front-end sales charge or a CDSC.

Note 2  |  Significant accounting policies  |  The following is a summary of significant accounting policies of the Funds. The policies are in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The Funds are investment companies and, accordingly, follow the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946—Investment Companies, which is part of U.S. GAAP.

Use of estimates  |  The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures. Actual results could differ from those estimates and those differences could be material.

Valuation of securities  |  The price of each fund’s shares is based on the NAV per share of each class of a fund. Each fund normally determines the NAV of its shares each business day as of the scheduled close of regular trading on the New York Stock Exchange (NYSE) and the Nasdaq (typically 4:00 p.m. ET). A fund will not treat an intraday unscheduled disruption in trading on either the NYSE or Nasdaq as a closure of that particular market, and will price its shares as of the normally scheduled close of the NYSE and Nasdaq if the disruption directly affects only one of those markets. If the NYSE or other securities exchange modifies the published closing price of securities traded on that exchange after the NAV is calculated, the Funds are not required to recalculate their NAV.

Generally, the Funds value portfolio securities for which market quotations are readily available at market value; however, a fund may adjust the market quotation price to reflect events that occur between the close of those markets and the time of the fund’s determination of the NAV.

A market quotation may be considered unreliable or unavailable for various reasons, such as:

 

   

The quotation may be stale;

   

The security is not actively traded;

   

Trading on the security halted before the close of the trading market;

   

The security is newly issued;

   

Issuer-specific or vendor specific events occurred after the security halted trading; or

   

Due to the passage of time between the close of the market on which the security trades and the close of the NYSE and the Nasdaq.

Issuer-specific events that may cause the last market quotation to be unreliable include:

 

   

A merger or insolvency;

   

Events which affect a geographical area or an industry segment, such as political events or natural disasters; or

   

Market events, such as a significant movement in the U.S. markets.

For most securities, both the latest transaction prices and adjustments are furnished by independent pricing services, subject to oversight by the Trust’s Board of Trustees (“Board”). The Funds value all other securities and assets for which market quotations are unavailable or unreliable at their fair value in good faith using Pricing and Valuation Procedures (“Procedures”) approved by the Board. A fund may fair value small-cap securities, for example, that are thinly traded or illiquid. Fair value is the amount that the owner might reasonably expect to receive for the security upon its current sale. Fair value requires consideration of all appropriate factors, including indications of fair value available from independent pricing services. A fair value price is an estimated price and may vary from the prices used by other mutual funds to calculate their NAV.

Pursuant to the Procedures, and subject to the Board’s oversight, Carillon Tower has established a Valuation Committee (“Valuation Committee”), comprised of certain officers of the Trust and other employees of Carillon Tower and its affiliates, to carry out various functions associated with properly valuing securities in the Funds’ portfolios. The composition of this Valuation Committee may change from time to time. The Valuation Committee follows fair valuation guidelines as set

 

44             


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

forth in the Procedures to make fair value determinations on all securities and assets for which market quotations are unavailable or unreliable. For portfolio securities fair valued by the Valuation Committee, Carillon Tower checks fair value prices by comparing the fair value of the security with values that are available from other sources (if any). Carillon Tower compares the fair value of the security to the next-day opening price or next actual sale price, when applicable. Carillon Tower documents and reports to the Valuation Committee such comparisons when they are made. The Valuation Committee reports such comparisons to the Board at their regularly scheduled meetings. The Board retains the responsibility for periodic review and consideration of the appropriateness of any fair value pricing methodology established or implemented for each fund. Fair value pricing methods, the Procedures and independent pricing services can change from time to time as approved by the Board and may occur as a result of look-back testing results or changes in industry best practices.

There can be no assurance, however, that a fair value price used by a fund on any given day will more accurately reflect the market value of a security than a market price of such security on that day, as fair valuation determinations may involve subjective judgments made by the Valuation Committee. Fair value pricing may deter shareholders from trading a fund’s shares on a frequent basis in an attempt to take advantage of arbitrage opportunities resulting from potentially stale prices of portfolio holdings. However, it cannot eliminate the possibility of frequent trading. Specific types of securities are valued as follows:

 

   

Domestic exchange-traded equity securities  |  Market quotations are generally available and reliable for domestic exchange-traded equity securities. If the prices provided by the independent pricing service and independent quoted prices are unavailable or unreliable, the Valuation Committee will fair value the security using the Procedures.

 

   

Foreign equity securities  |  If market quotations are available and reliable for foreign exchange-traded equity securities, the securities will be valued at the market quotations. Because trading hours for certain foreign securities end before the close of the NYSE and the Nasdaq, closing market quotations may become unreliable. Consequently, fair valuation of portfolio securities may occur on a daily basis. The Valuation Committee, using the Procedures, may fair value a security if certain events occur between the time the trading of a particular security ends in a foreign market and a fund’s NAV calculation. The Valuation Committee, using the Procedures, may also fair value a particular security if the events are significant and make the closing price unavailable or unreliable. If an issuer-specific event has occurred that Carillon Tower determines, in its judgment, is likely to have affected the closing price of a foreign security, it will price the security at fair value. Carillon Tower also utilizes a screening process from a pricing vendor to indicate the degree of certainty, based on historical data, that the closing price in the principal market where a foreign security trades is not the current market value as of the close of the NYSE. Securities and other assets quoted in foreign currencies are valued in U.S. dollars based on exchange rates provided by an independent pricing service. The pricing vendor, pricing methodology or degree of certainty may change from time to time. Fund securities primarily traded on foreign markets may trade on days that are not business days of the Funds. Because the NAV of a fund’s shares is determined only on business days of the fund, the value of the portfolio securities of a fund that invests in foreign securities may change on days when shareholders would not be able to purchase or redeem shares of the fund.

 

   

Fixed income securities  |  Government bonds, corporate bonds, asset-backed bonds, municipal bonds, medium-term notes, short-term securities (investments that have a maturity date of 60 days or less), and convertible securities, including high yield or junk bonds, normally are valued on the basis of evaluated prices provided by independent pricing services. Evaluated prices provided by the independent pricing services may be determined without exclusive reliance on quoted prices, and may reflect appropriate factors and appropriate methodologies that have been considered by the Board such as institution-size trading in similar groups of securities, developments related to special securities, dividend rate, maturity and other market data. If the evaluated prices provided by the independent pricing service and independent quoted prices are unavailable or unreliable, the Valuation Committee will fair value the security using the Procedures.

 

   

Futures and Options  |  Futures and options are valued on the basis of market quotations, if available and reliable. If prices provided by independent pricing services and independent quoted prices are unavailable or unreliable, the Valuation Committee will fair value the security using the Procedures. During the period ended April 30, 2022, only the Core Plus Bond Fund and Unconstrained Bond Fund held futures. Only Unconstrained Bond Fund held options during the period ended April 30, 2022.

 

   

Swaps  |  Swaps are valued with prices provided by independent pricing services. If prices provided by independent pricing services are unavailable or unreliable, the Valuation Committee will fair value the security using the Procedures. During the period ended April 30, 2022, only the Core Bond Fund, Core Plus Bond Fund and Unconstrained Bond Fund held swaps.

 

   

Forward contracts  |  Forward contracts are valued daily at current forward rates provided by an independent pricing service. If prices provided by independent pricing services and independent quoted prices are unavailable or unreliable, the Valuation Committee will fair value the security using the Procedures. During the period ended April 30, 2022, only the Core Plus Bond Fund and Unconstrained Bond Fund held forwards.

 

   

Investment companies and exchange-traded funds (ETFs)  |  Investments in other open-end investment companies are valued at their reported NAV. The prospectuses for these companies explain the circumstances under which these companies will use fair value pricing and the effect of the fair value pricing. In addition, investments in closed-end funds and ETFs are valued on the basis of market quotations, if available and reliable. If the prices provided by independent pricing services and independent quoted prices are unavailable or unreliable, the Valuation Committee will fair value the security using the Procedures.

Fair value measurements  |  Each fund utilizes a three-level hierarchy of inputs to establish a classification of fair value measurements. The three levels are defined as:

Level 1—Valuations based on unadjusted quoted prices for identical securities in active markets;

Level 2—Valuations based on inputs other than quoted prices that are observable, either directly or indirectly, including inputs in markets that are not considered active; and

Level 3—Valuations based on inputs that are unobservable and significant to the fair value measurement, and may include the Valuation Committee’s own assumptions on determining fair value of investments.

Inputs that are used in determining fair value of an investment may include price information, credit data, volatility statistics, and other factors. These inputs can be either observable or unobservable. The availability of observable inputs can vary between investments and is affected by various factors such as the type of investment and the volume and/or level of activity for that investment or similar investments in the marketplace. The inputs will be considered by the Valuation

 

               45  


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

Committee, along with any other relevant factors in the calculation of an investment’s fair value. A fund uses prices and inputs that are current as of the valuation date, which may include periods of market dislocations. During these periods, the availability of prices and inputs may be reduced for many investments. This condition could cause an investment to be reclassified between the various levels within the hierarchy. Investments falling into the Level 3 category may be classified as such due to a lack of market transparency and corroboration to support the quoted prices. Additionally, valuation models may be used as the pricing source for any remaining investments classified as Level 3. These models may rely on one or more significant unobservable inputs and/or significant assumptions by the Valuation Committee. Inputs used in valuations may include, but are not limited to, financial statement analysis, capital account balances, discount rates and estimated cash flows, and comparable entity data.

The following is a summary of the inputs used to value each fund’s investments as of April 30, 2022:

    Level 1     Level 2     Level 3  
Capital Appreciation Fund

 

   
Common stocks (a)     $578,456,004       $—       $—  
Money market funds     4,084,628              
Total investment portfolio     $582,540,632       $—       $—  
International Stock Fund

 

   
Common stocks (a):      

Australia

    $—       $1,548,572       $—  

Austria

          99,902        

Belgium

          197,640        

Canada

    341,533              

Denmark

          1,259,700        

Finland

          720,946        

France

          2,899,247        

Germany

          2,182,325        

Hong Kong

          629,859        

Ireland

          85,735        

Israel

    182,910              

Italy

          423,299        

Japan

          7,745,787        

Netherlands

          1,889,543        

Norway

          289,830        

Singapore

    80,669       334,915        

Spain

          1,078,459        

Sweden

          238,724        

Switzerland

          2,337,708        

United Kingdom

    276,523       4,986,719        
Preferred stocks           253,362        
Exchange traded funds     302,016              
Total investment portfolio     $1,183,651       $29,202,272       $—  
Growth & Income Fund

 

   
Common stocks (a)     $912,192,115       $—       $—  
Total investment portfolio     $912,192,115       $—       $—  
Mid Cap Growth Fund

 

   
Common stocks (a)     $6,291,013,102       $—       $—  
Total investment portfolio     $6,291,013,102       $—       $—  
    Level 1     Level 2     Level 3  
Small Cap Growth Fund

 

   
Common stocks (a)     $1,314,630,332       $—       $—  
Total investment portfolio     $1,314,630,332       $—       $—  
International Fund      
Common stocks (a):      

Australia

    $—       $20,230,862       $—  

Austria

          1,341,404        

Belgium

          2,632,754        

Canada

    4,620,518              

Denmark

          16,335,815        

Finland

          9,381,854        

France

          37,903,293        

Germany

          28,542,435        

Hong Kong

          8,254,364        

Ireland

          1,155,925        

Israel

    2,403,960              

Italy

          5,609,823        

Japan

          100,933,583        

Netherlands

          24,767,266        

Norway

          3,826,219        

Singapore

    1,056,976       4,394,274        

Spain

          14,145,117        

Sweden

          3,125,435        

Switzerland

          30,488,216        

United Kingdom

    3,561,435       65,230,872        
Preferred stocks           3,312,756        
Total investment portfolio     $11,642,889       $381,612,267       $—  
Mid Cap Fund

 

   
Common stocks (a)     $4,096,991,970       $—       $—  
Money market funds     1,597,104              
Total investment portfolio     $4,098,589,074       $—       $—  
Small Cap Fund

 

   
Common stocks (a)     $301,522,746       $—       $—  
Total investment portfolio     $301,522,746       $—       $—  
 

 

46             


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

    Level 1     Level 2     Level 3  
Core Bond Fund

 

   
Corporate bonds (a)     $—       $149,612,182       $—  
Mortgage and asset-backed securities           160,302,152        
Foreign government bonds           359,100        
U.S. Treasuries           179,827,148        
Total investment portfolio     $—       $490,100,582       $—  
Credit default swaps     $—       $83,295       $—  
Core Plus Bond Fund

 

   
Domestic corporate bonds (a)     $—       $339,597,233       $—  
Foreign corporate bonds (a)           36,740,876        
Mortgage and asset-backed securities           403,358,627        
Foreign government bonds           77,048,149        
U.S. Treasuries           455,547,810        
Total investment portfolio     $—       $1,312,292,695       $—  
Futures contracts (b)     $(918,274     $—       $—  
Credit default swaps     $—       $2,748,131       $—  
Inflation rate swaps (b)     $—       $(1,396,187     $—  
Forward contracts (b)     $—       $(2,797,068     $—  
    Level 1     Level 2     Level 3  
Unconstrained Bond Fund

 

   
Domestic corporate bonds (a)     $—       $306,707,540       $—  
Foreign corporate bonds (a)           23,757,822        
Mortgage and asset-backed securities           163,422,666        
Foreign government bonds           92,309,994        
U.S. Treasuries           584,049,771        
Medium-term notes           589,415        
Total investment portfolio     $—       $1,170,837,208       $—  
Futures contracts (b)     $2,077,999       $—       $—  
Written options     $(145,800     $—       $—  
Credit default swaps     $—       $3,946,838       $—  
Inflation rate swaps (b)     $—       $(6,704,963     $—  
Forward contracts (b)     $—       $(3,503,923     $—  

(a) Please see the investment portfolio for details.

(b) Amounts presented for Futures Contracts, Inflation Rate Swaps, and Forward Contracts represent total unrealized appreciation (depreciation) as of the date of this report.

 

At April 30, 2022, the Funds did not hold any Level 3 investments.

Derivatives  |  The following disclosure provides certain information about the Funds’ derivative and hedging activities. The use of derivatives involves the risk that the fund could lose more than the amount invested in derivatives.

 

   

Forward currency contracts  |  Each of the funds’ policies, except Small Cap Growth, Core Bond, Mid Cap, and Small Cap, permit the Funds to enter into forward currency contracts (“forward contracts”) for hedging (such as to hedge the impact of adverse changes in the relationships between the US dollar and various foreign currencies), including transaction hedging, anticipatory hedging, cross hedging, proxy hedging, and position hedging, or for any other lawful purpose consistent with their investment objectives including taking active currency exposure. Forward contracts are agreements between two parties to exchange different currencies at a specified rate at an agreed upon future date. Non-deliverable forward currency contracts (“NDF”) are settled with the counterparty in US dollars without the delivery of foreign currency. The fair value of a forward contract fluctuates with changes in currency exchange rates. Outstanding forward contracts are valued daily at current forward rates and the resulting change in market value is recorded as unrealized appreciation or depreciation. When a forward contract is closed, the fund records a realized gain or loss equal to the difference between the value at the time the forward contract was opened and the value at the time it was closed. The risks to the Funds of entering into forward contracts include the inability of counterparties to meet the terms of their contracts, future adverse movement in currency values and contract positions that are not exact offsets. Details of Forward Contracts, if any, at period end are included in the Investment Portfolios under the caption “Forward Contracts.” Refer to Note 6 for additional information.

 

   

Futures contracts  |  Each of the funds’ policies, except Capital Appreciation, International Stock, Small Cap Growth, International, Mid Cap, and Small Cap, permit the Funds to enter into futures contracts (“Futures”), including interest rate, bond, U.S. Treasury and fixed income index Futures, as a hedge against movements in the equity and bond markets in order to establish more definitively the effective return on securities held or intended to be acquired by the Funds or for other purposes permissible under the Commodity Exchange Act, including as a means to gain or reduce exposure to a reference instrument without actually buying or selling it. When a fund enters into Futures, it must deliver to an account controlled by the futures commission merchant (“FCM”) an amount referred to as “initial margin.” Initial margin requirements are determined by the respective exchanges on which the Futures are traded and the FCM. Thereafter, a “variation margin” amount may be required to be paid by the fund or received by the fund in accordance with margin controls set for such accounts, depending upon changes in the marked-to-market value of the Futures. The account is marked-to-market daily and the unrealized gains or losses are recorded as variation margin and monitored by the Manager and custodian on a daily basis. When Futures are closed out, the fund recognizes a realized gain or loss. The risks of entering into Futures include the possibility that a change in the value of the contract may not correlate with the changes in the value of the underlying instrument. Details of futures contracts, if any, at period end are included in the Investment Portfolios under the caption “Futures Contracts.” Refer to Note 6 for additional information.

 

   

Options and Options on Futures  |  Each of the funds’ policies, except Capital Appreciation, International Stock, Small Cap Growth, International, Mid Cap, and Small Cap, permit the Funds to use options for hedging, substitution or investment purposes, certain options, including options on securities, equity and debt indices, currencies and futures. However, Growth & Income may only purchase and write call options on securities as discussed below. Certain risks and special characteristics of these strategies are discussed below. The purchase of call options can serve as a long hedge, and the purchase of put options can serve as a short hedge. Writing put or call options can enable a fund to enhance income or yield by reason of the premiums paid by the purchasers of such options. However, if the market price of the security underlying a put option declines to less than the exercise price of the option, minus the premium received, the fund would expect to suffer a loss. On written call options the maximum loss of capital can be unlimited. The maximum loss of capital on written

 

               47  


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

  put options is limited to the notional contract values of those positions. A fund effectively may terminate its right or obligation under an option by entering into a closing transaction. If a fund wished to terminate its obligation to purchase or sell the investment under a put or call option it has written, the fund may purchase a put or call option of the same series (i.e., an option identical in its terms to the option previously written); this is known as a closing purchase transaction. Conversely, in order to terminate its right to purchase or sell under a call or put option it has purchased, a fund may write a call or put option of the same series; this is known as a closing sale transaction. Closing transactions essentially permit the fund to realize profits or limit losses on its options positions prior to the exercise or expiration of the option. Whether a profit or loss is realized from a closing transaction depends on the price movement of the underlying security, index, currency or futures contract and the market value of the option. A fund may purchase and write call and put options on futures contracts that are traded on a U.S. exchange or board of trade. A fund may purchase put options on futures contracts in lieu of, and for the same purpose as, the sale of a futures contract. A fund also may purchase such put options in order to hedge a long position in the underlying futures contract. A fund may purchase call options on futures contracts in lieu of, and for the same purpose as, the actual purchase of the futures contracts. A fund also may purchase call options on futures contracts in anticipation of a market advance when it is not fully invested. While a fund’s use of options on futures contracts for hedging may protect the fund against adverse movements in the general level of interest rates or securities prices, such transactions could also preclude the opportunity to benefit from favorable movement in the level of interest rates or securities prices. There can be no guarantee that a fund’s forecasts about market value, interest rates and other applicable factors will be correct or that there will be a correlation between price movements in the hedging vehicle and in the securities being hedged. Details of options and options on futures contracts, if any, at period end are included in the Investment Portfolios under the caption “Schedule of Options.” Refer to Note 6 for additional information.

 

   

Swap contracts  |  The Core Bond, Core Plus Bond and Unconstrained Bond Funds’ policies permit the Funds to enter into swap agreements to enhance the Funds’ returns, increase liquidity and/or gain exposure to certain instruments, issuers, markets (i.e., the corporate bond market), or securities in a relatively efficient way. A fund expects to enter into these transactions primarily to preserve a return or spread on a particular investment or portion of its portfolio, to protect against currency fluctuations, as a duration management technique or to protect against any increase in the price of securities the fund anticipates purchasing at a later date. Interest paid to or by the Funds is accrued daily and included in realized gain (loss) on swap agreements. When a fund enters into a centrally cleared swap, it must deliver to the central counterparty an amount referred to as “initial margin” During the term of the swap agreement, a “variation margin” amount may also be required to be paid by a fund or may be received by the fund in accordance with margin controls set for such accounts, depending upon changes in the marked-to-market value of the swap agreement. At the conclusion of the term of the swap agreement, if a fund has a loss of less than the margin amount, the excess margin is returned to the fund. If a fund has a gain, the full margin amount and the amount of the gain is paid to the fund. The contracts are marked-to-market daily using fair value estimates provided by an independent pricing service. Daily fluctuations in the value of swaps are recorded in variation margin on the Statements of Assets and Liabilities. Gains or losses are realized upon termination of the contracts. Swaps sold by a fund may involve greater risks than if the fund had invested in the reference obligation directly. Swaps are subject to general market risk, liquidity risk, counterparty credit risk and credit risk of the issuer. Details of swap contracts, if any, at period end are included in the Investment Portfolios under the caption “Swap Contracts.” Refer to Note 6 for additional information.

 

   

Credit default swap contracts  |  The credit default swap agreement may have as a reference obligation one or more securities that are or are not currently held by a fund. The Funds may enter into credit default swap agreements for investment purposes or to hedge against the risk of default of debt securities held in their portfolio. The buyer in a credit default swap agreement is obligated to pay the seller a periodic fee, typically expressed in basis points on the principal amount of the underlying obligation (the “notional value”), over the term of the agreement in return for a contingent payment upon the occurrence of a credit event with respect to the underlying reference obligation. A credit event is typically a default. If a fund is a buyer and no credit event occurs, the fund may lose its investment and recover nothing. If a fund is a buyer of protection and a credit event occurs, as defined under the terms of that particular swap agreement, the fund will either (i) receive from the seller of protection an amount equal to the notional value of the swap and deliver the referenced obligation, other deliverable obligations or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional value of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index. As a seller, a fund accrues for and receives a fixed rate of income throughout the term of the agreement, which typically is between one month and five years, provided that no credit event occurs. As the seller, a fund would effectively add leverage to its portfolio because, in addition to its total net assets, the fund would be subject to investment exposure on the notional value of the swap. If a fund is a seller of protection and a credit event occurs, as defined under the terms of that particular swap agreement, the fund will either (i) pay to the buyer of protection an amount equal to the notional value of the swap and take delivery of the referenced obligation, other deliverable obligations or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional value of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index. If a credit event occurs, the maximum payout amount for a sale contract is limited to the notional value of the swap contract (“Maximum Payout Amount”). Recovery values are estimated by market makers considering either industry standard recovery rates or entity specific factors and considerations until a credit event occurs. If a credit event has occurred, the recovery value is determined by a facilitated auction whereby a minimum number of allowable broker bids, together with a specified valuation method, are used to calculate the settlement value. Credit default swap agreements on credit indices involve one party making a stream of payments to another party in exchange for the right to receive a specified return in the event of a write-down, principal shortfall, interest shortfall or default of all or part of the referenced entities comprising the credit index. A credit index is a basket of credit instruments or exposures designed to be representative of some part of the credit market as a whole. These indices are made up of reference credits that are judged by a poll of dealers to be the most liquid entities in the credit default swap market based on the sector of the index. Components of the indices may include, but are not limited to, investment grade securities, high yield securities, asset-backed securities, emerging markets, and/or various credit ratings within each sector. Credit indices are traded using credit default swaps with standardized terms including a fixed spread and standard maturity dates. An index credit default swap references all the names in the index, and if there is a default, the credit event is settled based on that name’s weight in the index. The composition of the indices changes periodically, usually every six months, and for most indices, each name has an equal weight in the index. A fund may use credit default swaps on credit indices to hedge a portfolio of credit default swaps or bonds, which is less expensive than it would be to buy many credit default swaps to achieve a similar effect.

 

48             


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

   

Interest rate swap contracts  |  An interest rate swap is an agreement between two parties to exchange interest rate payment obligations and is used primarily to manage interest rate risk. Typically, one is based on an interest rate fixed to maturity while the other is based on an interest rate that changes in accordance with changes in a designated benchmark (for example, the London Interbank Offered Rate (LIBOR), the Secured Overnight Financing Rate (SOFR), prime rate, commercial paper rate, or other benchmarks). Each party’s payment obligation under an interest rate swap is determined by reference to a specified notional amount of money. Therefore, interest rate swaps generally do not involve the delivery of securities, other underlying instruments, or principal amounts; rather, they entail the exchange of cash payments based on the application of the designated interest rates to the notional amount. These agreements may be executed on a registered exchange (centrally cleared interest rate swaps). The Funds may enter into interest rate swaps in which they either pay or receive a fixed interest rate and pay or receive a floating interest rate. Barring swap counterparty default, the risk of loss in an interest rate swap is limited to the net amount of interest payments that the fund is obligated to make or receive (as applicable), as well as any early termination payment payable by or to the fund upon early termination of the swap.

 

   

Inflation rate swap contracts  |  An inflation swap is an agreement between two parties to transfer inflation risk, with one party paying the floating rate based on an inflation index (such as the Consumer Price Index (CPI), and the other party paying a fixed rate, typically based on the notional principal amount of the underlying asset. Inflation swap contracts are used primarily to gain exposure to inflation (inflation risk). Inflation swaps may be used to protect the value of securities against an unexpected change in the rate of inflation measured by an inflation index since the value of these agreements is expected to increase if there are unexpected inflation increases. Similar to an interest rate swap, the Funds may enter into inflation rate swaps in which they either pay or receive a fixed interest rate and pay or receive a floating interest rate based upon an inflation index, such as the CPI. Barring swap counterparty default, the risk of loss in an inflation rate swap is limited to the net amount of payments that the fund is obligated to make or receive (as applicable), as well as any early termination payment payable by or to the fund upon early termination of the swap.

 

   

Total return swap contracts  |  Total return swaps are two-party contracts that generally obligate one party to pay a set rate (either fixed or based on an index) and the other party to make payments based on the return of a specified reference security, security index or index component during the period of the swap, and are used primarily to gain exposure to the underlying referenced instruments, obtain leverage or attain the returns from ownership without actually owning the underlying position. Total return swaps normally do not involve the delivery of securities or the underlying assets. If the counterparty to a total return swap defaults, a fund’s risk of loss consists of the net amount of the payments the fund is contractually entitled to receive, if any.

During the period ended April 30, 2022, the average of month-end derivative positions (notional value in U.S. dollars) were as follows:

 

    Inflation
Rate Swap
Contracts
    Credit Default
Swap Contracts
(Sell Protection)
    Futures
Contracts - Long
    Futures
Contracts - Short
    Forward
Contracts - USD
Received
    Forward
Contracts - USD
Delivered
    Purchased
Options
    Written
Options
 
Core Bond Fund     $—       $11,601,429       $—       $—       $—       $—       $—       $—  
Core Plus Bond Fund     78,707,857       227,801,429       214,980,292       (55,893,907     62,575,080       37,637,097              
Unconstrained Bond Fund     155,277,714       214,422,857       599,990,751       (257,656,744     127,509,654       116,081,404       177,476       (186,883

Foreign currency transactions  |  The books and records of each fund are maintained in U.S. dollars. Foreign currency transactions are translated into U.S. dollars on the following basis: (i) market value of investment securities, other assets and other liabilities at the daily rates of exchange, and (ii) purchases and sales of investment securities, dividend and interest income and certain expenses at the rates of exchange prevailing on the respective dates of such transactions. The Funds do not isolate that portion of gains and losses on investments which is due to changes in foreign exchange rates from that which is due to changes in market prices of the investments. Such fluctuations are included with the net realized and unrealized gains and losses from investment transactions. Net realized gain (loss) on foreign currency transactions and the net change in unrealized appreciation (depreciation) on translation of assets and liabilities denominated in foreign currencies include gains and losses between trade and settlement date on securities transactions, gains and losses arising from the purchase and sale of forward foreign currency exchange contracts and gains and losses between the ex and payment dates on dividends, interest and foreign withholding taxes.

To-Be-Announced Securities  |  The Core Bond, Core Plus Bond and Unconstrained Bond Funds’ policies permit the Funds to enter into to-be-announced securities. A to-be-announced mortgage-backed security (“TBA”) is a mortgage-backed security, such as a Ginnie Mae pass-through security, that is purchased or sold with specific pools of cash, or cash equivalents, set aside in an amount equal to the price of the Ginnie Mae pass-through security, to be announced on a future settlement date. At the time of purchase of a TBA, the seller does not specify the particular mortgage-backed securities to be delivered but rather agrees to accept any mortgage-backed security that meets specified terms. The fund and the seller would agree upon the issuer, interest rate and terms of the underlying mortgages, but the seller would not identify the specific underlying mortgages until shortly before it issues the mortgage-backed security. TBAs increase interest rate risks because the underlying mortgages may be less favorable than anticipated by a fund. As a purchaser of a TBA, the fund will segregate or “earmark” liquid securities in accordance with procedures adopted by the Board equal to the value of the TBA, marked to-market daily in accordance with pertinent SEC positions. As a seller of a TBA, the fund will segregate or “earmark” in accordance with procedures adopted by the Board the equivalent deliverable security up to the obligation required to be delivered.

Real estate investment trusts (“REIT(s)”)  |  There are certain additional risks involved in investing in REITs. These include, but are not limited to, economic conditions, changes in zoning laws, real estate values, property taxes and interest rates. Dividend income is recorded at the Manager’s estimate of the income included in distributions from the REITs. Distributions received in excess of the estimated amount are recorded as a reduction of the cost of the investments. The actual amounts of income, return of capital and capital gains are only determined by each REIT after the Funds’ fiscal year-end and may differ from the estimated amounts.

Repurchase agreements  |  Each fund, except Capital Appreciation, International Stock and International, may enter into repurchase agreements whereby a fund, through its custodian, receives delivery of the underlying securities, the market value of which at the time of purchase is required to be in an amount of at least 100% of the resale price. Repurchase agreements involve the risk that the seller will fail to repurchase the security, as agreed. In that case, the fund will bear the risk of market value fluctuations until the security can be sold and may encounter delays and incur costs in liquidating the security. In the event of bankruptcy or insolvency of the seller, delays and costs may be incurred. During the period ended April 30, 2022, none of the Funds held any repurchase agreements.

 

               49  


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

Revenue recognition  |  Investment security transactions are accounted for on a trade date basis. Dividend income is recorded on the ex-dividend date. Interest income is recorded on an accrual basis.

Foreign taxes  |  The Funds may be subject to taxes imposed by countries in which they invest, with respect to their investments in issuers existing or operating in such countries. The Funds may also be subject to foreign taxes on income, gains on investments or currency repatriation, a portion of which may or may not be recoverable. The Funds record such taxes and recoveries as applicable, when the related income or capital gains are earned and based upon the current interpretation of tax rules and regulations that exist in the markets in which a fund invests. Some countries require governmental approval for the repatriation of investment income, capital or the proceeds of sales earned by foreign investors.

As a result of court cases involving several countries across the European Union, the International Fund has filed tax reclaims in respect of previously withheld taxes on dividends earned (“EU tax reclaims”). These filings are subject to various administrative proceedings by each local jurisdiction’s tax authority, as well as judicial proceedings. EU tax reclaims that have been recognized, if any, are reflected as “Foreign withholding tax claims and interest” in the Statements of Operations. Generally, unless Carillon Tower believes that recovery amounts are collectible and free from significant contingencies, recoveries will not be reflected in a fund’s net asset value. EU tax reclaims recognized by a fund, if any, reduce the amount of foreign taxes, if any, that a fund may elect to pass-through to its shareholders from a U.S. federal tax perspective. In certain circumstances and to the extent that EU tax reclaims recognized by a fund were previously passed- through as foreign tax credits to its U.S. taxable shareholders, a fund may enter into a closing agreement with the U.S. Internal Revenue Service (the “IRS”). The closing agreement will result in the fund paying a compliance fee to the IRS, on behalf of its shareholders, representing the estimated tax savings generated from foreign tax credits claimed by fund shareholders on their tax returns in prior years. Based on current guidance from the IRS, it is expected that International Fund will enter into a closing agreement with the IRS. Accordingly, estimated charges related to International Fund’s closing agreement liability are presented as “IRS compliance fee and related expenses for withholding tax claims” in the Statements of Operations and its estimated closing agreement liability is presented as “IRS compliance fee and related expenses for withholding tax claims” in the Statements of Assets and Liabilities. The actual IRS compliance fee in connection with the closing agreement may differ from the estimate and that difference may be material.

Expenses  |  Each fund is charged for certain expenses which are directly attributable to it and certain other expenses which are allocated proportionately among the Carillon Family of Funds based upon methods approved by the Board. Expenses that are directly attributable to a specific class of shares, such as distribution fees, shareholder servicing fees and administrative fees, are charged directly to that class of shares. Other expenses of each fund are allocated to each class of shares based upon its relative percentage of net assets.

Class allocations  |  Each class of shares has equal rights to earnings and assets except that each class may bear different expenses for administration, distribution and/or shareholder services. Income, expenses (other than expenses attributable to a specific class), and realized and unrealized gains or losses on investments are allocated to each class of shares based on its relative percentage of net assets.

Segregation and Collateralization  |  In cases in which the 1940 Act and the interpretive positions of the Securities and Exchange Commission (“SEC”) require that a fund either deliver collateral or segregate assets in connection with certain investments (e.g., forward currency contracts, securities with extended settlement periods, futures and swaps), the fund will segregate collateral or designate on its books and records cash or other liquid securities having a value at least equal to the amount that is required to be physically segregated for the benefit of the counterparty. Furthermore, based on requirements and agreements with certain exchanges and third party broker- dealers, each party has requirements to deliver/deposit cash or securities as collateral for certain investments.

Distributions  |  Each fund, except the Growth & Income Fund, Core Bond Fund, Core Plus Bond Fund and Unconstrained Bond Fund, distributes net investment income annually. Distributions of net investment income are made quarterly from the Growth & Income Fund and monthly from the Core Bond Fund, Core Plus Bond Fund and Unconstrained Bond Fund. Net realized gains from investment transactions during any particular fiscal year in excess of available capital loss carryforwards, which, if not distributed, would be taxable to each applicable fund, will be distributed to shareholders annually in the following fiscal year. If a fund is involved in a reorganization wherein it acquires the net assets of another fund, or has its net assets acquired by another fund, a separate and additional distribution of net investment income and/or net realized gains may be made prior to such reorganization. Each fund uses the identified cost method for determining realized gain or loss on investments for both financial and federal income tax reporting purposes.

Distributions made to shareholders from earnings were as follows:

 

Distributions from earnings      Class A      Class C      Class I      Class R-3      Class R-5      Class R-6      Class Y  
Capital Appreciation Fund      11/1/21 to 4/30/22        $14,716,038        $1,446,357        $25,552,378        $37,541        $379,818        $94,234        $1,724  
     11/1/20 to 10/31/21        25,460,982        2,732,124        39,632,761        55,541        673,815        148,117        2,350  
International Stock Fund      11/1/21 to 4/30/22        56,628        17,493        159,071        744        77        1,188        220  
     11/1/20 to 10/31/21        22,625        1,251        43,033        6,690        41        1,825        104  
Growth & Income Fund      11/1/21 to 4/30/22        19,652,724        6,291,429        56,512,850        139,210        586,530        775,245        39,701  
     11/1/20 to 10/31/21        8,894,323        3,561,007        28,286,806        55,575        367,453        202,200        11,764  
Mid Cap Growth Fund      11/1/21 to 4/30/22        86,905,995        17,025,720        171,946,281        5,215,746        92,470,549        385,326,429        418,862  
     11/1/20 to 10/31/21        20,093,745        4,387,423        38,581,641        1,207,650        20,226,980        81,577,686        85,197  
Small Cap Growth Fund      11/1/21 to 4/30/22        95,432,723        14,934,190        232,783,017        17,185,244        20,622,322        214,213,403        6,377  
     11/1/20 to 10/31/21        64,822,457        14,122,282        140,336,438        11,939,971        36,523,428        244,026,117        4,790  
International Fund      11/1/21 to 4/30/22        117,988        14,207        55,779,825        1,397        1,482        409,035        2,540  
     11/1/20 to 10/31/21        77,987        8,947        44,768,746        905        926        344,188        1,087  
Mid Cap Fund      11/1/21 to 4/30/22        3,056,792        3,186,900        459,672,618        505,625        441,972        29,463,894        381,187  
     11/1/20 to 10/31/21        514,569        502,805        72,820,267        77,809        64,161        5,079,358        251,046  

 

50             


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

Distributions from earnings (cont'd)      Class A      Class C      Class I      Class R-3      Class R-5      Class R-6      Class Y  
Small Cap Fund      11/1/21 to 4/30/22        $ 2,720,537        $ 494,473        $ 52,696,746        $ 25,405        $ 3,817        $ 1,702,995        $ 22,752  
     11/1/20 to 10/31/21        1,109,296        496,151        25,459,340        14,180        2,044        877,259        14,777  
Core Bond Fund      11/1/21 to 4/30/22        24,536        25,431        3,099,814        567        87        8,045        201,783  
     11/1/20 to 10/31/21        105,142        236,026        16,046,120        1,144        340        20,639        1,405,747  
Core Plus Bond Fund      11/1/21 to 4/30/22        33,650        26,309        7,005,482        704        69        21,876        361,730  
     11/1/20 to 10/31/21        335,471        252,855        62,478,259        4,494        635        69,636        5,451,144  
Unconstrained Bond Fund      11/1/21 to 4/30/22        67,703        22,902        16,070,668        143        2,352        1,052,582        388,908  
     11/1/20 to 10/31/21        24,362        27,393        19,606,141        202        1,285        1,081,790        591,576  

Other  |  In the normal course of business the Funds enter into contracts that contain a variety of representations and warranties which provide general indemnifications. The Funds’ maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Funds and/or their affiliates that have not yet occurred. However, based on experience, the risk of loss to each fund is expected to be remote.

NOTE 3  |  Purchases and sales of securities  |  During the period ended April 30, 2022, purchases and sales of investment securities (excluding short-term obligations) were as follows:

 

    Capital
Appreciation Fund
    International
Stock Fund
    Growth &
Income Fund
    Mid Cap
Growth Fund
    Small Cap
Growth Fund
    International
Fund
 
Purchases     $95,655,248       $42,403,893       $96,539,959       $1,043,126,190       $355,314,372       $398,237,886  
Sales     50,301,461       19,980,908       108,702,886       1,602,463,726       825,384,300       433,790,360  
            Mid Cap
Fund
    Small Cap
Fund
    Core Bond Fund     Core Plus
Bond Fund
    Unconstrained
Bond Fund
 
Purchases       $3,431,958,147       $26,660,033       $443,188,172       $1,271,117,925       $378,059,137  
Purchases - U.S. Treasury securities                   768,032,112       2,111,201,067       1,593,268,092  
Sales       3,736,308,356       42,002,707       353,980,029       941,867,746       331,078,083  
Sales - U.S. Treasury securities                   740,520,825       2,095,374,316       1,285,403,515  

NOTE 4  |  Investment advisory fees and other transactions with affiliates  |  Each fund has agreed to pay to the Manager an investment advisory and an administrative fee equal to an annualized rate based on a percentage of each fund’s average daily net assets, computed daily and payable monthly. For advisory services provided by the Manager, the investment advisory rate for each fund is as follows:

 

Investment advisory fee rate
schedule
  Breakpoint   Investment
advisory fee
 
Capital Appreciation Fund  

First $1 billion

Over $1 billion

   

0.60%

0.55%

 

 

Growth & Income Fund   First $100 million $100 million to $500 million Over $500 million    

0.60%
0.45%
0.40%
 
 
 

Mid Cap Growth Fund,

Small Cap Growth Fund,

Small Cap Fund

 

First $500 million

$500 million to $1 billion

Over $1 billion

   

0.60%

0.55%

0.50%

 

 

 

Investment advisory fee rate
schedule (cont’d)
  Breakpoint   Investment
advisory fee
 

International Stock Fund*,

International Fund

 

First $1 billion

Over $1 billion

   

0.70%

0.60%

 

 

Mid Cap Fund  

First $1 billion

Over $1 billion

   

0.80%

0.70%

 

 

Core Bond Fund, Core Plus Bond Fund   All assets     0.40%  
Unconstrained Bond Fund  

First $3 billion

Over $3 billion

   

0.60%

0.55%

 

 

 

 

* Prior to the Board approved change effective March 1, 2022, the investment advisory fee for the International Stock Fund was 0.70% on all assets

Subadvisory fees  |  The Manager has entered into subadvisory agreements with certain parties (the “subadviser” or “subadvisers”) to provide investment advice, portfolio management services (including the placement of brokerage orders), certain compliance and other services to the Funds. Under these agreements, Carillon Tower pays the subadvisers, each an affiliate of Carillon Tower, annualized rates identical to those disclosed in the investment advisory fee rate schedule. Carillon Tower may receive payments from the subadvisers for certain marketing and related expenses. The subadvisers for the Funds are as follows:

 

   

ClariVest Asset Management LLC (“ClariVest”) serves as subadviser for the Capital Appreciation Fund, International Stock Fund and International Fund*,

   

Eagle Asset Management, Inc. serves as subadviser for the Growth & Income Fund, Mid Cap Growth Fund, and Small Cap Growth Fund, and

   

Scout Investments, Inc. (“Scout”) serves as subadviser for the Mid Cap Fund, Small Cap Fund, Core Bond Fund, Core Plus Bond Fund, and Unconstrained Bond Fund

* Prior to the Board approved change effective March 1, 2022, Scout served as subadviser for the International Fund

 

               51  


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

Administrative fees  |  For administrative services provided by the Manager, each fund has agreed to pay an administrative rate of 0.10% of the average daily net assets of all share classes.

Distribution and service fees  |  Pursuant to the Class A, Class C, Class R-3 and Class Y Distribution plans and in accordance with Rule 12b-1 of the Investment Company Act of 1940, as amended (“Rule 12b-1 Plans”), the Funds are authorized to pay Carillon Fund Distributors, Inc. (“Distributor”), an affiliate of the Manager, a fee based on the average daily net assets for each class of shares, accrued daily and payable monthly. Each fund of the Carillon Series Trust, except the Capital Appreciation Fund and the Growth & Income Fund, is authorized to pay the Distributor distribution and service fees of up to 0.35% of that fund’s average daily net assets attributable to Class A shares of that fund. The Capital Appreciation Fund and the Growth & Income Fund are authorized to pay the Distributor distribution and service fees of up to 0.50% of those Funds’ average daily net assets attributable to Class A shares of those Funds. Currently, the distribution and service fee is 0.25% for Class A shares of each fund. Each fund also is authorized, and currently pays, the Distributor distribution and service fees of 1.00% for Class C shares, 0.50% for Class R-3 shares, and 0.25% for Class Y shares. The Funds do not incur any distribution expenses related to Class I, Class R-5 or Class R-6 shares. However, Carillon Tower or any third party may make payments for the sale and distribution of all share classes, including Class I, Class R-5 or Class R-6 shares, from its own resources.

Sales charges  |  During the period ended April 30, 2022, total front-end sales charges and contingent deferred sales charges (“CDSC”) paid to the Distributor were as follows:

 

    Capital
Appreciation Fund
    International
Stock Fund
    Growth &
Income Fund
    Mid Cap
Growth Fund
    Small Cap
Growth Fund
    International
Fund
 
Front-end sales charges - Class A     $16,286       $307       $74,311       $68,319       $21,590       $417  
CDSC - Class A     6             4                    
CDSC - Class C     1       11       38       18       8        
          Mid Cap
Fund
    Small Cap
Fund
    Core Bond
Fund
    Core Plus
Bond Fund
    Unconstrained
Bond Fund
 
Front-end sales charges - Class A       $17,937       $5,483       $2,484       $913       $114  
CDSC - Class A                                
CDSC - Class C                         4        

The Distributor paid commissions to salespersons from these fees and incurred other distribution costs.

Agency commissions  |  During the period ended April 30, 2022, total agency brokerage commissions paid and agency brokerage commissions paid directly to Raymond James & Associates, Inc. (“RJA”), an affiliate of the Manager, were as follows:

 

    Capital
Appreciation Fund
    International
Stock Fund
    Growth &
Income Fund
    Mid Cap
Growth Fund
    Small Cap
Growth Fund
    International
Fund
 
Total agency brokerage commissions     $23,640       $31,126       $48,484       $474,567       $709,493       $436,491  
Paid to RJA                       4,767       82,613        
          Mid Cap
Fund
    Small Cap
Fund
    Core Bond
Fund
    Core Plus
Bond Fund
    Unconstrained
Bond Fund
 
Total agency brokerage commissions       $2,019,294       $35,104       $—       $30,240       $135,639  
Paid to RJA                                

Internal audit fees  |  RJA provides internal audit services to the Funds. Each fund paid RJA a fixed and/or hourly fee for these services through February 28, 2022. Beginning on March 1, 2022 none of the internal audit services fees are paid by the Funds.

Transactions with affiliates  |  An issuer in which a fund’s holdings represent 5% or more of the outstanding voting securities of the issuer is an “affiliated” issuer as defined in the 1940 Act. A schedule of Small Cap Growth Fund’s investments in securities of affiliated issuers is set forth below:

 

    Value at
10/31/21
     Purchases      Sales      Net Realized
Gain (Loss)
     Net Change in Unrealized
Appreciation (Depreciation)
     Value at
4/30/22
     Dividend
Income
     Shares owned
at 4/30/22
 
Fast Acquisition Corp.*     $20,193,920        $—        $(15,674,650)        $(1,792,864)        $(2,726,406)        $ —        $—         
Universal Electronics, Inc.     39,058,077               (10,843,692)        (1,453)        (9,043,478)        19,169,454               649,812  
 

 

 

    
Total     $59,251,997        $—        $(26,518,342)        $(1,794,317)        $(11,769,884)        $19,169,454        $—     
 

 

 

    

* This security is no longer held by the fund as of the date of this report.

 

52             


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

Expense limitations  |  Carillon Tower has contractually agreed to reduce its fees and/or reimburse expenses to each class of the Funds through February 28, 2023 to the extent that the annual operating expense ratio for each class of shares exceeds the following annualized ratios as a percentage of the average daily net assets of each class of shares.

 

Expense limitations rate schedule    Class A      Class C      Class I      Class R-3      Class R-5      Class R-6      Class Y  
Capital Appreciation Fund      1.00%        1.75%        0.70%        1.25%        0.70%        0.60%        1.00%  
International Stock Fund*      1.25%        2.00%        0.95%        1.50%        0.95%        0.85%        1.25%  
Growth & Income Fund      1.25%        2.00%        0.95%        1.50%        0.95%        0.85%        1.25%  
Mid Cap Growth Fund      1.25%        2.00%        0.95%        1.50%        0.95%        0.85%        1.25%  
Small Cap Growth Fund      1.25%        2.00%        0.95%        1.50%        0.95%        0.85%        1.25%  
International Fund      1.25%        2.00%        0.95%        1.50%        0.95%        0.85%        1.25%  
Mid Cap Fund      1.45%        2.20%        1.15%        1.70%        1.15%        1.05%        1.45%  
Small Cap Fund      1.25%        2.00%        0.95%        1.50%        0.95%        0.85%        1.25%  
Core Bond Fund      0.80%        1.55%        0.40%        1.05%        0.50%        0.40%        0.80%  
Core Plus Bond Fund      0.80%        1.55%        0.40%        1.05%        0.50%        0.40%        0.80%  
Unconstrained Bond Fund      0.80%        1.55%        0.50%        1.05%        0.50%        0.40%        0.80%  

* Prior to the Board approved changes effective March 1, 2022, the expense limitation rate schedule for the International Stock Fund was as follows:

 

Expense limitations rate schedule    Class A      Class C      Class I      Class R-3      Class R-5      Class R-6      Class Y  
International Stock Fund      1.45%        2.20%        1.15%        1.70%        1.15%        1.05%        1.45%  

Fees and expenses waived and/or reimbursed based on the expense rate limitation schedule were as follows:

 

Expenses waived and/or reimbursed
11/1/21 to 4/30/22
  Class A     Class C     Class I     Class R-3     Class R-5     Class R-6     Class Y  
Capital Appreciation Fund     $115,673       $6,174       $323,736       $380       $5,067       $1,281       $3  
International Stock Fund     36,977       17,646       98,571       1,629       43       37,066       139  
Growth & Income Fund                                          
Mid Cap Growth Fund                                          
Small Cap Growth Fund                                          
International Fund     398       7       201,732                   1,516        
Mid Cap Fund                                          
Small Cap Fund                                          
Core Bond Fund     3,281       7,541       620,694       117       5       1,110       37,177  
Core Plus Bond Fund     3,018       3,539       1,450,078       97       2       2,981       49,147  
Unconstrained Bond Fund     6,995       3,095       1,909,728       10       377       145,184       53,100  

A portion or all of a fund’s fees and expenses waived and/or reimbursed by the Manager in prior fiscal years may be recoverable by Carillon Tower prior to their expiration date. Any previously waived and/or reimbursed fees and expenses are recoverable by Carillon Tower only from the same class of shares and within two years from the fund’s fiscal year-end during which the fees and expenses were originally waived and/or reimbursed. Previously waived and/or reimbursed fees and expenses are recovered by Carillon Tower within the following two fiscal years when fees and expenses in the current fiscal year fall below the lesser of the current expense cap or the expense cap in effect at the time of the waiver and/or reimbursement. Carillon Tower receives payments from ClariVest and Scout for amounts waived and/or reimbursed under each contractual fee waiver and expense reimbursement agreement and provides to ClariVest and Scout any recoupment that Carillon Tower receives from the Funds. The following tables show the amounts that Carillon Tower may be allowed to recover by class of shares and the dates that these amounts will expire:

 

               53  


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

Recoverable expenses - 10/31/2024    Class A      Class C      Class I      Class R-3      Class R-5      Class R-6      Class Y  
Capital Appreciation Fund      $115,673        $6,174        $323,736        $380        $5,067        $1,281        $3  
International Stock Fund      36,977        17,646        98,571        1,629        43        37,066        139  
Growth & Income Fund                                                 
Mid Cap Growth Fund                                                 
Small Cap Growth Fund                                                 
International Fund      398        7        201,732                      1,516         
Mid Cap Fund                                                 
Small Cap Fund                                                 
Core Bond Fund      3,281        7,541        620,694        117        5        1,110        37,177  
Core Plus Bond Fund      3,018        3,539        1,450,078        97        2        2,981        49,147  
Unconstrained Bond Fund      6,995        3,095        1,909,728        10        377        145,184        53,100  
Recoverable expenses - 10/31/2023    Class A      Class C      Class I      Class R-3      Class R-5      Class R-6      Class Y  
Capital Appreciation Fund      $228,446        $14,380        $583,383        $773        $9,211        $2,537        $20  
International Stock Fund      119,321        61,753        166,198        18,321        152        4,114        491  
Growth & Income Fund                                                 
Mid Cap Growth Fund                                                 
Small Cap Growth Fund                                                 
International Fund      255               217,787                      1,888         
Mid Cap Fund                                                 
Small Cap Fund                                                 
Core Bond Fund      5,606        14,994        1,596,984        132        11        1,721        104,214  
Core Plus Bond Fund      6,731        8,049        3,045,629        129        7        3,379        139,037  
Unconstrained Bond Fund      5,880        6,656        3,415,623        30        463        210,822        170,371  
Recoverable expenses - 10/31/2022    Class A      Class C      Class I      Class R-3      Class R-5      Class R-6      Class Y  
Capital Appreciation Fund      $261,382        $21,010        $549,306        $1,572        $11,348        $12,814        $91  
International Stock Fund      104,016        63,252        145,449        32,089        182        5,188        386  
Growth & Income Fund                                                 
Mid Cap Growth Fund                                                 
Small Cap Growth Fund                                                 
International Fund      117        73               43        51               74  
Mid Cap Fund                                                 
Small Cap Fund                           239        46                
Core Bond Fund      3,718        5,323        878,828        95        88        379        27,619  
Core Plus Bond Fund      1,279        1,784        1,854,988        66        68        104        55,569  
Unconstrained Bond Fund      1,837        2,446        2,953,078        83        89        135,002        72,334  

 

54             


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

The Manager recovered previously waived expenses during the period ended April 30, 2022 as follows:

 

Recovered fees previously waived    Class A      Class C      Class I      Class R-3      Class R-5      Class R-6      Class Y  
Capital Appreciation Fund      $—        $—        $—        $—        $—        $—        $—  
International Stock Fund                                                 
Growth & Income Fund                                                 
Mid Cap Growth Fund                                                 
Small Cap Growth Fund                                                4  
International Fund                           4        1               5  
Mid Cap Fund                                                 
Small Cap Fund                           23        14                
Core Bond Fund                                                 
Core Plus Bond Fund                                                 
Unconstrained Bond Fund                                                 

Trustees and officers compensation  |  Each Trustee of the Carillon Family of Funds receives an annual retainer along with meeting fees for those Carillon Family of Funds’ regular or special meetings attended in person and 25% of such meeting fees are received for telephonic meetings. All reasonable out-of-pocket expenses are also reimbursed. Except when directly attributable to a fund, Trustees’ fees and expenses are paid equally by each fund in the Carillon Family of Funds.

Certain officers of the Carillon Family of Funds may also be officers and/or directors of Carillon Tower. Such officers receive no compensation from the Funds except for the Funds’ Chief Compliance Officer. A portion of the Chief Compliance Officer’s total compensation was paid equally by each fund in the Carillon Family of Funds through February 28, 2022. Beginning on March 1, 2022 none of the Chief Compliance Officer’s total compensation is paid by the Funds.

NOTE 5  |  Federal income taxes and distributions  |  Each fund is treated as a single corporate taxpayer as provided for in the Tax Reform Act of 1986, as amended. Accordingly, no provision for federal income taxes is required since each of the Funds intends to continue to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code and distribute to shareholders all of its taxable income and gains. The Manager has analyzed the Funds’ tax positions taken or expected to be taken on federal income tax returns for all open tax years (tax years ended October 31, 2018 to October 31, 2021) and has concluded that no provision for federal income tax is required in the Funds’ financial statements.

Federal income tax regulations differ from GAAP; therefore, distributions determined in accordance with tax regulations may differ significantly in amount or character from net investment income and net realized gains for financial reporting purposes. These differences primarily relate to deferral of losses from wash sales and non-REIT return of capital.

For income tax purposes, distributions paid during the fiscal periods indicated were as follows (tax character for the period ended April 30, 2022 is estimated):

 

          Capital
Appreciation Fund
     International
Stock Fund
     Growth &
Income Fund
     Mid Cap
Growth Fund
     Small Cap
Growth Fund
     International
Fund
 
Ordinary Income    11/1/21 to 4/30/22      $1,681,718        $235,421        $21,061,252        $—        $—        $14,796,723  
   11/1/20 to 10/31/21      1,109,904        75,569        14,067,522                      9,331,172  
Long-term capital gain    11/1/21 to 4/30/22      40,546,372               62,936,437        759,309,582        595,177,276        41,529,751  
   11/1/20 to 10/31/21      67,595,786               27,311,606        166,160,322        511,775,483        35,871,614  
                 Mid Cap
Fund
     Small Cap
Fund
     Core Bond
Fund
     Core Plus
Bond Fund
     Unconstrained
Bond Fund
 
Ordinary Income    11/1/21 to 4/30/22         $79,256,173        $7,143,672        $3,360,263        $7,449,820        $17,605,258  
   11/1/20 to 10/31/21         16,967,987        6,780,837        17,583,235        64,698,216        21,332,749  
Long-term capital gain    11/1/21 to 4/30/22         417,452,815        50,523,053                       
   11/1/20 to 10/31/21         62,342,028        21,192,210        231,923        3,894,278         

 

               55  


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

At October 31, 2021, the components of distributable earnings (losses) on a tax basis were as follows:

 

    Capital
Appreciation Fund
    International
Stock Fund
    Growth &
Income Fund
    Mid Cap
Growth Fund
    Small Cap
Growth Fund
    International
Fund
 
Cost of investments     $254,546,319       $9,686,141       $607,947,240       $4,614,326,156       $1,285,316,614       $290,913,983  
Gross unrealized appreciation     385,773,271       1,921,141       369,281,770       4,217,790,787       1,139,010,862       220,670,468  
Gross unrealized depreciation     (3,940,070     (442,159     (3,355,025     (103,680,978     (59,240,742     (16,122,925
Net unrealized appreciation/(depreciation)     381,833,201       1,478,982       365,926,745       4,114,109,809       1,079,770,120       204,547,543  
Undistributed ordinary income     1,681,713       226,581       14,303,654                   9,019,435  
Undistributed long-term gain     40,546,372             62,936,128       759,309,374       595,177,208       41,529,654  
Total undistributed earnings     42,228,085       226,581       77,239,782       759,309,374       595,177,208       50,549,089  
Other accumulated gains (losses)     (1     (7,975           (24,628,859     (11,456,923     830,843  
Total distributable earnings (loss)     $424,061,285       $1,697,588       $443,166,527       $4,848,790,324       $1,663,490,405       $255,927,475  
            Mid Cap
Fund
    Small Cap
Fund
    Core Bond
Fund
    Core Plus
Bond Fund
    Unconstrained
Bond Fund
 
Cost of investments       $3,695,872,194       $226,385,903       $466,231,933       $1,141,623,895       $1,045,922,738  
Gross unrealized appreciation       1,352,850,184       187,131,184       5,403,000       17,092,757       14,945,291  
Gross unrealized depreciation       (140,422,274     (18,142,557     (3,437,191     (10,302,520     (7,522,629
Net unrealized appreciation/(depreciation)       1,212,427,910       168,988,627       1,965,809       6,790,237       7,422,662  
Undistributed ordinary income       75,818,023       7,039,389       1,145,630       5,264,794       16,411,814  
Undistributed long-term gain       417,451,907       50,522,990                    
Total undistributed earnings       493,269,930       57,562,379       1,145,630       5,264,794       16,411,814  
Other accumulated gains (losses)       139       (7,949     (9,971,717     (10,794,026     (3,047
Total distributable earnings (loss)       $1,705,697,979       $226,543,057       $(6,860,278     $1,261,005       $23,831,429  

At October 31, 2021, the difference between book-basis and tax-basis unrealized appreciation (depreciation) was attributable primarily to the tax deferral of losses from wash sales and differences in the accounting treatment for non-REIT returns of capital, investments in passive foreign investment companies and swaps.

NOTE 6  |  Other Derivative Information  |  At April 30, 2022, the Funds have invested in derivative contracts which are reflected on the Statements of Assets and Liabilities as follows:

 

            Asset     Liability  
    Risk Exposure Category   Statements of Assets and Liabilities Location   Fair Value Amount     Fair Value Amount  
Core Bond Fund   Credit   Open credit default swap contracts, at value*     $83,295       N/A  
     

 

 

 
  Total       $83,295       N/A  
     

 

 

 
Core Plus Bond Fund   Credit   Open credit default swap contracts, at value*     $2,748,131       N/A  
  Inflation   Unrealized appreciation - open inflation swap contracts*     684,408       N/A  
  Inflation   Unrealized depreciation - open inflation swap contracts*     N/A       $2,080,595  
  Interest rate   Unrealized appreciation - open futures contracts^     181,154       N/A  
  Interest rate   Unrealized depreciation - open futures contracts^     N/A       1,099,428  
  Currency   Unrealized depreciation - open forward contracts     N/A       2,797,068  
     

 

 

 
  Total       $3,613,693       $5,977,091  
     

 

 

 
Unconstrained Bond Fund   Credit   Open credit default swap contracts, at value*     $3,946,838       N/A  
  Inflation   Unrealized appreciation - open inflation swap contracts*     928,692       N/A  
  Inflation   Unrealized depreciation - open inflation swap contracts*     N/A       $7,633,655  
  Equity   Written options, at value     N/A       145,800  
  Interest rate & Currency   Unrealized appreciation - open futures contracts^     7,255,098       N/A  
  Interest rate & Currency   Unrealized depreciation - open futures contracts^     N/A       5,177,099  
  Currency   Unrealized depreciation - open forward contracts     N/A       3,503,923  
     

 

 

 
  Total       $12,130,628       $16,460,477  
     

 

 

 

* Included in Deposit at broker—open swap contracts.

^ Included in Deposit at broker—open futures contracts.

 

56             


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

Financial Accounting Standards Board Accounting Update 2011-11, Disclosures about Offsetting Assets and Liabilities requires an entity that has financial instruments that are either 1) offset or 2) subject to an enforceable master netting arrangement or similar agreement to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. As of April 30, 2022, the Funds did not hold any financial or derivative instruments that are offset or subject to enforceable master netting agreements (or related arrangements).

For the period ended April 30, 2022, the effect of derivative contracts on the Funds’ Statements of Operations is as follows:

 

    Risk Exposure Category   Derivative Instrument   Net Realized
Gains (Losses)
    Net Change in Unrealized
Appreciation (Depreciation)
 
Core Bond Fund   Credit   Swap contracts     $(41,722     $(77,845
     

 

 

 
  Total       $(41,722     $(77,845
     

 

 

 
Core Plus Bond Fund   Credit   Swap contracts     $46,516       $(3,047,349
  Inflation   Swap contracts     1,796,868       (1,396,187
  Interest rate & Currency   Futures contracts     2,599,510       559,486  
  Currency   Forward contracts     (390,557     (6,318,832
     

 

 

 
  Total       $4,052,337       $(10,202,882
     

 

 

 
Unconstrained Bond Fund   Equity   Written options     $1,099,712       $145,473  
  Credit   Swap contracts     2,093,947       (5,071,765
  Inflation   Swap contracts     1,804,987       (6,704,963
  Interest rate & Currency   Futures contracts     6,996,846       2,592,369  
  Currency   Forward contracts     (4,796,887     (8,030,787
     

 

 

 
  Total       $7,198,605       $(17,069,673
     

 

 

 

Refer to Note 2 for additional information regarding investments in derivatives.

NOTE 7  |  Securities lending  |  To earn additional income, each fund may loan portfolio securities to qualified broker dealers. The primary objective of securities lending is to supplement a fund’s income through investment of the cash collateral in short-term interest bearing obligations. The collateral for a fund’s loans will be marked-to-market daily so that at all times the collateral exceeds 100% of the value of the loan. A fund may terminate such loans at any time and the market risk applicable to any security loaned remains its risk. Although voting rights, or rights to consent, with respect to the loaned securities pass to the borrower, a fund retains the right to call the loans at any time on reasonable notice, and it may choose to do so in order that the securities may be voted by it if the holders of such securities are asked to vote upon or consent to matters materially affecting the investment. A fund also may call such loans in order to sell the securities involved. The borrower must add to the collateral whenever the market value of the securities rises above the level of such collateral. While securities are on loan, the Funds continue to receive certain income associated with that security and any gain or loss in the market price that may occur during the term of the loan. In the case of domestic equities, the value of any dividend is received in the form of a substitute payment approximately equal to the dividend. In the case of foreign securities, a negotiated amount may be received that is less than the actual dividend, but higher than the dividend amount minus the foreign tax that the Funds would be subject to on the dividend. Securities loans involve some risk. There is a risk that a borrower may default on its obligations to return loaned securities; however, the Funds’ securities lending agent may indemnify a fund against that risk. A fund could incur a loss if the borrower should fail financially at a time when the value of the loaned securities is greater than the collateral, and a fund could lose rights in the collateral should the borrower fail financially. The securities in which the collateral is invested may not perform sufficiently to cover the return collateral payments owed to borrowers. In addition, delays may occur in the recovery of securities from borrowers, which could interfere with a fund’s ability to vote proxies or to settle transactions. A fund will also be responsible for the risks associated with the investment of cash collateral. In any case in which the loaned securities are not returned to a fund before an ex-dividend date, the payment in lieu of the dividend that a fund receives from the securities’ borrower would not be treated as a dividend for federal income tax purposes and thus would not qualify for treatment as “qualified dividend income.”

Each security on loan as of the date of this report is footnoted on each fund’s Investment Portfolio, along with the total value of all securities on loan. Cash collateral received for securities on loan has been invested in the First American Government Obligations Fund Class X (the “money market fund”). The money market fund is included in each respective fund’s Investment Portfolio and is footnoted as having been purchased with cash collateral received for securities on loan. The value of the money market fund is included as an asset on the Statements of Assets and Liabilities as part of “Investments—unaffiliated, at value.” A liability of equal value to the cash collateral received and subsequently invested in the money market fund is included on the Statements of Assets and Liabilities as “Payable for securities lending collateral received.” Income earned from securities lending, net of applicable fees, is shown on the Statement of Operations as income from “Securities lending, net.”

NOTE 8  |  Line of Credit  |  As of April 30, 2022, the Trust has a secured line of credit of up to $350,000,000 with U.S. Bank N.A, secured by a first priority lien on the Trust’s assets. Each fund, except International Stock Fund and International Fund, may borrow up to 33.33% of the net market value of such fund’s assets. International Stock Fund and International Fund may borrow up to 30.00% of the net market value of such fund’s assets. The maximum aggregate borrowing limit is $350,000,000 for all Funds. Borrowings under this arrangement bear interest at U.S. Bank N.A.‘s prime rate minus 1.00%, which as of April 30, 2022 was

 

               57  


Notes to Financial Statements

(UNAUDITED)    |    04.30.2022

 

2.50% (prime rate of 3.50% minus 1.00%). The following table shows the details of the Funds’ borrowing activity during the period ended April 30, 2022. Funds that are not listed did not utilize the line of credit during the period.

 

    Maximum Outstanding Balance   Average Daily Balance   Total Interest Incurred   Average Annual Interest Rate
Capital Appreciation Fund     $2,739,000       $17,669       $200       2.25
International Stock Fund     764,000       8,392       95       2.25  
Mid Cap Growth Fund     12,737,000       273,271       3,091       2.25  
Small Cap Growth Fund     56,290,000       1,610,160       18,240       2.25  
International Fund     4,568,000       46,000       520       2.25  
Mid Cap Fund     42,350,000       233,978       2,647       2.25  

As of April 30, 2022, none of the Funds had any amounts outstanding under the line of credit.

NOTE 9  |  Regulatory Changes  |  In October 2020, the SEC adopted new regulations governing the use of derivatives by registered investment companies (“Rule 18f-4”). Rule 18f-4 will impose limits on the amount of derivatives a fund could enter into, eliminate the asset segregation framework currently used by funds to comply with Section 18 of the 1940 Act, and require funds whose use of derivatives is greater than a limited specified amount to establish and maintain a comprehensive derivatives risk management program and appoint a derivatives risk manager. The Funds will be required to comply with Rule 18f-4 by August 19, 2022. It is not currently clear what impact, if any, Rule 18f-4 will have on the availability, liquidity or performance of derivatives. Management is currently evaluating the potential impact of Rule 18f-4 on the Funds. When fully implemented, Rule 18f-4 may require changes in how a fund uses derivatives, adversely affect the fund’s performance and increase costs related to the fund’s use of derivatives.

In December 2020, the SEC adopted a new rule providing a framework for fund valuation practices (“Rule 2a-5”). Rule 2a-5 establishes requirements for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 will permit fund boards to designate certain parties to perform fair value determinations, subject to board oversight and certain other conditions. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the 1940 Act and the threshold for determining whether a fund must fair value a security. In connection with Rule 2a-5, the SEC also adopted related recordkeeping requirements and is rescinding previously issued guidance, including with respect to the role of a board in determining fair value and the accounting and auditing of fund investments. The Funds will be required to comply with the rules by September 8, 2022. Management is currently assessing the potential impact of the new rules on the Funds’ financial statements.

NOTE 10  |  Other Matters  |  The ongoing novel coronavirus (“COVID-19”) pandemic has disrupted markets globally and caused significant uncertainty in the global economy. The pandemic has resulted in, among other things, travel restrictions, closed international borders, prolonged quarantines, cancellations, and supply chain disruptions, as well as general concern and uncertainty. Although an economic expansion is underway, it continues to be uneven and characterized by meaningful dispersion across sectors and industries. The duration, extent, and ultimate impact of COVID-19 and the extent to which COVID-19 impacts the Funds are impossible to predict and will continue to evolve. The effects may impact the value and performance of the Funds, their ability to buy and sell investments at appropriate valuations, their ability to achieve their investment objectives, and their cash flows.

On February 24, 2022, Russia commenced a military attack on Ukraine. The outbreak of hostilities between the two countries could result in more widespread conflict and could have a severe adverse effect on the region and the markets. In addition, sanctions imposed on Russia by the United States and other countries, and any sanctions imposed in the future could have a significant adverse impact on the Russian economy and related markets. The price and liquidity of investments may fluctuate widely as a result of the conflict and related events. How long such conflict and related events will last and whether it will escalate further cannot be predicted, nor its effect on the Funds.

NOTE 11  |  Subsequent events  |  

Chartwell Reorganizations: On June 1, 2022 Raymond James Financial, Inc. (“RJF”) completed its acquisition of TriState Capital Holdings, Inc. including its asset management subsidiary, Chartwell Investment Partners (“Chartwell”). On July 1, 2022, six series of Chartwell Funds (each a “Chartwell Fund”) will be reorganized into corresponding newly-created series of the Carillon Series Trust (“Carillon Chartwell Funds”) that are advised by Carillon Tower and subadvised by Chartwell Investment Partners. (“Chartwell”). The Chartwell Funds previously were advised by Chartwell, an investment adviser that became a wholly-owned subsidiary of Carillon Tower on June 1, 2022. The Carillon Chartwell Funds will commence operations on July 1, 2022. They currently include the Carillon Chartwell Mid Cap Value Fund, the Carillon Chartwell Small Cap Growth Fund, the Carillon Chartwell Small Cap Value Fund, the Carillon Chartwell Income Fund, the Carillon Chartwell Short Duration Bond Fund, and the Carillon Chartwell Short Duration High Yield Bond Fund.

Portfolio Manager Updates: Effective June 23, 2022, David Cavanaugh, currently a Senior Research Analyst for the Carillon Eagle Mid Cap Growth Fund (“Mid Cap Growth Fund”) and Carillon Eagle Small Cap Growth Fund (“Small Cap Growth Fund”), will become a Portfolio Manager for each fund. In addition, effective as of the close of business on February 28, 2023, Bert L. Boksen, CFA® will transition to a new phase of his career at Eagle Asset Management, Inc. and no longer serve as a Portfolio Manager of the Mid Cap Growth Fund or Small Cap Growth Fund.

Fund Reorganization: On November 19, 2021, the Board of Trustees (“Board”) of Carillon Series Trust approved a Plan of Reorganization and Termination pursuant to which the Carillon ClariVest International Fund, formerly the Carillon Scout International Fund, would be reorganized into the Carillon ClariVest International Stock Fund, effective on or about July 16, 2022.

The Manager has evaluated subsequent events through June 22, 2022, the date these financial statements were issued, and determined that no other material events or transactions would require recognition or disclosure in the Funds’ financial statements.

 

58             


Understanding Your Ongoing Costs

(UNAUDITED)    |    04.30.2022

 

As a shareholder of a fund, you incur two types of costs: (1) transaction costs, including sales charges on purchases, contingent deferred sales charges, or redemption fees; and (2) ongoing costs, including investment advisory fees, distribution (12b-1) fees, and other fund expenses. The following sections are intended to help you understand your ongoing costs (in dollars) of investing in each fund and to compare these costs with the ongoing costs of investing in other mutual funds. Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect one-time transaction expenses, such as sales charges or redemption fees. Therefore, if these transactional costs were included, your costs would have been higher. For more information, see your fund’s prospectus or contact your financial adviser.

Actual expenses  |   The table below shows the actual expenses you would have paid on a $1,000 investment made in each fund on November 1, 2021 and held through April 30, 2022. It also shows how much a $1,000 investment would be worth at the close of the period, assuming actual returns after

ongoing expenses. This table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the line under the heading entitled “Expenses paid during period” to estimate the expenses you paid on your account during this period.

Hypothetical example for comparison purposes  |   The table below shows each fund’s expenses based on a $1,000 investment held from November 1, 2021 through April 30, 2022 and assuming for this period a hypothetical 5% annualized rate of return before ongoing expenses, which is not the fund’s actual return. Please note that you should not use this information to estimate your actual ending account balance and expenses paid during the period. You can use this information to compare the ongoing expenses (but not transaction expenses or total costs) of investing in the Funds with those of other funds. All mutual fund shareholder reports will provide this information to help you make this comparison.

 
            Actual expenses      Hypothetical expenses         
      Beginning
Account Value
     Ending
Account Value
     Expenses paid
during period (a)
     Ending
Account Value
     Expenses paid
during period (a)
     Annualized
expense ratio
 
Capital Appreciation Fund                  

Class A

     $1,000.00        $844.80        $4.57        $1,019.84        $5.01        1.00

Class C

     1,000.00        841.60        7.99        1,016.12        8.75        1.75  

Class I

     1,000.00        845.90        3.20        1,021.32        3.51        0.70  

Class R-3

     1,000.00        843.60        5.71        1,018.60        6.26        1.25  

Class R-5

     1,000.00        846.00        3.20        1,021.32        3.51        0.70  

Class R-6

     1,000.00        846.30        2.75        1,021.82        3.01        0.60  

Class Y

     1,000.00        844.70        4.57        1,019.84        5.01        1.00  
International Stock Fund                  

Class A

     1,000.00        912.60        6.54        1,017.95        6.90        1.38  

Class C

     1,000.00        909.20        10.13        1,014.18        10.69        2.14  

Class I

     1,000.00        914.30        5.08        1,019.49        5.36        1.07  

Class R-3

     1,000.00        911.50        7.73        1,016.71        8.15        1.63  

Class R-5

     1,000.00        914.50        5.17        1,019.39        5.46        1.09  

Class R-6

     1,000.00        914.60        4.18        1,020.43        4.41        0.88  

Class Y

     1,000.00        912.90        6.55        1,017.95        6.90        1.38  
Growth & Income Fund                  

Class A

     1,000.00        956.20        4.61        1,020.08        4.76        0.95  

Class C

     1,000.00        952.30        8.13        1,016.46        8.40        1.68  

Class I

     1,000.00        957.40        3.30        1,021.42        3.41        0.68  

Class R-3

     1,000.00        954.70        6.01        1,018.65        6.21        1.24  

Class R-5

     1,000.00        957.30        3.40        1,021.32        3.51        0.70  

Class R-6

     1,000.00        957.80        2.91        1,021.82        3.01        0.60  

Class Y

     1,000.00        955.80        4.80        1,019.89        4.96        0.99  
Mid Cap Growth Fund                  

Class A

     1,000.00        775.40        4.53        1,019.69        5.16        1.03  

Class C

     1,000.00        772.70        7.52        1,016.31        8.55        1.71  

Class I

     1,000.00        776.50        3.17        1,021.22        3.61        0.72  

Class R-3

     1,000.00        774.40        5.68        1,018.40        6.46        1.29  

Class R-5

     1,000.00        776.50        3.26        1,021.12        3.71        0.74  

Class R-6

     1,000.00        776.90        2.82        1,021.62        3.21        0.64  

Class Y

     1,000.00        775.40        4.53        1,019.69        5.16        1.03  
Small Cap Growth Fund                  

Class A

     1,000.00        732.00        4.68        1,019.39        5.46        1.09  

Class C

     1,000.00        729.50        7.63        1,015.97        8.90        1.78  

Class I

     1,000.00        733.20        3.39        1,020.88        3.96        0.79  

Class R-3

     1,000.00        731.00        5.79        1,018.10        6.76        1.35  

Class R-5

     1,000.00        733.20        3.39        1,020.88        3.96        0.79  

Class R-6

     1,000.00        733.50        2.97        1,021.37        3.46        0.69  

Class Y

     1,000.00        732.50        4.21        1,019.93        4.91        0.98  

 

               59  


Understanding Your Ongoing Costs

(UNAUDITED)    |    04.30.2022

 

 

60             
            Actual expenses      Hypothetical expenses         
      Beginning
Account Value
     Ending
Account Value
     Expenses paid
during period (a)
     Ending
Account Value
     Expenses paid
during period (a)
     Annualized
expense ratio
 
International Fund                  

Class A

     $1,000.00        $897.70        $5.88        $1,018.60        $6.26        1.25

Class C

     1,000.00        894.60        9.40        1,014.88        9.99        2.00  

Class I

     1,000.00        899.30        4.47        1,020.08        4.76        0.95  

Class R-3

     1,000.00        896.50        7.05        1,017.36        7.50        1.50  

Class R-5

     1,000.00        899.90        4.48        1,020.08        4.76        0.95  

Class R-6

     1,000.00        899.80        4.00        1,020.58        4.26        0.85  

Class Y

     1,000.00        898.20        5.88        1,018.60        6.26        1.25  
Mid Cap Fund                  

Class A

     1,000.00        900.60        5.70        1,018.79        6.06        1.21  

Class C

     1,000.00        897.10        9.22        1,015.08        9.79        1.96  

Class I

     1,000.00        901.20        4.48        1,020.08        4.76        0.95  

Class R-3

     1,000.00        899.20        7.06        1,017.36        7.50        1.50  

Class R-5

     1,000.00        901.40        4.48        1,020.08        4.76        0.95  

Class R-6

     1,000.00        901.70        4.01        1,020.58        4.26        0.85  

Class Y

     1,000.00        900.50        5.61        1,018.89        5.96        1.19  
Small Cap Fund                  

Class A

     1,000.00        794.50        5.21        1,018.99        5.86        1.17  

Class C

     1,000.00        791.70        8.53        1,015.27        9.59        1.92  

Class I

     1,000.00        795.70        4.14        1,020.18        4.66        0.93  

Class R-3

     1,000.00        793.20        6.67        1,017.36        7.50        1.50  

Class R-5

     1,000.00        795.40        4.23        1,020.08        4.76        0.95  

Class R-6

     1,000.00        795.80        3.70        1,020.68        4.16        0.83  

Class Y

     1,000.00        794.80        5.07        1,019.14        5.71        1.14  
Core Bond Fund                  

Class A

     1,000.00        907.20        3.78        1,020.83        4.01        0.80  

Class C

     1,000.00        904.40        7.32        1,017.11        7.75        1.55  

Class I

     1,000.00        909.90        1.89        1,022.81        2.01        0.40  

Class R-3

     1,000.00        906.10        4.96        1,019.59        5.26        1.05  

Class R-5

     1,000.00        908.70        2.37        1,022.32        2.51        0.50  

Class R-6

     1,000.00        909.90        1.89        1,022.81        2.01        0.40  

Class Y

     1,000.00        907.90        3.78        1,020.83        4.01        0.80  
Core Plus Bond Fund                  

Class A

     1,000.00        910.50        3.79        1,020.83        4.01        0.80  

Class C

     1,000.00        907.10        7.33        1,017.11        7.75        1.55  

Class I

     1,000.00        912.00        1.90        1,022.81        2.01        0.40  

Class R-3

     1,000.00        909.30        4.97        1,019.59        5.26        1.05  

Class R-5

     1,000.00        911.50        2.37        1,022.32        2.51        0.50  

Class R-6

     1,000.00        912.30        1.90        1,022.81        2.01        0.40  

Class Y

     1,000.00        910.30        3.79        1,020.83        4.01        0.80  
Unconstrained Bond Fund                  

Class A

     1,000.00        945.40        3.86        1,020.83        4.01        0.80  

Class C

     1,000.00        941.70        7.46        1,017.11        7.75        1.55  

Class I

     1,000.00        947.10        2.41        1,022.32        2.51        0.50  

Class R-3

     1,000.00        945.10        5.06        1,019.59        5.26        1.05  

Class R-5

     1,000.00        947.10        2.41        1,022.32        2.51        0.50  

Class R-6

     1,000.00        948.20        1.93        1,022.81        2.01        0.40  

Class Y

     1,000.00        945.40        3.86        1,020.83        4.01        0.80  

(a) Expenses are calculated using each fund’s annualized expense ratios for each class of shares, multiplied by the average account value for the period, then multiplying the result by the actual number of days in the period (181), and then dividing that result by the actual number of days in the fiscal year (365).


Amendments to Investment Advisory and Subadvisory Agreements

(UNAUDITED)

 

Approvals Related to Carillon ClariVest International Stock Fund  |  At the November 18-19, 2021 meetings, the Board of Trustees (“Board”) of Carillon Series Trust (“Trust”) considered proposed amendments to (1) the existing investment advisory agreement between Carillon Tower Advisers, Inc. (“Carillon”) and the Trust with respect to the Carillon ClariVest International Stock Fund (“Fund”), and (2) the investment subadvisory agreement between Carillon and ClariVest Asset Management, LLC (“ClariVest”) with respect to the Fund (collectively, the “Agreements”).

The Board considered that the only substantive change proposed for the Agreements was the addition of a breakpoint to the fee schedule that would reduce the fee rate payable by the Fund to Carillon and the fee payable by Carillon to Scout at higher asset levels. The Board also took into consideration that it had reviewed, among other things, the nature, extent and quality of services being provided to the Fund by Carillon and ClariVest at the Board’s August 19-20, 2021 meetings in connection with its annual renewal of the Agreements and that there were no relevant material changes to the information provided to the Board since those meetings. Additionally, the Board considered that it receives substantial amounts of information regarding the Fund, including the nature, extent and quality of services provided to the Fund by Carillon and ClariVest, at its meetings held throughout the year.

Based on the considerations described above, the Board, including a majority of Trustees who are not “interested persons” of the Fund, the Carillon or ClariVest, as that term is defined in the Investment Company Act of 1940, as amended, concluded that the proposed investment advisory and subadvisory fee rates are fair, reasonable and in the best interests of the Fund, and approved the Amendments.

Overview. At meetings held on November 18-19, 2021, the Board of Trustees (“Board” or “Trustees”) of Carillon Series Trust (the “Trust”), including its independent members (the “Independent Trustees”), approved an investment subadvisory agreement (the “Subadvisory Agreement”) between Carillon Tower Advisers, Inc. (“Carillon”) and ClariVest Asset Management, LLC (“ClariVest”) appointing ClariVest as the subadvisor to the Carillon Scout International Fund (the “Fund”), a series of the Trust.

Prior to the meetings, the Board, with the assistance of independent legal counsel, requested and received comprehensive responses to items of information requested by counsel to the Independent Trustees in letters to Carillon and ClariVest, to assist the Board in determining whether to approve the Subadvisory Agreement. The Board also considered information that had previously been provided by Carillon and ClariVest to the Board in connection with the Board’s consideration of the renewal of the subadvisory agreement between Carillon and ClariVest as it related to the Carillon ClariVest International Stock Fund (“International Stock Fund”), another series of the Trust. At the meeting, the Board met with representatives of Carillon and posed questions regarding certain key aspects of the materials submitted in support of the approval.

The Board accorded appropriate weight to the work, deliberations and conclusions of its various committees in determining whether to approve the Subadvisory Agreement. Legal counsel to the Independent Trustees provided the Board with a memorandum regarding its responsibilities pertaining to the approval of the Subadvisory Agreement. The memorandum explained the regulatory requirements surrounding the Trustees’ process for evaluating investment advisors and the terms of investment advisory contracts.

Additional Considerations and Conclusions with Respect to the Subadvisory Agreement

With respect to the approval of the Subadvisory Agreement, the Board took into consideration various factors, including: (1) the nature, extent and quality of services to be provided to the Fund; (2) the investment performance of the International Stock Fund and other accounts managed by ClariVest in the strategy of the International Stock Fund, net of fees (“Composite”); (3) the

estimated costs to be incurred by ClariVest and its affiliates and the resulting profits or losses; (4) the fees to be paid under the Subadvisory Agreement; (5) the extent to which economies of scale, if any, have been taken into account in setting the fee schedule; (6) comparisons of services and fees with contracts entered into by ClariVest with the International Stock Fund and other clients; and (7) any benefits derived by ClariVest from its relationship with the Fund.

Provided below is a discussion of the factors the Board considered at its November 2021 meetings to form the basis of its approval of the Subadvisory Agreement. The Board did not identify any particular information that was most relevant to its consideration of the Subadvisory Agreement, and each Trustee may have afforded different weight to the various factors.

Nature, Extent and Quality of Services. The Trustees considered that the Board previously had considered information regarding ClariVest’s principal business activities, overall capabilities to perform the services under the Subadvisory Agreement, infrastructure, the adequacy of its compliance program and ClariVest’s representation regarding the strength of its financial condition. The Board also considered the background and experience of the personnel who would be assigned responsibility for managing the Fund. The Board considered that ClariVest had represented that its staffing levels were sufficient to provide services to the Fund. In addition, the Board took into consideration Carillon’s recommendation of ClariVest. Based on this information, the Board concluded that the nature, extent and quality of the advisory services to be provided by Scout were appropriate for the Fund in light of its investment objective and, thus, supported a decision to approve the Subadvisory Agreement.

Investment Performance. The Board considered comparisons of the performance of the International Stock Fund and the Composite against the International Stock Fund’s benchmark index and a peer group of funds within its Morningstar, Inc. (“Morningstar”) category for the year-to-date, one-year, three-year and five-year periods ended September 30, 2021. The Board considered that the International Stock Fund and the Composite outperformed the Morningstar category for all relevant periods, and the benchmark for the year-to-date and one-year periods, but underperformed the benchmark for the three-year and five-year periods. As relevant, the Board also considered ClariVest’s explanation regarding underperformance relative to the benchmark index. Based on the foregoing information, the Board concluded that the historical investment performance record of ClariVest with respect to the International Stock Fund supported approval of the Subadvisory Agreement.

Fees and Expenses. The Board considered that the proposed subadvisory fee rate payable by Carillon to ClariVest would be equal to the subadvisory fee rate currently paid by Carillon to the Fund’s current subadvisor, and that the proposed subadvisory fee rate was higher than the average fee rate charged by ClariVest to accounts within the Composite. After evaluating this information, the Board concluded that proposed subadvisory fee rate under the Subadvisory Agreement was reasonable in light of the services to be provided to the Fund.

Costs, Profitability and Economies of Scale. The Trustees considered that the Board previously had considered Carillon’s estimated costs and profitability in providing services to the Fund, consolidated with the Fund’s current subadviser. The Board considered that both ClariVest and the Fund’s current subadvisor are wholly-owned subsidiaries of Carillon. The Board took into consideration that, as a result, the estimated costs and profitability of ClariVest generally are less significant to the Board’s evaluation of the fee rates and expenses paid by the Fund than Carillon’s advisory fee rate and estimated profitability of the Fund’s overall expense ratios. The Board considered that there will be no changes to the expense caps of the Fund. In addition, the Board considered that the subadvisory fee rate includes breakpoints as Fund assets grow, which reflects economies of scale for the benefit of the Fund’s investors. Based on this information, the Board concluded that the estimated costs to be incurred by Carillon, ClariVest and their affiliates and the resulting profits or losses, as well as the potential for the Fund to benefit from economies of scale, supported the approval of the Subadvisory Agreement.

 

 

               61  


Amendments to Investment Advisory and Subadvisory Agreements

(UNAUDITED)

 

Benefits. In evaluating compensation, the Board considered benefits that may be realized by ClariVest and its affiliates from their relationship with the Fund. In this connection, the Board considered ClariVest’s representation that ClariVest may benefit from research provided by brokers used to execute Fund transactions. Based on the foregoing information, the Board concluded that the potential benefits accruing to ClariVest by virtue of its relationship with the Fund appear to be fair and reasonable.

Conclusions. Based on the various considerations described above, the Board, including a majority of the Independent Trustees, concluded with respect to the Fund that: (1) the fees proposed to be paid to ClariVest under the Subadvisory Agreement are fair and reasonable; (2) the Fund and its shareholders would benefit from ClariVest’s management of the Fund; and (3) approved the Subadvisory Agreement.

Approvals related to six new series of the Trust relating to Chartwell fund reorganizations

Overview. At meetings held on November 18-19, 2021, the Board of Trustees (“Board” or “Trustees”) of Carillon Series Trust (the “Trust”), including its independent members (the “Independent Trustees”), approved an investment advisory agreement between Carillon Tower Advisers, Inc. (“Carillon”) and the Trust, on behalf of six new series of the Trust (“Advisory Agreement”): the Carillon Chartwell Income Fund, the Carillon Chartwell Mid Cap Value Fund, the Carillon Chartwell Short Duration Bond Fund, the Carillon Chartwell Short Duration High Yield Fund, the Carillon Chartwell Small Cap Growth Fund, and the Carillon Chartwell Small Cap Value Fund (each, a “Fund” and collectively, the “Funds”).

The Board also approved an investment subadvisory agreement between Carillon and Chartwell Investment Partners, LLC (“Chartwell”) pursuant to which Chartwell will serve as the subadviser to each Fund (“Subadvisory Agreement”). The Advisory Agreement and Subadvisory Agreement are collectively referred to herein as the “Agreements.”

Prior to the meetings, the Board, with the assistance of independent legal counsel, requested and received comprehensive responses to items of information requested by counsel to the Independent Trustees in letters to Carillon and Chartwell, to assist the Board in determining whether to approve the Agreements and the proposed reorganization of each of the mutual funds currently advised by Chartwell (each, a “Chartwell Fund”) into the corresponding Fund (the “Reorganizations”). The Board also considered information that had been provided to the Board by Carillon in connection with the Board’s considerations of the renewal of the investment advisory agreement between Carillon and other series of the Trust (collectively, the “Existing Funds”). At the meetings, the Board met with representatives of Carillon and Chartwell and posed questions regarding certain key aspects of the materials submitted in support of the approval.

The Board accorded appropriate weight to the work, deliberations and conclusions of its various committees in determining whether to approve the Agreements. Legal counsel to the Independent Trustees provided the Board with a memorandum regarding its responsibilities pertaining to the approval of the Agreements. The memorandum explained the regulatory requirements surrounding the Trustees’ process for evaluating investment advisors and the terms of investment advisory contracts.

With respect to the approval of the Agreements, the Board took into consideration various factors, including: (1) the nature, extent and quality of services to be provided to the Funds; (2) the investment performance of the Chartwell Funds; (3) the estimated costs to be incurred by Carillon, Chartwell and their affiliates and the resulting profits or losses; (4) the extent to which economies of scale, if any, have been taken into account in setting the fee schedule; (5) comparisons of services and fees with contracts entered into by Carillon and Chartwell with the Existing Funds and other clients (such as pension funds and other institutional investors); and (6) any benefits derived by Carillon or Chartwell from their relationships with the Funds.

Provided below is a discussion of the factors the Board considered at its November 2021 meetings to form the basis of its approval of the Agreements. The Board did not identify any particular information that was most relevant to its consideration of the Agreements, and each Trustee may have afforded different weight to the various factors.

Nature, Extent and Quality of Services. The Board considered information regarding the services to be provided by Carillon and the background and experience of the Carillon personnel who would be responsible for overseeing the Funds. The Board considered that Carillon would monitor the subadvisory services provided by Chartwell and services provided by the Funds’ other service providers, and that Carillon’s oversight of the Funds’ service providers would be the same as the oversight services it provides to the Existing Funds. The Board also took into consideration that Carillon would be responsible for oversight of compliance with the Funds’ investment objectives and policies, review of brokerage matters, oversight of the Funds’ compliance with applicable law and implementation of Board directives as they relate to the Funds. Additionally, the Board considered that Carillon and its affiliate, Carillon Fund Distributors, Inc. (“CFD”), would provide certain administration and distribution services to the Funds.

The Board considered that Raymond James Financial, Inc., Carillon’s parent company, had reached an agreement with TriState Capital Holdings, Inc. (“TriState”), Chartwell’s parent company, to purchase TriState (the “Transaction”), and that, following the completion of the Transaction, Chartwell would become a wholly-owned subsidiary of Carillon. The Board considered information regarding Chartwell’s principal business activities, its financial condition and overall capabilities to perform the services under the Subadvisory Agreement. The Board considered that Chartwell would be responsible for making investment decisions on behalf of the Funds, and for placing all orders for the purchase and sale of the Funds’ securities and other investments. In addition, the Board considered: (1) information regarding the Carillon Tower and Chartwell personnel who will be responsible for providing services to the Funds; (2) certifications as to the adequacy of the compliance program of Chartwell; (3) the financial information provided regarding Chartwell; and (4) Carillon’s recommendation of Chartwell. Based on this information, the Board concluded that the nature, extent and quality of the advisory services to be provided by Carillon and Scout were appropriate for each Fund in light of its investment objective and, thus, supported a decision to approve the Agreements.

Investment Performance. The Board considered that the Funds are new and, therefore, had no historical performance for the Board to review. However, as each Fund would be adopting the historical performance of a corresponding Chartwell Fund, in connection with their consideration of the Subadvisory Agreement, the Board considered comparisons of the performance of each Chartwell Fund relative to the performance of its benchmark indices and a refined population (“Morningstar Population”) of funds within a Fund’s Morningstar, Inc. (“Morningstar”) category for one-year, three-year, five-year and ten-year periods, as applicable, ended September 30, 2021. For each Fund, as relevant, the Board also considered Chartwell’s explanation regarding a Chartwell Fund’s relative underperformance.

With respect to the strategy pursuant to which Chartwell would manage the Carillon Chartwell Income Fund, the Board considered a number of factors regarding performance, including: (1) that the Chartwell Fund outperformed a blended index (the “Blended Index”), comprised 25% of the Russell 3000 Value Index, 55% of the Bloomberg Barclays US Aggregate Bond Index, and 20% of the ICE BofA High Yield Cash Pay Blend Index for the one-year period, but underperformed the Blended Index for the three-year, five-year and ten-year periods ended September 30, 2021; (2) the Chartwell Fund’s performance as compared to each of the component indexes of the Blended Index; and (3) that the Chartwell Fund outperformed the average of its Morningstar Population for the one-year and ten-year periods, but underperformed for the three- and five-year periods.

 

 

62             


Amendments to Investment Advisory and Subadvisory Agreements

(UNAUDITED)

 

With respect to the strategy pursuant to which Chartwell would manage the Carillon Chartwell Mid Cap Value Fund, the Board considered a number of factors regarding performance, including: (1) that the Chartwell Fund underperformed its benchmark index for all relevant periods; and (2) that the Chartwell Fund outperformed the average of its Morningstar Population for the ten-year period, but underperformed for the one-year, three-year and five-year periods.

With respect to the strategy pursuant to which Chartwell would manage the Carillon Chartwell Short Duration Bond Fund, the Board considered that, as the Chartwell Fund commenced operations on September 22, 2021, no historical performance information was available.

With respect to the strategy pursuant to which Chartwell would manage the Carillon Chartwell Short Duration High Yield Fund, the Board considered a number of factors regarding performance, including that the Chartwell Fund underperformed its benchmark index and the average of its Morningstar Population for all relevant periods.

With respect to the strategy pursuant to which Chartwell would manage the Carillon Chartwell Small Cap Growth Fund, the Board considered a number of factors regarding performance, including: (1) that the Chartwell Fund outperformed its benchmark for all relevant periods; and (2) that the Chartwell Fund underperformed the average of its Morningstar Population for the one-year period, but outperformed for the three-year period.

With respect to the strategy pursuant to which Chartwell would manage the Carillon Chartwell Small Cap Value Fund, the Board considered a number of factors regarding performance, including that the Chartwell Fund underperformed its benchmark index and the average of its Morningstar Population for all relevant periods.

Based on the foregoing information, the Board concluded that the historical investment performance record of Chartwell with respect to each Chartwell Fund supported approval of the Agreements.

Fees and Expenses.    The Board considered the proposed advisory fee rate payable by each Fund to Carillon under the Agreement, the proposed subadvisory fee rates payable to Chartwell, each Fund’s projected total expense ratio. The Board also considered that, while the proposed advisory and subadvisory fee rates payable to Carillon and Chartwell, respectively, would be lower than the rates currently paid by the Chartwell Funds, each Fund would pay Carillon a separate fee for administrative services. The Board considered that, as a result, the proposed total advisory and administrative fee rate for each Fund is the same as the total advisory and administrative fee rate currently charged to the applicable Chartwell Fund. The Board considered that the subadvisory fee rate that Carillon proposed to pay to Chartwell is identical to the proposed advisory fee rate paid to Carillon by a Fund.

In considering the proposed subadvisory fee rate to be paid by Carillon, the Board considered, to the extent applicable, the fee rate charged by Chartwell to other accounts managed by Chartwell in the strategy of each Fund (each, a “Composite”), noting Chartwell’s representation that it requires greater resources to provide services to the Chartwell Funds than to serve other accounts in each Composite. The Board also took into consideration comparisons of each Chartwell Fund’s advisory fee rate and expense ratio to the average expense ratio of its Morningstar Population and a refined group of peer funds (“Morningstar Peer Group”) within its Morningstar category based on data ended September 30, 2021. In addition, the Board considered that Carillon has agreed to contractually limit the expenses of each Fund for at least two years from the date of the Reorganizations at levels that are equal to the current expense caps, if any, for the applicable Chartwell Fund. The Board considered that, to the extent that Carillon would waive its advisory fee or reimbursed expenses, it proposed to reduce the amount it pays to Chartwell proportionately. In addition, the Board considered that, if Carillon subsequently recoups previously waived advisory fees from a Fund, Carillon would make a payment to Chartwell in an amount equal to the recoupment.

With respect to the Carillon Chartwell Income Fund, the Board considered that the corresponding Chartwell Fund’s combined advisory and administrative fee rate and net expense ratio were lower than the average of its Morningstar Population and Morningstar Peer Group.

With respect to the Carillon Chartwell Mid Cap Value Fund, the Board considered that the corresponding Chartwell Fund’s combined advisory and administrative fee rate was higher than the average of its Morningstar Population and Morningstar Peer Group. The Board also considered that the Chartwell Fund’s net expense ratio was higher than the average of its Morningstar Population and lower than the average of its Morningstar Peer Group.

With respect to the Carillon Chartwell Short Duration Bond Fund, the Board considered that the corresponding Chartwell Fund’s combined advisory and administrative fee rate and net expense ratio were lower than the average of its Morningstar Population and Morningstar Peer Group.

With respect to the Carillon Chartwell Short Duration High Yield Fund, the Board considered that the corresponding Chartwell Fund’s combined advisory and administrative fee rate and net expense ratio were lower than the average of its Morningstar Population and Morningstar Peer Group.

With respect to the Carillon Chartwell Small Cap Growth Fund, the Board considered that the corresponding Chartwell Fund’s combined advisory and administrative fee rate and net expense ratio were lower than the average of its Morningstar Population and Morningstar Peer Group.

With respect to the Carillon Chartwell Small Cap Value Fund, the Board considered that the corresponding Chartwell Fund’s combined advisory and administrative fee rate was lower than the average of its Morningstar Population and higher than the average of its Morningstar Peer Group. The Board also considered that the Chartwell Fund’s net expense ratio was higher than the average of its Morningstar Peer Group and equal to the average of its Morningstar Population.

After evaluating this information, the Board concluded that proposed advisory and subadvisory fee rates under the Agreements were reasonable in light of the services to be provided to the Funds.

Costs, Profitability and Economies of Scale. In analyzing the cost of services and profitability of Carillon and Chartwell, the Board considered the estimated revenues to be earned and the expenses to be incurred by Carillon and Chartwell. The Board also took into consideration that Carillon will pay to Chartwell a subadvisory fee equal to the entirety of the advisory fee to be paid by the Funds, but that Carillon will receive fees for providing administrative services to the Funds. The Board considered Carillon’s representation that it did not expect to earn a profit on the Funds, based on the Chartwell Funds’ expenses for the fiscal year ended December 31, 2020. The Board also considered that, during the fiscal year ended December 31, 2020, Chartwell earned a profit with respect to each of the Chartwell Funds.

In addition, the Board considered that the advisory fee rate structures for certain of the Funds provide for breakpoints, which is a reduction of the applicable fee rate as assets increase. The Board also considered that each Fund may benefit from economies of scale, and shareholders may realize such economies of scale, through: (1) reduced advisory fees achieved when a Fund’s asset size reaches breakpoints in the fee schedules instituted by Carillon; (2) increased services to a Fund; or (3) allocation of fixed fund expenses over a large asset size. Based on this information, the Board concluded that the estimated costs to be incurred by Carillon, Chartwell and their affiliates and the resulting profits or losses, as well as the potential for each Fund to benefit from economies of scale, supported the approval of the Agreements.

Benefits. In evaluating compensation, the Board considered other benefits that may be realized by Carillion, Chartwell and their affiliates from their relationship

 

 

               63  


Amendments to Investment Advisory and Subadvisory Agreements

(UNAUDITED)

 

with the Funds. The Board took into consideration that Carillon Tower and its affiliates have entered into revenue sharing and services agreements with third parties for marketing and/or shareholder services. The Board also considered that the Funds would compensate Carillon for providing administrative services. The Board considered that, as the Funds’ principal underwriter and distributor, CFD would provide services and distribution activities, although the Board was not being asked to authorize Rule 12b-1 payments from the Funds to compensate CFD for these activities. These activities could lead to growth in the Funds’ assets and the corresponding benefits of that growth, including economies of scale and greater diversification. In addition, other affiliates of Carillon have entered into agreements with CFD to sell Fund shares and receive compensation from CFD. The Board also considered that Chartwell also is expected to be an affiliate of Carillon following the Transaction. The Board considered Carillon’s representation that Carillon’s relationship with the Funds may provide Carillon with increased market exposure, the ability to spread certain fixed costs across a greater number of clients, assets and revenues, and opportunities to cross sell other Carillon products to new clients. The Board also considered Carillon’s representation that there may be certain floats on monies that are retained by Carillon for a period of time before payment to Chartwell. Additionally, the Board considered Chartwell’s representation that it directs brokerage transactions for its portfolios to brokers who provide research and execution services to Chartwell and indirectly to Chartwell’s clients. Based on the foregoing information, the Board concluded that the potential benefits accruing to Carillon and Chartwell by virtue of their relationship with the Funds appear to be fair and reasonable.

Conclusions. Based on the various considerations described above, the Board, including a majority of the Independent Trustees, concluded with respect to the Funds that: (1) the fees proposed to be paid to Carillon and Chartwell under the Agreements are fair and reasonable; (2) the Funds and their shareholders would benefit from Carillon’s and Chartwell’s management of the applicable Funds; and (3) approved the Agreements.

 

64             


Principal Risks

(UNAUDITED)

 

Additional Information About Principal Risk Factors

The greatest risk of investing in a mutual fund is that its returns will fluctuate and you could lose money. Turbulence in financial markets and reduced liquidity in equity, credit and fixed income markets may negatively affect many issuers worldwide, which could have an adverse effect on the funds. Additionally, while the portfolio managers seek to take advantage of investment opportunities that will maximize a fund’s investment returns, there is no guarantee that such opportunities will ultimately benefit the fund. There is no assurance that the portfolio managers’ investment strategy will enable a fund to achieve its investment objective. An investment in a fund is not a deposit with a bank and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. The following table identifies the risk factors of each fund in light of its principal investment strategies. These risk factors are explained following the table.

The principal risks of investing in each fund listed below are presented in alphabetical order and not in order of importance or potential exposure. Among other matters, this presentation is intended to facilitate your ability to find particular risks and compare them with the risks of other funds. Each risk summarized below is considered a “principal risk” of investing in a fund, regardless of the order in which it appears.

 

Risk   Carillon
ClariVest
Capital
Appreciation
Fund
    Carillon
ClariVest
International
Stock
Fund
    Carillon
Eagle
Growth &
Income
Fund
    Carillon
Eagle
Mid Cap
Growth
Fund
    Carillon
Eagle
Small Cap
Growth
Fund
    Carillon
ClariVest
International
Fund
 
Currencies       X             X  
Emerging markets       X             X  
Equity securities     X       X       X       X       X       X  
Focused holdings         X        
Foreign securities       X       X           X  
Growth stocks     X       X       X       X       X       X  
Initial public offerings             X    
Japan       X             X  
Large-cap companies     X       X       X           X  
Liquidity       X             X  
Market     X       X       X       X       X       X  
Market timing       X             X  
Mid-cap companies     X       X       X       X       X       X  
Other investment companies, including money market funds and ETFs       X             X  
Quantitative strategy     X       X             X  
Sectors     X           X       X    
Securities lending     X       X       X       X       X       X  
Small-cap companies     X       X         X       X       X  
Value stocks         X        

 

               65  


Principal Risks

(UNAUDITED)

 

Risk   Carillon
Scout
Mid Cap
Fund
    Carillon
Scout
Small Cap
Fund
    Carillon
Reams
Core Bond
Fund
    Carillon
Reams
Core Plus
Bond
Fund
    Carillon
Reams
Unconstrained
Bond
Fund
 
Callable securities         X       X       X  
Counterparties         X       X       X  
Credit         X       X       X  
Credit ratings         X       X       X  
Currencies     X           X       X  
Derivatives         X       X       X  
Emerging markets     X       X           X  
Equity securities     X       X        
Focused holdings       X        
Foreign securities     X       X       X       X       X  
Growth stocks     X       X        
Hedging         X       X       X  
High-yield securities           X       X  
Income         X       X       X  
Interest rate         X       X       X  
Issuer         X       X       X  
Leverage         X       X       X  
LIBOR         X       X       X  
Liquidity         X       X       X  
Market     X       X       X       X       X  
Market timing     X       X           X  
Maturity         X       X       X  
Mid-cap companies     X       X        
Mortgage- and asset-backed securities         X       X       X  
Other investment companies, including money market funds and ETFs     X       X        
Portfolio turnover     X         X       X       X  
Prepayment and extension         X       X       X  
Redemptions         X       X       X  
Sectors       X        
Securities lending     X       X       X       X       X  
Short sales             X  
Small-cap companies     X       X        
U.S. government securities and government sponsored enterprises     X       X       X       X       X  
U.S. Treasury obligations     X       X       X       X       X  
Valuation         X       X       X  
Value stocks     X       X        

 

Callable securities  |  A fund may invest in fixed-income securities with call features. A call feature allows the issuer of the security to redeem or call the security prior to its stated maturity date. In periods of falling interest rates, issuers may be more likely to call in securities that are paying higher coupon rates than prevailing interest rates. In the event of a call, a fund would lose the income that would have been earned to maturity on that security, the proceeds received by a fund may be invested in securities paying lower coupon rates or

other less favorable characteristics, and a fund may not benefit from any increase in value that might otherwise result from declining interest rates. Thus, a fund‘s income could be reduced as a result of a call and this may reduce the amount of a fund’s distributions. In addition, the market value of a callable security may decrease if it is perceived by the market as likely to be called, which could have a negative impact on a fund‘s total return.

 

 

66             


Principal Risks

(UNAUDITED)

 

Counterparties  |  A fund is subject to the risk that a party or participant to a transaction, such as a broker or derivative counterparty, will be unwilling or unable to satisfy its obligation to make timely principal, interest or settlement payments or to otherwise honor its obligations to a fund. As a result, a fund may not recover its investment or may only obtain a limited recovery, and any recovery may be delayed. Not all derivative transactions require a counterparty to post collateral, which may expose a fund to greater losses in the event of a default by a counterparty. The participants in over-the-counter or “interdealer” markets are typically not subject to credit evaluation and regulatory oversight to the same extent as are members of “exchange-based” markets. This exposes a fund to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions because of a credit or liquidity problem with the counterparty. Recent turbulence in the financial markets could exacerbate counterparty risk resulting from over-the-counter derivative transactions. A fund may also be subject to the risk that a futures commission merchant would default on an obligation set forth in an agreement between a fund and the futures commission merchant. This risk exists at and from the time that a fund enters into derivatives transactions that are centrally cleared. In such cases, a clearing organization becomes a fund‘s counterparty and the principal counterparty risk is that the clearing organization itself will default. In addition, the futures commission merchant may hold margin posted in connection with those contracts and that margin may be re-hypothecated (or repledged) by the futures commission merchant, and lost, or its return delayed, due to a default by the futures commission merchant or other customer of the futures commission merchant. The futures commission merchant may itself file for bankruptcy, which would either delay the return of, or jeopardize altogether, the assets posted by the futures commission merchant as margin in response to margin calls relating to cleared positions. If a counterparty fails to meet its contractual obligations, goes bankrupt, or otherwise experiences a business interruption, a fund could miss investment opportunities or otherwise hold investments it would prefer to sell, resulting in losses for a fund.

Credit  |  A fund could lose money if the issuer or a counterparty, in the case of a derivatives contract, is unable or unwilling, or is perceived as unable or unwilling (whether by market participants, ratings agencies, pricing services or otherwise) to meet its financial obligations or goes bankrupt. Securities are subject to varying degrees of credit risk, which are often reflected in their credit ratings. Generally, the longer the maturity and the lower the credit quality of a security, the more sensitive it is to credit risk. The downgrade of the credit rating of a security held by a fund may decrease its value and may make it more difficult for the fund to sell it. Credit risk may change over the life of an instrument. Credit risk usually applies to most fixed income securities. U.S. government securities, especially those that are not backed by the full faith and credit of the U.S. Treasury, such as securities supported only by the credit of the issuing governmental agency or government-sponsored enterprise, carry at least some risk of nonpayment, and the maximum potential liability of the issuers of such securities may greatly exceed their current resources. There is no assurance that the U.S. government would provide financial support to the issuing entity if not obligated to do so by law. Further, any government guarantees on U.S. government securities that a fund owns extend only to the timely payment of interest and the repayment of principal on the securities themselves and do not extend to the market value of the securities themselves or to shares of the fund.

Credit ratings  |  Ratings by nationally recognized rating agencies generally represent the agencies’ opinion of the credit quality of an issuer. However, these ratings are not absolute standards of quality and do not guarantee the creditworthiness of an issuer, and may prove to be inaccurate. Ratings do not necessarily address market risk and may not be revised quickly enough to reflect changes in an issuer’s financial condition.

Currencies  |  A fund may have exposure to foreign currencies through its investments. Foreign currencies may fluctuate significantly over short periods of time for a number of reasons, including changes in interest rates, may be affected unpredictably by intervention, or the failure to intervene, of the U.S. or

foreign governments, central banks, or supranational entities such as the International Monetary Fund, and may be affected by the imposition of currency controls or political developments in the U.S. or abroad. As a result, a fund’s exposure to foreign currencies may reduce the returns of a fund. Foreign currencies may decline in value relative to the U.S. dollar and other currencies and thereby affect a fund’s investments. In addition, changes in currency exchange rates could adversely impact investment gains or add to investment losses. Currency futures and forwards, if used, may not always work as intended, and in specific cases, a fund may be worse off than if it had not used such instrument(s). In the case of hedging positions, the U.S. dollar or other currency may decline in value relative to the foreign currency that is being hedged and thereby affect a fund’s investments. There may not always be suitable hedging instruments available. Even where suitable hedging instruments are available, a fund may choose to not hedge its currency risks.

Derivatives  |  Derivatives, such as options, futures contracts, currency and other forwards, including NDFs, or swap agreements, (including credit default swaps and credit default swap index products), may involve greater risks than if a fund had invested in the reference obligation directly. Derivatives are subject to general market risks, liquidity risks, interest rate risk, and credit risks. Derivatives also present the risk that the other party to the transaction will fail to perform. Counterparty risk is generally thought to be greater with derivatives that are traded over-the-counter than with derivatives that are exchange-traded or centrally cleared. However, derivatives that are traded on organized exchanges and/or through clearing organizations involve the possibility that the futures commission merchant or clearing organization will default in the performance of its obligations. Derivatives involve an increased risk of mispricing or improper valuation of the derivative instrument, and imperfect correlation between the value of the derivative and the underlying instrument, in which case a fund may not realize the intended benefits. When used for hedging, changes in the value of the derivative may also not correlate perfectly with the underlying asset, rate or index. Derivatives risk may be more significant when derivatives are used to enhance fund returns, increase liquidity, manage the duration of a fund’s portfolio and/or gain exposure to certain instruments or markets, rather than solely to hedge the risk of a position held by the fund.

Derivatives can cause a fund to participate in losses (as well as gains) in an amount that significantly exceeds the fund’s initial investment, and some derivatives have the potential for unlimited loss, regardless of the size of a fund’s initial investment, for example, where a fund may be called upon to deliver a security it does not own. Derivatives can create leverage, which can magnify the impact of a decline in the value of the reference instrument underlying the derivative, and a fund could lose more than the amount it invests. There may be material and prolonged deviations between the theoretical value and realizable value of a derivative. Also, suitable derivative transactions may not be available in all circumstances and there can be no assurance that a fund will engage in these transactions to reduce exposure to other risks when that would be beneficial. Derivatives may at times be highly illiquid, and a fund may not be able to close out or sell a derivative position at a particular time or at an anticipated price.

The regulation of cleared and uncleared swap agreements, as well as other derivatives, is a rapidly changing area of law and is subject to modification by government and judicial action. It is not possible to predict fully the effects of current or future regulation. Changes in government regulation of various types of derivatives instruments may make derivatives more costly or limit the availability of derivatives, which may: limit or prevent a fund from using certain types of derivative instruments as part of its investment strategy; affect the character, timing of recognition and amount of a fund’s taxable income or recognized gains or losses; or otherwise adversely affect the value or performance of derivatives. Compared to other types of investments, derivatives may also be less tax efficient. A fund’s use of derivatives may be limited by the requirements for taxation of the fund as a regulated investment company. The SEC has adopted a new Rule 18f-4 that, among other matters,

 

 

               67  


Principal Risks

(UNAUDITED)

 

places limits on the use of derivatives by registered investment companies, such as a fund. A fund may have to comply with certain conditions depending on the extent of its use of derivatives, including (as applicable), the adoption and implementation of policies and procedures designed to manage a fund’s derivatives risks, recordkeeping and reporting requirements, compliance with a limit on the amount of leverage-related risk that a fund may obtain, and maintaining a derivatives risk management program and designating a derivatives risk manager. Compliance with the rule will likely subject a fund’s derivatives transactions to additional oversight and regulatory requirements.

 

    Swap Agreements. Swaps can involve greater risks than a direct investment in an underlying asset, because swaps typically include a certain amount of embedded leverage and as such are subject to leveraging risk. If swaps are used as a hedging strategy, a fund is subject to the risk that the hedging strategy may not eliminate the risk that it is intended to offset, due to, among other reasons, the occurrence of unexpected price movements or the non-occurrence of expected price movements, as well as a lack of correlation between the swaps and the portfolio of assets that the swaps are designed to hedge or replace. Swaps also may be difficult to value. Swaps may be subject to liquidity risk, counterparty risk and credit risk. Swaps that are traded over-the-counter are not subject to standardized clearing requirements and may involve greater liquidity and counterparty risks. Credit default swaps may be subject to credit risk and the risks associated with the purchase and sale of credit protection. With respect to a credit default swap, if a fund is selling credit protection, there is a risk a fund is subject to many of the same risks it would be if it were holding debt obligations of the issuer; however, a fund would not have any recourse against such issuer and would not benefit from any collateral securing such issuer’s debt obligations. Therefore, when selling protection, a fund could be forced to liquidate other assets upon the occurrence of a credit event in order to pay the counterparty. There is also the risk that the transaction may be closed out at a time when the credit quality of the underlying investment has deteriorated, in which case a fund may need to make an early termination payment. If a fund is buying credit protection, there is the risk that no credit event will occur and a fund will receive no benefit (other than any hedging benefit) for the premium paid. There is also the risk that the transaction may be closed out at a time when the credit quality of the underlying investment has improved, in which case a fund may need to make an early termination payment.

 

    Futures and Forward Contracts. Futures and forward contracts, including NDFs, are subject to counterparty risk, credit risk and liquidity risk. There may at times be an imperfect correlation between the movement in the prices of futures contracts and the value of their underlying instruments or indexes. There are no limitations on daily price movements of forward contracts. There can be no assurance that any strategy used will succeed. Not all forward contracts, including NDFs, require a counterparty to post collateral, which may expose a fund to greater losses in the event of a default by a counterparty. There can be no assurance that, at all times, a liquid market will exist for offsetting a futures contract that a fund has previously bought or sold and this may result in the inability to close a futures contract when desired. Forward currency transactions include the risks associated with fluctuations in currency. Interest rate and Treasury futures contracts expose a fund to price fluctuations resulting from changes in interest rates. A fund could suffer a loss if interest rates rise after a fund has purchased an interest rate futures contract or fall after a fund has sold an interest rate futures contract. Similarly, Treasury futures contracts expose a fund to potential losses if interest rates do not move as expected. Fixed income index futures contracts expose a fund to volatility in an underlying securities index.

 

    Options. The movements experienced by a fund between the prices of options and prices of the assets (or indices) underlying such options, may differ from expectations, and may cause a fund to not achieve its
   

objective. In order for a call option to be profitable, the market price of the underlying security or index must rise sufficiently above the call option exercise price to cover the premium and transaction costs. These costs will reduce any profit that might otherwise have been realized had a fund bought the underlying security instead of the call option. The buyer of a call option assumes the risk of losing its entire investment in the call option. The seller (writer) of a call option that is covered (i.e., the writer holds the underlying security) assumes the risk of a decline in the market price of the underlying security below the purchase price of the underlying security less the premium received, and gives up the opportunity for gain on the underlying assets above the exercise price of the option. The seller of an uncovered call option assumes the risk of a theoretically unlimited increase in the market price of the underlying assets above the exercise price of the option. The securities necessary to satisfy the exercise of the call option may be unavailable for purchase by such writer except at much higher prices. Purchasing securities to satisfy the exercise of the call option can itself cause the price of the securities to rise further, sometimes by a significant amount, thereby exacerbating the loss. For a put option to be profitable, the market price of the underlying security or index must decline sufficiently below the put option’s exercise price to cover the premium and transaction costs. These costs will reduce any profit that might otherwise have been realized from a fund having shorted the declining underlying security by the premium paid for the put option and by transaction costs. The buyer of a put option assumes the risk of losing its entire investment in the put option. The seller (writer) of a put option that is covered (i.e., the writer has a short position in the underlying assets) assumes the risk of an increase in the market price of the underlying assets above the sales price (in establishing the short position) of the underlying assets plus the premium received, and gives up the opportunity for gain on the underlying assets below the exercise price of the option. The seller of an uncovered put option assumes the risk of a decline in the market price of the underlying assets below the exercise price of the option. If an option that a fund has purchased expires unexercised, a fund will experience a loss in the amount of the premium it paid. The writer of an option, unlike the holder, generally is subject to initial and variation margin requirements on the option position. There can be no guarantee that the use of options will increase a fund’s return or income. The premium received from writing options may not be sufficient to offset any losses sustained from exercised options. In addition, there may be an imperfect correlation between the movement in prices of options and the securities underlying them, and there may at times not be a liquid secondary market for options.

 

    Options on futures contracts. Options on futures contracts are subject to the risks associated with purchasing or writing call or put options on futures contracts. The risks associated with options generally apply to options on futures contracts, such as a buyer’s risk of losing premium if a purchased option expires unexercised or a seller’s risk of being required to sell the underlying asset at a disadvantageous price. In addition to the risks associated with options generally, there is a risk of imperfect correlations between the movement in prices of the option and the futures contract, as well as the futures contract and the underlying security, which could in turn impact the price of the option.

Emerging markets  |  When investing in emerging markets, the risks of investing in foreign securities discussed below are heightened. Emerging markets have unique risks that are greater than or in addition to those associated with investing in developed markets because emerging markets are generally smaller, less developed, less liquid and more volatile than the securities markets of the U.S. and other foreign developed markets. There are also risks of: greater political uncertainties; an economy’s dependence on revenues from particular commodities or on international aid or development assistance; currency transfer restrictions; a limited number of potential buyers for such securities; delays and disruptions in securities settlement procedures; less

 

 

68             


Principal Risks

(UNAUDITED)

 

stringent, or a lack of, uniform accounting, auditing, financial reporting and recordkeeping requirements or standards; less reliable clearance and settlement, registration and custodial procedures; trading suspensions and other restrictions on investment; and significant limitations on investor rights and recourse. The economies and governments of emerging market countries tend to be more unstable than those of developed countries, resulting in more volatile rates of return than the developed markets and significantly greater risk to investors. The governments of emerging market countries may also be more unstable and more likely to impose capital controls, nationalize a company or industry, place restrictions on foreign ownership and on withdrawing sale proceeds of securities from the country, intervene in the financial markets, and/or impose burdensome taxes that could adversely affect security prices. There may be less publicly available or less reliable information regarding issuers in emerging markets, which can impede a fund’s ability to accurately evaluate foreign securities. In certain emerging market countries, fraud and corruption may be more prevalent than in developed market countries, and investor protections may be more limited than those in other countries. It may be difficult to obtain or enforce legal judgments against non-U.S. companies and non-U.S. persons in foreign jurisdictions, through either the foreign judicial system or through a private arbitration process. Additionally, a fund may experience more volatile rates of return. These matters have the potential to impact a fund’s investment objective and performance.

Equity securities  |  A fund’s equity securities investments are subject to market risk. A fund may invest in the following equity securities, which may expose a fund to the following additional risks:

 

    Common Stocks. The value of a company’s common stock may fall as a result of factors directly relating to that company, such as decisions made by its management or decreased demand for the company’s products or services. A stock’s value may also decline because of factors affecting not just the company, but also companies in the same industry or sector. The price of a company’s stock may also be affected by changes in financial markets that are unrelated to the company, such as changes in interest rates, exchange rates or industry regulation. Companies that pay dividends on their common stock generally only do so after they invest in their own business and make required payments to bondholders and on other debt and preferred stock. Therefore, the value of a company’s common stock will usually be more volatile than its bonds, other debt and preferred stock. Common stock generally is subordinate to preferred stock upon the liquidation or bankruptcy of the issuing company. In the event of an issuer’s bankruptcy, there is substantial risk that there will be nothing left to pay common stockholders after payments, if any, to bondholders and preferred stockholders have been made.

 

    Preferred Stocks. Preferred securities, including convertible preferred securities, are subject to issuer-specific and market risks; however, preferred securities may be less liquid than common stocks and offer more limited participation in the growth of an issuer. If interest rates rise, the dividend on preferred stocks may be less attractive, causing the price of preferred stocks to decline. Distributions on preferred stocks generally are payable at the discretion of an issuer and after required payments to bondholders. Preferred shareholders may have only certain limited rights if distributions are not paid for a stated period, but generally have no legal recourse against the issuer and may suffer a loss of value if distributions are not paid. Preferred stocks may have mandatory sinking fund provisions, as well as provisions for their call or redemption prior to maturity which can have a negative effect on their prices when interest rates decline. Because the rights of preferred stock on distribution of a corporation’s assets in the event of its liquidation are generally subordinated to the rights associated with a corporation’s debt securities, in the event of an issuer’s bankruptcy, there is substantial risk that there will be nothing left to pay preferred stockholders after payments, if any, to bondholders have been made. For this reason, the value of preferred securities will usually react more strongly than bonds and other debt
   

securities to actual or perceived changes in the company’s financial condition or prospects. Preferred stocks may also be subject to credit risk, which is the risk that an issuer may be unable or unwilling to meet its financial obligations.

 

    Convertible Securities. The investment value of a convertible security (“convertible”) is based on its yield and tends to decline as interest rates increase. The conversion value of a convertible is the market value that would be received if the convertible were converted to its underlying common stock. Since it derives a portion of its value from the common stock into which it may be converted, a convertible is also subject to the same types of market and issuer-specific risks that apply to the underlying common stock. Convertible securities are subject to the risk that the credit standing of the issuer may have an effect on the convertible securities’ investment value. Convertible securities also are sensitive to movements in interest rates. Generally, a convertible security is subject to the market risks of stocks when the underlying stock’s price is high relative to the conversion price, and is subject to the market risks of debt securities when the underlying stock’s price is low relative to the conversion price. A convertible may be subject to redemption at the option of the issuer at a price established in the convertible’s governing instrument, which may be less than the current market price of the security. Convertibles typically are “junior” securities, which means an issuer may pay interest on its non-convertible debt before it can make payments on its convertibles. In the event of a liquidation, holders of convertibles may be paid before a company’s common stockholders but after holders of a company’s senior debt obligations.

 

    Depositary Receipts. A fund may invest in securities issued by foreign companies through American Depositary Receipts (“ADRs”), Global Depositary Receipts (“GDRs”) and European Depositary Receipts (“EDRs”). These securities are subject to many of the risks inherent in investing in foreign securities, including, but not limited to, currency exchange rate fluctuations, political and financial instability in the home country of a particular depositary receipt, less liquidity, more volatility, less government regulation and supervision and delays in transaction settlement.

 

    REITS. REITS or other real estate-related securities are subject to the risks associated with direct ownership of real estate, including, among other risks, declines in the value of real estate, risks related to general and local economic conditions or changes in demographic trends or tastes, increases in operating expenses, defaults by mortgagors or other borrowers and tenants, lack of availability of mortgage funds or financing, extended vacancies of properties, especially during economic downturns, losses due to environmental liabilities, and adverse governmental, legal or regulatory action (such as changes to zoning laws, changes in interest rates, condemnation, tax increases, regulatory limitations on rents, or enforcement of or changes to environmental regulations). Additionally, REITs are dependent on the skills of their managers. Shares of REITs may trade less frequently and, therefore, are subject to more erratic price movements than securities of larger issuers. REITs typically incur fees that are separate from those incurred by a fund, meaning a fund’s investment in REITs will result in the layering of expenses such that as a shareholder, a fund will indirectly bear a proportionate share of a REIT’s operating expenses. A domestic REIT could fail to qualify for tax-free “pass-through” of distributed net income and net realized gains under the Internal Revenue Code, or to maintain its exemption from registration under the 1940 Act.

 

   

Dividend-Paying Stocks. Securities of companies that have historically paid a high dividend yield may reduce or discontinue their dividends, reducing the yield of the fund. Low priced securities in the fund may be more susceptible to these risks. Past dividend payments are not a guarantee of future dividend payments. Securities that pay dividends may be sensitive to changes in interest rates, and a sharp increase in interest rates, or

 

 

               69  


Principal Risks

(UNAUDITED)

 

    other market downturn, could result in a decision to decrease or eliminate a dividend. Also, the market return of high dividend yield securities, in certain market conditions, may perform worse than other investment strategies or the overall stock market. Changes to the dividend policies of companies in which a fund invests and the capital resources available for dividend payment at such companies may harm fund performance. A fund may also be harmed by changes to the favorable federal income tax treatment generally afforded to dividends.

 

    Rights and Warrants. Investments in rights and warrants may be more speculative than certain other types of investments because rights and warrants do not carry dividend or voting rights with respect to the underlying securities or any rights in the assets of the issuer. In addition, the value of a right or a warrant does not necessarily change with the value of the underlying securities and a right or a warrant ceases to have value if it is not exercised prior to its expiration date. If a warrant or right to subscribe to additional shares is not exercised or, when permissible, sold prior to the warrant’s or right’s expiration date or redemption by the issuer, a fund could lose all or substantially all of the purchase price of the warrant or right. The market for warrants and rights may be very limited and there may at times not be a liquid secondary market for warrants and rights.

Focused holdings  |  For funds that normally hold a core portfolio of securities of fewer companies than other funds, the increase or decrease of the value of a single investment may have a greater impact on the fund’s NAV and total return when compared to other diversified funds. Although a focused portfolio has the potential to generate attractive returns over time, it also may increase a fund’s volatility.

Foreign securities  |  Investments in foreign securities involve greater risks than investing in domestic securities. As a result, a fund’s return and NAV may be affected by fluctuations in currency exchange rates or political or economic conditions and regulatory requirements in a particular country. Foreign markets, as well as foreign economies and political systems, may be less stable than U.S. markets, and changes in the exchange rates of foreign currencies can affect the value of a fund’s foreign assets. Foreign laws and accounting standards typically are not as strict as they are in the U.S., and there may be less government regulation and supervision of foreign stock exchanges, brokers and listed companies. In addition, there may be less public information available about foreign companies. The unavailability and/or unreliability of public information available may impede the fund’s ability to accurately evaluate foreign securities. Custodial and/or settlement systems in foreign markets may not be fully developed and the laws of certain countries may limit the ability to recover assets if a foreign bank or depository or their agents goes bankrupt. Foreign issuers may utilize unfamiliar corporate organizational structures, which can limit investor rights and recourse. Moreover, it may be difficult to enforce contractual obligations or invoke judicial or arbitration processes against non-U.S. companies and non-U.S. persons in foreign jurisdictions. Foreign securities may be less liquid than domestic securities and there may be delays in transaction settlement in some foreign markets. Securities of issuers traded on foreign exchanges may be suspended, either by the issuers themselves, by an exchange, or by government authorities. Over a given period of time, foreign securities may underperform U.S. securities—sometimes for years. A fund could also underperform if it invests in countries or regions whose economic performance falls short. The risks associated with investments in governmental or quasi-governmental entities of a foreign country are heightened by the potential for unexpected governmental change, which may lead to default or expropriation, and inadequate government oversight and accounting. Obligations of supranational entities are subject to the risk that the governments on whose support the entity depends for its financial backing or repayment may be unable or unwilling to provide that support. The effect of recent, worldwide economic instability on specific foreign markets or issuers may be difficult to predict or evaluate. Some national economies continue to show profound instability, which may in turn affect their international trading and financial partners or

other members of their currency bloc. Foreign security risk may also apply to ADRs, GDRs and EDRs.

Growth stocks  |  Growth companies are expected to increase their earnings at a certain rate. When these expectations are not met, the prices of these stocks may decline, even if earnings showed an absolute increase. Growth company stocks also typically lack the dividend yield that can cushion stock prices in market downturns. The price of a growth company’s stock may fail or not approach the value that has been placed on it. If a growth investment style shifts out of favor based on market conditions and investor sentiment, a fund could underperform funds that use a value or other non-growth approach to investing or have a broader investment style.

Hedging  |  A fund may enter into hedging transactions with the intention of reducing or controlling risk. It is possible that hedging strategies will not be effective in controlling risk, due to unexpected non-correlation (or even positive correlation) between the hedging instrument and the position being hedged, increasing, rather than reducing, both risk and losses. To the extent that a fund enters into hedging transactions, the hedges will not be static but rather will need to be continually adjusted based on a subadviser’s assessment of market conditions, as well as the expected degree of non-correlation between the hedges and the portfolio being hedged. The success of a fund’s hedging strategies will depend on a subadviser’s ability to implement such strategies efficiently and cost-effectively, as well as on the accuracy of a subadviser’s judgments concerning the hedging positions to be acquired by a fund. A counterparty to a hedging transaction may be unable to honor its financial obligation to a fund. In addition, a subadviser may be unable to close the transaction at the time it would like or at the price it believes the security is currently worth. A fund may not, in general, attempt to hedge all market or other risks inherent in a fund’s investments, and may hedge certain risks only partially, if at all. Certain risks, either in respect of particular investments or in respect of a fund’s overall portfolio, may not be hedged, particularly if doing so is economically unattractive. As a result, various directional market risks may remain unhedged. Gains or losses from positions in hedging instruments may be much greater than the instrument’s original cost. If a fund uses a hedging instrument at the wrong time or judges the market conditions incorrectly, or the hedged instrument does not correlate to the risk sought to be hedged, the hedge might be unsuccessful. The use of hedges may fail to mitigate risks, reduce a fund’s return, or create a loss. In addition, hedges, even when successful in mitigating risk, may not prevent a fund from experiencing losses on its investments. Hedging instruments may also reduce or eliminate gains that may otherwise have been available had a fund not used the hedging instruments. When hedging is combined with leverage, a fund risks losses that are multiplied by the degree of leverage used.

High-yield securities  |  Investments in securities rated below investment grade, or “junk bonds,” generally involve significantly greater risks of loss of your money than an investment in investment grade bonds. Compared with issuers of investment grade bonds, issuers of junk bonds are more likely to encounter financial difficulties and to be materially affected by these difficulties, leading to a greater risk that the issuer will default on the timely payment of principal and interest. Rising interest rates may compound these difficulties and reduce an issuer’s ability to repay principal and interest obligations. Issuers of lower-rated securities also have a greater risk of default or bankruptcy, especially when the economy is weak or expected to become weak. If an issuer defaults, a fund may incur additional expenses to seek recovery. Issuers of securities that are in default or have defaulted may fail to resume principal or interest payments, in which case a fund may lose its entire investment. Additionally, due to the greater number of considerations involved in the selection of a fund’s securities, the achievement of a fund’s objective depends more on the skills of the portfolio manager than investing only in higher-rated securities. Therefore, your investment may experience greater volatility in price and yield. High-yield securities may be less liquid than higher quality investments. A security whose credit rating has been lowered may be particularly difficult to sell. The higher yields of high-yielding securities may not reflect the value of the income stream

 

 

70             


Principal Risks

(UNAUDITED)

 

that holders of such securities may expect, but rather the risk that such securities may lose a substantial portion of their value as a result of their issuer’s financial restructuring or default. Investments in high-yield securities are inherently speculative.

Income  |  A fund’s income could decline due to falling market interest rates. In a falling interest rate environment, a fund may be required to invest its assets in lower-yielding securities. Because interest rates vary, it is impossible to predict the income or yield of a fund for any particular period.

Initial public offerings  |  The market value of shares sold in an initial public offering (“IPO”) may fluctuate considerably due to factors such as the absence of a prior public market, unseasoned trading, the small number of shares available for trading and limited information about the issuer. In addition, the prices of securities sold in IPOs may be highly volatile or may decline shortly after the IPO. The purchase of IPO shares may also involve high transaction costs. The limited number of shares available for trading in some IPOs may make it difficult for a fund to acquire shares of an issuer in which it would like to invest, and may also make it more difficult for a fund to buy or sell significant amounts of shares without an unfavorable impact on prevailing prices. . In addition, some companies initially offering their shares publicly may be involved in relatively new industries or lines of business, which may not be widely understood by investors. Many IPOs are by small- or micro-capitalization companies that are undercapitalized. Investments in IPOs may result in losses to a fund.

Interest rate  |  Investments in investment grade and non-investment grade fixed income securities are subject to interest rate risk. The value of a fund’s fixed income investments typically will fall when interest rates rise. A fund may be particularly sensitive to changes in interest rates if it invests in debt securities with intermediate and long terms to maturity. Debt securities with longer durations tend to be more sensitive to changes in interest rates, usually making them more volatile than debt securities with shorter durations. For example, if a bond has a duration of eight years, a 1% increase in interest rates could be expected to result in a 8% decrease in the value of the bond. Very low or negative interest rates may magnify interest rate risk. During periods of very low or negative interest rates, the fund may be unable to maintain positive returns or pay dividends to fund shareholders. Certain European countries and Japan have experienced negative interest rates on deposits and debt securities have traded at negative yields. Negative interest rates may become more prevalent among non-U.S. issuers, and potentially within the United States. Changing interest rates, including rates that fall below zero, may have unpredictable effects on markets, may result in heightened market volatility and may detract from fund performance to the extent the fund is exposed to such interest rates. Conversely, interest rates may rise significantly and/or rapidly, potentially resulting in substantial losses to a fund.

Issuer  |  The value of a security may decline for a number of reasons which directly relate to the issuer, such as management performance, financial leverage and reduced demand for the issuer’s goods or services, as well as the historical and prospective earnings of the issuer and the value of its assets.

Japan  |  A significant portion of a fund’s total assets may be invested in the securities of Japanese issuers, in accordance with the fund’s benchmark. Japan, like many Asian countries, is still heavily dependent upon international trade and may be adversely affected by protectionist trade policies, competition from Asia’s other low-cost emerging economies, the economic conditions of its trading partners, the strength of the yen, and regional and global conflicts. The domestic Japanese economy faces several concerns, including large government deficits, a shrinking workforce, and, in some cases, companies with poor corporate governance. Japan has in the past intervened in the currency markets, which could cause the value of the yen to fluctuate sharply and unpredictably. Japan is located in a part of the world that has historically been prone to natural disasters such as earthquakes and tsunamis. Relations with its neighbors, particularly China, North Korea, South Korea and Russia, have at times been strained due to territorial disputes, historical animosities

and defense concerns. As a country with few natural resources, Japan is also heavily dependent on oil and other commodity imports, and higher commodity prices could therefore have a negative impact on the Japanese economy. These and other factors could have a negative impact on a fund’s performance and increase the volatility of an investment in a fund.

Large-cap companies  |  Investments in large-cap companies may underperform other segments of the market, in some cases for extended periods of time, because such companies may be less responsive to competitive challenges and opportunities, such as changes in technology and consumer tastes. Large-cap companies generally are expected to be less volatile than companies with smaller market capitalizations. However, large-cap companies may be unable to attain the high growth rates of successful smaller companies, especially during periods of economic expansion, and may instead focus their competitive efforts on maintaining or expanding their market share.

Leverage  |  Certain transactions of a fund may give rise to a form of leverage. Such transactions may include, among others, the use of buybacks, dollar rolls, and when-issued, delayed delivery or forward commitment transactions. Certain derivatives that a fund may use may also create leverage. Derivatives that involve leverage can result in losses to a fund that exceed the amount originally invested in the derivatives. Certain types of leveraging transactions, such as short sales that are not “against the box,” could be subject to unlimited losses in cases where a fund, for any reason, is unable to close out the transaction. The use of leverage may cause a fund to liquidate portfolio positions when it may not be advantageous to do so to satisfy its obligations or to meet segregation requirements. Leveraging may cause a fund to be more volatile than if the fund had not been leveraged. This is because leveraging tends to exaggerate the effect of any increase or decrease in the value of a fund’s portfolio securities.

LIBOR  |  Certain of the instruments identified in a fund’s principal investment strategies have variable or floating coupon rates that are based on ICE LIBOR (“LIBOR”), the Secured Overnight Financing Rate (“SOFR”), Euro Interbank Offered Rate and other similar types of reference rates (each, a “Reference Rate”). These Reference Rates are generally intended to represent the rate at which contributing banks may obtain short-term borrowings within certain financial markets. Most maturities and currencies of LIBOR were phased out at the end of 2021, with the remaining ones to be phased out on June 30, 2023. These events and any additional regulatory or market changes may have an adverse impact on a fund or its investments, including increased volatility or illiquidity in markets for instruments that rely on LIBOR. Regulators and market participants are working together to develop successor Reference Rates. SOFR has been selected by a committee established by the Board of Governors of the Federal Reserve System and the Federal Reserve Bank of New York to replace LIBOR as a Reference Rate in the United States. Other countries have undertaken similar initiatives to identify replacement Reference Rates for LIBOR in their respective markets. However, there are obstacles to converting certain existing investments and transactions to a new Reference Rate, as well as risks associated with using a new Reference Rate with respect to new investments and transactions. It is expected that market participants will focus on the transition mechanisms by which Reference Rates in existing contracts or instruments may be amended, whether through legislation, marketwide protocols, fallback contractual provisions, bespoke negotiations or amendments or otherwise. Nonetheless, there remains uncertainty about the nature of any replacement rate for LIBOR and the impact of the transition from LIBOR on a fund and the financial markets generally. The transition process, or the failure of an industry to transition, could lead to increased volatility and illiquidity in markets that currently rely on LIBOR to determine interest rates and a reduction in the values of some LIBOR-based investments, all of which could impact a fund.

Liquidity  |  Liquidity risk is the possibility that a fund’s securities may have limited marketability, be subject to restrictions on resale, be difficult or impossible to purchase or sell at favorable times or prices, or become less

 

 

               71  


Principal Risks

(UNAUDITED)

 

liquid in response to market developments or adverse credit events that may affect issuers or guarantors of a debt security, any of which could have the effect of decreasing the overall level of the fund’s liquidity. The market prices for such securities may be volatile. An inability to sell a portfolio position can adversely affect a fund’s NAV or prevent a fund from being able to take advantage of other investment opportunities. A fund could lose money if it cannot sell a security at the time and price that would be most beneficial to a fund. A fund may be required to dispose of investments at unfavorable times or prices to satisfy obligations, which may result in losses or may be costly to a fund. Market developments may cause a fund’s investments to become less liquid and subject to erratic price movements. In addition, the market-making capacity of dealers in certain types of securities has been reduced in recent years, in part as a result of structural and regulatory changes, such as fewer proprietary trading desks and increased capital requirements for broker-dealers. Further, many broker-dealers have reduced their inventory of certain debt securities. This could negatively affect a fund’s ability to buy or sell debt securities and increase the related volatility and trading costs. For example, liquidity risk may be magnified in rising interest rate environments due to higher than normal redemption rates.

Market  |  Markets may at times be volatile and the values of a fund’s stock and fixed income holdings, as well as the income generated by a fund’s fixed income holdings, may decline, sometimes significantly and/or rapidly, because of adverse issuer-specific conditions or general market conditions, including a broad stock market decline, which are not specifically related to a particular issuer. These conditions may include real or perceived adverse political, regulatory, market, economic or other developments, such as natural disasters, public health crises, pandemics, regional or global economic instability and interest, inflation and currency rate fluctuations. These and other conditions may cause broad changes in market value, the general outlook for corporate earnings, public perceptions concerning these developments or adverse investment sentiment generally. These events may lead to periods of volatility, which may be exacerbated by changes in market size and structure. Changes in the financial condition of a single issuer, industry or market segment also can impact the market as a whole. In addition, adverse market events may lead to increased redemptions, which could cause a fund to experience a loss when selling securities to meet redemption requests by shareholders. The risk of loss increases if the redemption requests are unusually large or frequent. Adverse market conditions may be prolonged and may not have the same impact on all types of securities. Conversely, it is also possible that, during a general downturn in the securities markets, multiple asset classes may decline in value simultaneously. Changes in value may be temporary or may last for extended periods. During times of market turmoil, investors tend to look to the safety of securities issued or backed by the U.S. Treasury, causing the prices of these securities to rise and the yields to decline. Reduced liquidity in fixed income and credit markets may negatively affect many issuers worldwide. Prices in many financial markets have increased significantly over the last decade, but there have also been periods of adverse market and financial developments and cyclical change during that timeframe, which have resulted in unusually high levels of volatility in domestic and foreign financial markets that has caused losses for investors and may occur again in the future, particularly if markets enter a period of uncertainty or economic weakness. Periods of unusually high volatility in the financial markets and restrictive credit conditions, sometimes limited to a particular sector or geographic region, continue to recur. Even when securities markets perform well, there is no assurance that the investments held by a fund will increase in value along with the broader market.

The increasing interconnectedness of markets around the world may result in many markets being affected by events in a single country or events affecting a single or small number of issuers. Events such as natural disasters, public health crises, pandemics, governments’ reactions to and public perceptions concerning these developments, and adverse investor sentiment could cause uncertainty in the markets and may adversely affect the performance of the

global economy. Terrorism and related geopolitical risks, including tensions or open conflict between nations, or political or economic dysfunction within some nations that are major players on the world stage or major producers of oil have led, and may in the future lead, to increased short-term market volatility and may have adverse long-term effects on world economies and markets generally. Likewise, systemic market dislocations of the kind that occurred during the financial crisis in 2008, if repeated, could be highly disruptive to economies and markets, adversely affecting individual companies and industries, securities markets, interest rates, credit ratings, inflation, investor sentiment and other factors affecting the value of a fund’s investments.

Political and diplomatic events within the United States and abroad, such as changes in the U.S. presidential administration and Congress and domestic political unrest, the U.S. government’s inability at times to agree on a long-term budget and deficit reduction plan, the threat of a federal government shutdown and threats not to increase the federal government’s debt limit, may affect investor and consumer confidence and may adversely impact financial markets and the broader economy, perhaps suddenly and to a significant degree. The severity or duration of adverse economic conditions may also be affected by policy changes made by government or quasi-governmental organizations.

In addition, markets and market participants are increasingly reliant upon both publicly available and proprietary information data systems. Data imprecision, software or other technology malfunctions, programming inaccuracies, unauthorized use or access, the execution of ransomeware and other cyberattacks, and similar circumstances may impair the performance of these systems and may have an adverse impact upon a single issuer, a group of issuers, or the market at large. In certain cases, an exchange or market may close or issue trading halts on either specific securities or even the entire market, which may result in a fund being, among other things, unable to buy or sell certain securities or financial instruments or accurately price its investments. These fluctuations in stock prices could be a sustained trend or a drastic movement. The financial markets generally move in cycles, with periods of rising prices followed by periods of declining prices. The value of your investment may reflect these fluctuations.

Recent Market Events  |  An outbreak of infectious respiratory illness caused by a novel coronavirus known as COVID-19 was first detected in China in December 2019 and has subsequently spread globally. The impact of the outbreak has been rapidly evolving, and the transmission of COVID-19 and efforts to contain its spread have resulted, and may continue to result, in ongoing and repeated disruptions to business operations and supply chain, travel restrictions, closed international borders, enhanced health screenings at ports of entry and elsewhere, disruptions of and delays in healthcare service preparation and delivery, quarantines and stay-at-home orders, cancellations, widespread business closures and layoffs, service and event cancellations, reductions and other changes, and lower consumer demand, as well as general concern and uncertainty about the state of the global economy. The current pandemic has accelerated trends toward working remotely and online shopping and delivery of services, which may negatively affect the value of office and commercial real estate and companies that have been slow to transition to an online business model. Certain industries may suffer long-term negative effects from the pandemic and resulting changes to public behavior. The impact of the COVID-19 pandemic may last for an extended period of time and may result in a sustained economic downturn or recession. Governments’ efforts to limit potential negative economic effects of the pandemic may be altered, delayed, or eliminated at inopportune times for political, policy or other reasons. Although vaccines, boosters, and treatments have been released, they may not be widely available, and the efficacy may be impacted by further pandemic developments. The impact of COVID-19, and other infectious illness outbreaks that may arise in the future, could adversely affect the economies of many nations or the entire global economy, individual

 

 

72             


Principal Risks

(UNAUDITED)

 

issuers and capital markets in ways that cannot necessarily be foreseen. Deteriorating economic fundamentals may in turn increase the risk of default or insolvency of particular issuers, increase the possibility that countries may be unable to make timely payments on their sovereign debt, negatively impact market value, increase market volatility, cause credit spreads to widen, and reduce liquidity. In addition, the impact of infectious illnesses in emerging market countries may be greater due to generally less established healthcare systems and vaccine and treatment delivery systems. Public health crises caused by the COVID-19 outbreak may exacerbate other pre-existing political, social and economic risks in certain countries or globally. The duration of the COVID-19 outbreak and its effects cannot be determined with certainty.

The Board of Governors of the Federal Reserve System (also known as “the Fed”) has taken numerous measures to address the economic impact of the COVID-19 pandemic, such as the reduction of the federal funds target rate and the introduction of several credit and liquidity facilities, and the U.S. federal government has taken steps to stimulate the U.S. economy. The Fed and the U.S. federal government may continue to take steps to address the impact of the pandemic. However, such measures ultimately will depend on agreement among political parties, which is not certain. The likelihood and effect of these and other efforts may not be known for some time, and it is not known whether and to what extent they will be successful.

Decisions by the Fed regarding interest rate and monetary policy, which can be difficult to predict and sometimes change direction suddenly in response to economic and market events, continue to have a significant impact on securities prices as well as the overall strength of the U.S. economy. The Fed has started to decrease and unwind its interventions through quantitative tightening. The Fed also has raised and is expected to continue to raise interest rates in 2022, in part to address an increase in the annual inflation rate in the U.S., which may adversely affect the present value of a fund’s assets and distributions. Central banks, which also reduced rates to combat the economic effects of the COVID-19 pandemic, also have announced plans to raise interest rates and end quantitative easing. Because there is little precedent for this situation, it is difficult to predict the impact on various markets of a significant rate increase or other policy changes. Future legislative, regulatory and policy changes may impact current international trade deals, result in changes to prudential regulation of certain players in the financial market, and provide significant new investments in infrastructure, the environment, or other areas. Markets may react strongly to expectations about the changes in these policies, which could increase volatility, especially if the markets’ expectations for changes in government policies are not borne out.

A rise in protectionist trade policies, slowing global economic growth, risks associated with ongoing trade negotiations with China, risks associated with the United Kingdom’s departure from the European Union on December 31, 2020, commonly referred to as “Brexit,” and the ratification of a trade agreement between the United Kingdom and the European Union, the possibility of changes to some international trade agreements, tensions or open conflict between and among nations, such as between Russia and Ukraine, could affect the economies of many nations, including the United States, in ways that cannot necessarily be foreseen at the present time. The outcomes may cause increased volatility and have a significant adverse impact on world financial markets, other international trade agreements and the broader global economy.

Russia’s military invasion of Ukraine beginning in February 2022, the responses and sanctions by the United States and other countries, and the potential for wider conflict have had, and could continue to have, severe adverse effects on regional and global economies and could further increase volatility and uncertainty in the financial markets. The

United States and other countries have imposed broad-ranging economic sanctions on Russian and certain Russian individuals, banking entities and corporations as a response to its invasion of Ukraine. The United States and other countries have also imposed economic sanctions on Belarus and may impose sanctions on other countries that provide military or economic support to Russia. These sanctions, as well as any other economic consequences related to the invasion, such as additional sanctions, boycotts or changes in consumer or purchaser preferences or cyberattacks on governments, companies or individuals, may further decrease the value and liquidity of certain Russian securities and securities of issuers in other countries that are subject to economic sanctions related to the invasion. To the extent that a fund has exposure to Russian investments or investments in countries affected by the invasion, the fund’s ability to price, buy, sell, receive or deliver such investments may be impaired. In addition, any exposure that a fund may have to counterparties in Russia or in countries affected by the invasion could negatively impact the fund’s investments. The extent and duration of military actions and the repercussions of such actions (including any retaliatory actions or countermeasures that may be taken by those subject to sanctions) are impossible to predict. These events have resulted in, and could continue to result in, significant market disruptions, including in certain industries or sectors such as the oil and natural gas markets, and may further strain global supply chains and negatively affect inflation and global growth. These and any related events could significantly impact the fund’s performance and the value of an investment in the fund beyond any direct exposure the fund may have to Russian issuers or issuers in other countries affected by the invasion.

Economists and others have expressed increasing concern about the potential effects of global climate change on property and security values. Impacts from climate change may include significant risks to global financial assets and economic growth. A climate-driven increase in sea levels or flooding and/or an increase in powerful windstorms could cause coastal properties to lose value or become unmarketable altogether. Economists warn that, unlike previous declines in the real estate market, properties in affected coastal zones may not ever recover their value. Large wildfires driven by high winds and prolonged drought may devastate businesses and entire communities and may be very costly to any business found to be responsible for the fire. Regulatory changes and divestment movements tied to concerns about climate change could adversely affect the value of certain land and the viability of industries whose activities or products are seen as accelerating climate change. These losses could adversely affect corporate issuers and mortgage lenders, the value of mortgage-backed securities, the bonds of municipalities that depend on tax or other revenues and tourist dollars generated by affected properties, and insurers of the property and/or of corporate, municipal or mortgage-backed securities. Since property and security values are driven largely by buyers’ perceptions, it is difficult to know the time period over which these market effects might unfold.

Market timing  |  Frequent trading by fund shareholders poses risk to other shareholders in a fund, including (i) the dilution of a fund’s NAV, (ii) an increase in a fund’s expenses, and (iii) interference with a portfolio manager’s ability to execute efficient investment strategies. Because of specific securities a fund may invest in, it could be subject to the risk of market timing activities by fund shareholders. Some examples of these types of securities are high-yield, small-cap and foreign securities. Typically, foreign securities offer the most opportunity for these market timing activities. A fund generally prices these foreign securities using their closing prices from the foreign markets in which they trade, typically prior to a fund’s calculation of its NAV. These prices may be affected by events that occur after the close of a foreign market but before a fund prices its shares. In such instances, a fund may fair value foreign securities. However, some investors may engage in frequent short-term trading in a fund to take advantage of any price differentials that may be reflected in

 

 

               73  


Principal Risks

(UNAUDITED)

 

the NAV of a fund’s shares. There is no assurance that fair valuation of securities can reduce or eliminate market timing. There is no guarantee that Carillon Tower Advisers, Inc., as the manager and transfer agent of the funds, can detect all market timing activities.

Maturity  |  A fund will invest in fixed income securities of varying maturities. A fixed income security’s maturity is one indication of the interest rate exposure of a security. Generally, the longer a fixed income security’s maturity, the greater the risk. Conversely, the shorter a fixed income security’s maturity, the lower the risk.

Mid-cap companies  |  Investments in mid-cap companies generally involve greater risks than investing in large-capitalization companies. Mid-cap companies may have narrower commercial markets and limited managerial and financial resources compared to larger, more established companies. The performance of mid-cap companies can be more volatile, and their stocks less liquid, compared to larger, more established companies, which could increase the volatility of a fund’s portfolio and performance. Shareholders of a fund that invests in mid-cap companies should expect that the value of the fund’s shares will be more volatile than a fund that invests exclusively in large-cap companies. Generally, the smaller the company size, the greater these risks.

Mortgage- and asset-backed securities  |  Mortgage- and asset-backed security risk arises in part from the potential for mortgage failure, particularly during periods of market downturn, premature repayment of principal, or a delay in the repayment of principal, and can increase in an unstable or depressed housing market. The reduced value of the fund’s securities and the potential loss of principal as a result of a mortgagor’s failure to repay would have a negative impact on the fund. If a borrower repays the principal early, a fund may have to reinvest the proceeds at a lower rate, thereby reducing a fund’s income. Conversely, a delay in the repayment of principal could lengthen the expected maturity of the securities, thereby increasing the potential for loss when prevailing interest rates rise, which could cause the values of the securities to fall sharply. In a to-be-announced (“TBA”) mortgage-backed transaction, a fund and the seller agree upon the issuer, interest rate and terms of the underlying mortgages. However, the seller does not identify the specific underlying mortgages until it issues the security. TBA mortgage-backed securities increase interest rate risks because the underlying mortgages may be less favorable than anticipated by a fund.

Other investment companies, including money market funds and ETFs  |  Investments in the securities of other investment companies, including money market funds and exchange-traded funds (“ETFs”) (which may, in turn invest in equities, bonds, and other financial vehicles), may involve duplication of advisory fees and certain other expenses. By investing in another investment company, a fund becomes a shareholder of that investment company. As a result, fund shareholders indirectly bear the fund’s proportionate share of the fees and expenses paid by the other investment company, in addition to the fees and expenses fund shareholders indirectly bear in connection with the fund’s own operations. Investments in other investment companies will subject a fund to the risks of the types of investments in which the investment companies invest.

As a shareholder, a fund must rely on the other investment company to achieve its investment objective. If the other investment company fails to achieve its investment objective, the value of the fund’s investment will typically decline, adversely affecting the fund’s performance. In addition, because ETFs are listed on national stock exchanges and are traded like stocks listed on an exchange, ETF shares may potentially trade at a discount or a premium. Investments in ETFs are also subject to brokerage and other trading costs, which could result in greater expenses to a fund. Finally, because the value of ETF shares depends on the demand in the market, the portfolio manager may not be able to liquidate a fund’s holdings of ETF shares at the most optimal time, adversely affecting the fund’s performance. An ETF that tracks an index may not precisely replicate the returns of its benchmark index. A passively managed ETF may not be permitted to sell poorly performing stocks that are included in its index.

Portfolio turnover  |  A fund may engage in more active and frequent trading of portfolio securities to a greater extent than certain other mutual funds with similar investment objectives. A fund’s turnover rate may vary greatly from year to year or during periods within a year. A high rate of portfolio turnover may lead to greater transaction costs, result in adverse tax consequences to investors (from increased recognition of net capital gains, which are taxable to shareholders when distributed to them) and adversely affect performance.

Prepayment and extension  |  When interest rates fall, borrowers will generally repay the loans that underlie certain debt securities, especially mortgage-related and other types of asset backed securities, more quickly than expected, causing the issuer of the security to repay the principal prior to the security’s expected maturity date. This could also occur if a debt security is called or otherwise converted or redeemed before maturity. If this occurs, a fund may need to reinvest the proceeds at a lower interest rate, reducing its income. Securities subject to prepayment risk generally offer less potential for gains when prevailing interest rates fall. If a fund buys those securities at a premium, accelerated prepayments on those securities could cause a fund to lose a portion of its principal investment. The impact of prepayments on the price of a security may be difficult to predict and may increase the security’s price volatility. The rate of prepayments tends to increase as interest rates fall, which could cause the average maturity of the portfolio to shorten. Prepayments could also create capital gains tax liability in some instances. Extension risk is the risk that a decrease in prepayments may, as a result of higher interest rates or other factors, result in the extension of a security ‘s effective maturity, increase the risk of default and delayed payment, heighten interest rate risk and increase the potential for a decline in its price. In addition, as a consequence of a decrease in prepayments, the amount of principal available to a fund for investment would be reduced. If a fund’s investments are locked in at a lower interest rate for a longer period of time, a fund may be unable to capitalize on securities with higher interest rates or wider spreads.

Quantitative strategy risk  |  The success of a fund’s investment strategy may depend in part on the effectiveness of a subadviser’s quantitative tools for screening securities. Securities selected using quantitative analysis can react differently to issuer, political, market, and economic developments than the market as a whole or securities selected using only fundamental analysis, which could adversely affect their value. A subadviser’s quantitative tools may use factors that may not be predictive of a security’s value, and any changes over time in the factors that affect a security’s value may not be reflected in the quantitative model. The quantitative tools may not react as expected to market events, resulting in losses for a fund. Data for some companies, particularly non-U.S. companies, may be less available and/or less current than data for other companies. There may also be errors in the computer code for the quantitative model or in the model itself, or issues relating to the computer systems used to screen securities. A subadviser’s stock selection can be adversely affected if it relies on insufficient, erroneous or outdated data or flawed models or computer systems. Additionally, a previously successful strategy may become outdated or inaccurate, which may not be identified by a subadviser and therefore may also result in losses.

Redemptions  |  A fund may experience periods of heavy redemptions that could cause a fund to sell assets at inopportune times or at a loss or depressed value. Redemption risk is greater to the extent that one or more investors or intermediaries control a large percentage of investments in a fund, have short investment horizons, or have unpredictable cash flow needs. The risk of loss is also greater if redemption requests are frequent, occur in times of overall market turmoil or declining prices for the securities sold, or when the securities a fund wishes to sell are illiquid. A general rise in interest rates has the potential to cause investors to move out of fixed income securities on a large scale, which may increase redemptions from mutual funds that hold large amounts of fixed income securities. This, coupled with a reduction in the ability or willingness of dealers and other institutional investors to buy or hold fixed income securities, may result in decreased liquidity and increased volatility in

 

 

74             


Principal Risks

(UNAUDITED)

 

the fixed income markets, and heightened redemption risk. Heavy redemptions, whether by a few large investors or many smaller investors, could hurt a fund’s performance.

Sectors  |  A fund may hold a significant amount of investments in companies that are in similar businesses, which may be similarly affected by particular economic or market events that may, in certain circumstances, cause the value of securities of all companies in a particular sector of the market to change. To the extent a fund has substantial holdings within a particular sector, the risks associated with that sector increase. In addition, when a fund focuses its investments in certain sectors of the economy, its performance could fluctuate more widely than if a fund invested more evenly across sectors. Individual sectors may be more volatile, and may perform differently, than the broader market. As a fund’s portfolio changes over time, a fund’s exposure to a particular sector may become higher or lower.

Financials sector  |  Financial services companies are subject to extensive governmental regulation, which may limit both the amounts and types of loans and other financial commitments they can make, the interest rates and fees they can charge, the scope of their activities, the prices they can charge and the amount of capital they must maintain. Profitability is largely dependent on the availability and cost of capital funds and can fluctuate significantly when interest rates change or due to increased competition. In addition, deterioration of the credit markets generally may cause an adverse impact in a broad range of markets, including U.S. and international credit and interbank money markets generally, thereby affecting a wide range of financial institutions and markets. Certain events in the financial sector may cause an unusually high degree of volatility in the financial markets, both domestic and foreign, and cause certain financial services companies to incur large losses. Securities of financial services companies may experience a dramatic decline in value when such companies experience substantial declines in the valuations of their assets, take action to raise capital (such as the issuance of debt or equity securities), or cease operations. Credit losses resulting from financial difficulties of borrowers and financial losses associated with investment activities can negatively impact the sector. Insurance companies may be subject to severe price competition. Adverse economic, business or political developments could adversely affect financial institutions engaged in mortgage finance or other lending or investing activities directly or indirectly connected to the value of real estate.

Health care sector  |  The health care sector may be affected by government regulations and government health care programs, restrictions on government reimbursement for medical expenses, increases or decreases in the cost of medical products and services and product liability claims, among other factors. Many health care companies are (1) heavily dependent on patent protection and intellectual property rights and the expiration of a patent may adversely affect their profitability, (2) subject to extensive litigation based on product liability and similar claims, and (3) subject to competitive forces that may make it difficult to raise prices and, may result in price discounting. Health care companies may also be thinly capitalized and susceptible to product obsolescence. Many health care products and services may be subject to regulatory approvals. The process of obtaining such approvals may be long and costly, and delays in or failure to receive such approvals may negatively impact the business of such companies. Additional or more stringent laws and regulations enacted in the future could have a material adverse effect on such companies in the health care sector. Issuers in the health care sector include issuers having their principal activities in the biotechnology industry or in medical laboratories and research, which pose additional risks. A biotechnology company’s valuation can often be based largely on the potential or actual performance of a limited number of products and, accordingly, can be significantly affected if one of its

products proves unsafe, ineffective or unprofitable. Many biotechnology companies invest heavily in research and development, and their products or services may not prove commercially successful or may become obsolete quickly due to technological change. Biotechnology companies can also be significantly affected by technological change and obsolescence, product liability lawsuits and consequential high insurance costs. The values of biotechnology companies are also dependent on the development, protection and exploitation of intellectual property rights and other proprietary information. Any impairment of such rights may have adverse financial consequences. Biotechnology companies are subject to regulation by, and the restrictions of, the Food and Drug Administration, the Environmental Protection Agency, state and local governments, and foreign regulatory authorities. A biotechnology company may be unable to raise prices on its products or services to cover its development and regulatory costs because of managed care pressure or price controls. Biotechnology stocks, especially those issued by smaller, less-seasoned companies, can be more volatile than the overall market.

Information technology sector  |  The information technology sector includes companies engaged in internet software and services, technology hardware and storage peripherals, electronic equipment, instruments and components, and semiconductors and semiconductor equipment. Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins. Information technology companies may have limited product lines, markets, financial resources or personnel. The products of information technology companies may face rapid product obsolescence due to technological developments and frequent new product introduction, unpredictable changes in growth rates and competition for the services of qualified personnel. Failure to introduce new products, develop and maintain a loyal customer base or achieve general market acceptance for their products could have a material adverse effect on a company’s business. Companies in the information technology sector are heavily dependent on intellectual property and the loss of patent, copyright and trademark protections may adversely affect the profitability of these companies.

Securities lending  |  A fund may lend its portfolio securities to brokers, dealers and financial institutions to seek income. Borrowers of a fund’s securities typically provide collateral in the form of cash that is reinvested in securities. A fund will be responsible for the risks associated with the investment of cash collateral. A fund may lose money on its investment of cash collateral or may fail to earn sufficient income on its investment to meet obligations to the borrower. There is a risk that a borrower may default on its obligations to return loaned securities; however, a fund’s securities lending agent may indemnify the fund against that risk. There is a risk that the assets of a fund’s securities lending agent may be insufficient to satisfy any contractual indemnification requirements to the fund. In addition, delays may occur in the recovery of securities from borrowers, which could interfere with a fund’s ability to vote proxies or to settle transactions and there is the risk of possible loss of rights in the collateral should the borrower fail financially. In any case in which the loaned securities are not returned to a fund before an ex-dividend date, the payment in lieu of the dividend that the fund receives from the securities’ borrower would not be treated as a dividend for federal income tax purposes and thus would not qualify for treatment as “qualified dividend income.”

Short sales  |  A short sale creates the risk of a loss if the price of the underlying security increases in value between the date of the short sale and the date on which an offsetting position is purchased, thus increasing the cost to a fund of buying those securities to cover the short position. The potential for greater losses may be incurred due to general market forces, such as a lack of securities available for short sellers to borrow for delivery, or increases in the price of a security sold short. A fund may lose more money than the actual cost

 

 

               75  


Principal Risks

(UNAUDITED)

 

of a short sale investment. Also, there is the risk that the third party to the short sale may fail to honor its contract terms, causing a loss to a fund.

Small-cap companies  |  Investments in small-cap companies generally involve greater risks than investing in large-capitalization companies. Companies with smaller market capitalizations generally have lower volume of shares traded daily, less liquid stock and more volatile stock prices. Companies with smaller market capitalizations also tend to have a limited product or service base and limited access to capital. Newer companies with unproven business strategies also tend to be smaller companies. The above factors increase risks and make these companies more likely to fail than companies with larger market capitalizations, and could increase the volatility of a fund’s portfolio and performance. Shareholders of a fund that invests in small-cap companies should expect that the value of the fund’s shares will be more volatile than a fund that invests exclusively in mid-cap or large-cap companies. Generally, the smaller the company size, the greater these risks.

U.S. Government securities and Government sponsored enterprises  |  A security backed by the U.S. Treasury or the full faith and credit of the United States is guaranteed by the applicable entity only as to the timely payment of interest and principal when held to maturity. The market prices for such securities are not guaranteed and will fluctuate. Investments in securities issued by Government sponsored enterprises are debt obligations issued by agencies and instrumentalities of the U.S. Government. These obligations vary in the level of support they receive from the U.S. Government. They may be: (1) supported by the full faith and credit of the U.S. Treasury, such as those of the Government National Mortgage Association; (2) supported by the right of the issuer to borrow from the U.S. Treasury, such as those of the Federal Home Loan Bank and the Federal Farm Credit Banks; (3) supported by the discretionary authority of the U.S. Government to purchase the agency obligations, such as those of the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation; or (4) supported only by the credit of the issuer, such as those of the Federal Farm Credit Bureau. The U.S. Government may choose not to provide financial support to U.S. Government sponsored agencies or instrumentalities if it is not legally obligated to do so. In such circumstances, if the issuer defaulted, a fund may not be able to recover its investment from the U.S. Government. Like all bonds, U.S. Government securities and Government-sponsored enterprise bonds are also subject to interest rate risk, credit risk and market risk. The rising U.S. national debt may lead to adverse impacts on the value of U.S. government securities due to potentially higher costs for the U.S. government to obtain new financing.

U.S. Treasury obligations  |  Securities issued or guaranteed by the U.S. Treasury are backed by the “full faith and credit” of the United States; however, the U.S. government guarantees the securities only as to the timely payment of interest and principal when held to maturity, and the market prices of such securities may fluctuate. The value of U.S. Treasury obligations may vary due to changes in interest rates. In addition, changes to the financial condition or credit rating of the U.S. government may cause the value of a fund’s investments in obligations issued by the U.S. Treasury to decline. Certain political events in the U.S., such as a prolonged government shutdown, may also cause investors to lose confidence in the U.S. government and may cause the value of U.S. Treasury obligations to decline. Because U.S. Treasury securities trade actively outside the United States, their prices may also rise and fall as changes in global economic conditions affect the demand for these securities. The total public debt of the U.S. as a percent of GDP has grown rapidly since the beginning of the recent financial and market volatility as a result of the coronavirus pandemic. Although high debt levels do not necessarily indicate or cause economic problems, they have the potential to create systemic risks if sound debt management practices are not implemented.

Valuation  |  Securities held by a fund may be priced by an independent pricing service and also may be priced using dealer quotes or fair valuation methodologies in accordance with valuation procedures adopted by the fund’s Board. The prices provided by the independent pricing service or dealers or the fair valuations may be different from the prices used by other mutual funds or from the prices at which securities are actually bought and sold. This risk may be pronounced for investments that may be illiquid or may become illiquid and for securities that trade in relatively thin markets and/or markets that experience extreme volatility.

Value stocks  |  Investments in value stocks are subject to the risk that their true worth may not be fully realized by the market or that their prices may decline. This may result in the value stocks’ prices remaining undervalued for extended periods of time. A fund’s performance also may be affected adversely if value stocks remain unpopular with or lose favor among investors. If a value investment style shifts out of favor based on market conditions and investor sentiment, a fund could underperform funds that use a non-value approach to investing or have a broader investment style.

 

 

76             


LOGO

Go Paperless with eDelivery
eDelivery is the most convenient, economical and environmentally-conscious way to receive information about your fund.
To enroll, please visit carillontower.com/eDelivery
Please consider the investment objectives, risks, charges and expenses of any fund carefully before investing. Call 800.421.4184 or your financial professional, or visit www.carillontower.com, for a prospectus, or summary prospectus, which contains this and other important information about the Carillon Family of Funds. Read the prospectus, or summary prospectus, carefully before you invest or send money.
This report is for the information of Shareholders of the Carillon Mutual Funds. If you wish to review additional information on the portfolio holdings of a fund, a complete schedule has been filed with the Securities and Exchange Commission (“Commission”) for the first and third quarters of each fund’s fiscal year end on Form N-PORT. These filings are available on the Commissions’s website at www.sec.gov and may be reviewed and copied at the Commission’s Public Reference Room in Washington, D.C. Information on the operations of the Public Reference Room may be obtained by calling 800.SEC.0330. A description of each fund’s proxy voting policies, procedures and information regarding how each fund voted proxies relating to portfolio securities for the most recent 12-month period ending June 30th of that year, is available without charge, upon request, by calling the Carillon Family of Funds, toll-free at the number above, by accessing our website at carillontower.com or by accessing the Commission’s website at www.sec.gov.
880 Carillon Parkway | St. Petersburg, FL 33716 | 800.421.4184 | carillontower.com
Carillon Fund Distributors, Inc. , Member FINRA


(b) Not applicable.

Item 2. Code of Ethics

Not applicable to semi-annual reports.

Item 3. Audit Committee Financial Expert

Not applicable to semi-annual reports.

Item 4. Principal Accountant Fees and Services

Not applicable to semi-annual reports.

Item 5. Audit Committee of Listed Registrants

Not applicable to the Trust.

Item 6. Schedule of Investments

Included as part of report to shareholders under Item 1.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies

Not applicable to the Trust.

Item 8. Portfolio Managers of Closed-End Management Investment Companies

Not applicable to the Trust.

Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers

Not applicable to the Trust.

Item 10. Submission of Matters to a Vote of Security Holders.

There have been no material changes to the Trust’s Nominating Committee Charter, which sets forth procedures by which shareholders may recommend nominees to the Trust’s Board of Trustees, since the Trust last provided disclosure in response to this item.

Item 11. Controls and Procedures

 

(a)

The Trust’s Principal Executive Officer and Principal Financial Officer evaluated the Trust’s disclosure controls and procedures within 90 days of this filing and have concluded that the Trust’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) are appropriately designed to ensure that information required to be disclosed by


  the Trust in the reports that it files on Form N-CSR (a) is recorded, processed, summarized and reported, within the time periods specified in the rules and forms adopted by the U.S. Securities and Exchange Commission; and (b) is accumulated and communicated to the Registrant’s management, including its principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

 

(b)

There was no change in the internal controls over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) of the Trust that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

 

Item 12.

Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable to the Trust.

 

Item 13.

Exhibits

 

(a)(1)

Not applicable to semi-annual reports.

 

(a)(2)

The certifications required by Rule 30a-2(a) of the Investment Company Act are filed and attached hereto as Exhibit 99.CERT.

 

(a)(3)

Not applicable to the Trust.

 

(a)(4)

Not applicable to the Trust.

 

(b)

The certification required by Rule 30a-2(b) of the Investment Company Act and Section 1350 of Chapter 63 of Title 18 of the United States Code is filed and attached hereto as Exhibit 99.1350CERT.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Trust has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

      CARILLON SERIES TRUST
Date: June 22, 2022      
     

/s/ Susan L. Walzer

      Susan L. Walzer
      Principal Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the Trust and in the capacities and on the dates indicated.

 

      CARILLON SERIES TRUST
Date: June 22, 2022      

/s/ Susan L. Walzer

      Susan L. Walzer
      Principal Executive Officer
Date: June 22, 2022      

/s/ Carolyn Gill

      Carolyn Gill
      Principal Financial Officer

CERTIFICATIONS

CARILLON SERIES TRUST

FORM N-CSR

Exhibit 99.CERT

CERTIFICATION

I, Susan L. Walzer, certify that:

1. I have reviewed this report on Form N-CSR of Carillon Series Trust;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and


(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: June 22, 2022

 

/s/ Susan L. Walzer

Susan L. Walzer
Principal Executive Officer


CERTIFICATION

I, Carolyn Gill, certify that:

1. I have reviewed this report on Form N-CSR of Carillon Series Trust;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and


(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: June 22, 2022

 

/s/ Carolyn Gill

Carolyn Gill
Principal Financial Officer

906 CERTIFICATIONS

CARILLON SERIES TRUST

FORM N-CSR

Exhibit 99.1350CERT

SECTION 1350 CERTIFICATION

Pursuant to 18 U.S.C § 1350, each of the undersigned officers of Carillon Series Trust (the “Trust”), hereby certifies, to the best of such officer’s knowledge, that the Trust’s report on Form N-CSR for the period ended April 30, 2022 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust as of, and for, the periods presented in the Report.

Date: June 22, 2022

 

/s/ Susan L. Walzer

Susan L. Walzer
Principal Executive Officer

/s/ Carolyn Gill

Carolyn Gill
Principal Financial Officer

This certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required by 18 U.S.C. § 1350 has been provided to the Trust and will be retained and furnished to the U.S. Securities and Exchange Commission or its staff upon request.